0001517126-15-000047.txt : 20150313 0001517126-15-000047.hdr.sgml : 20150313 20150313172724 ACCESSION NUMBER: 0001517126-15-000047 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20141130 FILED AS OF DATE: 20150313 DATE AS OF CHANGE: 20150313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gala Global Inc. CENTRAL INDEX KEY: 0001513403 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 421771014 STATE OF INCORPORATION: NV FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-172744 FILM NUMBER: 15700401 BUSINESS ADDRESS: STREET 1: 2780 SOUTH JONES BLVD., #3725 CITY: LAS VEGAS, NEVADA STATE: X1 ZIP: 89146 BUSINESS PHONE: (702) 900-6074 MAIL ADDRESS: STREET 1: 2780 SOUTH JONES BLVD., #3725 CITY: LAS VEGAS, NEVADA STATE: X1 ZIP: 89146 10-K 1 form10k.htm FORM 10-K Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - Gala Global Inc. - Form 10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

þ  ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended November 30, 2014

 

o TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE EXCHANGE ACT

 

For the transition period from _________ to _________

 

Commission File Number: 000-52044

 

GALA GLOBAL INC.

(Name of Small Business Issuer in its charter)

 

Nevada

42-1771014

(state or other jurisdiction of incorporation or organization)

(I.R.S. Employer I.D. No.)


2780 South Jones Blvd. #3725

Las Vegas, Nevada 89146

(Address of principal executive offices)

 

(775) 321-8238

Issuer’s telephone number


Securities registered under Section 12(b) of the Exchange Act: None


Securities registered under Section 12(g) of the Exchange Act: Common Stock, $0.001 par value


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes o    No þ


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes o     No þ


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ    No o


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definition of large accelerated filer and accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.  (Check one):


Large accelerated filer o            Accelerated filer o         Non-accelerated filer o        Smaller reporting company þ


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act)  Yes o    No þ


Aggregate market value of the voting and non-voting stock of the registrant held by non-affiliates of the registrant as of the last business day of the registrants most recently completed fiscal quarter:  $5,299,200


As of March 11, 2015 the registrant’s outstanding stock consisted of 123,140,000 common shares.

 

 

                
             


GALA GLOBAL INC.


Table of Content

PART I

 

 

 

Item 1.     Description of Business

3

Item 1A.  Risk Factors

4

Item 1B.  Unresolved Staff Comments

4

Item 2.     Description of Property

4

Item 3.     Legal Proceedings

4

Item 4.     Mine Safety Disclosures

4

 

 

PART II

 

 

 

Item 5.     Market for Common Equity, Related Stockholder Matters and Small Business Issuer Purchases of Equity Securities

5

Item 6.     Selected Financial Data

6

Item 7.     Management’s Discussion and Analysis of Financial Condition and Results of Operation

6

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk

9

Item 8.     Financial Statements and Supplementary Data

10

Item 9.    Changes in and Disagreements With Accountants on Accounting and Financial Disclosure                                      

11

Item 9A.  Controls and Procedures

11

Item 9B.  Other Information

11

 

 

PART III

 

 

 

Item 10.   Directors, Executive Officers and Corporate Governance

12

Item 11.   Executive Compensation

13

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters                    

15

Item 13.   Certain Relationships, Related Transactions and Director Independence

15

Item 14.    Principal Accountant Fees and Services

16

Item 15.    Exhibits and Financial Statement Schedules

17

Signatures

17




2              

             



PART I


Item 1.  Description of Business


General


GALA Global Inc. (“the Company”, “we”, “us” or “our”) was incorporated in the State of Nevada on March 15, 2010 (Inception). The Company was formed to provide garment tailoring and alteration services. 

On May 19, 2014, a change in control of the Company occurred when IDG Ventures Ltd., the Company’s then controlling shareholder, sold all of its 3,547,000 shares of the Company’s common stock, representing 60.04% of our issued and outstanding common shares, in a private share purchase transaction to Messrs. Haas, Lefevre and Naccarato.

On June 26, 2014, the Company had a change in management when Mr. Robert Frei resigned as President and Director of the Company and Mr. Lefevre was appointed as his successor. Concurrent with the change of management, the Company acquired two 100% owned subsidiary companies, Cannabis Ventures Inc (USA), incorporated on February 27, 2014 in the state of Nevada and Cannabis Ventures Inc. (Canada), incorporated on April 9, 2014 in Vancouver, British Columbia. Neither of these subsidiary companies had traded prior to their acquisition by the Company other than as described below.

GALA Global, Inc. is currently distributing all-natural everyday custom tailored women's clothing products from England. The Company is exploring different hemp alternatives of fabric and materials needed to produce our all new custom designed apparel.  Our new products are scheduled for launch in the latter part of 2015.

GALA Global, Inc., since its change in management effective June 26, 2014, has expanded into the Hemp and Cannabidiol (“CBD”) industry. The expansion is focusing on the development, research, and commercialization of products derived from the Hemp and Cannabis Plant. GALA Global, Inc. currently markets a new CBD flavored Thin-film strip. The film strip delivery system uses a dissolving film strip that is absorbed in the mouth. The film-strip method is an advanced method of providing CBD for dietary supplement. GALA also is seeking acquisition candidates in this area of interest in the nutraceutical and pharmaceutical industries.The Company also plans to enter into the medical marijuana cultivation industry as approved in the United States and Canada to build legalized cultivation operations

GALA Global, Inc.’s services include the development of cannabinoid based health and wellness products; the development of medical grade compounds; the licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry.

  3            

             

 

Cannabis Ventures Inc. (USA) (“CVI”)

In September 2014, CVI entered into a promissory note agreement with Globe Farmacy, Inc., an Arizona non-profit corporation (“GFI”), to finance a potential cultivation project. CVI has advanced funds of $189,972 to GFI under the promissory note, which is unsecured, bears interest at 5% per annum, and was due on December 31, 2014. As GFI was delinquent in performing certain obligations under the terms of the promissory note and our ability to recover this advance is currently uncertain, we have a provided in full against the value of this promissory note and recognized an impairment expense of $189,972 effective December 31, 2014.   

Cannabis Ventures, Inc. (Canada) (“CVI (Canada)”)

In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI (Canada).

In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) in February 6, 2015. We responded on February 26, 2015 and Health Canada acknowledged receipt on February 27, 2015.    

The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada. During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been recognized in our statement of operations.

The Contract had been extended on a month to month basis and as of February 2015, the Company continues to pay the property owner a reduced nonrefundable payment of $2,500 a month while it awaits the determination from Health Canada. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.


Trademark


We do not have a trademark registered at this time.  At present, we have not established a valuable brand which requires protection.  We may register a trademark in the next 12 months when we feel that our brand is able beginning to gain value and recognition.  


Government Regulation


To comply with U.K. laws, in order to do business in the U.K., since we are a Nevada corporation, we will have to register as an overseas company at the Companies House in Britain within one month from the beginning of trade.  Companies House is the United Kingdom Registrar of Companies.  All forms of companies are incorporated and registered with Companies House as required by the current Companies Act 2006.  All registered limited companies, including subsidiary, small and inactive companies, must file annual financial statements, in addition to annual company returns, which are all public records.  All forms of companies as permitted by United Kingdom Companies Act are incorporated and registered with Companies House.  We are not required to be registered as an overseas company in London until we start to execute business transactions with our U.K. customers and start to earn revenue.

 

We do not believe that government regulations will have a material impact on the way we conduct business.

  4             

             

Research and Development

We have not spent any amounts on research and development activities during the years ended November 30, 2014 or 2013. We anticipate that we will not incur any expenses on research and development over the next 12 months. Our planned expenditures on our operations or a business combination are summarized under the section of this annual report entitled “Management’s Discussion and Analysis of Financial Position and Results of Operations”.


Employees and Employment Agreements


At present, we have no employees other than our sole officer and director who devotes approximately 20-30 hours a week to our business. We presently do not have pension, health, annuity, insurance, stock options, profit sharing or similar benefit plans; however, we may adopt such plans in the future. There are presently no personal benefits available to any officers, directors or employees.


Item 1A.  Risk Factors

 

Not applicable to smaller reporting companies.


Item 1A.  Unresolved Staff Comments


 Not applicable to smaller reporting companies.


Item 2.  Description of Property


We do not currently own any property or real estate of any kind. Our mailing address located at 2780 South Jones Blvd. #3725, Las Vegas, Nevada 89146.We currently do not maintain an office at this time and have no need of a dedicated office at this stage of our business plan.

 

Item 3.  Legal Proceedings


We are currently unaware of any legal matters pending or threatened against us.


Item 4.  Mine Safety Disclosures

 

Not applicable to our Company.

 

  5             

             


PART II


Item 5.  Market for Common Equity, Related Stockholder Matters and Small Business Issuer Purchases of Equity Securities

 

Market Information


Our shares of common stock are listed on the Over the Counter Bulletin Board under the symbol GALA.  Set forth below are high and low bid prices for our common stock for each quarterly period in the two most recent fiscal years.  Such quotations reflect inter-dealer prices, without retail mark-up, markdown or commissions and may not necessarily represent actual transactions in the common stock.  

 

Period

High

Low

Fiscal 2014

 

 

First Quarter ended February 28, 2014

$3.50

$3,50

Second Quarter ended May 31, 2014

$3.50

$3.50

Third Quarter ended August 31, 2014

$3.50

$1.97

Fourth Quarter ended November 30, 2014

$3.00

$0.06

 

 

 

Fiscal 2013

 

 

First Quarter ended February 28, 2013

$3.50

     $3.50

Second Quarter ended May 31, 2013

$3.50

$3.50

Third Quarter ended August 31, 2013

$3.50

$3.50

Fourth Quarter ended November 30, 2013

$3.50

$3.50


Number of Holders


As of November 30, 2014, the 119,140,000 issued and outstanding shares of common stock were held by a total of 46 shareholders of record.


Dividends

 

No cash dividends were paid on our shares of common stock during the fiscal years ended November 30, 2014 and 2013. We have not paid any cash dividends since our inception and do not foresee declaring any dividends on our common stock in the foreseeable future.


Recent Sales of Unregistered Securities


On September 2, 2014, the Company sold 1,000,000 shares of common stock pursuant to a stock purchase agreement valued at $0.10 per share for gross proceeds of $100,000.


Purchase of our Equity Securities by Officers and Directors


None.


Other Stockholder Matters


None



  6             

             


Item 6.  Selected Financial Data

 

Not applicable to smaller reporting companies.


Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations


You should read the following discussion and analysis in conjunction with our financial statements, including the notes thereto, included in this Report.  Some of the information contained in this Report may contain forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended (the “Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  This information may involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements.  Forward-looking statements which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by the use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology.  These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that the projections included in these forward-looking statements will come to pass.  Our actual results could differ materially from those expressed or implied by the forward looking statements as a result of various factors.  We undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.


Our auditors’ reports contain a statement that our net loss and limited working capital raise substantial doubt about our ability to continue as a going concern. Our independent registered public accountants have stated in their report (included in Item 8. Financial Statements) that our significant operating losses and working capital deficit raise substantial doubt about our ability to continue as a going concern. We incurred net losses of $278,875 and $35,990, respectively, for the fiscal years ended November 30, 2014 and November 30, 2013. We will be required to raise substantial capital to fund our capital expenditures, working capital, and other cash requirements since our current cash assets are exhausted and we have generated no revenues to date to sustain our operations. We will need to seek other financing to complete our business plans. The successful outcome of future financing activities cannot be determined at this time and there are no assurances that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operational results.


In addition to our current deficit, we expect to incur additional losses during the foreseeable future.  Until we are able to successfully execute our business plan. Consequently, we will require substantial additional capital to continue our development and marketing activities. There is no assurance that we will be able to obtain additional financing through private placements and/or public offerings necessary to support our working capital requirements. To the extent that funds generated from any private placements and/or public offerings are insufficient, we will have to raise additional working capital through other sources, such as bank loans and/or financings. No assurance can be given that additional financing will be available, or if available, will be on acceptable terms.


We are incurring increased costs as a result of being a publicly-traded company. As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act of 2002, as well as new rules subsequently implemented by the Securities and Exchange Commission, have required changes in corporate governance practices of public companies. These new rules and regulations have increased our legal and financial compliance costs and have made some activities more time-consuming and costly. For example, as a result of becoming a public company, we have created additional board committees and have adopted policies regarding internal controls and disclosure controls and procedures. In addition, we have incurred additional costs associated with our public company reporting requirements. In addition, these new rules and regulations have made it more difficult and more expensive for us to obtain director and officer liability insurance, which we currently cannot afford to do. As a result of the new rules, it may become more difficult for us to attract and retain qualified persons to serve on our Board of Directors or as executive officers. We cannot predict or estimate the amount of additional costs we may incur as a result of being a public company or the timing of such costs.


 

  7             

             

 

RESULTS OF OPERATIONS


Operating Revenues


During the fiscal years ended November 30, 2014 and 2013, the Company did not recognize any revenue.


Operating Expenses


Operating expenses for the year ended November 30, 2014 were $88,903 compared with $35,990 for the year ended November 30, 2013. A summary of the operating expenses are as follows:  


Analysis of Operating Expenses


 

November 30,

November 30,

Variance

Operating Expense

2014

2013

$

%

 

 

 

 

 

Depreciation

$     -

$   475

$  (475)

(100.0)%

Land Purchase Option

$28,000

$     -

$28,000

100%

Management Fees

$6,000

$7,000

$(1,000)

(14.3)%

Professional Fees

$25,054

$6,500

$18,554

285.4%

Overhead and Administration

$23,905

$19,908

$3,997

20.1%

Transfer Agent and Filing Fees

$5,944

$2,107

$3,837

182.1%

 

 

 

 

 

 

$88,903

$35,990

$52,913

147.0%


Overall, the increase in operating expenses were due to payments of $28,000 for the a nonrefundable payment of $4,000 a month in respect of our proposed purchase of property in Canada and an increase in professional fees of $18,554 relating to the Company’s accounting, audit, and legal fees that were incurred as part of the SEC filing process. Additionally, the Company saw minor increases of $3,997 in overhead and administration expense due to an increase in the day-to-day activities in the Company, and $3,836 in transfer agent and filing fees relating to costs incurred with respect to the private placement that was issued during the year. The Company has fully amortized its property and equipment, which lead to the overall decrease in depreciation expense.  


Impairment of Loan Receivable


During the year ended November 30, 2014 we recognized an impairment expense of $189,972 (2013 - $0) in respect of funds we had advanced under a promissory note to Global Farmacy, Inc (“GFI”).


In September 2014, CVI entered into a promissory note agreement with GFI, an Arizona non-profit corporation, to finance a potential cultivation project. CVI has advanced funds of $189,972 to GFI under a promissory note which is unsecured, bears interest at 5% per annum and was due on December 31, 2014. As GFI was delinquent in performing certain obligations under the terms of the promissory note and our ability to recover this advance is currently uncertain, we have a provided in full against the value of this promissory note and recognized an impairment expense of $189,972 effective December 31, 2014.   


Net Loss


Net loss for the year ended November 30, 2014 was $278,875 or $(0.00) loss per share compared with a net loss of $35,990 and $(0.00) loss per share for the year ended November 30, 2013 due to the factors discussed above.   


  8             

             

 

Liquidity and Capital Resources


As of November 30, 2014, the Company has no revenue or other source of income, has a working capital deficit of $192,673, and an accumulated deficit of $387,071. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, its ability to obtain the necessary debt or equity financing, and generate profitable operations from the Company’s planned future operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.  


Working Capital


 

November 30,

2014

$

November 30,

2013

$

Current Assets

-

104

Current Liabilities

192,673

37,200

Working Capital (Deficit)

(192,673)

(37,096)


As at November 30, 2014, the Company had current assets of $nil and current liabilities of $192,673 compared with current assets of $104 and current liabilities of $37,200 at November 30, 2013. The increase in the working capital deficit was largely attributable to an increase in amounts due to related parties of $146,337 for amounts paid on behalf of the Company for operating expenditures and advanced to GFI under a promissory note receivable.


Cash Flows


 

Year ended

November 30,

2014

$

Year ended

November 30,

2013

$

Cash Flows from (used in) Operating Activities

(89,767)

(24,800)

Cash Flows from (used in) Investing Activities

(189,972)

-

Cash Flows from (used in) Financing Activities

279,635

-

Net Increase (decrease) in Cash During Period

(104)

(24,800)




Cashflow from Operating Activities


During the year ended November 30, 2014, the Company used $89,767 of cash for operating activities compared to the use of $24,800 of cash for operating activities during the year ended November 30, 2013. The increase in cash used for operating activities was mainly due to an increase in overall operating expenditures during the year.  


  9             

             


Cashflow from Investing Activities


During the year ended November 31, 2014 the Company used $189,972 of cash for investing activities compared to $nil for the year ended November 31, 2013. The increase in the cash used for investing activities was due to funds advanced by the Company under a promissory note receivable to GFI.  



Cashflow from Financing Activities


During the year ended November 30, 2014, $279,635 was provided by financing activities compared to $nil provided during the year ended November 30, 2013. Proceeds received include $184,635 provided by related parties and $100,000 provided from the sale of common shares. offset by a $5,000 repayment to a related party. The Company required the increased financing in the year ended November 31, 2014 to finance the operating expenses described above and the funds advanced by the Company under a promissory note receivable to GFI.  


Off-Balance Sheet Arrangements


We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.


Other events


On May 19, 2014, a change in control of Gala Global Inc. (the "Company") occurred when IDG Ventures Ltd. (“IDG”), the Company’s then controlling shareholder, sold all of its 70,940,000 (post-split) common shares in a private share purchase transaction to the three individuals listed below.  The consideration paid was $125,000 in cash.  The three individuals now have voting control over 60.99% in the aggregate of the Company’s issued and outstanding common stock.



Purchasers                              Share position                         Percentage of outstanding


James Haas

35,470,000 shares                                        30.02%

George Lefevre                        17,735,000 shares                                        15.01%

Owen Naccarato                      18,855,000 shares                                        15.96%


Cannabis Ventures Inc. (USA) (“CVI”)

In September 2014, CVI entered into a promissory note agreement with Globe Farmacy, Inc., an Arizona non-profit corporation (“GFI”), to finance a potential cultivation project. CVI has advanced funds of $189,972 to GFI under the promissory note, which is unsecured, bears interest at 5% per annum, and was due on December 31, 2014. As GFI was delinquent in performing certain obligations under the terms of the promissory note and our ability to recover this advance is currently uncertain, we have a provided in full against the value of this promissory note and recognized an impairment expense of $189,972 effective December 31, 2014.   

Cannabis Ventures, Inc. (Canada) (“CVI (Canada)”)

In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI (Canada).

In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) in February 6, 2015. We responded on February 26, 2015 and Health Canada acknowledged receipt on February 27, 2015.    

The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada. During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been recognized in our statement of operations.

The Contract had been extended on a month to month basis and as of February 2015, the Company continues to pay the property owner a reduced nonrefundable payment of $2,500 a month while it awaits the determination from Health Canada. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.

 10             

             

Subsequent Events


a)

On December 2, 2014, the Company entered into a marketing agreement for advertising services. The Company has agreed to issue 1,500,000 shares of common stock to the consultant as compensation for a six-month term. The agreement may be terminated by either party at the end of any month during the term of the agreement.

b)

On December 16, 2014, the Company entered into a consulting agreement with a consultant who is to become a director of the Company. The Company has agreed to issue 500,000 shares of common stock to the consultant as compensation. The agreement commences upon the date of the agreement, and continues until the Consultant resigns or upon mutual agreement with the Company to terminate such agreement.

c)

On January 9, 2015, the Company and its board of directors authorized a new class of equity instruments – Series A Preferred Stock, subject to authorized capital of 500,000 shares with a par value of $0.001 per share.  As of the date of filing, no Series A Preferred Stock have been issued.   


Going Concern


We have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive activities. For these reasons, our auditors stated in their report on our audited financial statements that they have substantial doubt that we will be able to continue as a going concern without further financing.


Future Financings


We will continue to rely on equity sales of our common shares in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund planned acquisitions and activities.


Critical Accounting Policies


Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.


We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in note (1) of the notes to our financial statements. In general, management's estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.


Use of Estimates


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes for the reporting period. Significant areas requiring the use of management estimates relate to the valuation of its mineral leases and claims and our ability to obtain final government permission to complete the project.


Stock-Based Compensation


The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.


Recently Issued Accounting Pronouncements


We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company other than those relating to Development Stage Entities as discussed below in our financial statements

Contractual Obligations


We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.


ITEM 7A.  Quantitative and Qualitative Disclosures about Market Risk


Not applicable to smaller reporting companies.


 

  11             

             




Item 8.  Financial Statements




 

GALA GLOBAL INC.


Consolidated Financial Statements


For the Years Ended November 30, 2014 and November 30, 2013


(Expressed in U.S. dollars)




Report of Independent Registered Public Accounting Firm F-1

Balance Sheets

F-2

Statement of Operations

F-3

Statements of Cash Flows

F-4

Statements of Changes in Stockholder’s Deficit

F-5

Notes to the Financial Statements

F-6

 

  12             

             

 

[form10k001.jpg]


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors

Gala Global, Inc.

Las Vegas, Nevada, 89146


We have audited the accompanying balance sheets of Gala Global, Inc. as of November 30, 2014 and 2013 and the related statement of operations, changes in stockholders' equity (deficit) and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Gala Global, Inc. as of November 30, 2014 and 2013, and the results of its operations, changes in stockholders’ equity (deficit) and cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

 The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements the Company has suffered losses and negative cash flow from operations which raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

 

 

 

 Wheat Ridge, formerly Arvada, Colorado

 [form10k002.jpg]

March 13,  2015

Cutler & Co., LLC


[form10k003.jpg]



 F-1          

             



GALA GLOBAL INC.

Consolidated Balance Sheets

(Expressed in U.S. dollars)


 

November 30,

2014

$

 November 30,

 2013

 $

 

 

 

ASSETS

 

 

 

 

 

Current Assets

 

 

Cash

104

       Total Current Assets

-

104

 

 

 

Total Assets

104

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable and accrued liabilities

8,038

8,902

Due to related parties

174,635

28,298

Loan payable to related party

10,000

-

      Total Current Liabilities

192,673

37,200

 

 

 

Total Liabilities


COMMITMENTS AND CONTINGENCIES

192,673

37,200

STOCKHOLDERS’ DEFICIT

 

 

Preferred Stock

Authorized: 10,000,000 preferred shares with a par value of $0.001 per share

Issued and outstanding: none

 

 

Common Stock

Authorized: 500,000,000 common shares with a par value of $0.001 per share

 

 

Issued and outstanding: 119,140,000 and 118,140,000 common shares, respectively

119,140

118,140

 

 

 

Additional Paid-In Capital

75,258

(47,040)

 

 

 

Accumulated Deficit

(387,071)

(108,196)

 

 

 

Total Stockholders’ Deficit

(192,673)

(37,096)

 

 

 

 

 

 

Total Liabilities and Stockholders’ Deficit

104

 

 

 


(The accompanying notes are an integral part of these financial statements)


 F-2            

             




GALA GLOBAL INC.

Consolidated Statements of Operations

(Expressed in U.S. dollars)


 

Year Ended

November 30,

2014

$

Year Ended

November 30,

2013

$

 



Revenues

      

 -–

 

 

 

Operating Expenses

 

 

Depreciation

475

General and administrative

54,903

35,515

Management fees

6,000

Option expense on proposed property acquisition – related party

28,000

 

 

 

Total Operating Expenses

88,903

35,990

 

 

 

 

 

 

Operating Loss

(88,903)

(35,990)

 

 

 

Other Income (Expense)

 

 

 

 

 

Impairment of loan receivable

(189,972)

Loss before taxes

(278,875)

(35,990)

Provision for income taxes

 

 

 

 

 

 

Net Loss

(278,875)

(35,990)


Net Loss per Share – Basic and Diluted


(0.00)*


(0.00)*


Weighted Average Shares Outstanding – Basic and Diluted

118,386,575

118,140,000

 

 

 


‘* denotes a loss of less than $(0.01) per share.


(The accompanying notes are an integral part of these financial statements)


 F-3            

             



GALA GLOBAL INC.

Statements of Changes in Stockholders’ Deficit

From December 1, 2012 to November 30, 2014

(Expressed in U.S. dollars)


 

Common Stock

 

Additional

Paid-In

 


Accumulated

 

 

 

Shares

 

Par Value

 

Capital

 

Deficit

 

Total

 

#

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

Balance – November30, 2012

118,140,000

 

118,140

 

(47,040)

 

(72,206)

 

(1,106)

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

 

 

(35,990)

 

(35,990)

 

 

 

 

 

 

 

 

 

 

Balance – November 30, 2013

118,140,000

 

118,140

 

(47,040)

 

(108,196)

 

(37,096)

 

 

 

 

 

 

 

 

 

 

Forgiveness of related party debt

 

 

23,298

 

 

23,298

 

 

 

 

 

 

 

 

 

 

Proceeds from sale of common stock

1,000,000

 

1,000

 

99,000

 

 

100,000

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

 

 

(278,875)

 

(278,875)

 

 

 

 

 

 

 

 

 

 

Balance – November 30, 2014

119,140,000

 

119,140

 

75,258

 

(387,071)

 

(192,673)

 

 

 

 

 

 

 

 

 

 


The Company completed a forward split of stock 20:1 on September 17, 2014 that has been retroactively reflected in these financial statements.


 

(The accompanying notes are an integral part of these financial statements)


 F-4            

             


GALA GLOBAL INC.

Consolidated Statements of Cash Flows

(Expressed in U.S. dollars)


 

Year Ended  November 30,

2014

$

Year Ended  November 30,

2013

$

 

 

 

Operating Activities

 

 

 

 

 

Net loss for the year

(278,875)

(35,990)

 

 

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation

 -–

 475

Impairment of promissory note receivable

 189,972

 –

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts payable and accrued liabilities

(864)

3,991

Due to related party

6,724

 

 

 

Net Cash Used In Operating Activities

(89,767)

(24,800)

 

 

 

Investing Activities

 

 

 

 

 

Loan receivable

 (189,972)

 –

 

 

 

Net Cash Used In Investing Activities

 (189,972)

 –

 

 

 

Financing Activities

 

 

 

 

 

Proceeds from related party

 174,635

 –

Proceeds from loan payable - related party

 10,000

 –

Repayment of due to related party

 (5,000)

 –

Proceeds from issuance of common stock

 100,000

 –

 

 

 

Net Cash Provided By Financing Activities

279,635

 

 

 

Decrease in Cash

(104)

(24,800)

 

 

 

Cash – Beginning of Period

104

24,904

 

 

 

Cash – End of Period

104

 

 

 

Non-cash Investing and Financing Activities

 

 

 

 

 

Forgiveness of related party debt

23,298

 

 

 

Supplemental Disclosures

 

 

 

 

 

Interest paid

Income tax paid

 

 


(The accompanying notes are an integral part of these financial statements)


 F-5            

             


GALA GLOBAL INC.

Notes to the Consolidated Financial Statements

For the twelve months ended November 30, 2014 and 2013

(Expressed in U.S. dollars)



 

1.

Organization and Nature of Operation

GALA Global Inc. (“the Company”, “we”, “us” or “our”) was incorporated in the State of Nevada on March 15, 2010 (Inception). The Company was formed to provide garment tailoring and alteration services. 

On May 19, 2014, a change in control of the Company occurred when IDG Ventures Ltd., the Company’s then controlling shareholder, sold all of its 3,547,000 shares of the Company’s common stock, representing 60.04% of our issued and outstanding common shares, in a private share purchase transaction to Messrs. Haas, Lefevre and Naccarato.

On June 26, 2014, the Company had a change in management when Mr. Robert Frei resigned as President and Director of the Company and Mr. Lefevre was appointed as his successor. Concurrent with the change of management, the Company acquired two 100% owned subsidiary companies, Cannabis Ventures Inc (USA), incorporated on February 27, 2014 in the state of Nevada and Cannabis Ventures Inc. (Canada), incorporated on April 9, 2014 in Vancouver, British Columbia. Neither of these subsidiary companies had traded prior to their acquisition by the Company other than as described below.

GALA Global, Inc. is currently distributing all-natural everyday custom tailored women's clothing products from England. The Company is exploring different hemp alternatives of fabric and materials needed to produce our all new custom designed apparel.  Our new products are scheduled for launch in the latter part of 2015.

GALA Global, Inc., since its change in management effective June 26, 2014, has expanded into the Hemp and Cannabidiol (“CBD”) industry. The expansion is focusing on the development, research, and commercialization of products derived from the Hemp and Cannabis Plant. GALA Global, Inc. currently markets a new CBD flavored Thin-film strip. The film strip delivery system uses a dissolving film strip that is absorbed in the mouth. The film-strip method is an advanced method of providing CBD for dietary supplement. GALA also is seeking acquisition candidates in this area of interest in the nutraceutical and pharmaceutical industries.The Company also plans to enter into the medical marijuana cultivation industry as approved in the United States and Canada to build legalized cultivation operations

GALA Global, Inc.’s services include the development of cannabinoid based health and wellness products; the development of medical grade compounds; the licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry.

Cannabis Ventures Inc. (USA) (“CVI”)

In September 2014, CVI entered into a promissory note agreement with Globe Farmacy, Inc., an Arizona non-profit corporation (“GFI”), to finance a potential cultivation project. CVI has advanced funds of $189,972 to GFI under the promissory note, which is unsecured, bears interest at 5% per annum, and was due on December 31, 2014. As GFI was delinquent in performing certain obligations under the terms of the promissory note and our ability to recover this advance is currently uncertain, we have a provided in full against the value of this promissory note and recognized an impairment expense of $189,972 effective December 31, 2014.   

Cannabis Ventures, Inc. (Canada) (“CVI (Canada)”)

In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI (Canada).

In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) in February 6, 2015. We responded on February 26, 2015 and Health Canada acknowledged receipt on February 27, 2015.    

The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada. During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been recognized in our statement of operations.

The Contract had been extended on a month to month basis and as of February 2015, the Company continues to pay the property owner a reduced nonrefundable payment of $2,500 a month while it awaits the determination from Health Canada. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.

 F-6            

             

 

2.    Going Concern

These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at November 30, 2014, the Company has not earned any revenue, has a working capital deficit of $192,673, and an accumulated deficit of $387,071. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to successfully implement its business plan and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.  

 

3.

Summary of Significant Accounting Policies

a)

Basis of Presentation

The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is November

b)

Principles of Consolidation

These consolidated financial statements include the accounts of the Company and its two wholly owned subsidiaries, Nevada incorporated Cannabis Ventures Inc. (USA) and Vancouver, British Columbia incorporated Cannabis Ventures Inc. (Canada), from the date of their acquisition by the Company effective June 26, 2014. All inter-company transactions and balances have been eliminated on consolidation.

c)

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and investments, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

d)

Cash and Cash Equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As of November 30, 2014 and 2013, there were no cash equivalents.

e)

Development Stage Company

The Company is a development stage company as defined by section 915-10-20 of the FASB Accounting Standards Codification and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders’ deficit and cash flows disclosed activity since the date of its inception (March 15, 2010) as a development stage company. The Company has generated no revenue since inception (March 15, 2010) and is still devoting substantially all of its efforts on establishing the business.  All losses accumulated since Inception (March 15, 2010) have been considered as part of the Company’s development stage activities.  Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required for annual reporting periods beginning after December 15, 2014 with the option for entities to early adopt these new provisions. The Company has elected to early adopt these provisions and consequently these additional disclosures are not included in these financial statements. 


 F-7            

             

3.

Summary of Significant Accounting Policies (continued)

f)

Financial Instruments

Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, and amounts due to related party. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

g)

Long-Lived Assets

In accordance with ASC 360, “Property Plant and Equipment”, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.

h)

Income Taxes

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

i)

Revenue Recognition

Revenue will be recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is assured.  The Company is not exposed to any credit risks as amounts are prepaid prior to performance of services.  

 

 F-8            

             

3.

Summary of Significant Accounting Policies (continued)

j)

Advertising Costs

The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $nil during the years ended November 30, 2014 and 2013.

k)

Stock-based Compensation

The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.  As at November 30, 2014 and 2013, the Company did not grant any stock options.  

l)

Comprehensive Loss

ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at November 30, 2014 and 2013, the Company has no items representing comprehensive income or loss.

m)

Basic and Diluted Net Loss per Share

The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at November 30, 2014 and 2013, the Company has no potentially dilutive common shares.  

n)

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

4.

Related Party Transactions

a)

During the year ended November 30, 2014, the Company incurred $6,000 (2013 - $nil) in management fees to the former President and Director of the Company.

During the year ended November 30, 2014, the former President and Director of the Company forgave all amounts outstanding totaling $23,298 which was recorded in additional paid-in capital. As at November 30, 2014, the Company owed $nil (November 30, 2013 - $28,298) to the former President and Director of the Company. The amounts owing were unsecured, non-interest bearing, and due on demand.

 

 F-9          

             

4.

Related Party Transactions (continued)

b)

During the year ended November 30, 2014, the Company received advances of $174,635 (2013 - $nil) from a shareholder of the Company to fund payment of operating expenditures and advanced to GFI under a promissory note receivebale. The amounts owing are unsecured, non-interest bearing, and due on demand.

c)

During the year ended November 30, 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.

During the year ended November 30, 2014, the Company incurred option expenses of $28,000 (2013 - $nil) under the term of a contract to purchase property in Vancouver, Canada to a director of CVI.

5.

Promissory Note Receivable

On September 30, 2014, Cannabis Ventures Inc. (USA), a wholly-owned subsidiary of the Company entered into a promissory note agreement with Anthony McDonald (“McDonald”) and Globe Farmacy Inc. (“GFI”), an Arizona non-profit corporation, for $189,972.

The amounts owing are unsecured, bears interest at 5% per annum, and is due on December 31, 2014.  As of November 30, 2014, the amount receivable was deemed to be uncollectible and a full impairment charge on the loan receivable has been made by the

Company. 
      

6.

Loan Payable - Related Party

On March 20, 2014, the Company issued a $10,000 promissory note to a shareholder of the Company.  Under the terms of the note, the amount is unsecured, non-interest bearing, and due on demand.  

 

7.

Common Shares

(a)

On August 27, 2014, the Company approved an increase in the total number of authorized shares of common stock from 75,000,000 to 500,000,000 shares and in preferred stock from nil to 10,000,000 shares. The amendment was filed and effected on August 28, 2014.

(b)

On September 2, 2014, the Company issued 1,000,000 shares of common stock at $0.10 per common share for gross proceeds of $100,000.  

(c)

On September 17, 2014, the Company effected a 20:1 forward stock split of the Company’s common stock, thereby increasing the number of the Company’s outstanding common shares from 5,907,000 to 118,140,000 shares of common stock.  

8.

Commitments and Contingencies

In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.

 

In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) on February 6, 2015 and we will be responding before February 27, 2015 and waiting to hear back from Health Canada.   


 

 F-10           

             

8.

Commitments and Contingencies (continued)

The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada.  During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been recognized in our statement of operations. 

 

The Contract has now been extended on a month to month basis and the Company continues to pay the property owner a nonrefundable payment of $4,000 a month while it awaits the determination from Health Canada.  As of February 2015, the monthly payment was reduced to $2,500. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.

9.

Income Taxes

The Company has $387,071 of net operating losses carried forward to offset taxable income in future years which expire commencing in fiscal 2030.  The income tax benefit differs from the amount computed by applying the US federal income tax rate of 34% to net loss before income taxes. As at November 30, 2014, the Company had no uncertain tax positions.  

 

 

November 30,

2014

$

November 30,

2013

$

 

 

 

 

Net loss before taxes

 

(278,875)

(35,990)

Statutory rate

 

34%

34%

 

 

 

 

Computed expected tax recovery

 

94,818

12,237

Valuation allowance

 

(94,818)

(12,237)

 

 

 

 

Income tax provision

 


 

The significant components of deferred income tax assets and liabilities at November 30, 2014 and 2013 are as follows:

 

 

 

November 30,

2014

$

November 30,

2013

$

 

 

 

 

Net operating loss carried forward

 

131,605

36,787

Valuation allowance

 

(131,605)

(36,787)

 

 

 

 

Net deferred income tax asset

 


 

10.

Subsequent Events

a)

On December 2, 2014, the Company entered into a marketing agreement for advertising services. The Company has agreed to issue 1,500,000 shares of common stock to the consultant as compensation for a six-month term. The agreement may be terminated by either party at the end of any month during the term of the agreement.

b)

On December 16, 2014, the Company entered into a consulting agreement with a consultant who is to become a director of the Company. The Company has agreed to issue 500,000 shares of common stock to the consultant as compensation. The agreement commences upon the date of the agreement, and continues until the Consultant resigns or upon mutual agreement with the Company to terminate such agreement.

c)

On January 9, 2015, the Company and its board of directors authorized a new class of equity instruments – Series A Preferred Stock, subject to authorized capital of 500,000 shares with a par value of $0.001 per share.  As of the date of filing, no Series A Preferred Stock have been issued.  .  

 

 F-11            

             

Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

 

None


Item 9A.  Controls and Procedures  


(a) Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Principal Financial Officer, after evaluating the effectiveness of our "disclosure controls and procedures" (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Annual Report on Form 10-K (the "Evaluation Date"), concluded that as of the Evaluation Date, our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms.


(b) Changes in internal control over financial reporting. There were no changes in our internal control over financial reporting during our most recent fiscal quarter that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Internal Controls


Disclosure controls and procedures, no matter how well designed and implemented, can provide only reasonable assurance of achieving an entity's disclosure objectives. The likelihood of achieving such objectives is affected by limitations inherent in disclosure controls and procedures. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors or mistakes or intentional circumvention of the established process.


Management's Report on Internal Control over Financial Reporting


Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in the Securities Exchange Act of 1934 Rule 13a-15(f). Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission ("1992 COSO Framework").


A material weakness is a deficiency or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.


Our management concluded we have a material weakness due to lack of segregation of duties. Our size has prevented us from being able to employ sufficient resources to enable us to have an adequate level of supervision and segregation of duties within our internal control system. There is mainly one person involved in processing of transactions. Therefore, it is difficult to effectively segregate accounting duties.   We have hired an additional administrative person and retained an outside professional firm to assist in the separation of duties on an ongoing basis.  The use of the outside firm has proven successful in assisting in the separation of duties.  However, additional people are not needed to do the administrative work therefore segregation of duties will continue to be an ongoing weakness.


Based on this evaluation and because of the material weaknesses, management has concluded that our internal control over financial reporting was not effective as of November 30, 2013.  


This annual report does not include an attestation report of the Company's independent registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's independent registered public accounting firm pursuant to rules of the SEC that permit the company to provide only management's report on internal control in this annual report.


 Item 9B.  Other Information.


None.

 

13            

             


 

PART III


Item 10.  Directors, Executive Officers, Promoters and Control Persons; Compliance With Section 16(a) of the Exchange Act


Directors, Executive Officers and Key Employees

 

The following table sets forth certain information regarding our directors, executive officers and key employees as of November 30, 2012 and as of the date of the filing of this report:

 

Name and Address

Age

Position(s) Held


George Lefevre

47

President, CEO, Secretary, Treasurer,

Principal Executive Officer and

Chairman of the Board of Directors

Paul Frank

47

Director


Erlend Olson

51

Director


Russell Anderson

59

Director



Background of Directors and Executive Officers


George Lefevre


Mr. Lefevre is the founder and President of HAPA Capital, LLC (“HAPA”) which has been in operation for over five years. HAPA is a business consulting firm specializing in mergers, acquisitions and structural guidance to public and private companies specifically in Bio-Tech and Hi-Tech Industries.  Mr. Lefevre is also an advisor and officer of a National Professional Employer Organization (PEO, and has served in senior management capacity with a number of life science ventures companies. From 1991 to 1998, Mr. Lefevre directly invested in and managed investment portfolios with Paine Webber and their subsidiary Correspondence Service Corporation. Mr. Lefevre was also the President of GL Investment Group, a regional investment bank in Southern California where he was directly responsible for providing in excess of $ 500 million in funding to Bio-Technology and High Tech companies.  Mr. Lefevre graduated from California State University, Long Beach with a Bachelor of Science in Business Administration, majoring in Finance.


Paul Frank


Mr. Frank has been a teacher at Orange Coast College, Costa Mesa, Ca, since 2002.  Mr. Frank is also an adjunct professor a currently is a teacher at the Art Center College of Design in Pasadena, Ca.   In addition from 2005 to present, Mr. Frank is the founder and president of Tree Stitch Design Inc.  Mr. Frank is best known for founding the Paul Frank Industries in 1995 where he created the iconic Julius the monkey character as well as the entire cast of Paul Frank characters which are still used today.  Since then Mr. Frank has assisted in various projects including movies,  designing custom musical instruments, bicycles, Lego, shoes and clothing, Marvel Comics, Nintendo, Mario Brothers, as well as participating in the Hello Kitty’s 40th birthday convention.  Mr. Frank has an AA degree in Fine Arts from Golden West College, Huntington Beach, Ca, with continuing fine arts studies from Orange Coast College.


Erland Olson


During the last five years to present, Mr. Erlend Olson was a consultant and has primarily consulted on various projects for a variety of private international ventures ranging from Medical to Energy sectors. Mr. Olson continues to maintain extensive contacts in both the medical and energy/oil/gas sectors in his current endeavors, and is experienced in international business and application of modern technology to traditional problems in natural resources, manufacturing and marketing. After a 15 year career at NASA’s Jet Propulsion Laboratory, he founded 6 successful companies during the period of 1999 through 2010, including two in ultra-low power electronics, two in natural resources exploration and two in the medical testing/diagnostics fields. Mr. Olson was also involved in raising private equity and debt capital for various private companies.   Mr. Olson is also the author/holder of 38 patents, applications and patents pending. In one of the companies he founded, Pivotal Technologies, was acquired by Broadcom in May of 2000.  Mr. Erlend Olson earned undergraduate and graduate degrees from New Mexico State University 1984 and at University of Southern California in Electrical Engineering 1986


 

14           

             

Russell Anderson


From October 2002 to present, Mr. Anderson has been the President and Principal Consultant of ANDERSON BIOMEDICAL CONSULTING.  From December 2008 to present, Mr. Anderson has been the Executive Vice President of Product Development & Engineering at ASCENTX MEDICAL CORPORATION; from September 2010 to present Mr. Anderson is also the President and Chairman of Board of Directors of BIOSTRATUS CORPORATION; and from March 2014 to present, Mr. Anderson has been a member of the Board of Directors for GENTHERA CORPORATION.  In addition, for over 28 years, Mr. Anderson has held senior management positions in Product Development and Process Engineering functions for several medical device and biopharma companies including Cohesion Technologies, Novare Surgical, Artes Medical, and AscentX Medical Corporation. Mr. Anderson has also served as a principal consultant for many clients including Amgen, Astute Medical, Baxter Pharmaceuticals, Boston Scientific, Genentech, Novartis, NuVasive, Roche and Sandoz. Mr. Anderson is a named inventor on over 30 patents in the medical device and biopharmaceutical fields. Mr. Anderson has various degrees and certificates including: Stevens Institute of Technology – M.Sci.PharmME   (4.0 GPA), Graduate Certification in Pharmaceutical Manufacturing Management; Graduate Certification in Bioprocess Systems and Biologics Management; Graduate Certification in Regulatory Affairs Management; Cal State Hayward – Master’s Degree in Business Administration, concentrations in Technology and Innovation Mgmt., Production & Operations Mgmt., and International Business Mgmt.  California Polytechnic State University at San Luis Obispo – BSEnvE, BSME; Riverside City College – A.S. in Chemistry, and additional graduate courses at Stanford, UC Riverside, UCSB, and University of La Verne.


  

Term of Office of Directors

 

Our directors are appointed for a one-year term to hold office until the next annual general meeting of our stockholders or until removed from office in accordance with our bylaws.  Our officers are appointed by our Board of Directors and hold office until the officer dies or resigns or the Board elects a successor or removes the officer.

 

Key Employees

 

None.

 

Family Relationships

 

None.

 

Involvement in Certain Legal Proceedings

 

None.

 

Audit Committee Financial Expert

 

No determination has been made as to whether any member of the audit committee qualified as an audit committee financial expert as defined in Item 401 of Regulation S-K.


Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers, and persons who beneficially own more than 10% of a registered class of our equity securities, to file reports of beneficial ownership and changes in the beneficial ownership of our securities with the SEC of Forms 3 (Initial Statement of Beneficial Ownership), 4 (Statement of Changes of Beneficial Ownership of Securities) and 5 (Annual Statement of Beneficial Ownership of Securities). Directors, executive officers and beneficial owners of more than 10% of our Common Stock are required by SEC regulations to furnish us with copies of all Section 16(a) forms that they file.  The required filings have been made.

 

Code of Ethics

 

We have adopted an informal Code of Ethics that applies to our officers, directors, which we feel is sufficient at this time, given we are still in the start-up, development stage and have no employees, other than our officers and directors.

 

Item 11.  Executive Compensation.


None

  

 

15

             

SUMMARY COMPENSATION TABLE


 

Name and Principal Position

Year

Salary

Bonus

Stock

Option

Non-Equity

Change in Pension

All Other

Total

(a)

(b)

($)

($)

Awards

Awards

Incentive

Value Nonqualified

Compensation

($)

 

 

(c)

(d)

($)

($)

Plan

Deferred

($)

(j)

 

 

 

 

(e)

(f)

Compensation

Compensation

(i)

 

 

 

 

 

 

 

($)

Earnings

 

 

 

 

 

 

 

 

(g)

($)

 

 

 

 

 

 

 

 

 

(h)

 

 

 

 

 

 

 

 

 

 

 

 

George Lefevre, Chairman, President, CEO, Secretary, Treasurer, CFO and Principal Executive Officer

2014

0

0

0

0

0

0

0

0


Robert Walter Frei, President, CEO, Secretary, Treasurer, CFO and Principal Executive Officer       

2013

11,000

0

0

0

0

0

0

11,000

 

 

 

 

 

 

 

 

 

 

 

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE

 

  

Name and Principal Position(s)

(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPTION AWARDS

STOCK AWARDS

Number of

Securities

Underlying

Unexercised

Options

(#)

(Exercisable)

(b)

 

 

 

 

 

 

 

 

 

Number of

Securities

Underlying

Unexercised

Options

(#)

(Unexercisable)

(c)

 

 

 

 

 

 

 

 

 

Equity

Incentive

Plan

Awards:

Number of

Securities

Underlying

Unexercised

Unearned

Options

(#)

(d)

 

 

 

 

 

Option

Exercise

Price

($)

(e)

 

 

 

 

 

 

 

 

 

 

 

 

Option

Expiration

Date

(f)

 

 

 

 

 

 

 

 

 

 

 

 

 

Number

of Shares

or Units

of Stock

That Have

Not

Vested

(#)

(g)

 

 

 

 

 

 

 

 

Market

Value of

Shares or

Units

of Stock

That Have

Not

Vested

($)

(h)

 

 

 

 

 

 

 

Equity

Incentive

Plan

Awards:

Number

of

Unearned

Shares,

Units or

Other

Rights

That

Have Not

Vested

(#)

(i)

 

Equity

Incentive

Plan

Awards:

Market

or Payout

Value of

Unearned

Shares,

Units or

Other

Rights

That

Have Not

Vested

($)

(j)

George Lefevre, Chairman, President, CEO, Treasurer, CFO and Principal Executive Officer

0

0

0

0

0

0

0

0

0


 

16           

             

 

Option Grants


No options were granted during the fiscal years ended November 30, 2014 and 2013.  


We had no warrants or stock options issued or outstanding during the fiscal years ending November 30, 2014 and 2013.

 

Director Compensation

 

None.

 

Employment Agreements

 

None.

 

Report on Repricing of Options

 

None.

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table provides certain information regarding the ownership of our common stock, as of November 30, 2014 and as of the date of the filing of this annual report by:

 

 

 

each of our executive officers;

 

 

 

each director;

 

 

 

each person known to us to own more than 5% of our outstanding common stock; and

 

 

 

all of our executive officers and directors and as a group.


As of November 30, 2014, we had a total of 118,140,000 shares of common stock issued and outstanding.  Except as indicated in footnotes to this table, the persons named in this table have sole voting and investment power with respect to all shares of common stock indicated below.  Except where noted, the address of all listed beneficial owners is in care of our office address.

 

 

Name and Address of  

Beneficial Owner

Title of Class

Amount and  

Nature of Beneficial  

Ownership (1)

(#)

Percent of  

Class (2)  

(%)

George Lefevre, Chairman, President, CEO, Secretary, Treasurer, CFO and Principal Executive Officer

Common

Shares

17,735,000

15.01

All Officers and Directors as a Group 

Common

Shares

17,735,000

15.01

 

Changes in Control

 

On May 19, 2014, a change in control of the Company occurred when IDG Ventures Ltd., the Company’s then controlling shareholder, sold all of its 3,547,000 shares of the Company’s common stock, representing 60.04% of our issued and outstanding common shares, in a private share purchase transaction to Messrs. Haas, Lefevre and Naccarato.

 

17            

             

 

Item 13.  Certain Relationships, Related Transactions and Director Independence


a)

During the year ended November 30, 2014, the Company incurred $6,000 (2013 - $nil) in management fees to the former President and Director of the Company.

During the year ended November 30, 2014, the former President and Director of the Company forgave all amounts outstanding totaling $23,298 which was recorded against additional paid-in capital. As at November 30, 2014, the Company owed $nil (November 30, 2013 - $28,298) to the former President and Director of the Company. The amounts owing were unsecured, non-interest bearing, and due on demand.

b)

During the year ended November 30, 2014, the Company received advances of $174,635 (2013 - $nil) from an affiliate of the Company to fund payment of operating expenditures. The amounts owing are unsecured, non-interest bearing, and due on demand.

 

c)

During the year ended November 30, 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.

During the year ended November 30, 2014, the Company incurred option expenses of $28,000 (2013 - $nil) under the term of a contract to purchase property in Vancouver, Canada to a director of CVI.


Director Independence

 

The OTC Bulletin Board does not have a requirement that a majority of our Board of Directors be independent.  However, with respect to the definition of independence utilized by NASDAQ, our officers and directors would be deemed to be independent.


Our Audit Committee is comprised of our officers and directors.  NASDAQ requires at least three members on the Audit Committee, each of whom must be independent.  NASDAQ also requires that, if its Chief Executive Officer’s compensation is determined by its Compensation Committee, the Compensation Committee must be comprised solely of independent directors.  The Company currently does not meet either of these requirements.

 

The NASDAQ rules have both objective tests and a subjective test for determining who is an “independent director.”  The objective tests state, for example, that a director is not considered independent if he or she is an employee of the Company or is a partner, executive officer or controlling stockholder of an entity to which the company made, or from which the Company received, payments in the current or any of the past three fiscal years that exceed the greater of $200,000 or 5% of the recipient’s consolidated gross revenue for that year or a family member serves in the current fiscal year or has served at any time during the last three fiscal years as an executive officer of the Company. The subjective test states that an independent director must be a person who lacks a relationship that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.



Item 14.  Principal Accountant Fees and Services 


The Company paid or accrued the following fees in each of the prior two fiscal years to its independent certified public accountants, Cutler & Co. Certified Public Accountants for the years ended November 30, 2014 and 2013:

 

 

For the Year Ended November 30,

 

2014

2013

Audit Fees

$7,500

$7,500

Audit-Related Fees

$0

$0

Tax Fees

$0

$0

All Other Fees

$0

$0

Total Fees

$7,500

$7,500


"Audit Fees" consisted of fees billed for services rendered for the audit of the Company’s annual financial  statements and audit related fees are for review of the financial statements included in the Company’s quarterly reports on Form 10-Q.

 

18            

             


Item 15.

Exhibits 

 

The financial statement schedules are omitted because they are inapplicable or the requested information is shown in our financial statements or related notes thereto.


Exhibits

Exhibit

Number

Exhibit

Description

31.1

Certification of the Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13a-14 or 15d-14 of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

EX-101.INS

XBRL Instance Document

EX-101.SCH

XBRL Taxonomy Extension Schema

EX-101.CAL

XBRL Taxonomy Extension Calculation Linkbase

EX-101.LAB

XBRL Taxonomy Extension Label Linkbase

EX-101.PRE

XBRL Taxonomy Extension Presentation Linkbase

EX-101.DEF

XBRL Taxonomy Extension Definition Linkbase



SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  

GALA GLOBAL INC.

  

  

  

By: /s/ George Lefevre

Date:  March 13, 2015

George Lefevre

  

Chairman, President, Chief Executive Officer

  

Chief Financial Officer, Director, Secretary, Treasurer

 

 


Pursuant to the requirements of the Exchange Act this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

Title

Date

 

  

  

/s/ George Lefevre

President, Chairman

March 13, 2015

George Lefevre

Chief Executive Officer, Chief Financial Officer, Director, Secretary, Treasurer

 




 

19           

             

EX-31.1 2 exhibit311.htm EXHIBIT 31.1 Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - Gala Global Inc. - Exhibit 31.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. ss 1350, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, George Lefevre, certify that:

1.                    I have reviewed this Annual Report on Form 10-K of Gala Global Inc.;

2.                    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.                    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.                    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.              Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.             Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.              Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.             Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.                    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.              All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.             Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Dated:  March 13, 2015

 

 

 

 

 

 

 

 

/s/ George Lefevre

 

 

 

 

George Lefevre

 

 

President, Chief Executive Officer, Chief Financial Officer, Treasurer and Director
(Principal Executive Officer, Principal Financial Officer
and Principal Accounting Officer)

 

 

 

 

 

 



                
             

EX-32.1 3 exhibit321.htm EXHIBIT 32.1 Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - Gala Global Inc. - Exhibit 32.1


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, George Lefevre, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)           the Annual Report on Form 10-K of Gala Global Inc. for the year ended November 30, 2014 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)           the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Gala Global Inc.

 

 

 

Dated:  March 13, 2015

 

 

 

 

 

 

 

 

/s/ George Lefevre

 

 

 

 

George Lefevre

 

 

President, Chief Executive Officer, Chief Financial Officer, Treasurer and Director

 

 

(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

 

 

 


                
             


GRAPHIC 4 form10k001.jpg IMAGE begin 644 form10k001.jpg M_]C_X``02D9)1@`!`0$`E@"6``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBD)QUH M`6BHGN(8\[Y8UQURP&*@?5K",X:[AY]&S32;%=%RBLMO$.FJ<"X#'./E4FM% MW$<;.>B@DT.+6Z!-/8?17-OXO@`^2VD)]R!5>3QA+SY=H@]"S$UHJ%1]"/:Q M[G645Q;^++YL;8X%^BD_UJN_B/4WR//"Y_NJ*M8:8O;1.[I:X&WU?4);V$/= MRD%U!`.!UKN9_P#CVE_W#_*LZE)P:3*C-2V%::),[I$7'7)J%]2L8\;[N$9] M7%><%F/4D_C25T+"KJS)U_([]]?TQ`?]*5O]T$U`_BC3E.`TC?1*X>BJ6%@3 M[:1V2^*[:26...WE)=@OS8&,UM7,I@M990`2B%@#["O.;3_C]@_ZZ+_.O0]0 M_P"0=<_]NT\0_\BYJ7_7M)_Z":XK3/^0I:_\`75?YUVOB#_D7=2_Z]I/_`$$U MS5_XD36'P2/FB&>:W;?!*\;$8)1BIQ^%78O$&L0ILCU2[5?03-_C6=17T;A& M6Z/EE.2V9T4/COQ/"X9=8N"0,8?##\B*O0_$[Q3$I!O8Y\5]QJL366TG]YZ;H?Q0UN^UJQL[B"T:.:58V*H0>3C/6O4=9U`Z3HMYJ` MC\PV\32;,XW8&<9KYW\,?\C3I7_7U'_Z$*][\8_\B;J__7J_\J\C&T*<*L(Q M5DSV,#7J3HSE)W:.,B^,MH=GG:1./[Q24''TXJ_!\7=!D)\RWO8L="R*<_D: M\2HKN>6T'T.!9EB%U/?(?B?X8E52UW+&2>CQ'C\JT(?'/AF=BJ:S;`@9^=M@ M_,XKYSHK-Y72>S9HLUJK=(^G;77=)OF5;74K29F.U0DRDD^G6M"OG'P1_P`C MKI/_`%\#^M>Z>+F*^$=59201;-@@^U>;B<*J-103W/2PN+=:G*;6QLYHKY?B MU?4K=2L.HW<:DY(2=@/T-:$7C'Q'"RE-9O/EZ!I"P_(UTO*I])(YEFT.L6?2 M-%?/L/Q'\4P@C^TO,S_?C4X_2K\/Q8\1Q[-XM)0O7=$06_(UF\LK+:QJLTHO M>Y[G17EGASXI:CJVNVFGW-A:A;B0)OC+`K^9.:]3KDK4)T7RS.RC7A67-`** M**Q-@HHHH`**9)+'$I:1U10,DL<`"J\6J6$\@CBOK:1ST5)E)/X9H`MT4@8, M,@@CVI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI"<#)X%59 M-4T^&0QRWUJCCJK3*"/PS0!;HJK#J-C<.4@O+>5@,D)*K']#5J@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`/.7U:_D.6NY?P;%5WN)G&'FD8>A8FHZ*]912V1PW8$DGFBBBF(='_K M4^HKTNY_X]9O]P_RKS2/_6)]17I=S_QZ3?[A_E7)BMT;T=F>94445UF`4444 M`3V?_'[!_P!=%_G7HUQ_Q[2_[A_E7G-G_P`?L'_71?YUZ-TO^X?Y5QXG MXD=%'9GF5%%%=ASA1110!-:?\?L'_71?YUZ'J'_(.N?^N3?RKSRT_P"/V#_K MHO\`.O0]0_Y!US_UR;^5(?+\SV\N_W>?S_(^;:***]H\4****!&]X)_Y'32?^ MO@5]'U\X>"?^1TTG_KX%?1]>%FO\6/H>_E/\*7J%%%9/B7Q!8^%]`NM8U!B( M+=`H]R>*\L]4@\4^+M'\'Z6U]J]TL2\^7$.7E/HH[U\Z>+?CQXCUMY M(-'/]DV1.!Y>&E8>[$7;3R.UKI$#[9I\?,Y_NIQ@GIGTS0!Q=[JVHZE,TU[?7-Q(W5I968_J M:J*S*V58@^H-?:VA?#OPIX=C06&BVOF*/]=,@DDZ8SN;)'X5L7&A:1=PM#<: M792Q-U1[=6!_`B@#XET_Q)KFE$&PU>]M\=!'.P'Y9Q7HOA/XY^+[2^MK._:/ M5XI)%3;*@63DXX91R?J#7H/C[X%Z3J=A+>>&(%L=10%A;AOW4WM@_=/ICBOG M.VAN=.UZ&&9'@NH+E596&&1@W\Z`/N]"60$C!(Z>E+3(B3"A)R2HI]`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%>4_$+XV:9X5EDTW2$34=3488AOW4)ST8C MJ?851^-GQ,D\.VG_``CVCSE-3N%S<3+UAB(/`/9C^@KYG59+B8*H:25VP`!D ML3_,T`=+XA^(?BKQ/(QU+6)S&>/)B/EQ@>FU<9_'-S?WCT]OK7L%II&FV$:QV>GVMNBC:JQ0J MH`].!0!\'J[QME693['%=#I/CSQ5HZ^_YT`> ME_!KXEZSXVN+ZPUA(&DM(ED$\:[2^3C!`X_*O7:^;OV;'5?$FM(6`9K1"%)Y M.'YKZ1H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`/+:***]C:B+F&0V ML@4."<\=Z[F92\$BCJ5('Y5QXB2193B,J0QSCCO7-6J*4DT:TXM)W/,J*ZL0^&8LJ75CZEF-*+GPU'\H MB5L=]A-='MNT69>S\SDZ*ZP:OH"#:+,8'_3$4#Q+IBC"V3X'3Y%_QH]K+I$. M1=SG],5O[3M?E/\`K%[>]=IX@Y\.ZB!R?LTG_H)K/MO%$5Q&Q(K7)H<^&/^1ITO_KZC_P#0A7O?C'_D3=7_`.O63^5M_\`"!^!)(MT?B`C<,JQO(OY8I/^%6Z#+#OAUYCN'RMN0C]* M]+^T*76Z^1YG]GU>EOO/):*]5/P@@>(F'7`21\I,0(_G5=O@W>>63'K-NS8X M!B(!/UR:I8_#_P`WYB>`Q'\IR/@C_D==)_Z^!7N?B_\`Y$_5?^O9_P"5<)X> M^&&JZ1X@LM0FO;-X[>4.RH6R1[9%>A>(K.;4/#M_9VZAIIH61`3C)->9C*U. MI6C*+T_X)Z>"HU*="<9*S?\`D?,U%==)\-/%*1E_L"-CLLJDG]:J/X"\4(A8 MZ1.0.>"I/Y9KV5B*+^TOO/&>&K+>+^XYRBME_"7B&-"[:-?!1R?W)JJ^AZM& MC.^EWJJHR6:W<`#\JM5(/9HATIK=,O\`@G_D=-)_Z^!7T?7SKX+MIT\9:4S0 M2`"X&24-?15>)FC3J*W8]S*DU3E?N%?-'[07BXZCX@@\-V[G[/8#?/@\-*PX M'X#^9KZ5D<11/(W102?PKX6\2:E)K'B;4]1D)+7-U))],L<#\J\P]0K:7I\^ MK:K::?;+NGN95B0>['%?;_AS0K3PUX?L](LDVPVT87/=F[L?:F`2/?&TU]0U%);03.CRPQN\?W&902OT]*`.)\8^/'\&>`]+U^*U6_6=X(R MC2%-RO&6R#@\\>G>O//^&F1_T*A_\#__`+77O,UM!&.5`*%3U$:!0?RH`FKQ_QI\<&\&^+;W1'T`7@@V%91 M=>7D,H/(V'UKV"N?\6>%M)\1Z%?6U]8V\CR1,5E:,;D<*=K`]B?#7XAM\0K/4+HZ:+%;658U3SO,+9&17O[0L.D MZ]J>F7_A^1Q9W4L"RP7`^?8Y4$J1QP/6K,'[1GAEX@TVFZE&_=0%;'XYKQ/1 MO#.I?$3QY>6MBXWSW$MQ-<./EC4ODL?SZ5Z[9_LV:,;C M1;2XEGBBCC._$D^F7EU-;QQVS3!X@"20RC'/UH`]CN M/VC?#<<>Z#3-1E?/W2%7]%`YZ>M M9E_^S99,C'3_`!!.C[3@3PA@6[=,<5YKX:TB]\%_&?2-,U*,&XM[^.,[#\K! MC@,">WS9H`^FO'WBJ3P9X1N=-3$S[0P9PIYP?6O)O^&F1_T*A_\` M`_\`^UU[W-!%<1&*>))8SU5U#`_@:^5/COH5CHOCU7L((X([RV69XHUVJ&R5 M)`'KC-`'8_\`#3(_Z%0_^!__`-KKT/X:?$1OB':ZC(OB-I>GWT:R6Q+R/&W1PBEL'\J^Q;:SMK-"MM;PP*>HB0* M#^5`$]%%%`'E?Q#^,#^`?$R:6=%6^CDMEF#BX\L@DL,?=/I7*_\`#3"]_"A_ M\#__`+77MNK:%IFN6<]MJ%E#.DT9C8N@+8/H>U?#NK6?]G:Q>V)()MKB2'([ M[6(_I0!]"?\`#2FC_P#0`OO^_J4U_P!I321&QC\/WK/@[0TR`$]LGG'Y5S_P M?^%OASQCX:FU76%NY)4N&A$<BM\!?`94@65VI(ZBZ?B@#C M?^&F!_T*A_\``_\`^UUZQX"\5GQKX4@ULVRVIEDD0PK)OV;6(&3@74JVJAY;>XPQ*=R&`'3KTZ5V7[/%PDGP]N(%SOBOI-W MIRJXH`V?B7\36^'D^G#^RA?I=JY(\_RRI4COM.>IK@_^&F1_T*A_\#__`+77 MNE[IUEJ,1CO;2"Y0@KMFC#C!Z]:^,OB+H]MH'Q`UK3+-0EM#/^[0=%5@&`_# M./PH`]6D_:88QL(O"H5\?*6OL@'W'EBJ:_M*ZKN&[P[9E<\XG;_"L3X&^$=$ M\6:OJ\>MV8NH[>!&C4NR@$L-P&5 MU.0P/0@U\(ZQI-WH6KW6EWT>RZMI#'(ON/3V[U[S^SSXQN;M+OPM>2-(+>/[ M1:ECDJN0&7Z9((^IH`]XHHHH`*S]5?'_5 M6L/AU]D1L&^N4B/NH^<_^@B@#YDUG5KG7=9N]4O'+W%U*9'/U[?0=*].^`7A M*/6_%WTM045AD&5L[3^`!/UQ7D5?5/[/U@MK\.3G\-?3=1QPQ0@B*-$!.<*H%.D=(XV>1@J*,LS'``]30`ZN2 MUSXF>#_#L[0:CKD"SJ<&*(-*P/H0@./QKPWXI_&*]UV\GT;0+A[;2HV*/-&< M/<$9!Y'1/;O7$>$_A]XC\:R.=*LR8%/SW,QV1@^F[N?IF@#Z+M_COX#GD*OJ M%S``,[I;5R#[?*":[71/$NB^(X#-H^I6]X@Z^6_*_4=1^-?,6O?`OQAHEH]U M'';:C$B[F%HY+CU^4@$_A7G]AJ-_HU^EU8W,UK=1-P\;%6!'8_X4`?>=%>7? M"7XJ+XTMFTS5"D>M0+N)&%6X7^\H]1W'XUZC0`4444`H26&IZW M:VMW&`7BD)R,C([56'Q/\$F`S#Q+8;`VT_.)-,U+6XXY( MM9B@,BRI)\LFQ>%8'CH.V*^3Z`/M:P^(WA#5;^&QL=?M)[J=MD<2$Y8^@XKJ M*\=^$_PKT.UT+1O$MTLLVK.!I!'TH`I0_$_ MP3.^R/Q+8%L$\N1T^HJ/_A:O@7_H9;+\V_PKY+\6Z$?#/BS4]&+EQ:3E$<]6 M7JI/X$5Z!\&/AMI?C4ZA?ZT)7M+5ECCBC?;N<\G)'.`/YT`?3MC>VVI6,%[9 MS+-;3H)(I%Z,IZ$58JII6FVVC:5:Z;9J5MK6)8HE9LD*!@<]ZMT`%%%_% M[P'82>7-XA@9LD?N8Y)<8]U4U\QZOXC\5?$?7$AFDN+R>5\0V<`.Q/\`=4?S MKT'1?VS+#)AA0R,O'<\#/TS0!ZQ;?&/P#=.5C\0Q*0,_O898 MQ^;**ZO3=;TO6(S)INHVMVHZF&4-C\J^>-;_`&=-2;2=4MK\KDB%T,3D M=L'D$_E7F>DB]T#Q?9178N;&:"[C6=,M&ZC<,CCGI0!]Q44BD%01T(XI:`.3 M7PQ:@$2:DN?8#_&A=#T<+\^I9/LZBN9HKT?9S_F.3FCV.F%AX=5>;TL1WW]? MTHV^&%7[[,0/]OFN9HH]D^LF'/Y'4+=^&U8%+8E@>/E/7\ZZ:1@D+LPR`I)' MK7FO#E:U-:4KW.9_X26P3F+3@&^@%(?%JJ#Y=B MJM_O?_6KF:*Z/80,O:2.C?Q?<$?):Q`^I)-1/XLOV'RQPK]%/^-8-%/V-/L+ MVDNYNP^)-0FN84+H%9P#A.HS78S$K!(P."%)'Y5YQ9_\?L'_`%T7^=>C7'_' MM+_N'^5/[IQ_*HGU"]>6G_'[!_P!=%_G7H>H?\@ZY_P"N3?RKDQ'Q1-Z.S/-J***ZS`****`+ M>F?\A2U_ZZK_`#KM?$/_`"+NI?\`7M)_Z":XK3/^0I:_]=5_G7:^(?\`D7-2 M_P"O:3_T$UR5_P")$VA_#D?,E%%%?2GRH4444"-;PQ_R-.E_]?4?_H0KWOQC M_P`B;J__`%ZO_*O!/#'_`"-.E?\`7U'_`.A"O>_&/_(FZO\`]>DG\J\?,/X] M/^NI[67?P*G]=#YNHHHKU['C7)5N9T4*LTBJ.@#D"IX]6U*%-D=_=(OHLS`? MSJG12<8O=#4I+J=AX+U_5Y/%>F6KZG=M;O.`\;3,5;ZC->T>)KJ:R\,ZC'FV_ZL>+0_$7Q3""/[3+Y_OQJ)XB2US#)G^_$./RKC:*] M5X:B]XH\I8FLOM,[V'XM^(8V)DBLY0>S1D8_(U:A^,6K*Q,VFV;KC@(64Y_$ MFO.**AX*@_LE+&UU]H]?T#XI7&KZ[::?+I<4:W#[-ZRDE?TKTZOG#P3_`,CI MI/\`U\"OH^O'S"C"E42@K:'M9=6G5IMS=]2CK7_("U#_`*]I/_037P=7WEJZ ML^BWZ("S-;R``=2=IKX.92C%6&"#@@]JX#T#UK]GC_DH<_\`UXR?^A+7U)7R M9\![[['\3[6(M@74$L73.3MW?^RU]9T`%%%%`!1110`5\P?M%_\`(^67_7@O M_H;5]/U\P?M%_P#(^67_`%X+_P"AM0!!^SS_`,E%E_Z\9/YK7U-7RS^SS_R4 M:7_KQD_FM?4U`!4%Y_QXW'_7-OY5/4-Y_P`>-Q_US;^5`'R%\)`#\7=&!`/[ M^3_T!J^NM1MGO=,NK6.7RGFA>-9,9VD@C.*^1OA'_P`E=T;_`*[2?^@-7V%0 M!YU\+_AG)\/WU1[B]BO)+MD$OZWJ>AC=H MNJ7]O!)?1&,0R2!6D5OE^7/UQ6?X(\":;X#TZ>RTVXNYDGD\QS<.#STX```X M_E7S=#XJNOB#\7M$U#4HDC4W<,<<4?1$5L@9[\\YKZZH`*^./C!_R5?7_P#K MLG_HM:^QZ^./C!_R5?7_`/KLG_HM:`/0_P!FJV'VK7[K<!]#D MFOBC:K>[6FV_\LE'1,_S]_I0!Z!>74=E93W.W MTR#QQ']D3PY+?^1]@V`N(P=N2W7DY'7K[5[CK$$5UHM];S3+#%+;R1O(QP$! M4@DGVS7RWX'N=0\36]I\-UEA^Q?VB;N2X$G!B3EE7UR1D?6@#ZOCD$L22+T9 M0PS[UX7^TM(XTSP]&'(1IIF*YX)`3!_4_G6[<:_X[?XK3>%-+GTU;"$1W7F2 M1$F.WX!0G^\?I^-8O[2ML[Z)H-T"-D=Q+&1WRR@C_P!!-`'SG7V#\%XXD^%. MC&(`%A(SX/\`%YC?_6KX^KZO^`5W'1_'OQ@^A^%HM%M)"EWJA(N5\J?M`7TMS\27MG/[ MNUM8T0?4;C^IH`\VTRPEU75;/3X!F6YF2%/JQ`'\Z^X?#^AV?AS0[32K&)8X M+>,*,#&X]V/N3S7R%\+$23XG^'U=0P^U`X([@$C]:^T*`"OF#X^^#H=$\10: MY91A+;4MWFHH`591U/\`P(<_7-?3]>8?'NP6[^&-Q.5)>UN8I5(&>IVG\,-^ ME`'S#X?UJY\.Z_9:O:-B>UE$@]QW'XC(_&ON+2]0AU;2K34+=@8;F%94/LPS M7P77V!\&+W[;\+=()9F,0>$ENVUSQ0!W]%%%`&?KW_(NZG_UZ2_^@&OA"ON_ M7O\`D7=3_P"O27_T`U\(4`?;/P[_`.2=^'_^O*/^5=-7,_#O_DG?A_\`Z\H_ MY5TU`!1110!\@_&NW2#XJZMLS^\$=VWE6./ MQ&3Z"OEW M/_'I-_N'^5>:1_ZQ/J*]+N?^/2;_`'#_`"KCQ6\3>CLSS*BBBNQ&`4444`3V M?_'[!_UT7^=>C7'_`![2_P"X?Y5YQ9_\?L'_`%T7^=>CW'_'M+_N'^5<>)^) M'11V9YE11178AZA_P`@ZY_ZY-_*O/+3_C]@_P"N MB_SKT/4/^0=<_P#7)OY5R8CXHF]'9GFU%%%=9@%%%%`%O3/^0I:_]=5_G7:^ M(?\`D7-2_P"O:3_T$UQ6F?\`(4M?^NJ_SKM?$'_(N:E_U[2?^@FN2O\`Q(FT M/@D?,E%%%?2GRH4444"-;PQ_R-.E?]?4?_H0KWOQC_R)NK_]>DG\J\$\,?\` M(TZ7_P!?4?\`Z$*][\8_\B;J_P#UZR?RKQ\P_CT_ZZGLY=_`J?UT/FZBBBO8 M/'"BBB@1O^"/^1UTG_KX%>Y^+_\`D3]5_P"O9_Y5X9X(_P"1UTG_`*^!7N?B M_P#Y$_5?^O9_Y5XN8?[Q#Y?F>WE_^[S^?Y'S;1117M'BA1110(WO!/\`R.FD M_P#7P*^CZ^%-4G5+NWXLF._M(Z>T?B'1]0`.R>V:+/;*-G_V:@#`^`EP M\/Q.@C7&)K:5&SZ8S_2OK"OB?X=ZQ'H/Q`T74)F"PQW(61CT"M\I/X`U]K@A M@"#D'H10`M5=2E2#2[N:0[42%V8^@"DFK5/^2JWO_7"'_T`5J?LZ?\`(_WG_8/?_P!#2LOX M\?\`)5;W_KA#_P"@"M3]G3_D?[S_`+![_P#H:4`?4%%%%`!7S'^T;_R.^G_] M>(_]#:OIROF/]HW_`)'?3_\`KQ'_`*&U`&'\"_\`DK&F?]Z7X=TNQ@OGG"B>-V*$,[84! MN<<I5\+^*_^1PUO_K_`)__`$8U?=%?"_BO_D<-;_Z_Y_\`T8U`'KWP M<^&WAGQ=X1GO]8LY)KA;IHPRS,OR@`]!]:]";X%^`RI`TV<$C&1!_CIHFF6LKRVDES#/`9""P4L1@X]"#7U- M5233+":]%Y+96[W2@!9FC!<`9Q@GD=37"V_Q4@N?BE-X,ATUYE5M@NXI00&" M[FW+CH.1U[4`>BU\;_&#_DJ^O_\`79/_`$6M?9%?&_Q@_P"2KZ__`-=D_P#1 M:T`9?A#P1K7C>[GM]&CA9[=5:4RR!`H)P#[_`(5+XT\!ZSX$O;>VU80-]HC+ MQR6[ED.#@C)`Y']:]*_9J_Y#>O?]>T7_`*$:]1^+?@\>+O!%S'#'NO[/_2+8 M@017P%@@\BOJSX)^.U\3^&%TJ\ESJFG*$;)YDB'"M^'0_AZT`1_M`:G&O'/A=$ACM(H%E$0P#@`JYQU MST/KD5Z[\1/!J>./"4^E"58;@,);>5AD*X]?8C(_&O+_``W\+/'5_91:!XHU M

&K9R?LD4H=I>X`(&=N?4\=A0!U_PD$NMQ:MXVOM@NM8N"L<:G(AA3A5SZ MYS^E3?&_1VU7X9WTD:EI;)TN0`,G`.&_0D_A7#^&OA%XRTW69-'GU;R?"RW: MW,GDS8-QM/&`.5/`SS^=>\75K#>6LMK<()(9D*2(>C*1@B@#X&KW;]G'Q"L& MH:IX>E=1]H`N80>[+PP'X8/X5Y3XT\+W7@_Q1>:1<@D1MNADQ@21G[K#_/4& ML_0]9O/#VMVFJV#[+FVD#H<9!]0?8C(H`^[Z*Y_P=XOTWQGH,.IZ?(,D`30D M_-"_=3_0]Q704`%%%97B/Q#IWA?19]4U.=8H(EX!/+MV51W)H`=)XBTB+7ET M234($U)HQ*MNS89E.>GKT/%?+WQX4CXIWI((!@AQ[_(*G\'-=_$[XT1:E?`B M-93=NHY$<:?<3\]H_&ND_:/T%X]2TK7HUS%+&;65O1E^9?S!/Y4`>;?#&>.V M^)GAZ20D+]L5.!W;Y1^I%?:5?!%A=R:?J%M>0G$MO*LJ'W4@C^5?M%V"[D11GN2ZX%=W7C7[1&OQ M6?A&VT17'VB^G61E_P"F:<_^A;?RH`^9:^O?@G9M9_"S2PV[,QDE^88QN4?\JZ:@`HKG_&?BVS\%^'9=8O8WE1'1%B M0@,Y8XXS[9/X5=\/:W;^(]!M-7M8Y8X+I-Z+*,,![T`?)/Q>_P"2K:__`-=E M_P#1:UZY^S9_R+&L_P#7XO\`Z!7D?Q>_Y*MK_P#UV7_T6M>N?LV?\BQK/_7X MO_H%`'MM%%,FEC@A>:5PD:*69CT`'4T`AS@FWD`&25/'X5S M$'BN:6>.,VL8W,%SN/>NHE8I"[#JJDUS5W)R7,K&U-*SLSSQ-*OW&5LYL>Z$ M4[^Q]1_Y\Y?^^:T?^$MO?^>4/Y'_`!J-O%6HELCRE'IMKIO5[(QM#N55T'4V M4$6K<^I%+_8&I_\`/JWYBK'_``E.I?WHO^^*8WB74V.1,J^P04KUO(/W9+;^ M'-2CN8G:)0JN"?G'3-=A=1--:31+CH_WH/^^S_A2IX3OB?FE@4? M[Q/]*H_VYJ?_`#^2?I3'U?47.6O)OP;'\JZ;5NZ,KP[&I_PB-W_S\0_K3T\( M3D'?=1@^RDUC?VI?_P#/Y/\`]]FF/?WYF)]W-+EJ_P`P7AV.DM?"SVUU M%,;I6$;!L;>N*W-1M3?:9C+_C7`?VQJ?_`$$+K_O\W^-2P^(-9MR3#JEXA/7$[<_K7M^R MQ7_/Q?<>#[7"/_EV_O.T_P"%/:O_`-!"S_\`'O\`"HIOA!KJ`>5=V,A[Y9EQ M^E/EKT_Q'93ZCX;U&SME#330,B`G`)( M]:\9T#QIXCNO$.G03ZM.\4EPBNIQ@@GD=*]D\3W,UEX7U.YMI#'-%;NZ..H( M'6O.Q:K*K#VC5^AZ6#=%TI^S3MU/&?\`A5_BG_GSB_[_`*_XU%-\-O%,(!_L M\/G^Y*IQ^M`^)/BH#']I#_ORG^%'_"RO%7_02'_?E/\`"O17US^[^)YO^Q_W MOP(O^%>^*/\`H%2?]]K_`(U%-X%\30`%M(G.?[F&_D:THOBEXHC0*9[>0_WG MA&?TI_\`PM;Q-_?M?^_/_P!>CFQE]D+EP?=B>$?"VNV?BS3+BXTNYBACF#.[ M)@`5Z_XJBDG\*ZG%%&TDCV[!409)..@%><^%_B3KFI^(;.PNUMGBN)0A*Q[2 MH]N:]-UV_DTS0KV^A56D@B9U#="1ZUYN,=5UH\Z5_P#@GIX-4E1ER-V_X!\Z M_P#"/:W_`-`?4/\`P&?_``J*;2-3ML>?IUW%GIO@9<_F*[>/XP:RK@R65FZ] MU`89_'-3_P#"Y+__`*!-M_W\:O2]KBOY%]YYGLL*_MO[CSO[#=_\^L__`'[- M->VGCQYD,B9Z;D(KT;_A9Z'\38=6UNSL%T&.`SR!/,$ MP.WWQM%>F"O*Q\YRFG.-M#ULOA"$&H2OJ%5=2TZTU;3I["^@6:VG0I)&PR"# M5JDK@/0/CKXC?#74O`NIL0DEQI,AS!=A<@?[+XX#?SKB89I;>9)H9'CE0AD= M&P5(Z$$=*^]+VQM=2LY+2]MX[BWE&UXY%W*P^E>,^*OV=]-OI7N?#E\;!SD_ M9IE+QD^S9ROZT`OS$57A^!_C^254;1HXE/5WNXL#Z MX8G]*`-?QC\>=;\06DECI-NNE6L@P\BN6F8>F[@*/H,^]<9\/-%'B+Q_H^GR M`M$]P'E]T7YF_05Z5H?[.&HS.KZYK$%M'P3';(9&/MDX`_6O7_"7PV\->#") MM,LMUYMVM=3-OD(/7V'X`4`=:`%4`#`'05POQ:\&-XQ\%S0VR;M1M#Y]K_M$ M?>7\1G\<5W=%`'P'(CPRM'(C)(APRL,$$=C7M'@3X]SZ)IL&E^(;.2\@@18X MKF$CS`H``#`GYOKFO3?'/P;T'QC-)?1,VFZF_+7$2;ED/JR<9^H(KRRY_9R\ M21S%;?5-.EC[,VY3^6#0!WES^T5X2C@9K>RU664=$:)%!_'<:\8^('Q)U;XA M7T4+1?9]/B?,%G&2V6Z!F_O-SBNLM?V$;J._F=]3U&/E)ID"K&?54YP?#_%O7;+Q%\1M1OM/E66V`2)9%.0^U0"1[9JQ\&_$E MGX:^(-O/J%P(+2XB>W>1ONJ3@KN/89`YKTT?LUZ5M&[Q#>$XY(@7_&F3?LU: M>8F$'B2Z23LTELK#\@1_.@#VZVO+:\4M;7$,ZC',3AAS]*GK@OAG\-C\.X=1 MC.J_;_MC(V?L_E;-H/\`M'/6N]H`BGN8+90T\T<2DX!D8*#^=?*?QT\0Z?K_ M`([3^S;B.XAM+986EC;^,/C M/:ZIJ;F>8-)=S.1QE5.WIT`)7\J[V3]FK33&PB\1W:OCY2UNI`/N,BNE^''P M@3P!K5SJ3:Q]O>6#R57[-Y6S)!)^^<]*`.WU[Q)I7AW3;B\U&^@A6%"Q1I`& M8XX`'4DU\.W4WVB[FFY_>2,_/7DYKZ@\>_!4^-_%,NM?V^+/S(TC\G[)YF-H MQG.\?RK$A_9JTX1*)O$=TTG\12V50?H"3_.@#GOA+\5?#W@KPO+IFJQWQG>Y M:4-!$K*%(`[L/2O2_P#A>_@+_H(W/_@))_A7,?\`#->D_P#0PWO_`'X3_&C_ M`(9KTG_H8;W_`+\)_C0`GBG]H?3%T^>#PU:7,MXP*I<7"!43_:`SD^HSBN?_ M`&>=/DU/QCJ^MW+&22W@P78Y)>1CD_DI_.M:;]F>-I28/%+I'V#V(8_F''\J M]&^&WP]3X>Z7>6@OQ?27,HD:7R?+P`,`8W'W_.@#K+S4;+3XV>\O+>W4*6)E MD"@`=^:^+O'^LP^(?'FLZI;$-;SW!\I@/O(H"@_B`#7TC\2OA0?B%J=E>?VS M]@^S0F+9]F\W=DYSG<,5RT?[-6FB-1+XCNVDQ\Q6W4`GV&3C\Z`.4_9ZUS3] M*\4ZE:WUS%;M>6ZK"TKA59E;[N3W.>/I7TU%-%<1[XI$D0_Q(P(/XBO"[G]F MFS95^R^)IXS_`!>;:!\_3#"O5/`OA3_A"_"MOHGVS[7Y+.WG>5Y>=QSTR?YT M`?-/QD\''PKXUGFMXBNG:@3/`0.%8_?7/L>?H17)^%O$E]X2\0VNL6##S86^ M9">)%/53[$5]E^*?"FE>,-';3=6@\R+.Y&4X:-L?>4^M>&ZM^S=J<,])\8Z-%?Z?<1[RH$T!;YXGQRI']>]=%7SI MX>^`7B;3M;M+R?5K***"9)6$;.2X5@<=!Z5]%T`%%%%`'"?$[XA%> MT:1^TDHC5=9T$[_XI+23@_\``6_QJEKG[.%_%(SZ'K$,\9Z172%&'_`AD'\A M7)W/P+\>P.%CTN&X!&=T5U'@>WS$4`>@ZE^TG9+"1IF@SO*1P;F4*H/T7.:\ M;\7>.M=\:W:SZO=!HXR?*MXQMCCSZ#U]SS78Z?\`L_>,KIT^U_8;-&`)+S;R MOMA<\_C7H?A[]G?0K`QRZW?SZE*,$QQCRH\^G4DC\10!3_9PT)8=&U379%_> M3RBVC)_NJ`2?Q)_2O5O%WABS\7^&KO1[P`+,O[N7;DQ..C#Z?XUHZ;IECI%C M'9:=:Q6MM']V*)0JBK=`'PMXD\.:CX6UNXTO4H&CFB8@,1Q(O9E/<&NW^&'Q M;N/`J/IU]`]YI,C[PJ-\\+=RN>,'N*^E/%'@[1/&%B+76;)9@O,<@.UXSZJP M_ETKQO5_V;)?-9]'U]#&*]1\9^()M5U%AO;Y8HU^[$@)PH_/\:]*M/V(!M>X4"-3ZA.?U)H`Y;X(_"^:P MDC\5:Y!LE9B%NS'TKJ:^?;K0K+Q9^T(+C0?,:"QE6?4[DG*"5.-JY^ M@'Y^E?05`'*_$+6K32/`VM23WD<$K6`Q=E(4`=>I%?%1KZG\5?`VP\5 M>([S6+C7+R%[E]WE+&K*G`&!D^U94/[-NBK*K2Z[?21CJHB12?QYH`L>#_C+ MX+T?P=I.G7E_.ES;6R1R*+9R`P'/('-:MU\?O`T$8:*>^N6SC;%:D'_Q[`K, MD_9R\,-&P34M25R"%8LAP?7&*H_\,UZ3_P!##>_]^$_QH`\W^(?Q%N_B7K%E M96UNUKI\_]^$_QJ^O[.?A<*-VHZF3CD[D&?_': M`-=OCQX""DC4+EB!T%H_/Z5YS\1OCG#XAT.?1O#UKM:5`'PA9WNI^&]92YMI)K+4+5^ M#@JR,.H(_F#7NWAK]HRU^R1P^)-,F$ZC!GLP&#\=2I(P<^AKT_Q1\._#/B\; MM5TY#<=KF'Y)/^^AU_'->>S_`+-NB/,S0ZY?Q1GHAC1B/QXH`FU/]HWPY#:D MZ9IFH7-QCY5F58U!]R&)_2O(EU;5_BO\2=,BU.3*W%PB"%.(X8@"/#GA4?\2?2H+>3G,V-TAS_M')H` MWH8D@A2*-0L:*%51T`'04^BB@#RVBBBO7.`****`'1_ZQ/J*]+N?^/6;_EW/_`!Z3?[A_E7'BMXF]'9GF5%%%=A@%%%%`$UG_`,?L'_71 M?YUZ/TO^X?Y5YS9_\?L'_71?YUZ-9444 M5V'.%%%%`$UI_P`?L'_71?YUZ'J'_(.N?^N3?RKSRT_X_8/^NB_SKT/4/^0= M<_\`7)OY5R8GXHF]'9GFU%%%=9@%%%%`%O3/^0I:_P#75?YUVOB'_D7-2_Z] MI/\`T$UQ6F?\A2U_ZZK_`#KM?$/_`"+FI?\`7M)_Z":Y*_\`$B;0_AR/F2BB MBOI3Y4****!&MX8_Y&G2_P#KZC_]"%>]^,?^1-U?_KUD_E7@GAC_`)&G2O\` MKZC_`/0A7O?C'_D3=7_Z])/Y5X^8?QX?UU/:R[^!4_KH?-U%%%>P>,%%%%`C M?\$?\CKI/_7P/ZU[GXO_`.1/U7_KV?\`E7AG@C_D==)_Z^!7N?B__D3]5_Z] MG_E7BYA_O$/E^9[>7?[O/Y_D?-M%%%>T>*%%%%`&]X)_Y'32?^O@5]'U\X>" M?^1TTG_KX%?1]>%FO\6/H>]E/\*7J0WDK064\J8+)&S#/J!FO%O^%L^)?^?: MQ_[\O_\`%5[<0",'D&H#9VO_`#[P_P#?`KCH5:<+\\>8[*]*I4:Y)\IXS_PM MGQ+_`,^UC_WY?_XJC_A;/B7_`)]K'_OR_P#\57LPM+0]+>'_`+X%+]BM?^?: M'_O@5O\`6:'_`#Z_$Y_JN(_Y^GB__"V?$O\`S[6/_?E__BJ7_A;/B7_GWL?^ M_+__`!5>S?9+3_GWA_[X%+]CM?\`GVA_[X%'UFA_SZ_$/JM?_GZ>,?\`"V?$ MO_/M8_\`?E__`(JC_A;/B7_GVL?^_+__`!5>S_8[7_GVA_[X%)]DM#_R[P_] M\"CZS0_Y]?B'U6O_`,_3QG_A;/B7_GVL?^_+_P#Q5'_"V?$O_/M8_P#?E_\` MXJO9_L=K_P`^T/\`WP*0V=H.MO#_`-\"CZS0_P"?7XA]5Q'_`#]/&?\`A;/B M7_GVL?\`OR__`,51_P`+9\2_\^UC_P!^7_\`BJ]F^R6G_/O!_P!\"E^Q6O\` MS[0_]\"CZS0_Y]?B'U6O_P`_3QC_`(6SXE_Y]K'_`+\O_P#%4?\`"V?$O_/M M8_\`?E__`(JO9_L=K_S[0_\`?`H^QVO_`#[0_P#?`H^LT/\`GU^(?5<1_P`_ M3QC_`(6SXE_Y]K'_`+\O_P#%4?\`"V?$O_/M8_\`?E__`(JO9OLEH/\`EWA_ M[X%`L[0]+>'_`+X%'UFA_P`^OQ#ZK7_Y^GC/_"V?$O\`S[6/_?E__BJ/^%L^ M)?\`GVL?^_+_`/Q5>S_8[7_GVA_[X%'V.U/_`"[0_P#?`H^LT/\`GU^(?5<1 M_P`_3QC_`(6SXE_Y]K'_`+\O_P#%4?\`"V?$O_/M8_\`?E__`(JO9_L=K_S[ M0_\`?`I/LEI_S[P?]\"CZS0_Y]?B'U6O_P`_3QG_`(6SXE_Y]K'_`+\O_P#% M4?\`"V?$O_/M8_\`?E__`(JO9_L=K_S[0_\`?`H-G:CK;P_]\"CZS0_Y]?B' MU7$?\_3QC_A;/B7_`)]K'_OR_P#\51_PMGQ+_P`^UC_WY?\`^*KV;[):'_EW MA_[X%+]CM?\`GVA_[X%'UFA_SZ_$/JM?_GZ>,?\`"V?$O_/M8_\`?E__`(JC M_A;/B7_GVL?^_+__`!5>S_8K7_GVA_[X%'V*U_Y]H?\`O@4?6:'_`#Z_$/JF M(_Y^GC'_``MGQ+_S[6/_`'Y?_P"*H_X6SXE_Y]K'_OR__P`57L_V.T_Y]X?^ M^!2?9+0_\N\/_?`H^LT/^?7XA]5K_P#/T\9_X6SXE_Y]K'_OR_\`\51_PMGQ M+_S[6/\`WY?_`.*KV?[':_\`/M#_`-\"C[':_P#/O#_WP*/K-#_GU^(?5<1_ MS]/&/^%L^)?^?:Q_[\O_`/%4?\+9\2_\^UC_`-^7_P#BJ]G^QVO_`#[0_P#? M`H^Q6O\`S[0_]\"CZS0_Y]?B'U7$?\_3QC_A;/B7_GVL?^_+_P#Q5'_"V?$O M_/M8_P#?E_\`XJO9_L=J.MM#_P!\"D%I:'I;P_\`?`H^LT/^?7XA]5K_`//T M\9_X6SXE_P"?:Q_[\O\`_%4?\+9\2_\`/M8_]^7_`/BJ]G^QVO\`S[0_]\"C M[':_\^T/_?`H^LT/^?7XA]5Q'_/T\8_X6SXE_P"?:Q_[\O\`_%4?\+9\2_\` M/M8_]^7_`/BJ]G^Q6O\`S[0_]\"C[%:_\^T/_?`H^LT/^?7XA]4Q'_/T\8_X M6SXE_P"?:Q_[\O\`_%4?\+9\2_\`/M8_]^7_`/BJ]G^QVO\`S[0_]\"C[':_ M\^T/_?`H^LT/^?7XA]5Q'_/T\8_X6SXE_P"?:Q_[\O\`_%4?\+9\2_\`/M8_ M]^7_`/BJ]F-G:#K;P_\`?`H^QVA_Y=X?^^!1]9H?\^OQ#ZK7_P"?IXS_`,+9 M\2_\^UC_`-^7_P#BJ/\`A;/B7_GVL?\`OR__`,57L_V*U_Y]H?\`O@4?8K7_ M`)]H?^^!1]9H?\^OQ#ZIB/\`GZ>,?\+9\2_\^UC_`-^7_P#BJ/\`A;/B7_GV ML?\`OR__`,57L_V*U_Y]H?\`O@4?8[3_`)]X?^^!1]9H?\^OQ#ZKB/\`GZ>, M?\+9\2_\^UC_`-^7_P#BJ3_A;/B7_GWL?^_+_P#Q5>T?8[7_`)]H?^^!1]CM M?^?:'_O@4?6:'_/K\0^J8C_GZ>,?\+9\2_\`/M8_]^7_`/BJ/^%L^)?^?:Q_ M[\O_`/%5[-]DM!UMX?\`O@4OV.U_Y]H?^^!1]9H?\^OQ#ZK7_P"?IXQ_PMGQ M+_S[6/\`WY?_`.*H_P"%L^)?^?:Q_P"_+_\`Q5>S_8[7_GVA_P"^!2?9+0?\ MN\/_`'P*/K-#_GU^(?5:_P#S]/&?^%L^)?\`GVL?^_+_`/Q5'_"V?$O_`#[6 M/_?E_P#XJO9_L=K_`,^T/_?`H^QVO_/M#_WP*/K-#_GU^(?5<1_S]/&/^%L^ M)?\`GVL?^_+_`/Q5'_"V?$O_`#[6/_?E_P#XJO9OLEI_S[P_]\"E^QVO_/M# M_P!\"CZS0_Y]?B'U6O\`\_3QC_A;/B7_`)]K'_OR_P#\51_PMGQ+_P`^UC_W MY?\`^*KV?[':_P#/M#_WP*/L=K_S[0_]\"CZS0_Y]?B'U7$?\_3P^U^).LV+ MSO:Z9I<#7$AEF:.V93(YZLV&Y-6?^%L^)?\`GVL?^_+_`/Q5>S_8[7_GVA_[ MX%'V*U_Y]H?^^!1]9H?\^OQ#ZKB/^?IXQ_PMGQ+_`,^UC_WY?_XJC_A;/B7_ M`)]K'_OR_P#\57LWV.T_Y]X?^^!2_8[3_GWA_P"^!1]9H?\`/K\0^JXC_GZ> M,?\`"V?$O_/M8_\`?E__`(JC_A;/B7_GVL?^_+__`!5>S_8[7_GVA_[X%)]D MM/\`GWA_[X%'UFA_SZ_$/JM?_GZ>,_\`"V?$O_/M8_\`?E__`(JC_A;/B7_G MVL?^_+__`!5>S"SM#TMX?^^!2_8[7_GVA_[X%'UFA_SZ_$/JM?\`Y^GC'_"V M?$O_`#[6/_?E_P#XJC_A;/B7_GVL?^_+_P#Q5>S_`&.TSC[/#G_<%'V.U_Y] MH?\`O@4?6:'_`#Z_$/JN(_Y^GC'_``MGQ+_S[6/_`'Y?_P"*H_X6SXE_Y]K' M_OR__P`57L_V.U_Y]H?^^!1]CM?^?:'_`+X%'UFA_P`^OQ#ZKB/^?IXQ_P`+ M9\2_\^UC_P!^7_\`BJ/^%L^)?^?:Q_[\O_\`%5[/]CM?^?>'_O@4?8[7_GVA M_P"^!1]9H?\`/K\0^JXC_GZ>,?\`"V?$O_/M8_\`?E__`(JC_A;/B7_GVL?^ M_+__`!5>S?9+3_GW@_[X%*+.U/\`R[0_]\"CZS0_Y]?B'U6O_P`_3QC_`(6S MXE_Y]K'_`+\O_P#%4?\`"V?$O_/M8_\`?E__`(JO9_L=K_S[0_\`?`I/LEIG M_CWA_P"^!1]9H?\`/K\0^JU_^?IG>%-4N-:\-66H7:HL\RDL$!`X8C@'/I6S M3418U"HH51T`&!3JX9--MH[XIJ*3/+:***]8X@HHHH`='_K$^HKTNY_X])O] MP_RKS2/_`%B?45Z7<_\`'K-_N'^5<>*WB;T=F>94445V&`4444`3V?\`Q^P? M]=%_G7HUQ_Q[2_[A_E7G-G_Q^P?]=%_G7HUQ_P`>TO\`N'^5<>)^)'11V9YE M11178H?\@ZY_ZY-_*O/+3_C]@_ZZ+_.O0]0_ MY!US_P!;4445UF`4444`6],_Y"EK_`-=5_G7:^(?^1TG_H)KDK_P`2)M#X)'S) M1117TI\J%%%%`&MX8_Y&G2O^OJ/_`-"%>]^,?^1-U?\`Z])/Y5X)X8_Y&G2O M^OJ/_P!"%>]^,?\`D3=7_P"O5_Y5X^8?QZ?]=3VY^+_P#D3]5_Z]G_`)5X9X(_Y'72?^O@?UKW/Q?_`,B? MJO\`U[/_`"KQH'I7%Z1:KXOFO=0U4O+9I1]/LXK762>'GUWQ`=8TV2[F_M!]C+;/)A>.,@>M>A:/%91 M:5`NGVY@M2,I&4*;D:CJTEG:Z=/#>7;7"F6X9&`/;`4^E=/ M8M>/:(;Z***X.=R0N64<\8)`_E6]>2EL_P`3GP\7'=?A^ID^-?\`D3-6_P"O M=JX>9/#LFCV47A^(Q^('2/R7MU9&WX&XL3@%>N:]#\1Z?-JOAZ^L+?/-N]S.A#DII6L.S:`C)W;BV>GI6Y2J-.UNPZ::<"NJ\-Q:/':2MH]BUI$S_.K0M&20.N#21Z1<+XSGU8F/[. M]HL(&?FW!L],=*VZNK43BHKLC.E3:DY/NQLG^J?Z&N9^'O\`R)]O_P!=9O\` MT8U=.X+(P'4C%8WA32KC1=`AL;HH94>1B8SD89R1_.H37LVO-?J:-/VB?D_T M-.^_X\+C_KDW\J\Q\+Q^$V\.6)O]&DGNBG[R06;N&.3W`P:]1N8VEM98UQN= M"HS[BN2T.S\5:)HUKIJ6.ERK`NT.;IP3R3TV>]:4I)0:OVZV[F5:+QK9BABA&(XT0?[*@5T0J MJ$$O4Y9T7.HWY(>*Y7Q!_P`CIX9_WYO_`$"NKK$\0Z-<:DMIYTO7->:"#5A M9VME%*LKQVTC2-,5.0"2!@9'O75=*<[*"CZBA=SU]K:'4UL;6TAG69U@D:1WVG(`)`Q6U.<5 M!)OO_5NIA5IR=1M+M_5^AU8KE?$/_([^%/\`KIQ:4LD\A0-N7;U`/O6%)I2U\_P`C>LFX:>7YG245E:;-KDEPPU.TLH8= MORM!.SDMGI@J.,9K5J&K&L7=7.4\)_\`(=\4?]?X_P#0!733S""WEF()$:%B M!WP,UD:'I%QIVIZU<3&,I>W0EBVDDA=H'/'6MME#*5(R",$5=5ISNO+\C.DF MH6?G^9QN@:3#XHTQ-9US==M=$O%;NW[N%,\`*.,\=:Z73='L-(C>/3[9+>-S MN94Z$^M8=GH^M^'DEM])DM;NR9R\4-TS(T63D@,`,YP>E9&G>!]#M M=+@MKC3+6:98PLDK1@EVQR<_6NBC.,$Y/^NYS5X3J-1CM^O0W[.ZBO;.&Z@< M/%*@=6'<&J'B75'T;P]>7\2[I(D^0'IN/`S[9-5_"FDWNB:2=.NI$DCAE86[ MJQ)\LG(!XX(S6IJ-C#J>G7%C<`F*="C8ZC/<5G[L:G=7-+RE3[.Q@V/A#3[J MRBFUF/\`M*\D4/)+<$M@DM.HY/K="I**^ MS9F3XNU6XTC07FM`/M4LB01,>BLQP"?I44/@O1FA7^T+?^T+C'SW%R2S,?Z# MV%:6M:3#KFDSZ?.S*DH&'7JI!R"/H:S(AXLLH4@":;?!!@3R2O$S#MD!3S3C M+W+1=F3./OWDKHWK:VBL[:.W@0)%&-JJ.PK#\6:A8WG`^N_.F+8W5B9&>'[1(R/$&.2O"D$9^E3"S@X^A<[J:E;N+X8_P"1H\5?]?4? M_H`KJZQ_#^C2:3#)?^17U7_KTD_]!-E<]X-T*_T*VODU"=)Y9[DR+(I)++@` M$\=>*Z:HK-.HW%ET$_9I21Y[J'A;0XO'6DV::9;K;RV\S21A>&(Q@FNXL-.L M]+M1;6-ND$`)(1!@9/6LV]TBXG\7:;JB-'Y%M#)&X)^;+8Q@8K+_O@445J9A]EM_P#GWB_[X%'V6W_Y]XO^^!110`OV6W_YX1?] M\"I",\'I1142*B1_9;?_`)]XO^^!2?9;?_GWB_[X%%%62'V6W_Y]XO\`O@4? M9;?_`)]XO^^!110`HM;<'(@B!'?8*E(R,&BBID4B'[+;_P#/O%_WP*/LMO\` M\^\7_?`HHJB0^RV__/O%_P!\"C[+;_\`/O%_WP***`#[+;@@B"($?[`J8@$8 M(!!Z@T45,MRD0_9;?_GWB_[X%'V6W_Y]XO\`O@4451(?9;?_`)]XO^^!1]EM M_P#GWB_[X%%%`"BV@4@B&,$="$%2.JNA5E#*1@@C((HHJ7N4MBG_`&3IO_0/ MM/\`ORO^%']DZ;_T#[3_`+\K_A1170<8?V3IO_0/M/\`ORO^%']DZ;_T#[3_ M`+\K_A113`5-,L(W#I8VRLIR&6)00?RJU(B2QLDB*Z,,%6&01116-3XD;4_A M94_LG3?^@?:?]^5_PH_LG3?^@?:?]^5_PHHK4Q#^R=-_Z!]I_P!^5_PH_LG3 M?^@?:?\`?E?\***8#H]-L(I%DCLK9'7D,L2@C\<59D1)(V2159&&"K#(-%%8 M5/B1O3^%E3^R=-_Z!]I_WY7_``H_LG3?^@?:?]^5_P`***V,`_LG3?\`H'VG M_?E?\*/[)TW_`*!]I_WY7_"BBF`Z/3;&*19([*V1U.0RQ*"/QQ5RBBL*NYT4 M=@I***R-A:2BBD`4M%%,!#1110`4M%%)`%%%%,`HHHI`%%%%`!1VHHH`**** M8!2=Z**`"EHHI`%%%%,!*6BBD`4&BBA@)2T44P$-%%%`!VHHHI"%I***!A2B MBB@`-)110`M%%%,`-%%%`"4HHHH`*2BBD`4444P"@T44@%I***8`*6BB@!!2 MT44`)2T44""BBB@84444`%)112`****`#M2T44P"DHHI`%%%%,!:***`/__9 ` end GRAPHIC 5 form10k002.jpg IMAGE begin 644 form10k002.jpg M_]C_X``02D9)1@`!`0$`W`#<``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,# M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_ MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``^`0X#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_***\K_; M(_;(\#_L*?!"\\?>/KZ:TT>UGCM8H;<(]U?3R$[8H49E#OM5W(R,)&[=%-`% M_P#:=_:R^'?[&WPRF\7_`!*\4Z;X7T..18(Y+@EI;J5B`L4,2@R2N^O/#^IO]J^'_ M`,/KZY$EC9Z8^'MVNK=6:,(8]FZ'.)VW-,I!VOB_\%"OB'8_\%*?^"NWP,_9 MR\'KINN>"?A7JY\0^-KNVMS>6<,MKMFGLI6C4K$J1PQVN=X7S]0\MP&CVD`_ M6BB@<44`%%%%`!16#\4OB/I?P=^&7B+Q=KDS6^B^%M,N=7U"50,QV]O$TLK< MD#A$8\D5YK_P3W_;,T__`(*`?LC>$OBMINBWOAV'Q)',LNG7+F;[+/!/)!*L MT70F\0:C%H^EC4+V*U M.I7LH8QVL&]AYDSA'*QKEF"-@'!K0US7++PQHMYJ6I7EKI^G:?`]S=75S*L, M-M$BEGD=V(555026)``!)K\:_!.EZW_P<@?\%`I/$6M6-]IO[+?P3OKO3[*& M,/#_`,)%-(JX'FLN?M$X6*5S'AK:W,*JTHHHH`*,XHK\O\`_@Z9 M_P""@_C+]DK]CWPM\,_A;=W,/Q.^/NK2>'+..QLI;C4FTU8PEV+,H,)"; MB:X\,^-],CU*T$VSS[8G*R6\P1F59H9%>*159@KQN`3C-?A)^TQ\-_V?_P#@ MW*_X)B>*OADTGA'XB?MB?&KPM<^'];O(46[ET.VO8MD^%9BUG:1P7!$>51KV M6-'9"B%8/TG_`.#:3]DGQ?\`L>?\$E?`^B>.M/U;0_$OB2\O?$D^D:BQ\[28 MKF7_`$>(H6/E%H$BF:+"LCSNKJL@<4`??%%%?!O_``4L_P""@?C?4_BY:_LS M_LU^7J7QT\01I+JNJ@*UIX(L6VLT\[LKI')Y;*V65BB2)M5I)858`[3_`(*) M?\%H/A;_`,$_=33PO(E]X_\`B=>%$M?"&@D2W4;N$,?VEP&%N'\R+:I5I&$L M96-E;=7S[9_\%I?VE_A9X-N_BC\5OV2M7\-_!>&\MX;NZ&H_8=DW'B*[7_A-OC#XD/VOQ#X MSU8_;+Y[B15_\%ZO'>I?%?1?@_P#LQ>%+ MY;?Q+\>O%]G#J3K8+J']GZ/9RK/-% M--\">%=,T/1[.'3](T:TBL;&UA&V.V@B0)'&H_NJJ@#V%:%`!1103M%`!17Y M7_L:?\%`_BG_`,%'_P#@MAK=_P##7Q!J\/[-7PST^YT[4[6YMQ;VNK!H'BAG M"$,3-+?*TL3,4<6UN00A,L;?JA0`45\D_P#!:?\`;QM?V#_V'/$FIV6J1V/C MKQ="^@^%(DD*W`NYEVM=)MY46\;&7>?E#B)2U@E;)+-M)<`X,:2I%@>50!],(?@S^S'>:I=V>KW7]D7^O:9:3_VAKL\I M,(M+`*!*B!VP94`=V"["(SF0`_17]N?_`(+-_`;_`()_W<^F>,/%#:MXJMRH ME\.Z$L=WJ,&Y`X,H9TCARK(P$LBL0P(!&2-;_@FS_P`%2_AS_P`%/?`OB#5O M`Z:IIE[X8O$M=1TO5%C6ZA61=T4P\MF5HWVR*"&SNB<$#`)_EJ_:&^"GB?X# M?&_Q/X9\92*OB31;GR=8E69)R;DA2\6\L5FG22;RYC$[@,'*EU&6_:__`(-/ M?V2-3\!_"7X@?%S5ENH8?&$MOH.BQR0RQ));VFYIYHRX`DC:61(U8#*M;2(2 MQ7@`_76_OH=+L9KJXEC@M[>-I99';:L:*,EB>P`&(9 M5;T;_@N?^T7XDM/A[X,_9]^'-Y#!\0OV@=2'A_S'B:9;'3)"(KB1U1MZJ_F` M%BI3RHKK)!45]>_LV?`'0/V6/@-X3^'GAB.1=$\(Z;%I\$DJ1+/=E1^\N)O* M1$,TTA>61E10TDCM@9H`^H?L'?L):QJWAN;R?&WB^Y7P[H,@Y:S MDE1WFNL*ZN/*MXY2KINVRM#E6!(/C'_!MW_P3)F_8^_9PF^)GB[3IK/Q]\3+ M>-[>VN%42Z-H_P`KPPD`91YF"S.I.0!`K*CHXK]!_BC\&_"/QP\/PZ3XT\*^ M'/%VE6]RMY%9:UID.H6\-+C;I>@P9AM8Y%6XU.X(/EVT(8C+L03_LJKN?E5B-3]D[]J#PO M^V=^SQX8^)O@N2^?PWXJ@>:V6\@\FXA:.5X98I%!8!XY8Y$.UF4E"59E(8@' MHE%&:Y+X[?''PQ^S7\(=?\=>,M4M]&\-^&[4W5[=3,!@9"I&@)^:21V2-$'S M.[HJ@E@*`/SZ_P"#B;]L[6-'\'^#?V8/AW<1-\1OCY>VNF72"Y>UDMM,N+H6 MR1^:&58_M<^8"S;U,,=RK)\ZL/NC]CS]F'0?V,?V8_!?PP\-C=I7@_3ELQ,4 M*->SDM)<7+*6;:TT[RRE02`9"!P`*_/K_@AM\`O$'[87[0'CC]MSXJ:?I?\` M;WCB>:P\&6L*QN-*@B+V<\BDPJV4BB2SCE#!G1+@R!MZM7U=_P`%*_\`@J=\ M/?\`@G=\--1_M36-/O/B)>:9+<^'O#>))9+R0%8T> M6=U<7[W$MCHUX\5YB5=JK]IN;C,\K?-QY0&QC*&_2:@`HHS10`CCN1W,MUY5D]M(\CW, M5U=B+Y0DJ3Q/'MS&&;]*?^#B#_@M%XK^'GC2V_9#_9OCOM4^.GQ",&DZMJ&G M-MNO#L=XL9BM;8D`+=W$4F3-N7[-$X=2)&62'Y,_X-:_V`O$/[)G_!:3XL>$ M?BUX;TFQ^(7PO\!^;#;23VU^VF37TE@ZW%O*A;+N8LRB()Y#\+O#]_P#\%-O^"Q6M M>/M4CAO?@[^S#OJ9M/\`".G/=BV5MCW\Y(2WM5;!VO-,\<2DC`,@ M)X!K\M?^#)OVH/C1X@OO%M_X=6X\*^''UB/S+JVNY#YUU/# M\J+!'''8KBY0E"T2U^KO[+7[-OAK]C_\`9\\*_#7P MA'N:S?6VF:/HMI+?7UY M%554L2>@!K\E_P#@EWX+U?\`X+'?\%$M>_;!^(UC##X-^&LJZ#\.M$>RM6BB MD3SI8S(=SNSVJ7"W'F,`7N;M'C9$MTB4`^X/^"37[!%C_P`$\OV-?#O@]H8? M^$LU"&/5/%-RC;A-J+QH'C3YF41PJJQ*$PIV%\!I')^F**^#_P#@O#^V_P"* M_P!GO]G_`$WX:_"FXU2/XP?%RYCTK29])D'V[1[5IHXY;B,;6/FRLZV\6#&^ MZ622.17@%`'R#\&O#EQ_P7D_X+/ZSXWUB/\`MS]G7X+HD-II]]:;;+555_,L M8C$[*S&XN$^V2"2)OW<"0R;?W:C]KJ^>?^"6W["5I_P3G_8S\-_#5+JSU35K M>6?4=:U*V@,(U"\GD+$G))?RXA%`KG!9+=#M7.T9/_!7#]OJ'_@G;^QOK'C* MW@^U^)M6E&B>'820$6^ECD99Y"00(X4C>4Y&&**F5W@@`^*O^"]O_!4G4?%7 MC"W_`&3_`((S/X@\=>+YO[(\3+8!696F4;-+1R=F^0'$X.`J.$W;O,0?2?\` MP1W_`."-OA?_`()O?"NSU/6[?2=>^+&I0B34=52V0QZ-N0*UI9,1N6,#(9^# M(^\/^&]2_:1^)%NUWXR\=337'AZ2XD\]VM)PKRZD M[,2XGN&9DPP#*B,4"(]6C\7V21REF;3S=3S(S`$J,IJMN<_* M>2,':2/TRH`*S?&'B_2_A]X2U37M)M%\*:#:_*][J5TL$;OM9A&FXYDD8 M*VV-`7;&`">*_%O_`(*X?\%:M2_X*?VOAW]GOX`V.NV>F^/->@LEU2ZA:VN/ M%@$TT<8BB)'E:<)(TE>:4JYV@%(Q')D`/"&CZ]_P:D32?6G_!;G_@K#HO_!+G M]G[2_A7\)[?0[3XG:YIT>G:#I5G`%@\*:8%\E9X[>/"APJ^7;Q?*@8;SN6/R MI?"_CI_P4E^'O_!(W]G'3?V6/V6+&U\=?&B,0Z/?:SH>FK+OA?-J?B7Q M':ZO(]Q<2ZE9W4=LJAU8KO@OYXY.I7]PP&58"@#]+/VHO$G[:UY_P1[^&/B3 MPN+Z+]H2VNK76?%EOH.GVJWCZ>(KN01&SN8L/C_!&^\$WVBZYX?UF[3Q-X=\+Z1=M)J=Q$ZI"LUH7DN0 M;25),Q&0(TC*9%'EH1^]'_!1W]LK3?V!OV,_&_Q.U!4GN=#LO*TJT;:?MVH3 M,(K6+:64LOFNK/M.X1K(P!VXKY/_`.#;;]F&\\*_LM:U\0L,^9/*\TS,K,)$:W)RRDT`>-_`/QM_P4*_:9T7PSX) M\'>"=%_9U^'OAS3!HSS7FA2Z4+>V53#&H6^:>]:18D!1[?;@XWOE@Z_,_P"S MG_P3A\-_M2?\%SM<^&>K>._$WQ3TWX9P_;_'GB+5@5G\27=I*@N(<2'S8XA< M2Q6C#S)G(BE=)`K?N_WL_:#^+UO^SY\!/&_CZ\L;G4K3P1H%_K\]G;LJS7:6 MEO).T:%B%#,(R`6(&2,\5^0'_!(C]HCP[_P3N_X)-?$?]H#QUXDL8_B3\<-0 MU34?#2:@XGO/%]W90O%$!$A:9R=2DNA)(^U5\U6;RU8,P![K_P`%=_\`@XHT MG]A7XAW7PW^%^BZ)XX\>Z?$XU6]OYY/[+T*Z#1%;1TBVM<2M&T@?;-&(6,8) M=O,2/V;_`((0?MO?$7]O7]B^^\8?$J!9-6M/$]_IUGJ46GQV4.HVJLLB81&( M)B,C0E@JC$2@EY%E<_A1_P`$R/V-+/\`X*#_`!>\0>)OB1\0=*\!?#+P?-%? M>.?&&L>(8(;JZGO;H>5`)IY]R3WA^T+YI"@,'9@S&..;]`?VN_\`@IKJ7[7O MB+PS^R-^Q+9/IWA:XM8M(N=>M+.2W@N++R]DD,)="\%E$N?.N"/-=D<*`H#7 M(!P/_!?7_@O+:_'/^U/@=\$=GSI)XK\565S"J^(4CD3_1=/D)S);+ M*5WR1$-,8R%/V=9#/]9?M_\`_!6F^_X)6?\`!$[X7^)KGQ)9^._C#X^\*:?H M_A74HKD3B^NWT])'UF7[4S2W,,"%)'D*-YT\T`=(EG/E_DM_P49_92^"OPG^ M,?@_X"_!B37_`!U\7M-O4\/^*M;GOA9Z;=:OYDJFRMH)6`CS(Y1W,FQ/*C`8 ML)F/O/\`P=&?L8>,/@/_`,$O/V/('OI/$VB_"^&[\/:[J:Z@UY'%>7EM:26Z MQ,50M:+]DNHHG9%V1I`G!8`@'TI_P:Q?\$IKOP7X"O/VM_C!;2:]\6/BVTVI M^';S5]]Q?:=I]R6>742\G/VJ_,C/YO+?9V7#XN)4/H'[(>J77AO_`(.R?VK- M'FA8P>)OAAHVLP2D-&%6VAT6VVX9`),M+(=ZL0NTKDMD)]Y?\$_OBM\/_C3^ MQ+\*_$/PMF63P#=>%]/BT:`W4=Q/IT$=ND8LYVC=U%Q!M\F5-[%)(W4G(-?% M7_!6K4[#]C;_`(+!_L9?M'7NGM;>&];N]2^$WC#7))H4M[*.^C+:4)#*P$2) M//?3O*N,1P.">BL`?IK7A?\`P4N_:-;]E/\`89^(WC2WFN[?5+72S8:5+:M& ML\-]=NMK;2IYAVGRY9DD(.?EC;@]#Q_[6/\`P6J_9=_8LT^_/CCXS>#1JVG7 M$ME-H>C7@UG5X[F/<&A>UM?,DA8,A0F8(BMPS+7QE_P7#_:X\&_MJ?\`!/K] MFWQ/X1>ZO_`/Q.\7VNMC4T>-9K"*.VN+::U<8>-+I#=3*P9ML;VD@)XR`#[8 M_P""/_[-B?LN_P#!/CX?:));^5JVM6?_``D.JO);^1<37-Y^^'GKM7]]'$T, M+$@']SS7TS0.E!.*`/E?]F3_`()'?#?]EW]N/XG?'S2KS7-4\8?$J>YF:+4) M(WM]'^U3"XN1``H8EY1PS$E$)0<%BWF__!7G_@N7X-_X)K63>%-$MK/QE\6+ MZW\R'26F9;/0U=/W5Q>L@)P2480*5=U():,.CM#_`,%)O^"M6I>![W6?A!^S MAI__``L3XX>5-08R/*(501_3I7Y%_P#!,O4M0_X*Y?\` M!6OQ5^U1=Z=KFB_#WX6V_P#8GA&UOV#&29[>6!(3^[,7R1SW-U-$C[X9KNVQ M))&U?KI0!^RJKQ6CPB8;4145[UHHQE+BXBDW?, M-WV!_P`%P?VIC^R=_P`$X?'.JVFJ7&D:[XH6+POI%Q`C^3P_;G38 MKI;)&>?3[W4+PB>5@K`D1VB6L@)X4%R<;@:_:ROQ7_X*=:K;?L8?\'$GPA^+ M&M*Q\.:_;V5W=W$Q:.VLHO*ETZZFW!<$P0HDSYS@>4"RAE``/V@TG2K?0M+M MK*SACM[2SB6"&*,;5B10%50.P``%6*@TW4[;6=.M[RSN(+JTNHUFAGAD$D%/@;X,N?$7C/Q)H?A70;/`FU#5KZ.SMHR>`"\A M`W$\`9R3P,F@#HZ*^8OV3/\`@K#\,_VV/VDO$WPY^']OXDU)O"^F-JLNO26B M1Z5>1":.$")MYE!9I&QYL<>X1N5W`$CZ=H`^1_V_/^";6M?'GXM^&_C/\'_& MDGPT^.G@VV:SM-1DW2:5K]I\Q%G?0@,-H9VQ(J,=K$,D@6/R_.=5^-'_``4, M^)6C?\(Q8?!GX4_#G6)(3;7'C*Y\30ZAIZN5*FXMK97DEC^8AU$T4P`4AD;( M%??U%`'Y[?!K_@@EHWC/XDV_Q&_:;\?^(OC_`..U)D2TOYI+?0]/+2";R8X0 MV]X8Y3-LC!BMRDS`VPXQ4_X*J_\`!OMH/_!1+XA^!O$'AGQO;_"K_A$-`C\+ M'3[7PW#=V(TZ&626W2WCCDMVA,9FE7;N9"ICVJFQO,_12B@#X_\`^";O_!%7 MX1?\$X(H]8TFWN/&'Q#8/YWBK6$7[1#YB;72UA7]W;1D%Q\NZ3;(Z-(R84<; M^QM_P28\4_LD?\%O'I3W5Q-J8O;R[MKZ9I$\M(51 M+A;H1D.[+'(%QEV8?>5%`'RC_P`%=O\`@FM>?\%1O@+X=\!V_C;_`(0FVTGQ M`FM7-PVG&^6<);7$*@1B2([E:8,/G`QN[X(^D?A=\-](^#?PS\.^$/#]O):: M#X5TRVT?38'F>9H;:WB6*)"[DLQ"(HW,23C))-;M%`'!_M3?"F\^/'[,GQ&\ M#Z?-:V]]XR\,:GH=M-=%A!%)=6DL"-(5!;8&<$[1G&<(V&T;XVCM_O$@B?:NQOVBHH`_) M?XL?\&EWPU\9_&;^V/#OQ.\5>&O!MQ,9+K0)K!-0NHHWD9I(K6\:5?*7:P5& MEAF=2-S-(<8^^/V'O^"=GPI_X)Z>!;K1?AOX?%G=:JZRZMK-ZXN-5UAU&%,\ M^!\HY(C0+&K.[*@+N6]PHH`^`?$__!MS^SWX[_:5UWXF>(+[XB:U>>)=:O-; MU+19-6M[72[F2ZDEE>(_9[>*X\I7F)4";=\B@LPR#]>?$;]E/X=?%K]FNZ^# M_B+PCH^J?#.\T>/07T"2,K:QV<2*D,<>TAHC%LC,;H5>-HT=&5E5AZ%10!^' MOC3_`(-"/%GP1\;ZIJW[-7[5'CGX<:??-;R1Z??+/#=^9"0RM+?6,T(DVR&1 MX_\`1P4R!ECEZ\[_`&@?^#43]J;XN_!34+7Q3^U=??$RX\*V/VGPMX8U>ZU& M\LKFXCBVK`DEU<^7:<&2-'",,%<[%9MO]`U%`'\[?_!NU_P1>_9$_;#^&FL? M\+O_'KP3?WVD^,?AWKNK/I":"\-T4CGCM+?R;LJ$,<?#S4$\2>'/#^F6,5A8W30PW4;V M<*QH%@>1;J5D*A09@@+(&:17$L<-OJ=N0P=-B"$R*K?NG*R17"I'&OU%^QG\9=8_:!_9<\ M$^+O$5KIMGXDU;35&LPZ<'%BE_$3#=?9_,)?R#/'(8]Y+["N[YLT`?)/P?\` M^#C[]GO4?A1;S?$K6M7^'?Q'TN%K?Q!X3NO#^H27-E?Q92:*-HXG0J9$<)O= M6`VAPC9%>:W7[>?[1?\`P6-UB\\*?LY^%=6^#WPAF86VJ?$O71Y=Y/$R2+*E MJ(R5WJP==MK))(&$1:>V#G'Z'?$S]D_X6_&KQ;;Z_P",OAKX!\6:[9P"U@U' M6?#UI?W<$08L(UEEC9U0,S$*#C+$]2:[Z.)88U555548``P`*`/`?V#?^":_ MPQ_X)[_"^YT#P=IC7VI:PH_MS7]32.74M;(!`65U55$2@D)"BA%RQP7=W;\U M]7_X-B?BY;^+]>\"Z#\=DT_]GW6=;.IKIES>7D]U&OEC:\NGJB6DURNR&'S3 M*NY5,F%.(1^U%%`'F_[)_P"R=X'_`&*O@EI7@#X?Z0FE:'I@+N[$/)M.FUK]B"^U#1H[J)[^UL?A9XKL[JYMPX,D<4SSRK%(R9"NT4@ M4D$HX&T_OABB@#\WO^#GKX#_`!)^.O[!>AK\.?!.O?$.Z\-^*;?5KS1-%A>X MOG40S0I-'!%&TTFPS$'RF!4.24<#*?,'PG_X*R_\%5OC5?:Q#X%_8M\'^'M# MT1T2TL_%/AS4M#EM[9RX@B22^U&S2Y9$CVNT$84':2D8=%/[@44`?$?_``2C M_:"_;>^,_C;Q=;_M6?!?X;_#'P_8V,$FA7F@:@3=7ETTC"2)H5O+Q7C"#<7, MD)0A`$F$C-#ZK_P4K_X)R>$/^"EOP`/@WQ--)I>H:?&(2R:=/M*D, MA(\R%U.'C)`;"D$,BL/H>B@#\'K'_@VG_::^#FNW&F^!?BEX9DT6_N3V(F9F(,DJ+&[;P@7(^?(/WR>GK_P`'?^#5"WN/$&GZS\3OB]J.J7*21SW= MIHMFP8O\C.L=U,Y(4N'Y,&X[LD_PC]@J*`/-_P!F?]D?X>?L@>#9M#^'WAFS FT&WO9?/OK@,\][J GRAPHIC 6 form10k003.jpg IMAGE begin 644 form10k003.jpg M_]C_X``02D9)1@`!`0$`E@"6``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BLGQ'XD MTWPKI3:EJLK1VRL$+*NXY/3BN-_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_ M`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\` MG_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\` MA>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/ M^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@# MTBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\` MN/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"? M^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"% MZ>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X M7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2 M**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X M_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[ MC_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7I MX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A> MG@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](H MKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_ M`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/ M^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@ M7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z> M!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO M-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\` MOP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[ M\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!? M^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX% M_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W M_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_ M!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP M:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y M_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_ M`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_ M`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\& MC_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H M`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_ M`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\` MG_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\` MA>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/ M^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@# MTBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\` MN/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"? M^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"% MZ>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X_P"_!H_X M7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[C_OP:`/2 M**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7IX%_Y_P"X M_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A>G@7_`)_[ MC_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](HKS?_`(7I MX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_`+\&C_A> MG@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/^_!H`](H MKS?_`(7IX%_Y_P"X_P"_!H_X7IX%_P"?^X_[\&@#TBBO-_\`A>G@7_G_`+C_ M`+\&C_A>G@7_`)_[C_OP:`/2**\W_P"%Z>!?^?\`N/\`OP:/^%Z>!?\`G_N/ M^_!H`](HKS?_`(7IX%_Y_P"X_P"_!KJ/"WC/1?&5O//HT[RI"P5RZ%<&@#H* M***`.5^(/A%_&WAA](CNEMF:17\QESTKR/\`X9KNO^A@A_[\FOH*XF6WMY)G M#%44L0HR3]!6!X?\71Z_=ZC;I87-O)98RLPPS9&1Q0!XY_PS7=?]#!#_`-^3 M1_PS7=?]#!#_`-^37KT7C`IK=KINHZ5/+ M>TFNWBL+BXL+*01W5TF-L9[\=\=ZFU[QM;:(;4BSN;F.X*8FC7Y%#="30!Y# M_P`,UW7_`$,$/_?DT?\`#-=U_P!#!#_WY->V>)=?'AW06U4V[3QHR!U!QM5C M@G\,U3O_`!G:6/B72M',3,VH)O64'A!CC/UH`\?_`.&:[K_H8(?^_)H_X9KN MO^A@A_[\FO;-(U]=6U;5;*.`JEA*(C*3PYQDXJSK.MV>A68N+MF^9ML<:#+2 M-V`%`'A7_#-=U_T,$/\`WY-'_#-=U_T,$/\`WY->ZZ=J4EUIS7EW9R6(&3LF M(R%'<^E8.G_$32;W2-2U1P\%K93>46?J_N*`/*/^&:[K_H8(?^_)H_X9KNO^ MA@A_[\FO8K[QC9VMQH2Q!9H=5F,2RAQB/"[LFN@AGBN(_,AD21/[R'(H`^?? M^&:[K_H8(?\`OR:/^&:[K_H8(?\`OR:]=\2>-;?P[KFEZ;+;M+]M)BX61"4^\`?N_6@#Y M]_X9KNO^A@A_[\FC_AFNZ_Z&"'_OR:^@8;F"Y4F":.0`X)1@<&JNM:M;Z'I- MQJ-UGRH5R0O4GL!0!X1_PS7=?]#!#_WY-'_#-=U_T,$/_?DU[3H>M:CJ2M-? M:2;"V,8DCD>8-D'U';BM@7,!*`2H3(,H`P^8>WK0!\_?\,UW7_0P0_\`?DT? M\,UW7_0P0_\`?DU[`WC;3[6VMY-05K1[BY:WCC=@22#C=]*WVO;5`A:XB42? M`?\,UW7_0P0_P#?DT?\,UW7_0P0_P#?DU[_`'<[V]K)-'"\[*,B M-.K?2N>L?&<+W]S8ZG93:=<00FXVS$$-&.X(H`\A_P"&:[K_`*&"'_OR:/\` MAFNZ_P"A@A_[\FO6M*\WLM% MGEMH9S`]SO`4$=3B@#R/_AFNZ_Z&"'_OR:/^&:[K_H8(?^_)KU&^\=W-MJ>K M6\&CO/;Z7C[1*)0#@C.0.]=9IU]#J>G6][`28IT#KGT-`'@7_#-=U_T,$/\` MWY-'_#-=U_T,$/\`WY->S>+_`!1'X3T?[>]NUPQ<(L2G!.:T[/4[:[TZVO?, M5([A`R;F`ZCI0!X-_P`,UW7_`$,$/_?DT?\`#-=U_P!#!#_WY-?0$=U;RL%C MGCZA52<`EP,F@#P+_AFNZ_Z&"'_OR:/^&:[K_H8(?^ M_)KZ"DN(8HA))*B1GHS,`*Q=`\46^MVM[W+.XPVWOF@#Q?_`(9K MNO\`H8(?^_)H_P"&:[K_`*&"'_OR:^@H9XKB,20R)(AZ,C9%5M7U6UT32Y]1 MO7V00+N8]S[#WH`\&_X9KNO^A@A_[\FC_AFNZ_Z&"'_OR:]GT+6]3U8^=_?;[/S%3[5#O?E5WC) M^E1:GJ4&F6,UQ*Z`QQLZH6`+X&<"@#P;_AFNZ_Z&"'_OR:/^&:[K_H8(?^_) MKW#1==@U;P[9:Q)MMH[F,2;9&'RY[9K461'C$B,&0C(8'(-`'SW_`,,UW7_0 MP0_]^31_PS7=?]#!#_WY->JK\0+9KA76QN#IS7'V87G&W?G'3KC-.O\`Q_:6 M=YJ^.;:PO)(+6RGOA!$)KAX<8B0]"?PIU]XWM8FLXM.M9M0N+F`W"Q0XRL8 M[F@#R+_AFNZ_Z&"'_OR:/^&:[K_H8(?^_)KW#3_$-AJ.@#68Y-ML$+/NX*D= M0?>H/"GB:#Q7I3ZA;0R11K,\6U^IVG&:`/%O^&:[K_H8(?\`OR:/^&:[K_H8 M(?\`OR:^AJ*`/GG_`(9KNO\`H8(?^_)H_P"&:[K_`*&"'_OR:^AJ*`/GG_AF MNZ_Z&"'_`+\FC_AFNZ_Z&"'_`+\FOH7 M//':^"ETX#3Y+V6^E,4:(P'/XT`>5?\`#-=U_P!#!#_WY-'_``S7=?\`0P0_ M]^37=)\7[9+355OM(N;/4M.B\U[24C+#V-=CX8\2VOB30;#4DV0R7<(E$!<% ME!H`\4_X9KNO^A@A_P"_)H_X9KNO^A@A_P"_)KZ`DN[:&58Y;B))&Z*S@$T2 MW=M#(L05+'IQUQ M0!Y#_P`,UW7_`$,$/_?DT?\`#-=U_P!#!#_WY->M:OXYM]-OKJ"&QN+R.R4/ M=RQ#B$'^?K5C5O%4EA91W]KI=Q>V+0B9IXB,*OT[T`>._P##-=U_T,$/_?DT M?\,UW7_0P0_]^37O>G:C;ZIID%_;L?(F0.I/'%].U&'5-,AO[;)BF3>N>M84?C!H]0_P##-=U_T,$/_?DT?\,UW7_0P0_]^37KVJ>,'T:[ M7[=I%U%8&98?M?!4$G`..N*CU3QS!8WMW#;V,]W'8J'NY8R`(P?YT`>2_P## M-=U_T,$/_?DT?\,UW7_0P0_]^37KFN^.;71=/MKQ;*ZN89U1]\:?*BL<`D_C M73Q.)8DD`P&4-^=`'SY_PS7=?]#!#_WY-'_#-=U_T,$/_?DU]#44`?//_#-= MU_T,$/\`WY-'_#-=U_T,$/\`WY-?0U(6"_>('U-`'SU_PS7=?]#!#_WY-'_# M-=U_T,$/_?DU]#44`?//_#-=U_T,$/\`WY-'_#-=U_T,$/\`WY-?0U%`'SS_ M`,,UW7_0P0_]^31_PS7=?]#!#_WY->G^._B`W@V]TVTBTJ6_GOR5C2-P#D=N M:VM"UZYO]+-WK&G/H\FXKY-RXSCUS0!XM_PS7=?]#!#_`-^31_PS7=?]#!#_ M`-^37OS7]HL(F:ZA$1.`Y<8)^M.%Y;&81"XB,A&X)N&<>N*`/G__`(9KNO\` MH8(?^_)H_P"&:[K_`*&"'_OR:^A%D1T+1L''^R]6-;\62:1;"]CTJXNM/6,2O_X9KN MO^A@A_[\FC_AFNZ_Z&"'_OR:]_LKN*_LH+N`YBF0.A]B*Q)O&%E'XRM_#:(\ MEQ+&SM(OW4QV/O0!XW_PS7=?]#!#_P!^31_PS7=?]#!#_P!^37KL_BVZ.OW> MEZ?HTUY]D*":97`"EAG'-6]4\40Z?=QV$%K->ZBZ;_LT`R4'JQZ"@#Q?_AFN MZ_Z&"'_OR:/^&:[K_H8(?^_)KZ`,L@M/-$),FS=Y>>PL+SP M_<0->R^7&WF*?J<#M0!Y7_PS7=?]#!#_`-^31_PS7=?]#!#_`-^37LFM>,++ M1M?;OB@#R?_AF MNZ_Z&"'_`+\FC_AFNZ_Z&"'_`+\FO7-1\;0VMV]M96,]\\5NMS-Y9`$<9&0> M>^*W],UM-@OK8DQ3*&7/6@#P3_AFNZ_Z&"'_OR:/^&:[K_H8(?^_)KZ&H MH`^>?^&:[K_H8(?^_)H_X9KNO^A@A_[\FOH:DW*3C(SZ9H`^>O\`AFNZ_P"A M@A_[\FC_`(9KNO\`H8(?^_)KZ&HH`^>?^&:[K_H8(?\`OR:/^&:[K_H8(?\` MOR:^AJ"0`23@"@#YY_X9KNO^A@A_[\FC_AFNZ_Z&"'_OR:]]&H6;1-*+J$QJ M=I;>,`^F:5[ZTC<(]S$K%=P!<9QZT`>`_P##-=U_T,$/_?DT?\,UW7_0P0_] M^37OPO[,Q)(+J$HYPK;Q@GT%(^H6<3NKW4*L@RP+@%1[T`>!?\,UW7_0P0_] M^31_PS7=?]#!#_WY->_B\MB8P+B+,O*?./F^GK3HKF"=W2*:-V0X8*P)7ZT` M?/W_``S7=?\`0P0_]^31_P`,UW7_`$,$/_?DU]`S75O;8\^>.//3>P&:8+^S M82%;J$B/ER''R_7TH`\!_P"&:[K_`*&"'_OR:/\`AFNZ_P"A@A_[\FO8_$7C MC1/#,%K+?7((N9`D7EX;)/?Z50U#X@6UGXUT;P[%;^>-33>MPCC:M`'E?_#- M=U_T,$/_`'Y-'_#-=U_T,$/_`'Y-?0$EY;0RK%)<1)(W16<`G\*:]]:1R-&] MS$KJ,LI<`B@#P'_AFNZ_Z&"'_OR:/^&:[K_H8(?^_)KZ`EO+:`J);B)"WW0S M@9^E1_VE8Y(^V0<-M_U@Z^E`'@?_``S7=?\`0P0_]^31_P`,UW7_`$,$/_?D MU]`37EM;`&>XBC!Z;W`S2MC(.//3>P&:`/G_`/X9KNO^ MA@A_[\FC_AFNZ_Z&"'_OR:]_>\M8I%CDN(E=ONJS@$TLMW;0R*DL\:.PR%9@ M"10!\_\`_#-=U_T,$/\`WY->E_#/X>R>`+"\MI+Y+LW$@<%5*XP*[+^T;+8K M_:X-K'`/F#!-6001D[&)V`YD'3F@#C8+J'QCXTM[V.6/^R])=A"2PS-,>"0/05/KG_)4?#W_7 M&6MFS\$^&["XCN+32((98VW(RYX/KUK5ETZSFOH;V2W1KF$$1RD-+1[#P%I-I([;0%VXXQC%9\.@Z5;Z M=/I\5C"EI.6,L07Y7)ZYH`YGX>301:"EW<3(EQJUP\Z*S89\G@#UXJGXWM3> M>-_#L%Q=R6MF?,_>(=OSXZ9[&NS70]+3['MLH1]B_P"/;C_5=N*EU#2['58/ M(O[:.>/.0KCH:`/+_M/B._LM6T2P\[5+.'4!"9_,`/:O:[#3K/2[86]C;QP0@YVH,5&NCZ;ZWIFG3O\`#ZT2&/[+)=$LD9P&/E\]*W/`4:VFM^);&#*VT-V# M''GAVCCCF9GD4#[Y/4FJ_\`PCNC_9[:W_L^#R;5_,@0 MCB-O44`>6W6CWLGBE=`S:^3!I$8MQ=N0NX_?9<=6!J]#H3/XPT'2M9D6\,6G MLKE6.U^>/K7H^I:%I>KF,W]E%.T?W&8D:?%,Y=/FW9NXD+JV0$.-W([ M5ZH_AO1I-.?3WTZ`VCR&5HBO!TBQAGAM=/@BCG&)5"\/]:`.2 M\(:/"7.YX,`C8Q'7VJ'1;R.;6?`,<=PKL+&3>H;)!QWK MTG3]`TG2HI([&PA@648<*OWA[DU#9^%="T^[2ZM-+MX9T)*R*O(SUQ0!Y!!: MVMQX>T>:[C1\>(9D+R?W=YXSZ5K:MIE[K?C#7-,A:RB2*!$M#<.5\M3'O M7IC^&M%DTXZ>^G0&T,IF,1'&\G);ZYHN_#6C7QA-SI\,AA7;&QSE1Z9H`=:R M'1_#L+ZG=7L,WBG3?$7B%&4&6R>"PA##<8QR6(]Z]-O=, MLM1T]K"[MTFM&7:T3="/2J&G>$M!TF<36&F0P2!=N5ST].30!P\]U;:DG@.* MQD5I%8.0AY153#$^E6-0MT\*^(-+?0-3ED&H7I%Q9-*)%8'DL/3%=M9^'-'T M^XEN+33H(993GK]*2R\-:-IUV;JTTZ"*<_\M`,G]>E`'EVI6$MYX@\: MNNKFSCC9&>$X"S`+G![_`)5Z-X3U:VO=!TY`L=O.UNK"V!Y5>F0/2I[CPGH- MW?R7UQI<$ES(07D8'YL>O8TMCX>M[/7;K5=VZ69%B1<8$:#L*`.0\;M>:MXR MTS2+&R6\^SP27$T;2!!R-HR37+/+)J'@K1=*O-\4UKJXM9E5^0,GC(]J]F33 MK./4);]+=!=RH$>7'S,HZ"JS>'='>5I6T^$NTPG)Q_RT'\7UH`X3QI''X-O] M+U6PC\JV%O)9%`3@9'R_K5-A!;Z3:^'6L;>>^%@UU--=OM6,-D\>IKT^_P!, MLM4@6"^MH[B)6#A7&0".AJ"^\/Z3J3:'/_`&E: M>#+76)M^GM'+G>^%=ES@$]^*G\.:EI^D^&[RS6TCNTN]:D@MHW?$><\$MZ"O M3G\,Z))IT6GOIMN;2([HXMO"GVI/^$6T/[`UC_9EO]E9_,,87C=Z_6@#C/A[ M=C3]2\30W4UO#;072D+&^8XR1T!-:?Q2CDN/`YF@!>.&Y@GEV\YC5@6_2M.^ M\%:5<6GV6V@2TB>5))Q$O^M"]`:Z$PQF#R613%MV[2,@CTH`XWQGK,5Q\/Y[ MG2;I&$B(%="L M7E>UTRWB,RE9-HX8'J,=*DL_#FCZ?%/'::?!$DZE90H^\I[?2@#R[PZEO>R> M%+'5F']F_P!CF1%=L*9/\<52B@;5;?PI8W3RM9-K,\*?.1OA`.!GTKUV;PUH MMQ8V]E-IT#VUN,0QD<(/05-_8FF?Z'_H4(%DV^VPN/*.,9%`'E?C2\M+BSU2 M/3+&UM_[*DCB-P\A63<",!!Z4^[%KJNJZ\==D!:'2$:U61\``IRP]\UZ1=^% M="O[J2YNM+MY9I!AW9?O?6GWGAK1=0>)[O38)FB78A9>B^GTH`\QT58KJU\# MV.HD?V:]BS;7;"NX]:ZOX>3NFBZJH+26=O>2K;9.E7+2RMK"V6VM($AA085$&`*`/%(4,=E!XA2X1K.35,_V/NX M5BV,@=<]\5H17,%MX`\76-TRK>&[D_=,?F;>1MP.]>F)X8T2._\`MR:9;BYW M;MX7OZXZ9I]QX=T>ZU%=0GTZ"2[7&)67GCI0!YOX>ECT8^)K?59%28V,;#S# M@LOEXX]>:@\!`Z-XAA.J.(A<:(GDF0X'RL2P&?8BO4+_`,/Z3JEQ'/?:?!/+ M']UW7D4NHZ#I6K1Q)?V,,ZQ?ZL,OW?I0!Y?I=MK-UX5MHK#3I+K3[C4)9IE1 MPI,8;(`SV)K>^$UQ<2:5J<,E@]M&E_,58L",[N5X]*[^""*VA2&"-8XD&%11 M@`5%9:?::=&\=G`D*.YD8(.K'J:`+-%%%`!390QB<(<.5.T^AIU%`'S]I7A' MXG1?$=;RXN9Q:"X+/,9-_'99WNO":VSJD MYOB(V89`.!@D5[)6?J>A:7K,EN^HV45RUL^^$R#.QO44`>1>)?`5QI'A+Q)X MBUC4?MVJW-J%+*FU57(Z"N2TNQ31)_AUJ%A)-'<7T8,Y\PD-STQZ5](WVGVF MI6,EE>P)/;2#:\;CAA6?_P`(GH.VQ7^R[?%@,6HQ_JA[4`?/>MS17L_C2\UJ M[DCU>TF46"F0J5&>-HK6UU+K6M7^'D.K/,);FT`N`&*EN>_X5[=>^$_#^I7Z MWUYI%K/=*`]*U!O$>FZC:/8VNFM9E;M8;_S'D&.7*^M>T6WAO1K M-[Q[?3;=&O#FXPN?-/O4.G^#_#VDW+W%AI%M;S."&9%QD'J*`,GX>VVAVNF7 M:Z'JLNH1&X8R/(Y8JV>165X['E:IIFH_V@MW`MTB#3205+9QN&.)XM.LXK:-V+LL:XR3WJM#X8T2#4#?1Z;`+HG=YF,G/KS0!P=O=VVG'QW%? MNLPN/^%3Z=;R:O]AFMK%6FA+`>:,9VMWYKNK[P]I&I M7<=U>Z?!//']UW7G_P"O3;WPUHVHW2W-YIT,TR@`,P/0=..E`%+PUJ%I<>&M M,A=8[62XM\);YP2,?ZQI.HZ=IL/A*VOK2YAGO0\21@F55W;CN[`#UKU9 M]*L)+NWNGM8C/;*5A?'*`]0*;::+IMCE M^*=2?69[/5;2Y9DC5P`<8VY'\0-.NOM7B;4;^Z%X-(NK?3HS<`G'VG*YPP/: MO5+OPWHU_>B\NM.@EN!@[V7DXZ9]:+[PWHVISK/>:=!-*HP&9><>G'6@#.\' MZO9W7AO3$Q%:RO!N6WW8(4<$@>E<]JH-K\1=(N6OQJ:7+LL5N2#]FX^\N/ZU MW']C:;]JCN?LJCVJ"P\-Z-IERUQ9:=##,W5P,G]>E`'*^)+ MV'Q7KL'ANVGC%G:S)/J$Q<`?*!O#+7+W)T>W\Z1M[N-P+-ZGFK=UX8T2]N5N+G38))E``8KV M'3/K^-`'(^+[E;OX2PSK!Y"N("(_[OS#BN^L_P#CR@_ZYK_*H[O3;._LOL=U M;1RVW'[MAQQTJRJA%"J,*!@"@!:***`"O'?C#X=\<:QJ-G)X=DF>R5<-%#)M M(;U->Q44`<[X&LM9T_PC8VVO3>;J")B1LY(]`3WKHJ**`"BBB@#Q;XU0SW'B MWPC#:W!MYWF(24#.PYZT_P`:W,FE)I'A[6GBUG4+IV*75VQBB0>^*]5U#0M+ MU6ZMKJ^L8IY[4[H7<:N=I]J`/G?PTT,W@7QG M8:I>?Z-:3![=HW)"2=MF>U;OP?ECU*_U>;Q!^*]<_X M07POY4L0T2T$H-?IIENMTT?E&4+R4QC'TQ0!C_#R MWT2T\..FAZI+J%IY[EII7W$-GD5C:]_HOCW0[MK\:E'<3F..U)!^S\??&/ZU MW.G:/IVDV;6FGV<5M;L2QCC7`)/6H++PUHVFW9NK33H(IS_RT`R?UZ4`>=QW M,%CHWCVSO'5;IKMR%8\N&7Y2/6KFO6TB^OTOKK3X);I,8D9>>.GUIEWX9T6^O!=W6G02SC&'<9Z=..E`%6PU5? M^$:LQ;11Q7TMF)(+,M@_=X`'I7F^GC5].\=:`U[HLPOIO.>9S*IWENI'L*]= M;3+)[Z&]:VC-S"A2.3'*J>PITNGVD][#>RP(US`"(I".5!ZXH`X#Q9:P^'9I M=>T35)8]1NKI#+:B4.LY)P1M[<5D);23ZUXMOKO5I]/O85$D2HX7`"9'7J,] MJ])C\,:)#J!OTTV`71;=YA&3GUYI]_X=T?5+A9[[3X)Y5X#,O/X^M`%+PEK; M:GX=TM[Z5%U*>U662+.&^N*Q]*8^(/'6H:MC?:Z8AM;8=B_5B/Y5UBZ58+>B M\6TB%R(_*$@&"$_N_2GV6GVFFPF&S@2&-F+%4'4GJ:`/&]5_MRUUJPO=2T27 M[;<:H&#B52"@X5!Z<4:O&^IKXEUJ*Y6QBMY@+C36;BYV8SN^OM7LEUI]I?/" MUS`DK0OOC+#[K>HJE<^&=$O+W[9<:;;R7&02Y7J??UH`\QU!6\1ZQ?SV=R-% M>VTV/S%)P;A2N=I![#I7HO@J[6]\(:=,EL+=3$`(QT&.*MW_`(SMX?TEM6.JM80&_*;#.5^8KZ4[2]#TO1$F73+*&U69]\@C&-S>IH`^8MVJ2 M6#:!#)*'T&YEN91DYVJW%=OX1TF3QOHWC#7)BY-_'Y-OR>-HSQ^->PIX9T6. MZN[E--MQ/>*5N'"\R#T-6-,TC3]&LA9:=:16UL"3Y<8P,GK0!\PVNLZG-:Z7 MJB/)Y7AP+'.,G[V['->F?#76-,\/Z$^L:U>"&;7[YF@WY.X9XQ7HJ>$?#\5K M=VJ:3;+!=MNG0+Q(?4U))X7T.:UL[632[9H+,[K="G$1]J`/(0UAKOQBU2V\ M673+;VZ@V4,DA1#Z$>M-CNG(Q[U#=>#/#=]=M=W.C6DL[+L:1H\DB@#P+Q/96TGPP\&WT\ M8+F=8Y)6)^YD9!KI=5AT^W^,/@A=($?V3[,3'Y9RIZ]*]?D\,:)-HZ:3)IEN M^GI]V!ERJ_2HX?"6@6]S97$.E6Z362[;9PO,0]!0!\\W2:OXCUSQ%'+]F&I) MUZAX.\.Z MK>?:[[1[6>X_YZ,G-6(?#VD6^K?VK#80I?>7Y7G@?-LQC'TH`\:\-Q:9K/Q+ MUN+Q7:7;3749!65D^8$>]<+X1^%R66N:U>>(+"SNH[FY\ZUS\Q7F@#A] M3UM=8T_2-&OK"W;4AIWF-=WTK(JC'&`.IK.TB#4M>^%$,?\`:T0-C?N1!<3[ M5N$'.W-?0>H>%M"U66&6^TJUGDA&(V=/NCTJJW@3PNUF+0Z):?9Q(9!'MX#' MJ:`.3\#>._#EGX*M+B>)=)B>U0LQZ MFIAX0\/BWO(!I-MY5ZV^Y7;Q*?4UJ6=I;V%I%:6L2Q6\2[8XUZ*/04`3T444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 1110`4444`%%%%`!1110!_]D_ ` end EX-101.INS 7 glag-20141130.xml XBRL INSTANCE DOCUMENT 0001513403 2012-12-01 2013-11-30 0001513403 2015-03-11 0001513403 2013-11-30 0001513403 2012-11-30 0001513403 us-gaap:CommonStockMember 2012-12-01 2013-11-30 0001513403 us-gaap:CommonStockMember 2012-11-30 0001513403 us-gaap:CommonStockMember 2013-11-30 0001513403 us-gaap:AdditionalPaidInCapitalMember 2012-12-01 2013-11-30 0001513403 us-gaap:AdditionalPaidInCapitalMember 2012-11-30 0001513403 us-gaap:AdditionalPaidInCapitalMember 2013-11-30 0001513403 us-gaap:RetainedEarningsMember 2012-12-01 2013-11-30 0001513403 us-gaap:RetainedEarningsMember 2012-11-30 0001513403 us-gaap:RetainedEarningsMember 2013-11-30 0001513403 us-gaap:PresidentMember 2013-11-30 0001513403 2013-12-01 2014-11-30 0001513403 2014-11-30 0001513403 us-gaap:PresidentMember 2013-12-01 2014-11-30 0001513403 us-gaap:PresidentMember 2014-11-30 0001513403 us-gaap:PresidentMember 2012-12-01 2013-11-30 0001513403 us-gaap:NotesPayableOtherPayablesMember GLAG:ShareholderMember 2014-03-20 0001513403 us-gaap:NotesPayableOtherPayablesMember GLAG:ShareholderMember 2014-03-19 2014-03-20 0001513403 us-gaap:CommonStockMember 2014-05-18 2014-05-19 0001513403 GLAG:ShareholderMember 2013-12-01 2014-11-30 0001513403 GLAG:ShareholderMember 2012-12-01 2013-11-30 0001513403 us-gaap:DirectorMember GLAG:SubsidiariesOneMember 2013-12-01 2014-11-30 0001513403 us-gaap:DirectorMember GLAG:SubsidiariesOneMember 2012-12-01 2013-11-30 0001513403 us-gaap:SubsidiariesMember us-gaap:NotesPayableOtherPayablesMember 2014-09-01 2014-09-30 0001513403 us-gaap:CommonStockMember 2014-09-16 2014-09-17 0001513403 us-gaap:CommonStockMember 2013-12-01 2014-11-30 0001513403 us-gaap:CommonStockMember 2014-11-30 0001513403 us-gaap:AdditionalPaidInCapitalMember 2013-12-01 2014-11-30 0001513403 us-gaap:AdditionalPaidInCapitalMember 2014-11-30 0001513403 us-gaap:RetainedEarningsMember 2013-12-01 2014-11-30 0001513403 us-gaap:RetainedEarningsMember 2014-11-30 0001513403 GLAG:SubsidiariesOneMember GLAG:PropertyAcquisitionContractMember us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:SubsequentEventMember 2015-02-01 2015-02-28 0001513403 us-gaap:PresidentMember 2013-11-29 2013-11-30 0001513403 us-gaap:CommonStockMember 2014-08-26 2014-08-27 0001513403 us-gaap:CommonStockMember 2014-09-01 2014-09-02 0001513403 us-gaap:CommonStockMember 2014-09-17 0001513403 us-gaap:PresidentMember us-gaap:AdditionalPaidInCapitalMember 2013-12-01 2014-11-30 0001513403 GLAG:SubsidiariesOneMember GLAG:PropertyAcquisitionContractMember 2014-05-01 2014-05-31 0001513403 GLAG:SubsidiariesOneMember GLAG:PropertyAcquisitionContractMember 2014-05-31 0001513403 GLAG:SubsidiariesOneMember GLAG:PropertyAcquisitionContractMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-05-01 2014-05-31 0001513403 us-gaap:SubsequentEventMember us-gaap:CommonStockMember GLAG:ConsultantMember 2014-12-01 2014-12-02 0001513403 us-gaap:SubsequentEventMember us-gaap:CommonStockMember GLAG:ConsultantOneMember 2014-12-15 2014-12-16 0001513403 us-gaap:SubsequentEventMember us-gaap:SeriesAPreferredStockMember 2015-01-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 123140000 -37096 -1106 118140 118140 -47040 -47040 -72206 -108196 -192673 119140 75258 -387071 28298 28298 174635 118140000 118140000 118140000 119140000 119140000 5807000 -35990 -35990 -278875 -278875 Gala Global Inc. 0001513403 10-K 2014-11-30 false --11-30 No No Yes Smaller Reporting Company FY 2014 <p style="font: 10pt Times New Roman, Times, Serif">&#160;Under the terms of the note, the amount is unsecured, non-interest bearing, and due on demand.&#160;</p> <p></p> <p style="margin: 0">The amounts owing are unsecured, non-interest bearing, and due on demand.</p> The amounts owing were unsecured, non-interest bearing, and due on demand. 0 0 5000 37200 192673 37200 192673 8902 8038 104 0 104 104 24904 -47040 75258 104 0 28000 28000 23298 23298 174635 174635 118140 119140 10000000 10000000 500000 500000000 500000000 20:1 -108196 -387071 0.001 0.001 0.001 0.001 0.001 118140000 119140000 118140000 118386575 -0.00 -0.00 -35990 -88903 35990 88903 35515 54903 475 -35990 -278875 1000000 1000000 100000 1000 99000 23298 23298 -24800 -104 279635 -189972 -24800 -89767 6724 3991 -864 100000 100000 <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>1.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Organization and Nature of Operations</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><br /> GALA Global Inc. (&#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) was incorporated in the State of Nevada on March 15, 2010 (Inception). The Company was formed to provide garment tailoring and alteration services.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On May 19, 2014, a change in control of the Company occurred when IDG Ventures Ltd., the Company&#8217;s then controlling shareholder, sold all of its 3,547,000 shares of the Company&#8217;s common stock, representing 60.04% of our issued and outstanding common shares, in a private share purchase transaction to Messrs. Haas, Lefevre and Naccarato.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On June 26, 2014, the Company had a change in management when Mr. Robert Frei resigned as President and Director of the Company and Mr. Lefevre was appointed as his successor. Concurrent with the change of management, the Company acquired two 100% owned subsidiary companies, Cannabis Ventures Inc (USA), incorporated on February 27, 2014 in the state of Nevada and Cannabis Ventures Inc. (Canada), incorporated on April 9, 2014 in Vancouver, British Columbia. Neither of these subsidiary companies had traded prior to their acquisition by the Company other than as described below.</font>&#160;</p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">GALA Global, Inc. is currently distributing all-natural everyday custom tailored women's clothing products from England. The Company is exploring different hemp alternatives of fabric and materials needed to produce our all new custom designed apparel. &#160;Our new products are scheduled for launch in the latter part of 2015.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">GALA Global, Inc., since its change in management effective June 26, 2014, has expanded into the Hemp and Cannabidiol (&#8220;CBD&#8221;) industry. The expansion is focusing on the development, research, and commercialization of products derived from the Hemp and Cannabis Plant. GALA Global, Inc. currently markets a new CBD flavored Thin-film strip. The film strip delivery system uses a dissolving film strip that is absorbed in the mouth. The film-strip method is an advanced method of providing CBD for dietary supplement. GALA also is seeking acquisition candidates in this area of interest in the nutraceutical and pharmaceutical industries.The Company also plans to enter into the medical marijuana cultivation industry as approved in the United States and Canada to build legalized cultivation operations</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">GALA Global, Inc.&#8217;s services include the development of cannabinoid based health and wellness products; the development of medical grade compounds; the licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cannabis Ventures Inc. (USA) (&#8220;CVI&#8221;)</i></font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In September 2014, CVI entered into a promissory note agreement with Globe Farmacy, Inc., an Arizona non-profit corporation (&#8220;GFI&#8221;), to finance a potential cultivation project. CVI has advanced funds of $189,972 to GFI under the promissory note, which is unsecured, bears interest at 5% per annum, and was due on December 31, 2014. As GFI was delinquent in performing certain obligations under the terms of the promissory note and our ability to recover this advance is currently uncertain, we have a provided in full against the value of this promissory note and recognized an impairment expense of $189,972 effective December 31, 2014.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cannabis Ventures, Inc. (Canada) (&#8220;CVI (Canada)&#8221;)</i></font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (&#8220;the Contract&#8221;). It is the Company&#8217;s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI (Canada).</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) in February 6, 2015. We responded on February 26, 2015 and Health Canada acknowledged receipt on February 27, 2015.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada. During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been recognized in our statement of operations.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Contract had been extended on a month to month basis and as of February 2015, the Company continues to pay the property owner a reduced nonrefundable payment of $2,500 a month while it awaits the determination from Health Canada. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.</font></p> <p style="font-family: Arial, Helvetica, Sans-Serif; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>2.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Going Concern</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at November 30, 2014, the Company has not earned any revenue, has a working capital deficit of $192,673, and an accumulated deficit of $387,071. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to successfully implement its business plan and obtain the necessary debt or equity financing, and generating profitable operations from the Company&#8217;s future operations. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</font></p> <p style="font-family: Arial, Helvetica, Sans-Serif; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left; vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif"><b>3.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Summary of Significant Accounting Policies</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basis of Presentation</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;US GAAP&#8221;) and are expressed in U.S. dollars. The Company&#8217;s fiscal year end is November</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Principles of Consolidation</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These consolidated financial statements include the accounts of the Company and its two wholly owned subsidiaries, Nevada incorporated Cannabis Ventures Inc. (USA) and Vancouver, British Columbia incorporated Cannabis Ventures Inc. (Canada), from the date of their acquisition by the Company effective June 26, 2014. All inter-company transactions and balances have been eliminated on consolidation.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use of Estimates</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and investments, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">d)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and Cash Equivalents</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 20pt; text-indent: 0pt; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As of November 30, 2014 and 2013, there were no cash equivalents.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">e)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Development Stage Company</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><br /> <font style="font: 10pt Times New Roman, Times, Serif">The Company is a development stage company as defined by section 915-10-20 of the FASB Accounting Standards Codification and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders&#8217; deficit and cash flows disclosed activity since the date of its inception (March 15, 2010) as a development stage company. The Company has generated no revenue since inception (March 15, 2010) and is still devoting substantially all of its efforts on establishing the business. &#160;All losses accumulated since Inception (March 15, 2010) have been considered as part of the Company&#8217;s development stage activities. &#160;Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required for annual reporting periods beginning after December 15, 2014 with the option for entities to early adopt these new provisions. The Company has elected to early adopt these provisions and consequently these additional disclosures are not included in these financial statements.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">f)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Financial Instruments</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><br /> Pursuant to ASC 820, <i>Fair Value Measurements and Disclosures</i>, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s financial instruments consist principally of cash, accounts payable and accrued liabilities, and amounts due to related party. Pursuant to ASC 820, the fair value of cash is determined based on &#8220;Level 1&#8221; inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">g)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Long-Lived Assets</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify">I<font style="font: 10pt Times New Roman, Times, Serif">n accordance with ASC 360<i>, &#8220;</i>Property Plant and Equipment&#8221;, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">h)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income Taxes</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, <i>Accounting for Income Taxes</i>. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">i)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenue Recognition</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenue will be recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is assured. &#160;The Company is not exposed to any credit risks as amounts are prepaid prior to performance of services.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">j)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Advertising Costs</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $nil during the years ended November 30, 2014 and 2013.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">k)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock-based Compensation</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company records stock-based compensation in accordance with ASC 718, <i>Compensation &#8211; Stock Compensation</i> using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. &#160;As at November 30, 2014 and 2013, the Company did not grant any stock options.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">l)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive Loss</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">ASC 220, <i>Comprehensive Income</i>, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at November 30, 2014 and 2013, the Company has no items representing comprehensive income or loss.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">m)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic and Diluted Net Loss per Share</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company computes net income (loss) per share in accordance with ASC 260, <i>Earnings per Share</i>. ASC 260 requires presentation of both basic and diluted earnings per share (&#8220;EPS&#8221;) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at November 30, 2014 and 2013, the Company has no potentially dilutive common shares.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">n)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Recent Accounting Pronouncements</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>4.</b></font></td><td style="width: 5pt"></td><td style="text-align: left; vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related Party Transactions</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the year ended November 30, 2014, the Company incurred $6,000 (2013 - $nil) in management fees to the former President and Director of the Company.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td><td style="width: 5pt"></td><td style="text-align: justify">During <font style="font: 10pt Times New Roman, Times, Serif">the year ended November 30, 2014, the former President and Director of the Company forgave all amounts outstanding totaling $23,298 which was recorded in additional paid-in capital. As at November 30, 2014, the Company owed $nil (November 30, 2013 - $28,298) to the former President and Director of the Company. The amounts owing were unsecured, non-interest bearing, and due on demand.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the year ended November 30, 2014, the Company received advances of $174,635 (2013 - $nil) from a shareholder of the Company to fund payment of operating expenditures and advanced to GFI under a promissory note receivebale. The amounts owing are unsecured, non-interest bearing, and due on demand.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the year ended November 30, 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (&#8220;the Contract&#8221;). It is the Company&#8217;s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the year ended November 30, 2014, the Company incurred option expenses of $28,000 (2013 - $nil) under the term of a contract to purchase property in Vancouver, Canada to a director of CVI.</font></td> </tr></table> <p style="margin-top: 0; margin-bottom: 0">&#160;</p> <p style="margin-top: 0; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>5.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Promissory Note Receivable</b></font></td> </tr></table> <p style="margin-top: 0; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On September 30, 2014, Cannabis Ventures Inc. (USA), a wholly-owned subsidiary of the Company entered into a promissory note agreement with Anthony McDonald (&#8220;McDonald&#8221;) and Globe Farmacy Inc. (&#8220;GFI&#8221;), an Arizona non-profit corporation, for $189,972.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The amounts owing are unsecured, bears interest at 5% per annum, and is due on December 31, 2014. &#160;As of November 30, 2014, the amount receivable was deemed to be uncollectible and a full impairment charge on the loan receivable has been made by the Company.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>6.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Loan Payable - Related Party</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On March 20, 2014, the Company issued a $10,000 promissory note to a shareholder of the Company. &#160;Under the terms of the note, the amount is unsecured, non-interest bearing, and due on demand.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>7.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common Shares</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(a)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 27, 2014, the Company approved an increase in the total number of authorized shares of common stock from 75,000,000 to 500,000,000 shares and in preferred stock from nil to 10,000,000 shares. The amendment was filed and effected on August 28, 2014.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(b)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On September 2, 2014, the Company issued 1,000,000 shares of common stock at $0.10 per common share for gross proceeds of $100,000.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(c)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On September 17, 2014, the Company effected a 20:1 forward stock split of the Company&#8217;s common stock, thereby increasing the number of the Company&#8217;s outstanding common shares from 5,907,000 to 118,140,000 shares of common stock.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>8.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Commitments and Contingencies</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (&#8220;the Contract&#8221;). It is the Company&#8217;s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) on February 6, 2015 and we will be responding before February 27, 2015 and waiting to hear back from Health Canada.</font></p> <p style="text-align: justify; margin-bottom: 5px"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada. &#160;During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Contract has now been extended on a month to month basis and the Company continues to pay the property owner a nonrefundable payment of $4,000 a month while it awaits the determination from Health Canada. &#160;As of February 2015, the monthly payment was reduced to $2,500. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b></b></font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>9.</b></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company has $387,071 of net operating losses carried forward to offset taxable income in future years which expire commencing in fiscal 2030. &#160;The income tax benefit differs from the amount computed by applying the US federal income tax rate of 34% to net loss before income taxes. As at November 30, 2014, the Company had no uncertain tax positions. &#160;</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="width: 56%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Net loss before taxes</font></p></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(278,875</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(35,990</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Statutory rate</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Computed expected tax recovery</font></p></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">94,818</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,237</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(94,818</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12,237</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Income tax provision</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="text-align: justify; margin: 0px; font: 10pt Times New Roman, Times, Serif">&#160;<br /></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0px; padding-left: 24px"><font style="font: 10pt Times New Roman, Times, Serif">The significant components of deferred income tax assets and liabilities at November 30, 2014 and 2013 are as follows:</font></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0px; padding-left: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0px; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><br /></font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="width: 56%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carried forward</font></p></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,605</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36,787</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(131,605</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(36,787</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Net deferred income tax asset</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><td style="width: 15pt; text-align: left; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>10.</b></font></td><td style="width: 5pt; font: 10pt Times New Roman, Times, Serif"></td><td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><b>Subsequent Events</b></font></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On December 2, 2014, the Company entered into a marketing agreement for advertising services. The Company has agreed to issue 1,500,000 shares of common stock to the consultant as compensation for a six-month term. The agreement may be terminated by either party at the end of any month during the term of the agreement.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On December 16, 2014, the Company entered into a consulting agreement with a consultant who is to become a director of the Company. The Company has agreed to issue 500,000 shares of common stock to the consultant as compensation. The agreement commences upon the date of the agreement, and continues until the Consultant resigns or upon mutual agreement with the Company to terminate such agreement.</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 9, 2015, the Company and its board of directors authorized a new class of equity instruments &#8211; Series A Preferred Stock, subject to authorized capital of 500,000 shares with a par value of $0.001 per share. &#160;As of the date of filing, no Series A Preferred Stock have been issued. &#160;.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">a)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basis of Presentation</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;US GAAP&#8221;) and are expressed in U.S. dollars. The Company&#8217;s fiscal year end is November</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">b)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Principles of Consolidation</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 24px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These consolidated financial statements include the accounts of the Company and its two wholly owned subsidiaries, Nevada incorporated Cannabis Ventures Inc. (USA) and Vancouver, British Columbia incorporated Cannabis Ventures Inc. (Canada), from the date of their acquisition by the Company effective June 26, 2014. All inter-company transactions and balances have been eliminated on consolidation.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">c)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use of Estimates</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and investments, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">d)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and Cash Equivalents</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As of November 30, 2014 and 2013, there were no cash equivalents.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0"><tr style="vertical-align: top; text-align: justify"> <td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">e)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Development Stage Company</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><br /> <font style="font: 10pt Times New Roman, Times, Serif">The Company is a development stage company as defined by section 915-10-20 of the FASB Accounting Standards Codification and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders&#8217; deficit and cash flows disclosed activity since the date of its inception (March 15, 2010) as a development stage company. The Company has generated no revenue since inception (March 15, 2010) and is still devoting substantially all of its efforts on establishing the business. &#160;All losses accumulated since Inception (March 15, 2010) have been considered as part of the Company&#8217;s development stage activities. &#160;Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required for annual reporting periods beginning after December 15, 2014 with the option for entities to early adopt these new provisions. The Company has elected to early adopt these provisions and consequently these additional disclosures are not included in these financial statements.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">f)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Financial Instruments</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Pursuant to ASC 820, <i>Fair Value Measurements and Disclosures</i>, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</font></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s financial instruments consist principally of cash, accounts payable and accrued liabilities, and amounts due to related party. Pursuant to ASC 820, the fair value of cash is determined based on &#8220;Level 1&#8221; inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">g)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Long-Lived Assets</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify">I<font style="font: 10pt Times New Roman, Times, Serif">n accordance with ASC 360<i>, &#8220;</i>Property Plant and Equipment&#8221;, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">h)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income Taxes</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, <i>Accounting for Income Taxes</i>. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">i)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenue Recognition</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenue will be recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is assured. &#160;The Company is not exposed to any credit risks as amounts are prepaid prior to performance of services.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">j)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Advertising Costs</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $nil during the years ended November 30, 2014 and 2013.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">k)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock-based Compensation</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company records stock-based compensation in accordance with ASC 718, <i>Compensation &#8211; Stock Compensation</i> using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. &#160;As at November 30, 2014 and 2013, the Company did not grant any stock options.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">l)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive Loss</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">ASC 220, <i>Comprehensive Income</i>, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at November 30, 2014 and 2013, the Company has no items representing comprehensive income or loss.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">m)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic and Diluted Net Loss per Share</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; text-indent: 48px; margin-bottom: 0"></p> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company computes net income (loss) per share in accordance with ASC 260, <i>Earnings per Share</i>. ASC 260 requires presentation of both basic and diluted earnings per share (&#8220;EPS&#8221;) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at November 30, 2014 and 2013, the Company has no potentially dilutive common shares.</font></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 30pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">n)</font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Recent Accounting Pronouncements</font></td> </tr></table> <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</font></p> <p style="font-family: Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As at November 30, 2014, the Company had no uncertain tax positions. &#160;<br /> </font>&#160;<br /></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="width: 56%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Net loss before taxes</font></p></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(278,875</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(35,990</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Statutory rate</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Computed expected tax recovery</font></p></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">94,818</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,237</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(94,818</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12,237</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Income tax provision</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="text-align: justify; margin: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</p> <p style="text-align: justify; margin: 0px; font: 10pt Times New Roman, Times, Serif"></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0px; padding-left: 24px"><font style="font: 10pt Times New Roman, Times, Serif">The significant components of deferred income tax assets and liabilities at November 30, 2014 and 2013 are as follows:</font></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0px; padding-left: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0px; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif"><br /></font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">November 30, </font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">$</font></p></td></tr> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="width: 56%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carried forward</font></p></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,605</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 8%; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36,787</font></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(131,605</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(36,787</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 9px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0px"><font style="font: 10pt Times New Roman, Times, Serif">Net deferred income tax asset</font></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;&#160;&#160;</font></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> 0.34 0.34 36787 131605 36787 131605 12237 94818 -12237 -94818 10000 10000 5299200 0.10 118140000 387071 Expire commencing in fiscal 2030 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 35pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td><td style="width: 5pt"></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 27, 2014, the Company approved an increase in the total number of authorized shares of common stock from 75,000,000 to 500,000,000 shares and in preferred stock from nil to 10,000,000 shares. The amendment was filed and effected on August 28, 2014.</font></td></tr></table> 189972 189972 6000 6000 10000 192673 189972 189972 3547000 0.6004 0.05 600000 2500 4000 1500000 500000 <p style="font-family: Times New Roman, Times, Serif"><a name="a_Hlk183828074"></a>The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada.</p> Denotes a loss of less than $(0.01) per share. The Company completed a forward split of stock 20:1 on September 17, 2014 that has been retroactively reflected in these financial statements. EX-101.SCH 8 glag-20141130.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements Of Changes In Stockholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization And Nature Of Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Promissory Note Receivable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Loan Payable - Related Party link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary Of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Income Taxes (Schedule of Income Tax Provision) (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Income Taxes (Schedule of Deferred Income Tax Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Organisation And Nature Of Operations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary Of Significant Accounting Policies (Accounting Costs) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Related Party Transation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Loan Payable - Related Party (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Common Shares (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Commitments And Contingencies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Subsequent Events (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 glag-20141130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.LAB 10 glag-20141130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Common Stock Equity Components [Axis] Additional Paid-In Capital Accumulated Deficit Mr. Robert Frei (Former President And Director) Related Party [Axis] CVI USA, Issued Promissory Notes To Globe Farmacy Inc. Short-term Debt, Type [Axis] Shareholder Director of CVI Cannabis Ventures Inc. Canada Legal Entity [Axis] Cannabis Ventures Inc. USA Subsequent Event Subsequent Event Type [Axis] Property Acquisition Contract Other Commitments [Axis] General and Administrative Expense Income Statement Location [Axis] Consultant for marketing agreement for advertising services Supplier [Axis] Consultant - Consulting agreement with a consultant who is to become a director of the Company Series A Preferred Stock Class of Stock [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Total Current Assets Total Assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities Accounts payable and accrued liabilities Due to related parties Loan payable to related party Total Current Liabilities Total Liabilities COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' DEFICIT Preferred Stock Authorized: 10,000,000 preferred shares with a par value of $0.001 per share Issued and outstanding: none Common Stock Authorized: 500,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 119,140,000 and 118,140,000 common shares, respectively Additional Paid-In Capital Accumulated Deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Preferred stock, shares authorized Preferred stock, par value per share Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, par value per share Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Operating Expenses Depreciation General and administrative Management fees Option expense on proposed property acquisition – related party Total Operating Expenses Operating Loss Other Income (Expense) Impairment of loan receivable Loss before taxes Provision for income taxes Net Loss Net Loss per Share - Basic and Diluted Weighted Average Shares Outstanding - Basic and Diluted Statement [Table] Statement [Line Items] Balance, shares Balance, amount Forgiveness of related party debt Proceeds from sale of common stock, shares Proceeds from sale of common stock, value Net loss for the year Balance, shares Balance, amount Statement of Cash Flows [Abstract] Operating Activities Adjustments to reconcile net loss to net cash used in operating activities: Impairment of promissory note receivable Changes in operating assets and liabilities: Accounts payable and accrued liabilities Due to related party Net Cash Used In Operating Activities Investing Activities Loan receivable Net Cash Used In Investing Activities Financing Activities Proceeds from related party Proceeds from loan payable - related party Repayment of due to related party Proceeds from issuance of common stock Net Cash Provided By Financing Activities Decrease in Cash Cash - Beginning of Period Cash - End of Period Non-cash Investing and Financing Activities Forgiveness of related party debt Supplemental Disclosures Interest paid Income tax paid Organization And Nature Of Operations Organization and Nature of Operations Going Concern Going Concern Accounting Policies [Abstract] Summary of Significant Accounting Policies Related Party Transactions [Abstract] Related Party Transactions Promissory Note Receivable Promissory Note Receivable Loan Payable - Related Party Loan Payable - Related Party Common Stock Common Stock Commitments And Contingencies Commitments and Contingencies Income Taxes Income Taxes Subsequent Events [Abstract] Subsequent Events Basis of Presentation Principles of Consolidation Use of Estimates Cash and Cash Equivalents Development Stage Company Financial Instruments Long-Lived Assets Income Taxes Revenue Recognition Advertising Costs Stock-Based Compensation Comprehensive Loss Basic and Diluted Net Loss Per Share Recent Accounting Pronouncements Income Taxes Tables Schedule of Income Tax Provision Schedule of Deferred Income Tax Assets Income Taxes Schedule Of Income Tax Provision Details Net loss before taxes Statutory rate Computed expected tax recovery Valuation allowance Income tax provision Income Taxes Schedule Of Deferred Income Tax Assets Details Net operating loss carried forward Valuation allowance Net deferred income tax asset IDG Ventures Ltd, sold shares to Messrs Hass, Lefevre and Naccarato Percentage of shares transfered Proceeds from receivable Promissory note interest rate Impairment expense Going Concern Narrative Details Working capital deficit Summary Of Significant Accounting Policies Accounting Costs Narrative Details Advertising Costs Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Management Fees Advance received from a shareholder Debt instrument terms Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Loan descriptions Increase in authorised shares of common stock Shares issued during the period for cash Equity issuance price Forwards stock split Common stock change Common stock outstanding before stock split Income Taxes Narrative Details Net operating loss carryforward Operating loss carryforward limitations on use Other Commitments [Table] Other Commitments [Line Items] Payments to acquire property Monthly payments to property owner Contract expiry date Shares issued during the period for services Working capital deficit Assets, Current Assets Liabilities, Current Liabilities Additional Paid in Capital Retained Earnings (Accumulated Deficit) Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses [Default Label] Operating Income (Loss) Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Debt Instrument, Decrease, Forgiveness Liquidity Disclosure [Policy Text Block] Short-term Debt [Text Block] Debt Disclosure [Text Block] DisclosureCommonStockAbstract Stockholders' Equity Note Disclosure [Text Block] Income Tax Disclosure [Text Block] Income Tax, Policy [Policy Text Block] Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Advertising Expense EX-101.PRE 11 glag-20141130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 12 glag-20141130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`E!5Y>V0$```04```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F-%NVC`4AN\G[1TBWT[$ MV-LZ-A&X8-UEA[3N`3S[0"(LV-_[7X,1*U)6SBCK'51L!XE-)Q\_C.]W`5*! MNUVJ6)US^,%YTC6T*I4^@,,["Q];E?%K7/*@]$HM@$$G?V:U+=A/0) M,1@_FM#=^7_`T[[?>#2Q,5#,5DA1RC]8M%H,%ZO M6SR!,H4(RJ0:(+>V[*]EJQKWS'TBOU^<>'\15P;I_E\_^$(.283C,Q&.+T0X MOA+AN"'"\8T(QX@(QWE9C+7+E0SC,/96/7I&3!'LGG?X4T> M`0``__\#`%!+`P04``8`"````"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR M96QS(*($`BB@``(````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````(R2ST[#,`S&[TB\0^3[ZFY( M"*&ENTQ(NR%4'L`D[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z M*$&Q,V)[UVIXK9]6#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC M8C0=3Q0+\>QRI9$P4P>J/OH\^;*W M-$UO>"_F?6*73HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;',@H@0!**```0`````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````"\6$UO@S`,O4_:?T"YK\&F[=JIM(=-DWK=NA\000JH$%"2??3? M+^HZ6*7-NR!?D.((\W@V[SFL-A]-';UIZZK6I`(FL8BTR=J\,D4J7G:/-PL1 M.:],KNK6Z%0;7%EU+@I9C$M%Z7UW)Z7+2MTH-VD[;<+. MOK6-\F%I"]FI[*`*+3&.Y]+^S"'6%SFC;9X*N\TA$='NV(5'_Y^\W>^K3#^T MV6NCC?_E&?*]M0=7:NU#4F4+[5/1AYP\[4`R"9B%_`-.X(,7SH*"@W-F.#BG MX'#7BBP5`CPDHWY6F:JS^U)5 M)KSC60+[$(6"NV/HAN'6/2!U#X-MLKH"QF2IEMQPEA0<;ATF99B[<A;9,@1%+G/+$B>69)11<:''SAZ8.:TE*K/YWP7Q\>?'LO"6X,V0LF)'WT, M?0]DJC(AEQ/_^_S+A['O&)OP?B?IF_?'&^4?KA7ZL%#`&DF?F[M MZB@(3)I#R!66G@F'29CXP;0=\D9[&2QX5=@YCK=#1[[B41SONW\Z*NX$ M;,S3(E=ZCS^$S-3&_16IW;95@@ULZD<_1&9S?!Z&8?O;!8AE;G<_(GQ`\&L& M<9_ZTY/U>#M&&"K%SJ45=LLN9<.^4"BA8_T2)XM\3Q\)_*(OL\@U3E%.D415 MB(PC1>R$%URFP&9NJ2$0,8&(_P."W7""DA"4FNL7&YE9[,?);=CU@EVO@*", M",JHWTMWX6G.Y1(,TL)F5J4/!`5Y;TG9ZZ-T2.E!Y=4%#9]QPC?:::RX-3^OD40@J;!3V,6ZT M*H4Q"KNY4A;8+:0@UOR^H*HF5-9H8--OBDML8NM6(0!IBO9!18V>\6E9JJ$3 M$BIB](PORU+8QHM.1!3"HB!X8@H\%XD`"_0M"H0]#`QAWA^S#4B#'-'Q8] MHET_+\:8T;EH(N.!H0>)[,Q&<:BAX]K002TFOL;Q8B$D9.Z:TJW^O-HYNR@> MHG$RCL?A`>I5J)07L]W['(>;OC[.N_.`[(-7B=(A9LB8(I7'/=1WQ%& M>_N-RX/=+6_Z&P``__\#`%!+`P04``8`"````"$`2-STDP`%```U$P``&``` M`'AL+W=O\C)LE5?0AA_,\SW>>P!;[Z\%[GU MQJLZ$^769A/7MGB9BGU6'K?V7W\^/:QLJVZ2PLA!5$72P&UU=.ISQ9-]ZU3DSM1U METZ19*4M(ZRK,3'$X9"E/!+I:\'+1@:I>)XTD']]RLZUBE:D8\(52?7R>GY( M17&&$,]9GC7?VZ"V5:3KK\=25,ES#KS?V3Q)5>SV9A"^R-)*U.+03""<(Q,= MV_924' MM6&><`:>A7A!Z-<]FL#9&7@_M3/P>V7M^2%YS9L_Q.57GAU/#4SW`A@AL?7^ M>\3K%!2%,)/I`B.E(H<$X-?>?#P.W[SS@^N MGWL@A&WIPG7,`QVI5BM^E#3);E.)BP45#7K4YP37!UM#+*6Z3+F?AQ]-`^B/ M01XQRM:&I0@*UU`[;[O%8N.\P72G'2080IB)"!4"YQ:C1M00:P8'\N])P'3] M#R0P"I)0SP^4X M$TC(O*<34D-$#;%F,%*#ZAR?&H*W-K"\UH)G2A!("/SVD*EO0D(%Z955AA_[ MQ`I"E86Z'I\^@HFR*S.W0$(T9:DAHH98,QC*+C^3&H*)LD2V0$+N*JL@O;+* M@,MV[I%U&ZM1*JKWFEJR$&.:QR4X0X'!:$<&"0\7O\63;(GE1%T&)G^:C4LG0Z@ MY6^XS!:^3V8MUEV,ZF'8@T:73XLFZ<_-P@XZC$S_X6;^LN_I^4M+YW.3@.9C M$L#^,YZ`[%;0&/JM>DD66L`DYII>.+!$`TNL6\P$L0N-3U#V++W=+&DG9!(C MU6(KW_?(`@@[Q)5"U%NNQ&F/BGO,H,:Q$XVG(/N608%V3"8QW81/O=6*;M1A M!]$Y&$XWJT0B6A]S$K!AC6<@VYO!@#9-?)>'?0@>V%<2%33L,2!H]PKXL5>L M>YDDL'>-)R$[G4&"ME;TZ#YF`RPB6D,VM=S#S^` M/MCTF>Q^.AF/['%!AY%DR#>(^V,^71UI?="]"_$$$DR=V/,+SX\[&9)\T M2)*5'728;NVSU6RU7`R7CM9PNSF3EMZ-S:$K$HWB+O:-U8/-3Z-SOT$SV2JA M#ZBR#X:F<&B*AJ;8,!D2P[>[D=-__-)KPY@=C99%T&%PA[_6#NG:X16D6$=# M$YXXX*X!H?H]5IX@R(_8@E=''O(\KZU4O.+I`%9S;^U/+AY;?V(/X$2CU9S: MI^OP%CZ:P@D(YD'PC\R'0/Z-$5!"'9HXO1,<6IR3(_\MJ8Y965LY/T#:[@0/ M"BIY["%O&G%N/\^?10/'%>W?$QQ/&PO=V]R:W-H965TP2H_ M$J,X'K,DM8OD)4^O-0]2II>XAOY7Y^Q6B6AY\I%P>5Q^>;E]2HK\!B&>LTM6 M?V^":J,\L?:G:U'&SQ<8]S=C%B:-/%>+Z<3`TP'SVG5>UF+*0V M2EZJNLC_XT9&&XH',=L@<&V#&/#QCL.T=8!KZV".E\9D/5U"HW?\9JT?7#_6 M$(1KA@?7GVIHT?HM.S]C.C97>Y'J_F\]EB]<[8#)A[ M/A4L"7YY+HQN1N'#QT1BD\5;[B?P[GSH/(F:G+3C.GY\*(O7$2QT:+*ZQ6S; M,"P6560CUZO+S[?2$_*217EB838:*`F95\&:^OIH+I'90@WK"1L1UL=@CT&`08A!)`$=M.P$!0W_#T%9&":H MZ/-6`&F@ZC!WPD*XV`)(+D@:1Y@('Y<#&)PTD2NU(6_(9JW:^"*P%&VW*3798>!C8&#@8N!AX'/@:P*(0$A(0X3 M24!1!1[6BBKLJ;.$*N:]U!C8&#@8N!Q\';#QZ?&\AR$1(0$G+2]S62@"(75,B*7/5=?^"V1Q:,H MH"@DH2*9J`*RREI>E/>S#/I"TXR\>G`C64!,[#90;^,0XK9$5"Z#18A'W/R6 MP*6KU"@**`I;U/[A@:XW8O+[] MD$"1!@5T/A+)52+-5Y,E*<.]UJ17SQ>1Y8G@`H"N8FX":A4JK1G&8+\CX?>& M`NITL:I;GJYWLIS4\5N#H!U%-D4.12Y%'D4^17N*`HI"BB(%J/ M)'A)+K_*X9IE"]4:RWXV<5W.KM#FL>N-1(;8%#D4N11Y%/D4[2D**`HI8N>6 M[7B@JUQ5?@[)SWSRM#REN_1RJ49)\<+.&`WVE.PP/P"%7=YB>SB$('<,N-.L M%'+'A#OF@,^3,87SU.G`'5!?G+3B:%,+7EP'VI]9\"XVP.<6O(T,\*4%U>$` M7UE0!@WPM06/?LKA2/AI:&Q;PX(3*6KO,ID&>,B.E@?XUK3@](;&L4T+3F@H M]T'L(1Z:%AR'@+W>"0HGQ[?XE/X1EZ?L6HTNZ1%F?3)F)YLE/WOF7^KBUAP& M/A&PO=V]R:W-H965T<,F%)@JIVJ#N5MJ55JN]/#M@@E7`R'::]N]W;`?' M)FV2[4,*P_'AG)FQA^7=:U-[+YAQ0MO4CT:A[^$VIP5IMZG_^]?CS:WO<8': M`M6TQ:G_AKE_M_K\:;FG[)E7&`L/&%J>^I40W2((>%[A!O$1[7`+3TK*&B3@ MEFT#WC&,"K6HJ8,X#&=!@TCK:X8%NX:#EB7)<4;S78-;H4D8KI$`_;PB'>_9 MFOP:N@:QYUUWD].F`XH-J8EX4Z2^U^2+IVU+&=K4X/LUFJ"\YU8W)_0-R1GE MM!0CH`NTT%//\V`>`--J61!P(-/N,5RF_GVTR*+(#U9+E:`_!.^Y=>WQBNZ_ M,%)\(RV&;$.=9`4VE#Y+Z%,A0[`X.%G]J"KP@WD%+M&N%C_I_BLFVTI`N:?@ M2!I;%&\9YCED%&A&\50RY;0&`?#K-42V!F0$O:;^&%Y,"E'!U6PT3<)Q!'!O M@[EX))+2]_(=%[3YJT'*D2&9'$C@_X$DBJ\E";0@Y2]#`JV6C.X]:!IX)>^0 M;,%H`<2],2W#6/W(*5B4)/>2)?6AV\$$A_*\K.(D6@8OD-+\@'G0&/@UF`%B M?8J()S.7)>LQLEI@P?B(71_O%Z:7*\%2KBR4U/^@`[:VV'WO^AU$,L!D[V". M\AVUT`=VUL^KE6#5.B9Q<3)VY3UHS,0X6@\#F15PI$#1KYNL/B@94+ M*O51;1\6\4F/P="6>;5E'I9!1HY]EQS/4=5W&PO=V]R:W-H965T(EZ,DIF]R1[DLUF+\^(K9(!VM`XSGS[K:*X5#>N M,K6Q+T5Q73F.BBXB#=5(7D4&WYQD MGH8%7.9G1UUS$1[+16GB>..Q[Z1AG-GD894/\2%/IS@2@8QNJ<@*'A*(^\.=AE'M MN[SHN$_C*)=*GHH1N',(M!OSTEDZX&F[/L80`:;=RL5I8[^XJ\";V,YV72;H M[UC<%?MLJ8N\_Y+'Q]_B3$"VH4Y8@8.4;RC]=D03+'8ZJU_+"OR>6T=Q"F]) M\8>\_RKB\Z6`P(_ M'!^+"WSR1[/Y>.*"W#H(5;S&Z-*VHILJ9/H/B=S*%3F95D[@?^7$]88Z<0BH MC"\(BW"[SN7=@DT#/ZFN(6Y!=P6.Z\`(HPGUOR*%$-')"WK9V+#;(0@%Y7G? M>K/EVGF'E$:59D<:^-MJIKZNV7?]N+HBJ!58+0BABZ!HG6BPL`UXTI_#HKC<.6W>_+'^TSO23)N`]J8A8`8-!6H^ M'`7%&QOB9"A&@7:D82AD\,M=X8_'!GI0ZYG/=N=HJ'"G#$=%L8ZZ\(RDD821 MDF%.^W?B+1?Z@J!>T(_J_P@JBG74R53_Y1U)*K)%AVS/OW?G4W\RTQT$7.!I M#K04SW^$&\4ZM^>;.28-RS$9*)*'I/6*_B3C<#5:UP0Z^_.["1>9T!,]63O2 M,&@RU.GO[N%Z03_S\O\PXR*3V=PAI&',IB%@!JWF+N2,Y_%Y_DIU7SNJ1(RF M8PFX1>?!%L_JVL-#`^%Y3W))Q'G(0B5]T)6:%?TE=;'O#^>E*<%Y.W=[Z7%C MU_NM>[M7`FB=;2-NFV8YTH(G3O1TXV1@^/@$,(5.UY-VFB<\#,\WFL[.K8<. MP_3;D5AR[AM1/8P#;M%1<588J/UWO$L31D>=&[=\)>([I!Y,+1>SZ%PX&!A7 M3^IHC$!NVN)U!CH^7,(]SWE,2\`U.@]V^^$\-!MX?CJCTB4-Q]$FRH-AR9?H M=-CAA]/1/.!TGF\,YIU;#XVZ5ON.)>`6G0>[]W`>ZO4]U:L'0LMC6@*7670> M;-3#>:BMZ_DQI[#+>G]UUY'ER1QNUK!MVO88C=@S)@BVD/[[LEQECC6SA50B MMO$:"^/R6S!J?HT("J"C&L-E(.J#(3,W'F1W7F?(="P!M^A<4,#A1?=0W3>$ M*Q%/'2UK+0'7Z#S8NMDF')@G:OCZ9C2?KN"<;K2VRD)'!&_1?;YJEK":MR4G M<#J[T]DV%?E9[$62*"N2-SR7>_!0WUB;=P8O'IZ8#/L>WB64!V^G^0*.\M?P M++Z'^3G.E)6($[@DK=AQ4N1BB^1P-#.[J_G-DVK)(Q@K M=5?0+$DI@4[H4G9U07__NK^XHL0ZWI6\U1T4]!DLO5E\_C3?:;.Q#8`CR-#9 M@C;.]3/&K&A`<9OH'CH\J;11W.'2U,SV!G@9+JF6Y6DZ98K+CD:&F?D(AZXJ M*>!.BZV"SD42`RUWJ-\VLK<'-B4^0J>XV6S["Z%5CQ1KV4KW'$@I46+V4'?: M\'6+OI^R,1<'[K`XHU=2&&UUY1*D8U'HN>=K=LV0:3$O)3KPL1,#54&7V6PU MIFPQ#_G\D;"S1\_$-GKWQX*&O*]9^7P'5F"@2)/D$\\D=(L"\)VVW<0.X7;:_> M^P9B.D!.E&!"QTI\6N-WV^"@R%_"5(\%3*X&_B@R8D('AXW5T<:)@O&I@O]G MX<$%17N#]6SZXBR^.6*FH6CIJ2J<*'__]5G4$V3*18CA/750O^W$8"\TR1[!26IV^^&):3D` M8BMZX4X!BI%DR[=6:4.W/?1]S*:47=CA<(>7@AEM=>,2P)%8Z'W/"[(@0*J* M6D`'WG9D>%/BUVRYFF!2%<&?WX*/]N89V4Z/GXVHOPK%P6P8DQ_`5NN=E[[5 M_B<()G?1FS"`[P;5O*'[WOW0XQ5>#)/9L_I)`,YVG+K-L(C,6)[Z[3\$T79&14A^1D" M]S,DRQ^%D%A0Z&]-':T*HT<$.P,I[4#]!F9+`/O&)F#/^XU!1S[FU0>%4%!; M&,:ARF?3@AS`07;6K-[17!4$DE\K@*RW%?P_LQ=#A1C=9)Y=N:&Z5=1,PT!O M$T'4XXF\N,2`NDDT_R=1U,R#`=DBGS]/KH+88=RGZ/=`6_Z-FE8HBWK>`#9- MGF'X)FY3/#@]!%^WVL$6A,<./GH.IJ<)B!NMW>7@]_7Z-U+]!0``__\#`%!+ M`P04``8`"````"$`4I+[,N0#``!$#0``&````'AL+W=OJ=6S/3M@$E2`&>Q4 MJOY^[K7!#::F1/*0L!R.C\]=N-E_>2T+[X4W,A=51.@\(!ZO$I'FU3DB?_WY M-/M,/*E8E;)"5#PB;UR2+X=?/NUOHGF6%\Z5!PR5C,A%J7KG^S*Y\)+)N:AY M!7K_4L$64-%*>\R-6;)B5>F>R^GBO1L%,!^WZE2Y9T MW/ID1%_F22.DR-0FP3W/8`=KN-3R+R`/=Q71#_,->&_1W MSF^R=^S)B[C]VN3IM[SBX#;$2;'3'[S@B>(I1(YX&)&3$,_XZ%>X%,`B4@-P M$?EOM\Q#B*OX=IG^<;?DDP[;]\9+><:NA?HA;K_Q_'Q1L-(*;$`W=NG;(Y<) MA`'6FH" M8,B4WGZ7EM4H,XBEE1KW+@S67=ZS+H(C`GNR/J^<=0T"OBUB/43$'<*-!*3[ M=`,0/!2R&2YS-(BE3A>ZHHME\--X;5'<(5PAZWN$('@HY+,CQ"#ZCFR'B+A# MN$(V]PA!\%`(=:O$0%;:DB7=;EQ#S'V=,X,4P1=QQ;33QWJU'EL,2-9V/$F1XV:_MBO;.J6=HOY6([A&><0 MQ48X78YIFP,Y3A\Y:L:(#.0X32"VF)$[V`ZGRS'-Y$[JU3@UFK%O!,KIQ5/S.AQ3P[=RL?)")3W M7DOME8W62<,%3"WPL4H'?8C>U9DUVG')K?\6T\^AT*G"V&)&0;NK/\/D.@J: M4\S'%F->6F$P+O91AS8SJIFY2MZ<>]4.T>UT:V_`.%JS M,_^=->>\DE[!,W@TF&\@5HT9:,V)$K6>Z$Y"P2"J#R_P;X7#(!3,`9P)H;H3 M],K^_SG\!P``__\#`%!+`P04``8`"````"$`%LJ\-'`"``#"!0``&0```'AL M+W=O?X7I:W3ZHA>S!6ZC:G MZ2BA!%JA"]E6.?WU\^%J1HEUO"UXHUO(Z3-8>KOZ^&%YT&9K:P!'D*&U.:V= MZQ:,65&#XG:D.VCQ2ZF-X@Z7IF*V,\"+L$DU+$N2&Z:X;&ED6)A+.'192@'W M6NP4M"Z2&&BX0_VVEIT]LBEQ"9WB9KOKKH16'5)L9"/=['\(!?#>D@)+O M&O=#'[Z`K&J'ISU!0][7HGB^!RLP4*0994&&T`T*P"M1TG<&!L*?POT@"U?G M='PSFDR3<8IPL@'K'J2GI$3LK-/J3P2E7E1/DKV0X/U(DEQ*PJ*@X.^>.[Y: M>@V#-8TG;<=V"Z0.*CL2BCM_J64U3G2=:>):?8[&C"XNGL5]ELMF1[C%2\ M8.XB!J\])NT1#-7TDE#&4-+K&1\K>["O[(/R4N[BBV&9[/4RX_>4\6`\M('X M;#;O>6/EB+D.C33T<_V>0AZ<4S31IY3-DY-"$7,3&ULE%;;;N(P$'U?:?\ARGMS(X2" M"%5#U=U*N])JM9=GDSC$:A)'MBGMW^],#)$=ND!Y@'AR?.;,Q1Z6=Z]-[;Q0 M(1EO4S?T`M>A;OQYM;UY&*M`6I>4M3]XU*]V[U^=-RS\6SK"A5 M#C"T,G4KI;J%[\N\H@V1'N]H"V]*+AJB8"FVONP$)46_J:G]*`@2OR&L=37# M0ES#PQCSWYSXPK98%@P@P M[8Z@9>K>AXMU&+K^:MDGZ`^C>VD\.[+B^R^"%=]82R';4">LP(;S9X0^%6B" MS?[)[L>^`C^$4]"2[&KUD^^_4K:M%)1["A%A8(OB[8'*'#(*-%XT1::!3=@1[,%P`,T86@R:M8XCU M?Z%"C$ARCRRI"^T.VR74YV45S2=+_P5RFA\PV3N8>&ICUD<,%@,$#BHA<:;* M]_-^%(-@%(-U0'69-L11+RP.9_-@Y%8#P+DA/QXPEA+(T?5*$`RUMGA'(6<: M$P]JUX;!\AQ_Q#."^WXS(DJ&B'1:-";ILY($^+$!:PWHI5E*H#_,'&#/)'"F MSE<%-XT5S6R'F<:$0X=RTV-[QXKJZ$#"J3B,?';[L M`#*]ZVWZP$93HW9:BQY?^G9OJ-C2-:UKZ>1\AZ,);[_!.HS-^P@OGI$]PW&* M=G]X`=.L(UOZG8@M:Z53TQ(H`V\&AU'H>:@7BG?]3-EP!7.L?ZS@?PN%:SCP M`%QRKHX+=##\$UK]`P``__\#`%!+`P04``8`"````"$`AX;,+;D#``"<#``` M&0```'AL+W=O)5)N.1'5S2<9$6[J"K=P/.F M;I71VM8*2_X1#78XT)S$+#]7I)9:A),RDQ"_.-%&7-6J_"-R5<:?SLU#SJH& M)/:TI/*U%;6M*E]^/]:,9_L2?+_XDRR_:K<7(_F*YIP)=I`.R+DZT+'GA;MP M06FS*B@X4&FW.#FL[4=_F?J^[6Y6;8+^H>0BC.^6.+'+5TZ+OVA-(-M0)U6! M/6-/BOJ]4!`L=D>KT[8"/[A5D$-V+N5/=OE&Z/$DH=P1.%+&EL5K3$0.&049 M)XB44LY*"`#^6Q55K0$9R5[:SPLMY&EMAU,GFGFA#W1K3X1,J9*TK?PL)*O^ MU:3642\2="(A1-_=#YQ@'OG1]!,JDTX%GONF\ME0IIT(?%Y%?&<>19/I?';7 MD*N3T^8ZSF2V67%VL:"!P;YH,K4=_"4H7Y.L4]*G_?^R#NE6(H]*96W#SH.$ M"FB5YTWH!2OW&XLS&7+B,0>E);G!0%E)QY30B_H'#5Q#GW[< MM2*O;5#O34YFO6R;_ZVF3/K$[#`0:V#6%MWW]-]0)+E/20W9@1_8.1_WH\C( MSWP8RE93##\8B#6PT'Z2!U3TY/W;J2$W\`$;U/2AMED()^+[7:D6#?V$'NJ- MK>88AC`08R#!0&H`@Z#A/#"#?C]811X&.VHF33%BQ4",@00#J09TNT5MM_45 M'L0^^TSLBHQBQXVC*4;L&(@QD&`@U<"-UAI$KN87=")/H$+O9U\M&CH(/;R7 M-<>P@($8`PD&4@,8!+T8!WV_O]4B'#3.N^9TQPLJ>'M$[33CS5:,@00#J0$, M7/BP)7'NIW>W:;L*^UCT;:D/TH[T%N9NA,0C)!DAJ8D,8UQ(60HK9V8_````__\#`%!+`P04``8` M"````"$`N`7!5M4#``"_#0``&````'AL+W=OZ[X!X;\!`0HB2K#94O5MI5UJM[G:?"3B)5<`(NTW[[6_, M.`$[39;T(0WPY^^?Q^/Q9/GYK2J=5]H*QNN52R:^Z]`ZYP6K]ROWOW^?'N:N M(V16%UG):[IRWZEP/Z__^K0\\O99'"B5#CC48N4>I&P6GB?R`ZTR,>$-K>') MCK=5)N&RW7NB:6E6="]5I1?X_LRK,E:[Z+!HQWCPW8[E])'G+Q6M)9JTM,PD M\(L#:\3)K0AZ.>?$2SQP6B\+!C-087=:NENY7\@B)7/76R^[`/UB M]"@&WQUQX,>_6U9\8S6%:,,ZJ178]B[>?NI6X$?K%'27O93R M)S_^0]G^(&&YIS`C-;%%\?Y(10X1!9M),%5..2\!`#Z=BJG4@(AD;]W_(ROD M8>6&L\DT]D,"?4;141;H4F@34*@U\^#L28>`G7S>\QD MMEZV_.A`TL"0HLE4"I(%&'\\(9B)TGY1XNX58!6P"J_K8+KT7B%PN99L/I"8 MBO0#Q>PL\0#KS`83'L^FQ!!6U^G9XK-MA[]!2=0%55NHE*R*A!8"2N(O(W`^M!$N-QXG?XQMPZC0:O=>5V(+JLQ+3!R4(1>)H M%EK%(!T*@GF0]-@&5W(/EQ);7-:P&Y1H+A_^S&"F^/Q*VAMD!-9N?,@ZM<76 MES:,F=9HN"28Q=92IX8BC.&D/^.;;/>5;BR[PS(5VO61H.86VU!QBTU5UM&I M1K`.0PD\EU`[PS=:,]B"PSMF8%0M'0RN-N'LCYN08`4V`F05Z8W67,F<;H'3 MVQH35!57"S3Y,RB6Y"%HU*>(SC+4Z)4D";$5*3$5\Z'"A+RKN*NFR-J>D5W= MM0;AXFDP[?7NO_`0``__\#`%!+`P04``8` M"````"$`>GIB==@"```O"0``&````'AL+W=OFZ5=JD:=K'M4D<8C6)(]N4]M_OV$XI M-FT$7``ACU\_Y\2)6=T\-S5ZHD(RWB8X#B*,:)OS@K7;!/_Y?7]UC9%4I"U( MS5N:X!T8;(@'>TA3,E%PU1<"BV MH>P$)849U-3A*(IF84-8BVW"4IR3P#;>)G%$0[7*].@OXSNY=%W)"N^_RI8 M\9VU%+H-UTE?@0WGCQI]*/1/,#@\&7UOKL!/@0I:DEVM?O']-\JVE8++/86* M=&'+XN6.RAPZ"C'!:*J3 M@O$2@G5A8VC/^X5!17K,K1YDA@(MX6H\K2?35?@$#@='*/QR1ST(:L'HS?$MWI216F1BFJSKRHY^<`0@Y5A@N#D:3C!$O4T\/]1E M)[;(W'0NCNS+1;)!Q)&;7"*G84_NVITYM[1$[#KMPT\N0L,B@WB#AR\TOD-.S)Q9Z<1>Q: MF_9KS2L@&V8&POMN'$F6W[\;\#LD!#66`DB*%UW[H@&;%'NXHPLA M4CT8#(Q%5E62S%9594UF%2D._&%@^`WL+P9LH+&?_13M-^DG\>]_(B(S,K.* MI&:E]AJ[P.PV5949<>+$.?]SC:AO?_=Q,DXNL[+*B^EW][8WM^XEV718C/+I M^7?WWI\>;CR[EU3S=#I*Q\4T^^[>=5;=^]V+__@?OJVJ><*[T^J[>Q?S^>SK MAP^KX44V2:O-8I9-^>:L*"?IG'^6YP^K69FEH^HBR^:3\<.=K:TG#R=I/KV7 M#(O%=/[=O2>[3^XEBVG^ET6V[S[9W=ZZ]^+;*G_Q[?S%03%<3++I/(&,Y.5T MGL^ODZ.I&Q^RD[7W)P?)_0??/IR_^/:A7G&O;>\DKXOI_*+BG5$VZG[]IKC< M3':WUI.=K>U'W2]?I^5FLKUM7S[N?EG3L[>4GN[CGN)WV7E>S[W_M1]N%#:8^,LH_)'[+K[G,U<:?7L]XDVUL;?UCY MPG%6YH48/$H.TGGOW3VV8&3;<#A.S[NC["_*$M*2P[P:0MZ?LK1<.=*1=L1V M,4W^F(W'&Q^FQ=4T.%-T/XD'^K$8+Z;SM+R&A/&2 MM^MG_Z%*WF6SHIPCXLG)/)TOJL13WYOR3UG5G=-3;I,D^_#IO"A[FW`R2<<0 M$4VT7TQFZ;3WH!_M>#$8Y\/D<%RD\Q43,L`$63^9%\,/Z\G)15IF5?)V,3?E M9"G=UVHY\#OB=_<07>JMZ?!/M[UM^[GTW?UB6A7C?`0G1LGW"/%TF$$>FEZM M4LQ8\W:[,P=!VJLJANA]FU87W<]^^?F7G[N?G19SI/#FL=PS*^;QXCS.TT$^ MSN=Y7Q#VA@9>53)+K]/!.#-T2H?#<@$C;GCO8)$E\R(IL[&Q;)8BB?W17Q7I MM!ZY\WA/BMJK?;6:9O?@#0^/GNY!^2@Y>'1_M'IUWF'I?9 M68:ZCYPT)GN+^451YG_-1E\GVUOK6UOV?PF8[Q^KG+1>Y?.+)&5597*9CF%# M<9;64?V3,+!KI_CJ9`@U=0F*=:%'QV)$@4C`QICB?@X;M M[>?KVX_?U?]N3;/.]E:S;#C/+[-Q;[OV1B,DJI@BH<=I/MHXF@(D MLQR)[2X0&5M,%DY0#K*S?)CWX,%MJ<'"13$>8C7;?N'RG5V_4\F.P M"#N;S7.@_\$JK1?49F8_V/;#?`I0Y.)`41DSDC_O#60>A_/_U.5"(V^50S^_ MEVDM=[>^T6N^ZAO;C=UA`^X4;J5_ZZ(VD M1R!?;R3VYRQY"T-32?-*N,>;*2;8A'K_5^_TN^PRFR[Z:.@GP6"__(AW6?6? M.,B`&P1*E'09_T,VA<:Q`^C1))^:'R;=[#[Y.IVFYTY(S[+^)&]G&C[)'`T) M?\[*8E94(*'^R$HKWDV/>@N\`@O)"^#%N)N3*%MF.67LF#=AS5-,LAPM+%8 MZ<<^/X[+XI*UP@>>27(W]](GWV3S9!G5X7,S`"P0Q[N,1#NLO(!]FTF.-8IIQAG_G5_`J/MK MV*KM!XVMZOGHM8B;9NSSTCEC`>\QQCJA^*__'%!Z%5YZ';57NPPPD>E^Z)VO M]22=*(9*4@*-*,;96?F\AXK;GM=>&5>TV4A;DW+>?!HY?/+>=![_A3>(QTSX@DM9#;.)/BIE/`J+4=)-<-CU2IM><2W M7V\+JTZR&09X`$IL/W51K^1ZGERDTO),2#`O"PRP.2W\ZVR,!\/(^53;767) M66VUJP#F54\)6JY"1R/PWA7D7*VT%0W&[8F.Y8[WZ*=%-1>&H9ARI(<%K@3[ M.@T"RJ?Z>ZCI%D)G5B!XQCI@0FR%-O+7W9UHPR.8/L'Z$]_A?Q",9P+`H'>G,NB0=Z)D*JMZ_5O-=J`)2[\.EH>IE5MN+5O+0P8_6Z>O/> M94SOV\'IU?.V=:NEQ=T]:3]J)BM$7!MLR0V&E3`_O0ZV;M0/NWIL;D\EQ\^B MV0Y>=`FLF<3KE_F(#?I>20AS<&]DPD$V)"V&7B$VVMWNP+;CF$,21].I)!=" MCBU)L^))I6Y6/O.FF&Z81C1[*!-[%T)/%C-`1IS$BSH@PX,96!#A=,DXFLXS M/IX3XN4]H^U=$]R#I5^_+<_3:?Y7<^`2)=;>D)G!'7@;NYC="5LO:37^)9C@ M-02_M/O2#WNO]N),6[*&BR9[YC'UU[_]K_6$CZZR\->BXJ\$J\>GQ:+D'P^2 M*U!3'D])*LD">391@QCB:1?>9)?I*!7PDDP<7B3;CPUTMY(U.`$4XS8]V$QB M+->08/@$"0+!9DZ:DO/4^6OS-!\390O`6&@ZAM6.65567N;#K(_$;S7U=4+0 M:CE.'(-D:#Z)!`[0!.W'HC1:>U(0<5IH?W6!13@Z^"'YD6W79B>OYJ/-]?CA M7__V/^0:\9P?;"SJS(BY4'0](34D6FV:'+S>77_\Z*F%Y=[6M:>W$=NVN91C M7T&#QGZ"!_;H*]',-B0N,C-V1+%+;=LMZ;"NM9)S*'%Q@7";-9DMV!`IGM*Q ME>P!NP3+7^-5E-5F\OLTK=:35Z0O+I%`)U?#80J_BXZY*Y6?AL__N)AFRI;#/SX0R*F$D38QB/7Y-I?E=@EDF>EED.I%7YN=*@2,.Q_C%B\4;$ M00Y2SQ'#-M/L.XT2")8?OI=$KJK&K$!ZF7 MJ[OW0%L2Z0VL/\P&Y4(#[`3'Q"N3N1F1,FDKEHZ\F:SQ.?JV9/0]-G^<>"70 M#OP(JA<+XH3UY/L21P"[ND_V>#+(TTW4EBP5/I+C,3*R;'WX3/"A3`7VC"Y_ MN)`FY&4K_AM_ABV^'!=JOX2948>R3\A`5=H^M_H!V)5Y*&&:DD#D?+)P#1Y0;Y6>D#R7[ MK'GF`(]9<4[-\S]+!Z6/$BDS8173<877EVE+''HR&[X^."'\F<(;3R*,]PHV M(ZN2C3>37WY^RV-ZI"92D:@*6J/%F`$5\8S3Q108]Y*)V\&DRF6:ITT-Z7$' M&N8O>CP%#Q%]4``N+`6$C"6;_]T%%/GHL`:.00UZ;=*6_-X8T^C$*`?09>W8;`-8N`ZCSU0(T+X(^@"`$3LY+F8R\I:])+8;7F`R&%V` MG)7*U@7[C'+4G!K!^TOQ2/&51NI2!8RQU?/-I,>/2,`F:?E!)8/4M@'ZD[-Q M>DGF882)S*<;9_F8Z`T9G+FU-/^&\C$$@![5=46`(X]?XR"R6)]++3%ZV"(> MEI\.@$(IG]]/0N;Y13/TADV53#(RVSS#\UB1T:78?L8^6,S$)B.\M1SA<=AP;$+^$SXO MYFHQ1M.);;@X0.%CG&?YR=2VYX*![3 M1V,W>V<.B,PG"#X.-`_'BQ&6NRVR8A53@EP]119"]'0<6H=ZB(L\$09Z0G@@<@UTN0]<.AD06+"I]G MP/-*9L3=N'ZL.I8>AO@)G,23@4)!8ZV:9]HN".O+/&'C"TF;L?D9BFJ9`%$ M3D2SB&.'TI'Q54?\]-V41$()2Y M)[86R7J':I-ILVU6GL3/<(D0<)!%"C\<6+6M.`;,SDY-($XFK:NT]F@RXA0^N6>WPJI5@C4R'/]=D>P+8(A$A`C#9JQ_V%[6+;+[<.AR'>$0"&=?(/[ M3WS-LPDEU:8QG(NFS>2(C;=(*<"Q89JD"]F6_47D4U)8E`")4<3W6-J1YH!+ M#4![J]V0AJFP6:P4'2U"HTT1SZJ2@^TPC$R>C/7O'3RZ=3C;UXR'Y)E[S\HK ME2IQ`G%G95:;($3J%QC:\WZ.%!7QUA+>8X\1%U&&/8$D9V<,05HT&6_UV.O7 MQ^^25X:_%#>(I_,+,U/B_6MOO(X7A.(R_33:J&0*8RL?8&-`9_P+UA8@,Z)= M"M;-9LBU42+1Y<"@JL\9"_7K[V%"O&QI=!V^N/CO\29=+0KCF%/N&EM5/^%# MQ,>FO^VU8AAH@X$QY[QCT\UP+>-W77#4]S-/X1`QG0F<12921`RS8%,@HH4^ M2LAWTPNU+CL<0>#9+G-ME+)_I:CQ5$S`;!;?`9"FR0E*H8R#2:"W4C:KTF1L`C)%2A]>W)W?P`*(=:R>XE8;\D0V6+3Z*>MP MB`ZS5(;IL`JNAU4%/"[37``$#\N,"K%\*DW*`GO2]@.9&R(*LC19.>V:Q=.5 ME1BW&I/,&:LF@C#L29-S&X]MTGARC7-@P'L]K)908<6FQ#M+/"(WWF+7M*EL M$&41R99*;2%C49U#>ZC5PBJ:X>#KHG3.P$!A)^;(7"1VC!JE]YU\+V9[KZ2] MVBH<,DN*P>S2=0FLLV#VG$Q#:1'5T/70(.36*",)N+_]?&?]R=-=Y[`!B_1G MU0TU\7.[S\A*/MUV1M`OVRF)W_H@K#9CFZ$(PBC#U[$\W0+0MW4'WK'-3=6, MH!!A=#9&_(IS;8(*?>8:SLRC:S0".XIKY7+P]E3@HL5T!C-.81S/:WNOBJ@2 MUQ(YFA,\*8H_-)WB%5\40['QRDU8&QQL8GJ_?/-;SA:6F&\>,ZZQN?@P9">Q MI2;JRIL1TY@5&A4+Z"@)!0EPD&V'"0;\-F2TYL`WT^>VZ-;S-`RMRY#)B)H? M8A+B0REEVBX4.MT;"BS"?&+"$(^@RA&9>K\QOD4I7#T8PZ7M!0N>>2&IJLP#_+_B?.DO=A2#1UF!(_QBK"VQNGNPDX!BTA5 MFIWM:*!A=AOE@!H4FSVS('<3KU892G\@(O7Y;G50Y'Y9RZMA,9 MEX(5*+7`:^\W3S81N_&84-$!1TM+7".T>B0(HGF! M_*Q'NN[*!SV&'3+1_V]O:],X,OR1DI<=TK3TH/D#+L=PU(*S944ULJ`60WH?66$&:]TW765JB_QI;0+B/'>P)NI[R_KZ2,CSK"2X8"%G.T])0A M%2F6B#FUVO%"NW$#?T*O`9QT]+1,"6OFA,SYAG+1WG(XLG)KP[`HTUE=_`[7 M/2VQ5V1%1=Q9&D>$,@+$V\65T*R-+);7)"^%ZJ[>1\FD;U^71<;7(R&$8<;" M4:\A*T/>DI%M_R\)I8L%6\N*RMJ`NR2YC!C.H>HM+!F#I68%4@$R6GBN/"\V M#/,2ETJ6'F*=ZP9$DCXV>7%>IH34'G9!D:)V9%&[\M-B=.X"\'1`!MZ-F);E MM;ZTY--M8B<:P#/JAU9D'A85,TMF:G&PU:B>,\4_8`TCU<5(//`1TFEHXI9? MX:/6'(=S&C*LI>$;R647H7FT9RFJCZE8Q9]$/83=F@`22,*1/:$#O,&LV$34 M6XA4.IFR\,FX`+DB.0SH)]"^J5EK?J5^+2V]'L,F=,R("0C'GZ->OAE72E:G?WQ$J1AG^!D!\@H+[9JC;VJYM9GK6J>PHNP(4)D MJN9XHNP$PG]^P0Z,.5Q&AD&9S7+A1,XY"N(Q@`&&FC4DG^T":`2/HA_6/H25 ME@;AF;HOR&F%]=0(<#T;+*[AL6#MZS-FMD-DPW9-2]C<*S+K"*7K4XM'<#:^ M7:#->AMQT%3L5(`A!/,,6.(BA*_DAI##B]Y$@ZRI72C%J$ M'MS"B[854Q3L(SGF1)Z\50S%YAMF@7`$`H\`/4$H"IEL:WA@/Q6X":)\;,OQI[A*GY"Q\MV-9VC29:,3DQZ7?V=];,@YP=8QM@Y4H"E3N_( M[O6U["6LT9&M@+@(V`K1=D;'_`*,0RWHLG^J(YEY44*@\4\$[J';+SW#F#2E M)=\_]LA1*%X43G@T'/CK:()B(@[MVXBO92(@SW[IWLI\\VT$<:J`-UBFG4:;NN_F\%NJ0 M@Q=$03KW]AI'BCJC=WQ0PH/:=_965/1TVX`^+SE"/2?-8ULJ#([44T(S1%]J5Q&"Q3199()WY#E5XNA,\@-(N*2(:SCNHZ+XB) M`#QC\N$FA)$)%11'*1UV0O1&XSH.FMPTC+/^,Y3_KS`N6I]O[I`[8ZSR\9V< MU8'MZHK5^_YTI"_J#GMES-YNZ]K\A?_85?$T/;53EQJ6Z]0<0[4ZG@L%H!`[ M+F#\RX+:OK7/R:>%B0;>]?+U0H4I$HRM8V&/0-TN&N(5? MXG)@KSF_"/?B3-ERX#RY5`\DRU!CT)F,E3YLY4/6G#OL%,P/].`;O3$IZ,+: MP.>VZ%>J;W\;%D!P1I,XUAAG!WH#*5&\=G[LP/49R&?O-,@3X/?-/U M@"Z3B.^.I@0G*UTA&[O+97CW[Y.-95CGU;;F@6\7HWWS7`83/9>PQ.SP;T3: M'?SL2/?QP6J)[&GU!C9#`X*A2@DZU)!/0M:C#0E9C^&AB!76 M`>UMK>KIC`%15TF<-UTG_]OKB]DDABI/8^8?]8,AZG$)&AOL&E-WB48 M.#ETP]0;4?>0MMM[WG.-7BGU],J4;\^0 MLBWFH/G\Q5'/V_E"GDX_&R\CO_MDJT?`%W2W[`A';\(OM.+CT*9@G:ZVM2^) M:F?R\)#7=D53[8*42GO)0K#-V8MS_)69Z_R35$;U*O.CL,66NT?<_`E3Y+R5 MAD,_U-!I8NEJXI+-D%;SIQ+E"4S)B(&W]2SCC)ZZ.*'GR\24"U2_*O/S<[1! MO0B7.=W2WK.G70X7Q@4[>#:8,1GV>?%U"^5&_K23V00IOP=KT`X MGCNX>,1A9GF4^K-SD+55CXYXFT&R:`2KZ*:Q4:2$W]1XX!I>FB2![)C/+."5 M^EB9',S`,B\^+^6RMI:6\D](0@1A(`JP;2M2EGTAUS8$W#0]ZQ@\&V##B)@& M?9R`P1EE+'R.V"W/U1K,/-7TN^S@1,>_Q_D'I3'-_?%"0[V)^H4SUAF7#0T=9`@A"2WB<=4(6/^*+%3"P(&VZ53F[RN>"RN:BA34$7W MCC7\$=.)P:RL'5G_59I!^3*Y'RJ;\ZR4V?>%RMCX(L!>J[=2F^VBMKJCR:!A M&8]@IG8LTG$C5%)OQZ*;6*Q&R\CSO^B9&A(XJEJ<]B\$D)59'GR?PA7OCS2. MA=0)!/$E$&R>.X^@-3@<%#]#%'$=NN[-IK=KO;(N3[F6Y3<-Y_>:`K,6TN>* MXOJ"TZH6<1B2VFAZY(4W]$;$*^6?%],T`AU M(DCAFP2E*OE";9,9QA-CIYSNLQ]Z1+FO$R1TX;- M^GU.TG*IC@,('M,Y^&J3Y)DOM=VR9.]Z"Y5"FL##(XB133$H(('&P".#3.-: MRBEVXVOH])(I<=736A=C3L@^UGPT!+'B4#N7*]Y#.3#?Q`\8(5<+5'SMN@"7 M[J4/([P!,]+0?5_#X]3*,ASG';/_[HB&=S01VP@!\AX"O!/`D<82:B,HLGL. M.IJ[]\(C@3>13!53>%ISR%E_Z#S+/\)C<38@M))-G).@CK.@?R1.Z2!M!(KX M,SI3*1\+QA+(5,[/4J)*+H4RF[Y/Q)W+=D(TI*\!>QY:@)RM4=>_4L8Q4'G@ M9,_,O,$JNW#!"5J95Q_8)OYGEVWP7[9WIK(]1286A:3R`L0CC'1Y.0_'4]8_ MJ?M3C\=[*AW.N5P%'=F7W]+E<$2I):9FZOI1;USHL3*_R8_`4J!&TJHL M&R[TD]6`:'-/VBRXF[4)"F6U&S\F)J<>4^96H6[<.V3VA*N]?E-[$B^4<^;_ MC9(>7#"KV5[_%[(8Z!.$W39&1 MM["=5(]S/=DH+M<``H+-J@P2,:99M63R=% M7?I\;TX<+MT$YK,.8*#U`!NLTAI"-@9<K.;UW) M:9/K/#]'\!?7S1>(4K7+LK44*9D8A M`'HHHI:Z().>Q'R/1S`TF?17A''X?6XWC,GF)B>Z^^&N,G0*V_8AR:P[_^7& M,2AG.$_9FNB*KOU:93)VGOS&(0MI?\Y:7059]8,!MKW1O0X/;7 M@3GR-J!@(J_>;Q--5[K)S=KX:YHK;9.=XWMY?&*-MKZX1PJG3@GY7:@%<=/? M#\48]::&TJ3-&T$\&(9X$( MUSDK:ZCP709*-1N+Y.=&AUXC0MNS]<:/[/-3SE&05)Y`%X6W4F[^(T4V07!\C@;WBA'I#O!^E M[2!E$`W&[OAZ%8;!,T1R9!\K@:SSOD.0$M/11/>UJHIUQ'/AM)4/1=W;[+L\ M./T?7H.KKMZ!EJ9'*/A2HM"=N;#O./Z&Q5(39B`.36_31SQG0:MLCLOC(39Q M6V0O1GGGKQD[IA/I.CF->L2[[%[]Y`UG+0X6=<-R."_`[O1BJ'89`5QTX=G] M)W;^<4W>&7=<*BQ[(!O5'"Y*=)FIE$G*IH`4$#MFY58)LSU:<;50CQ&?1.FG MS"2RSNU`.C(98NH87N>ZT5L2>G]G=WWG^3,?7NA\O3Q?.Z_#HJ->)(7B&WSD MSX6M5-PV6VG/&+G0=JV[`<;=G6>:_<'?Q4T+K^O%76DUUK.X("IG,Q5;Z(:$ M^MJ!`1$U#[F\A;]J8,1O+'!O3E?N/FEC]KVWTT07[K8`4X/[VT\?K3_9?9RT M!`F(R::R=2U/"&6S]2S4B:!OZ5#ZXBAVT M<#`^"N,.M5C,^V_X#@''A<\CTS4L^NY(G[!RHHWRZDKXMF0CL^"A))G=M")0 M>RN#^R';>,,>F@AT;D?H+0E;':X4?:,K167-:1S''^LJ]-OX/I;P,R4K[E7C M]K/W=K$:AV'MV-9&Y]B6[VUO=+4CN:PLD#4569UK7?:X.:#`2K\>'N@JB)&Y M[.$?]0&YUN4O_OA7?+$+*=N;[X'AK`(6.=S2?7W:OL$,EB"7>["XY7<%5QPUQZ.9>++>^' M@JTN58DN1AFZ\](^U.GFU=YDJ7N$LY8O3V[E0*_\//-[1EPN3;G&37`M^!?^6.WKC[R6O_(*NKG[\<(=Q*VW03K M_;&37KIKH[G'U6#$?GRD"6J:WRFHXT;+QU@,:L&+&=>GCP5.!E#P.OX)"Q^: M2)SP9[J!F[VL7#QO13^_X5X*-I.TO!EE2:R[?D6C.9<>Z448PW+)>TLZ>K*V MUC^FVL*HG1ND:KM>F5\*OL'0Q[;&`'257P+9WC)U#=]8=D"00$,,]6Y`RI6L M>1DA-4[UJ>P?N&Q1N?UT&9DU'U+6SFW93$H024N#$5??IQWIBVL&CI9@XE%F M**P7!WEW)OUUTJ#[>NS>QFMFAQ3G/EY_ON7N2M7&1C\ULIR'/59(Y'-_3_8> MF[T?CF0N.QP>/RS)N/'A7WX^OC%+!Q'4#% M.]VKM,(G@O'_%FY5`H_J"W/\K4IF3:\X-:?#2@-ENNV"):F9[S6JW_"0_=B] MPNTWIHN%[@,LR4E25ENR3UV+<6JAS;_&6Y5^^;F.]K"D_\_O5;J%<:H"7+E" M_!TO3(IPTF*JV^]&6GTG4OMN*$J2N&6?>B=2<`L;^:JO<,*$SW6Z-,2\+AWA M+FH"M>_;E4P&`<2";-:_WZK4I'.#`UECXY>]5V=K="NXD?1-U%`^[CT=V8KFW(NP'2!I?SD,M4USIP0,=V2E[? MOS\AQ4<4JZ1GW5%GS4I:W>ZCK^0;:I%6]_-PV3RIXY)$/CAA*R(?O(.9TK2Z M]AH15K+9W5PIJD,ZE4'"W=)U(]#R7H+6+%WXN-_]X$V';N;LWYJQMO/TV?JS MIX^[+_?RYVN[^%7/?2MZ3>>+$^J<"RHW=-`00G5'^:K[@1CBZEFA.5B<(#)4 MM_9U]^D?PWD89=Q=+U?WD;7GC]:?;3_K?;R]L[ZS^[3[\5&SR6B/.Y[9?>;7 MO_WWI;^,B+A$G;HF4[[XBZC4/8*-<+AF3)>T"]V8UBJX1%K,X%H>VA+[,DY: M<-7[T1/M:5OANNK67<[:-A<5/MGJ;?#:[I/UI\]Z'-($*Q?3'?N$JZJH8ZJN M\M*:ZV]]X(9D/N%&?;GITIBHDWMQ;?#"AR;KHJ`G[M(*_2#.F6RTD5W1!;R6 M?;``/MG6'8`60RZ/$D+>FERE+NFPK@U71,5_=<5;FQP9^;AAULVR8CZ,K&_[ M]<<(E3!3Q1,*"'S\S?DS*Y(`)D(FXDY!D,##C39J:ATAW68(%X;NA3$Q/[>7 M_L)"AZ%^:6V.^I[Z:-EDRF21`<8!:@N,M^\V%5&>T;=S_5_*\RY[H4=&`R-4 MGQO5L2!QLL6LT-%HIP#T-'^0!S#2Z_U5H>><>[^1*1MMPH4@&(I&VNJ#`D&P MX$F]L_[`XDW;\X\I9]E!3O<3"YW++2UI07EP4"B@%L3X"V21W?KW&^&]:G]V MNYJ>6=*A9"UQU/58Y9Z*5[YV;4D?KF98V,%?[68T:K@1D!$[.^3%`5%MKCCN M_A2I[X;R/`_\)WF"9*E0DYRL(">Z*JKIJ^K)]ZP>4-I\@!8M,J!3%YEO:`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`%WU_^B^DG*AJY`F67 M:?T%*4C]+(5(!(+<@7!#M1`0<3E:DPMN MFMJPF,OV_R8],)+HE>0'RMSEH-W!M,Q/AWPX<\/^?.GZ<2\Y]0+'DJ#4%X4_ MC=5F=T,QL^H1>5*WL MCHMSIJ9@RU7Z`$F>M;=RR.W0L<*&Z+YL>T9CA;/N40`/?-'9K`0IV9O^[Y>^ M]`=@>,].P%E;<'=PD$NE5IUET'DGJ[5VGVDM?&B7'G0?:7F?GV0I6F_>:IU6 M)*ZNX8&6T27K+2S"#22Y8YE7.[_N'Z5F2'G64B[$YE,U1W???GE+"KG[O/BT MLN*[2KYOQ*IU.7/.2NU%MQ[L^TZW=4!@62Q`I009=YT$O8S=6_(3I8*ZFM:; MH(CN%C4N6*(F--4%R]E?OR_76>Z=1NLEJ5Q9@4"^Y;-I2_I7\6,IW<7\8)?S MDZ?!DN^-2+-QPM6%%`ERH6IS]PV+(IIBE+$LL,JJSKU?:[]]#D%V)SO:G;;[ M/>%DK49W<"9)EFXFJ\#2O@Q9O^[$Y)UXTV>=NE]VJ=)"5N1K[O"J1Z`3PRCL M>Y,]%?A]2@JW-YD^]V=D:>AS=I?4(W`M6?+S':T/.PJN8O_J\` M````__\#`%!+`P04``8`"````"$`Q+\"20,+```O70``#0```'AL+W-T>6QE M2U`X7MA^%[D1_K"R<*5G;JS3W?2]^8+%T+G.OWSV$4VW,?H&YZ MINWDLMF''?&!Y\11$BW32Q#7B99+SW%W48X[XPY(NKT)UX$5I(GF1.LPG>A& M<4GCW[Q?3/0K7>,FSZ(%@/C#?]91^MWO^)]W?WSWKOOO;[_[YX_NXE\_?;/[ MW4_?ZIU<#9$)/C@L\[)[4"Q\S25W,@MN;Y912`PQ@29DZ_HUC#Z'%GX'P0#F MX<]N;Y)?M$^V#U=Z",^)_"C64O`RV,>NA';@\E_,;-^;QQ[^;&D'GO_&+QMX M@05&]KO``S?AQ0[7<%X](RNPE=$3_P\G^B6!3FDU^TBK=1A)U(VGG5!W]F4 M70W.9EG?ZEO#5BT38G'7;ZBP;[5)98U"ZVYX?S8ZVU>VS[HL#9^K!V"':Y=% M#[KN@?X]M/!UCC@Y\X#6JL=@`I?>^=YSR(?;9+V"&9T3>ZL4F:NB]Z36,MN$ MH8P1:EFS MX0F$/DS'L_:1SL;CMH4:%KQ:%GHWP%?+0BWX;]8:IUDV--L"6.M@U[I"=V5<`HW(;;WAA,.P4)*%0UGKZZ#_,O=)MF"N9IZ6;``QD8>$9(LV M;"SKWK(VDA9R-I(&DC:2%K(V0M>IZEPYDXMH#7NPVPZVK%&WRXM[LGH."R3` M*R*F&@1IL\MG;9,*1FO;-+45\LM.WY@:^&*SXPI+:UKLVEG3H,+*FA:R-HIQ MDWM7$%Z4+C`]5R#9XEOX^9?!`$6\88YG*PEF^0FW/OCFQ\%TEPTI,$(YKN]_ MQ#'C'\MBF(+*S^W-9DEV]^'(!6Y_X^$!?`OEU>PM'YKX!X"XKY&QMY%FKU;^ MV^,ZF+NQQ1;"/229OAP`,!1*O>E6%4IAK@= M>EI)`7PX0($%HVX[0UYO7\Y71@A)NH"A9`32P"%&VHM*DG-!9PG@,"/3%NH)8814A`'P*.D5 MY3RA)XP89Z2!0%"5(4DT&*I2),6@*D>6KC!4I4@"056&I)Y0E2(I!E4YDKA" M58HD$(`1)1F2>D)5BJ085.7(TA5]52F20%"5(8DG^B=.D1U:-N5%5%H_-;^H M?JIMEK6%U-Z^11/X/6_.5T]\Y0B^8&LILI3&/4@;#V)C[51[B6+O%UADXKU3 M#EQP8QWOM4L]AU[Y'-NK)W<#2U&^-;)9[J_U`I*\OK$=C"+"O9A*_5!:U[4F MREOGYP@LQQ-1:SE;U-<6YKABVU$UA MD,PA2D=GV^%":4(\6.&LNWHP">E+XV`$J[=V\H4X<6B)K$=^\L M3FR"")?)IP^K1H@@?[6*J(GRUAVD5#F-5W9TY+@.3O:GH"\=/PY1>$5W.B*! M*W6>T7;85K+3))Q:1]1$.?5%?[L.=FC68K&=J]HY#&6'CZT4G88W8O&Y$)X] M.K00.S50"DLUEL.D?4WHLFSUQ>1M5SV_VH@[`=!V2,.=5GG6IMEV[Y']ME$( M"M2=`>[_74Q6LDEJ`$+J$]C<\7WU\E9<;WY!YCZ64F%@.4,([(XTE1SC2B.O M<9`9OS@.G@'NL?0>C@G5WF]]#II7=FL3Z+X^)(3CU]:',-[RJ,2W4A6EZGZ_ M=X%+A<9^95:Y*R\H:!XRC918-N$'$(7CZ`7 MFRP:/I8%'F;7_;UVH=TY:!D,QWP,QU0_7WL^W&V)NR>X`>9`S2<*IOQBMF5Q M2!84"K@L`\.XH<:'),KBHK-*/F-Z)+#"YJ:S2C[BQ M3&2!R4UEE7X$A$26"4J:RBK]"%Z@LB#(-R8CG4DK?P3O"$EXQR+J7TEQC?IF1\L_0M/%=:`%\Z0&,,XK6LBIN@+(CUXU+B)&&C-T8CQAX=" MFXB!UER,F%1Q_B0CYGVX6A<>$G,I#MTR(CYXX:N[$"-'9-@`D#*2'MUU&L.C MXC*+Q"YE2!+SB+<;%C+$%,$?59??&YG-/Q_A[L)<)4[W23+`)8@,\+^N4T(C MMB)"L*PM(^3)2^'&Y+7\"CJ(Y[4S9XH#B>H>N9UXL/SO./, MV`S\Q_+:1":9F66%.B0-))?1O:XX`!P[IAEP&[ M[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B M).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%! ML#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90 MC",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^ M8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX M`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%' M1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW M5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\ M6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^ M4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X# M0[TJ=?L>FT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W M0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC M&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#> M6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\ M]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6 MTT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[ M]5'F%N.%BW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V M6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PD MU0$-D*"P'ZE0$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0 M"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$ MO#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+ M&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+& MR0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[ MMM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:&PO M=V]R:W-H965T:_V#YG3A+FT+5%-$B M9I`&:32:Y=EUG,1J'$>V2^'?S[4-H1NHO+1Q4LM^#>-Z,TK3;)S<)+J]::_8$KV@%B)5MAG#\5(LNE]W2E-5RWT M_92,*'ME^\$17@JFE5&5C0!'@M'CGJ_(%0'2?%8*Z,#%CC2O"GR33)=C3.8S MG\]?P;=FYQF91FV_:5'^$!V'L&&9W`*LE%H[Z7WI7D$Q.:J^\POP4Z.25W33 MVE]J^YV+NK&PVF-HR/4U+9]ON6$0*&"BU-M@J@4#\(ND<#L#`J%/_G\K2ML4 M.,NC\23.$I"C%3?V3C@D1FQCK)+_@BAQI@9(^@+)P/W+]_1<"`F&?'^WU-+Y M3*LM@CT#4YJ>NAV83`'L&LL@GM.-@1E7<^.*?"FH#2S&XSP=I3/R"`FR%\WB MA&9?L3RAR`<)`7^#2>C\\R9=$32#T8[);.#[1A9!,_(QN\Z6.R_V'`!FU\'' M\3AQ@0'U-G-Z&$_0Y#Z\)$OR>+QO;;DKR/+)Y63XOF=L]!EC3GQ@+'F+/$02 M-)/WC>T*/C`&^_K\Q)SXP%AZ$,@B:&#VMU2OADR\=[@!'.8=28@M'/%P!'I: M\P>J:]$9U/(*N'$T`88.!SP,K.K]5E\I"P?3/S9P#W/8+7$$XDHI^SIP5\AP ML\__`P``__\#`%!+`P04``8`"````"$`4+3$*:$#``"U"P``&0```'AL+W=O MV]7G',*KZ04WM1T$P]1M$6EQIW]V4M.E`8DUJ(EY[4==IROFW M;4L96M<0]TL8HW+0[E_.Y!M2,LKI1G@@YRNCYS'/_)D/2JM%12`"F7:'XN_7;XCAZ^,%)])RV&;,,ZR1584_HDJ=\J"<%@_VST M8[\"/YE3X0W:U^(7/7S%9+L3L-P)1"0#FU>O.>8E9!1DO"B12B6MP0`\G8;( MTH",H)?^_X%48K=T)U,O28-)"'1GC;EX)%+2=!H9 MFFQB#BK>XDQ'C@]ACK'",NBQOET"0TB2+$,:S&0*,,R,T_1V']Y@G)RHB-Z@ MQ*DI4RA.'/5YC,,TO1T)1CA03=>'(\E+%Z2U5)YT>W.9XDS[>[EV3;O35SICCI9?>*`,_+[@?*Z%X##/>P M573WR^[!!G(;*#3`\#@U/;[O39(M;[%='XJC M>;.!7`&7UZ#01AA>TX]XE63+:V*=)9GB:%YM(#\"85\P@1?8!XLVP+`J.P/M MQ'P_K9)L68WMPE4DVMG&2*HEFU@=P&"@TP MK(5PE>MYE%MH`MC[^>Q'F2:CQ#JFLB-)LWF&Y&=(<414\4Z2.`V"T^8TKU2_W,'[3&&^S[P@+RA5`POQ*W,2:)@]AM9_[]4K9H2J+:J0=[,YD^IEZ)%"71A_L_?YQ/D[?RUE3UY6'J MS!;327G9UX?J\O(P_?>_XC\VTTG3%I=#<:HOYUI6 M+\<6IOL./!*.^8>?8=GL(:(@,W/OA-*^/L$`X-_)N1*I`1$I?G2_[]6A/3Y, MO=7L;KWP'#"??"N;-JZ$Y'2R?VW:^OS?WJCS:!!QI0C\HH@S6SN+K;<&D4\: M>K+AP#+&!%/U_Q$;(B-B@5SL$2K",0*`%-@E- M$)D@-D%B@M0$F0ER!6B!@*6G!<*^86`N"&O8&K1<6.D.[GH;I]\:Q%0'C(2, M1(S$C"2,I(QDC.0JT5R'W6:$Z\(:5A+$45D':\-W:02[A6*TT8V"P6A(`48B M1F)&$D921C)&/<%18ZX[V1!ZC78(S$C(2,1(SDC"2,I(QDJM$P+AZ`J"A;/4-[EHN([#C1E)F&HZV$A53U?-ANNHFJM$"X*H>$9$H3/7PR"1 M&@>.0HF,Q##V_(BL<.0Q1PF73\E*30Y#/B,KE,\UI$=&%$5?7RYPDIL)(I&Z M,W`4(J)E%7$4YAG2?1?TSPN>^7(+3'N.Y$R<_K!,7=EME M`]CJ"1J@U7IH&"*B*C%"!,E+6LY"UXK1"M:Y8F44U@E:48\I(NHQ0Z3WZ.H] MYFCU48]Z2$5AI8:TO[^8B3NP]ECMO^]JDCV4W]F#;D'<7LCQ3(]TC#Q:P MXK>Q%02.M*(Z,T1$6A$BT>';HV?L4C%>AJ)(Z6(.BO=9U&PC?"YK^\@9='!G7C@`4O42!SC7C5`*YK-$!'5KA$B M$>2WQ^URXQA[;HP6U"A!1-(I(K+*$/72CNMZ1AF1HT772`^2*/;4(/W>HNM+ M1BUVLHK4MC?'N+<+'&E%TQY*Y%&B18B@7E-6E>%DC%H?;3;=_I"@%?68HCSU MF"'2>S1F+$>MCWK4(RVJ3372OUB"?7&JA;1'D(Z8H8$C$25(B(@2)$)$*RE& M1%8)(M)*$9%5AHBT#KL\)16-->ATR,MNR2" M4%)VN>SPE%KD=R*U7))/N7R&Z%/Y'+4LVYBH2$?D35_`:GDC$8TSD^CZNU75YK2Z3> M>7$4`H1$3W01%',4<) M(I)/$9%6QE&N(=WG<44J/!ED/LLBE4802"OH%<,02F3<81OE1$16V##F*.'R M*5DINY'Y9"F1$H8`HY"B3Y^"D,&..J8HX0KIV3U MP9,8,D#E7$-Z/$39^/4S490)9CQDX4EI$4@K)42A1$:F&&5@1%8X])BCA,NG M9*5FBB&?D17*YQK2(R,*PA&1$>9Z:07EC$#:OL%0B%84OXBCF*,$D;IO2'G2 MRM"*4*XAW6=1FHWPN:_DU`K)E<4=)(52`AI/,P*THI,S1$158231 MLUH8=XPQ;Y4@(NT4$6EGNK:W6F^,72O7&NE1,NO(WZK%75Y>2F3<)9MW>FA% M=Q.2#Q!1@H2(*$$B1/2`)$9$5@DBTDH1D56&B+1R1)V5 M[K-9E_Y6=L$7+>9V))'HF>;:-594@%8TUR$BFNL(D3[7YIT>6M%-;X*(Y%-$ M))\A^E1>?+4C?/24N^7^*YS^6XMS>7LI@_)T:B;[^E5\8=.=Q@.6G_^X"_\) ME"`]C"MPF^.+^P?;%?AF"*ILVQ47KG2>&&KPF=&3C>]`RJX$0K8>//AT<&<+([7U`*6;+PYEW@8J./#"UCN4 M,7#%UC^+`),(+%]X&7H+XXA4'OP*O-*"-[0H4 M^3`"6_BA9(<1V*[L(`8[JS]04?NB5N(C@,(:^K'%#0I+N&*+&Y18<,6J!F&S MQ@:"9N.[C;^SABS8^('U0KCQX76JQ8^M#R\7+1QF1;QEXU>2C2_>M?$+Z<:' MUZH6#EG9=3$?%AQ\/77ZM),3N4SK/U%]_;CUG]_U__1UE/_P,``/__`P!02P,$%``& M``@````A``I(N/RL"```#BD``!@```!X;"]W;W)KV/K9B=&DB*VT-T"N\!BL9=GQ582H;9E2$K3_OV2 M,YP9]V//][__-/M6]M]Z5_J>AA!A'U_-WX9AL-B M,NG7+_6NZJ_:0[V'E:>VVU4#?.R>)_VAJZN-G9EV7[?IU5^\'':2KM]4`_/N7YM";:+OU*>%V5??E]?!AW>X.$.*QV3;# M=Q5T/-JM%Y^?]VU7/6YAW]^2O%J;V.I#$'[7K+NV;Y^&*P@WT43#/=],;B80 MZ?YVT\`.,.VCKGZZ&S\DB[+(QY/[6Y6@?YKZK6?_'_4O[=LO7;/YK=G7D&VH M$U;@L6V_H.GG#4+@/`F\/ZD*_-&--O53];H=_FS??JV;YY,& M4P7)ZJ$-OMXGZ?7MY"N4;DTVRXB-M%@9"ZP3ABT9,`&^EC1D^G\@C5&0M+G< MT@!N%ZG'T%@8EY(!@B$4E3.,]Z/)'AI#YXGLW<@K+[5-HCL/D[,*D)(C@@T4 M]G0V:`S=`#MSQ!4ER"MI[I74.+*:.HAOIK".DB:JY>DT25MYZKC< MJN.^2@*H%)`D@/K("&!1YW#W<7Y926@Y-ZN]/!,SFPFB:ZU<63DDZ:*D,KI' MRDH"S#EIR"OKW.=$CKRL%N*;<;<7DB9*+J.)64W3FTO22N+-MT"0/"W>J%XE MULJEE4.2+VHRXWLDK:3@G).&9%IS;UZO$G+D:;402VONE%/21/EF-#&M^?22 MK.HY`$?5)&>9T&B`UG,:E#LMIF:U5L:Q=(X`2;HH[XSND:S2,."<-.1E-=!% M.T4<)POQS3CQ$C33LP:+LI:#Q4`SF\U5")4"D@0B@^6RTX*9\G3<0-!GK*Y. MCG5=G97-H8`DW[-F2QK.%H+P"HR3+XS&RC5$:6+))G7J)6F>-5O@OBE('4&\ MK@%4&D=E)0F@C+/^Q^.:)/G5'*3TS)N&E":"R\720+*P3I"IL.3HOB.4SM$_ ML/A=F1-^_\`J:^\DT)"0G'QI-HZTE,BPLT+R7UYRFT`X'U8>&K MMG'D=*UC0!?UG-$]DD*T]E)(D$AAX08"E=5:N?/*(=F'D;%Q?8//8LYNPW!N MI`1)OO[<<%:.KW4,MY70F2G/RYD5HKQXE#(H>9-R3P+&?7E^10 M19(U-Y#DZ\:5KKFSLGP%)/E&9LIE-<_"F6(@R=>?*<[*\:58ZBA)OF?-E"R< M*03)F5+X,\4XLCLP!W$1^,%,R;R9HFYLL^0225>AO#[0TP4%VLW%PI=T<@0K MEU?K")#,JS>#WM>C+!PS!'EY]27=.').%$ML9N;$5=(\:_)D-"W8D3<0^W(? M0J6`)('(F(''QQ<=\'#09'9>L,+.?%%W5JZPUC$H+!R^TT4R0VNOV30D"SOS MA=LX\L)2+%E8IZXRK][L.=)_X7S)".*%#:!26$D"*.ELF.")G647'5@:#KSK M[+S@=0V$VUJYNG)(\,V]0?-^PI2UK"M!7EU]<3:.K*X.XIMQ"BII>O/E",UP MAN0$L;J&4"D@2<`;&)0).!- M`JSKA4*4J+#DR.[XG:,OQ+DW.8YD+!P.*@`\'Q.%G?O#@:Q$ M82D6Y-)UQ-PIN,PKJO;IA26-9UJ7$\0+&T"EL)($O$F`A;W@\7D>C@@#`1N6 M!S>0J*CDR(O*(4D6]?GT;)&:\VQIR"NJ/QERU M"">#@5P7K4*H%)`D<-88*,(Q0)#76/YH,HZLL1S$&\O-#TD3]=FKZV5W3?#B M25!7@F1=W4"BNEHK5U<.:;[ZI13],L6N[I[K5;W=]J-U^XHOG,#MP_VMA?7; M,,LB-Z_#^"MYL2A!Z.%ZP$"+<,&,#];VSE!E9N8BLY,(#D1'QR8`!W,;$5R!O,[)<`7>&7N(=@%2CM@OH6VB]EBR MB/U#OGC0[Z3YV\`NBS@L(?/1Q$-VH\F%/4>WG,"6X4=^V/+$7AK>1CM4S_7O M5??<[/O1MGX"\9BJ+XF=?I]-?QC:`\Q/>">M'>`]-/7?%WCOL(8W@=3/<$]M M.Y@/>`'[)N/]?P```/__`P!02P,$%``&``@````A`*L9,['.`@``>P<``!@` M``!X;"]W;W)K[#Q@92YNP)M":4DM/.J2F%9SFOLD69,X#.=$4M'@CB'1MW"H MHA",9XKM)&]L1Z)Y32WH-Y5HS<`FV2UTDNKG77O'E&R!8BMJ8=\\*4:2)9_+ M1FFZK:'NUVA*V<#M'\[HI6!:&578`.A()_2\YGMR3X!IM5E$\7Y(7Z!KK,9L+F&/$XX!PQCK:["!` M0.\H&ES^#Z(=BQ,]?&XS!/Y6$9\H'!!#2G80.%((#3U4>'D4!_<<.,7P>\6] M#A-%H]K'LTAV&#E2`XV]78T#PS1`95?D]*")[_6I2_W+Z:@UZR,PTQGFCA"NJT=LNH.TF2 MZY(_\KHVB*F=6S1SL&6,CCMP';O\D_@&=J-OZFD\3F"X+N`G"?3Y/+Z>)FN_ MW$YY9OWN)>,+V'TM+?E7JDO1&%3S`B2'P0*JU-WV[!ZL:OU^V"H+:\_?5O`G MQ^%DA@&`"Z7L\.",&?\V5W\```#__P,`4$L#!!0`!@`(````(0`8*PXCA00` M`"P1```8````>&PO=V]R:W-H965T&ULK%C;CN(X$'T?:?\A MRON0.-P:!(R`J'='FI%&H[T\IX.!J),8Q:'I_ONMAF201P&M,[9KJ@/R_"O/Q\_/X0!;[-ZEY6LILOPC?+P MR^JW3XL+:Y[YD=(V`(2:+\-CVY[F4<3S(ZTR/F`G6H-GSYHJ:^%KY;45-0&^J$%7AB[!E#O^[0!,F1E_TH*O"C"79TGYW+]B>[_$&+P[&%XMI3P'10%FD(P1*6!H/"80' M3Y2WCP5"AD%^YBVK_NF"B(3J0!()`I\*9$!&\00AWDD;RC3XE&G(_)V$D4R` M3[6.0=9/C+K-"NW2K,U6BX9=`FA(V`X_9=C>9`Y@2K0.0H%RY3)FTQ-C1VQ5!-8&85/#$`%?31K4_06D$05)J^4V MRG#=1>(P5!$J)34,%D,HI,FPOP>5>A@,W?:N>ET,Z;H-Q=EZEM2T6&R@L!]G M@\'0#;`SHYB.$!L9-.QJ[:@DG2.M;"HMT-.]F!99"/HX60P69%5%-M(RT8MO M/4MJ6JRU)_;:^#2,H0EO?!H0Q28E+5-K_T-'-AVD]I*:%HLG`)D:(<\I//\W M,T4;[X/*5B5-]**371-B"S1?/=(/O^VFR>:$I[[!Z>Y#$U_-W))+ MDRVA^=3 MCDC.J21-MKSNK837"B::\IHFFR]>!(Z\A(SN.?!AJ/$(2Y--V+V=5*))6"?J M?N@&GNZEO:+-@6YI6?(@9V<<9L@,7L&TN9NT-F0"HY9X`_(\4_"(]3S/@QK/ M/$\,'C%[>1X=)P",ZSO,,P3/$T\?SC,`C7AH]SQ@\8F9S/#!3KOM7 M@82^-8!6;SR0ZN.T'LW7WZ_LH+JX`5S\V3R=X08B M[8!9]90=Z/>L.10U#TJZA_+'HF&;;MKMOK3L!&T!$RMK84H5_Q[A5PD*,T., M%\:>L59]P07T[QRK?P$``/__`P!02P,$%``&``@````A``9)QHGL!```]1,` M`!@```!X;"]W;W)KZ75:O?>9T*+5TR\EV'51G?Y-5NZ?[W[_-#Z#I-FU:;M.`56[H?K'&_K7[_ M;7'D]4NS9ZQUP$+5+-U]VQ[FGM=D>U:FS8@?6`5/MKPNTQ8^UCNO.=0LW%1WY]Y99I7+EJ8UT-L\.TVS]@3SUY+5K5HI&9%V@+_9I\?FI.U,AMBKDSK ME]?#0\;+`YA8YT7>?DBCKE-F\^^[BM?IN@"_W\DDS4ZVY8>>^3+/:M[P;3L" M9$'EE:+30X>"-F=FFV7[B.9)S1TO=5""O0S9\=&^]]I]OSX1YUO M_LHK!FI#G$0$UIR_".CWC5B"S5YO][.,P-^ULV';]+5H_^''/UF^V[<0[BEX M)!R;;SZ>6).!HF!F1*?"4L8+(`"_G3(7J0&*I._R[S'?M/NE.YZ-IH$_)@!W MUJQIGW-ATG6RUZ;EY2\$$64*C5!E9`SLU7,ZU(B'A*1_3VF;KA8U/SJ0-'!D M1S8!R-D)B/U0(,P#*8FM<1`C*=1 MY'<`@QFDKRZ)R)\Q7*_K01*;3&DT\R@-0C1IM`6#P,PD3S3E#%Z!R6N8,&*3R2^R;DF,D$"&CH11%-CIC(`+#A@417>R M[O[MV(E-5NPL!C%"M-AI"P:!Z"L$Q"93H_&XRTU,'H1,,+W#V<1\G.!CE'`< M:0H;Y`BDL2[/]X&.2RM>DF( M/@VC9@0Q>/!#&`6SP)+-1-!)Z%^H"414U.'DL/[JA3*RJE$L+2Y=+:7T%5,9 M44.''XX5UU#FL_@K91!SYU0@DVN9F7==8@9#;&6K8 M3)2TDTCC;F0AO:M+2+3-S&X3"G0A9ECY.HQX==39F^3`AMXC!J:>V&6^F1'? M;A8405HCU5=,%G=U`O$]UNI4H7T_%48%9TPCJU4D"G!!0I/=7:V"8JN`H'=O M]<2W3H\52-<&M\D5\W2K$UPOL?1.2+SN`0Q=#NF._4CK75XU3L&V8-(?!9"=-8YM\$/+#W+VL>8MC%OD MOWL8KS&8&/@C`&\Y;T\?Q#RB&]BM_@<``/__`P!02P,$%``&``@````A`"D< M'C.^N+:'%. M==>I*JAV]>T]S[0W6E8I*]8ZF9JZ1HN$'=+BM-9__@@GGJY5=5P5U-VH07<.;(RCVOX69Z, MZE+2^-"0\LRP3'-NY'%:Z.AA67[%!SL>TX0&++GFM*C124FSN(;]5^?T4G7> M\N0K[O*X?+U>)@G++^!BGV9I_=$XU;4\67X_%:R,]QG$_4YF<=+Y;GZ,W.=I M4K**'>LIN#-PH^.8%\;"`$^;U2&%"+CL6DF/:_V%+",RTXW-JA'H[Y3>*N&[ M5IW9+2K3P^]I04%MR!//P)ZQ5P[]?N`F(!LC=MADX,]2.]!C?,WJO]CM-YJ> MSC6DVX&(>&#+PT=`JP04!3=3R^&>$I;!!N!3RU->&J!(_-Y<;^FA/J]U>SYU M7-,F`-?VM*K#E+O4M>1:U2S_!T&D=85.K-8)7%LGSM3R'.+,N9,'1+LEPK4E M6O9T9CFNURS_@#EKF7#]?TO"AIJ`YSU1#/C!BFY+A&N[(B%3,C.;&!\+9:#H M30Z#N(XWJY+=-&@,D+6ZQ+S-R!+\\N394`*XBSZ=][():>1.7KB7M0X=#?0* M2O!MX\Y6QAM43=)"_`[""X!SMIU!X#@R)^@@'6>'!OCLUYD1F1-^`K%D2#2& MN/,>8H`PO3I03JHZQ.5E?*>Z.STX;ZW#9[]/U^U7:,+W$4*:WD)!T#)OY"/$ M@\3*E``!32LWC)W(F,Q<4V6$$L"U+'.(L_$020!"A/N2#M`=3^G`>8H.GAR4 MCQ#00=!*R>D6,:Z@C&FJXB!&$$4JT"R5:A(A91PM\ M]J5B*:2@@_1MT!GN4H#S%`649[*/$%$!M$"9WF^,#M(W M!AI0-'B^J6^$L",,2JI/UDAT060A)1%X/M1T?VD0:(BR$J[R>/=;C"A%:WI8_#VF MK_[>&3'XUY.RQ/=TBRKM(1=^7%\!N-T;^W_*H!S M&BRLV+=D"6>QL?V%V$NN[?@.!`MWFF(R>F=PZK_$)_I'7)[2HM(R>H1MF%,7 M!K`2_S?`'S6[-`?3/:OAO-]\/84P$?&ZNX'+&WT_QAM_@4``/__ M`P!02P,$%``&``@````A`&)5P-+O`@``+0@``!D```!X;"]W;W)K&ULE)7+;N(P%(;W(\T[1-Z3.P00H2I4G:DTE4:CN:R-XR16 MXSBR36G??HYC"$EH4;L!8O_^\YT+QZN;%UXYSU0J)NH4!:Z/'%H3D;&Z2-&? MW_>3.7*4QG6&*U'3%+U2A6[67[^L#D(^J9)2[8!#K5)4:MTL/4^1DG*L7-'0 M&G9R(3G6\"@+3S62XJP]Q"LO]/V9QS&KD758RH]XB#QGA-X)LN>TUM9$T@IK MX%@,6.54R_MJ;(X63Y4-1"XET%<;\$,28G[_;A MPIXS(H42N7;!SK.@ES$OO(4'3NM5QB`"DW9'TCQ%M\%R.T?>>M7FYR^C!]7[ M[:A2'+Y)EOU@-85D0YE,`79"/!GI0V:6X+!W[VCBD!"P<8-I\:)B`H`X-/AS'0&)`2_M-\'ENDR1=',G29^ M%(#B7%P8&> M@5>J!IL.#)9@?`K,8G2AOAA[&_\IXAI>2HV5QJ M@J%B>U*82@!>QPB!]QG?3OH)Q8@-BBF"8=O8!?`^LXW>^X9BUDD&))"A/HG) M5@3-=)W('`)='R`>A;ZQFKBCWO86!@3QD.#ZFXTX11#>.71_T45FTV,UL[9H MDS"9SY/I4+$=**+I8G&N[``-.KF?G.MH1CQ""Z+ABS=6$PEM;-Z1V+S9\6S'%Z>RH%M: M5GIE#CLE=?GTK"^=5U"J7UF>:5:QBB^AX.N=OEF4AD M=BI%U1B26A1I`_K5(3^JEJW,[J$KT_KE=/R2R?((%,]YD3?OFM1URBSZMJ]D MG3X7D/=;,$FSEEM_Z=&7>59+)7?-".@\([2?\X/WX`'3>KG-(0,LNU.+W;_:3 M=N#/VMF*77HJFK_D^7>1[P\-V#V%C#"Q:/N>")5!18%F%$Z1*9,%"(!_G3+' MK0$52=_TYSG?-H>5.YZ,PL4TF,X@WGD6JGG*D=-ULI-J9/FOB0HLEV$)+0M\ M6I9P-)W[X^`3'!/+`9^MDMF]))[)2AP9?,QFP&8GA$W$:@"4B;$,`# MO9UHJ.+_(!I94'2[W*8%+EF$5PK;B'9*0@"F<,P5#F^VMGH8#-N*52_@*V], M3&!V%18G[B$)19@:,);6Z[8:#(;=`)G=,-,&C;77$ZXUMH.3KK))%S[,R<3" MH;I?+`9KL:TC&XN00O60A")L[=EGUL9@OK9!PG&7>-Q#$HJPM>=\;3R)4S@` MM\W"25R#04*8>;%O?+6;8CN-.-0A9-KBLOV94OQI)#WCMD(,Y@HM0ASJ(0E% MV-H/GUD;@_G:!K&-7A^C'I)0A*T=P(\/35PWRW`^@NUTNP9Z(A=B(?"IW;EQ M&T5,G9(H_L`SVU=IR2Q$ M/>M!24`A+@![X_T";">E`@Q$#(J#'I0PB`O`!DD$H&>S\6@.)G]0#--9F6>V MV=)BV"AJ4`=1@V;#!L%C@LF[K4E'\];<0D13'\(WB^Z?.LK4Q[Q!S/6Z%/5> MQ*(HE)/)$[XO8..MEQUL'C_0\2+L9]`!>R,3&-$UZ(U,842?KM[('$;F@VP+ M&-%7W>LYH=^^OZY&X&'V.*P,J(;6@%0&X\<1W$S[&3Y.@%^_W:X6WD!^@^G- M(K@]]8DVD-M@:@\1_)8/Q`?PY#0W::];&IY\QW0OOJ?U/J^44X@=6.;K35V; M1Z/YTL@C6`GO/MG`6T__>8#'O8`;N8\7@9V43?L%EO:Z_RY8_P<``/__`P!0 M2P,$%``&``@````A`,\;L=K8`@``?0<``!D```!X;"]W;W)K&ULK%7);MLP$+T7Z#\(O$>4Y"T6+`=VA+0%6J`HNIQIBI*(B*)` MTG'R]QU22^2EA@^]:!F]>7[S9CA>/;R*RGMA2G-9)RCT`^2QFLJ,UT6"?OU\ MNKM'GC:DSD@E:Y:@-Z;1P_KCA]5!JF==,F8\8*AU@DICFAAC34LFB/9EPVKX MDDLEB(%756#=*$8RER0J'`7!'`O":]0RQ.H6#IGGG+)4TKU@M6E)%*N(`?VZ MY(WNV02]A4X0];QO[J@4#5#L>,7-FR-%GJ#QEZ*6BNPJJ/LUG!+:<[N7,WK! MJ9):YL8'.MP*/:]YB9<8F-:KC$,%UG9/L3Q!FS!.9PBO5\Z?WYP=].C9TZ4\ M?%(\^\IK!F9#FVP#=E(^6^B7S(8@&9]E/[D&?%=>QG*RK\P/>?C,>%$:Z/8, M"K)UQ=E;RC0%0X'&CYP,*BL0`%=/<#L98`AY=?<#STR9H&CNSQ;!)`2XMV/: M/'%+B3RZUT:*/RTHM*(&DJ@C@7M',O6C^UDXFUN2*XF3+A'N76*X?/_U*XG3 M+A'N7>)D)/L\$;=E.Q=38LAZI>3!@\F$PG1#[)R',9#U]K4,@Z'_\A,\L"0; MRY(@.%)@E889>%F'RV"%7Z!QM,-L+V".$8\]PEIK:=-1`(/>033X_!]$6Q8K MNO^Y;1]XKR(Z4=@C^I1T%#A2"`T=*[P\C;U[%IP@N%YQK\6$[=Q9!LVD7@,%SD/!(+H+%8.Y&3>WMX MNX-T\U!:(E=(WZUM%UD1S3^);V$[NIZ>QJ,89NL"?A)#F\_CFVF\<>OME&?6;5\\ M?(#MUY""?2.JX+7V*I:#Y,!?0)6JW9_MBY&-6P\[:6#ON<<2_N88S%[@`SB7 MTO0O(`@/?YSKOP```/__`P!02P,$%``&``@````A`)^F7O&O"```K"<``!D` M``!X;"]W;W)K&ULK%K;;N,X$GU?8/_!\'O'IB3; ML9%DH`MZ=X`=8+#8F7E6VTHBM&T9DM+I_ONMHDBQJLB.+YB7=N>P>'181=:1 M;#W\\OVPGWRKVJYNCH]3=3>?3JKCMMG5QY?'Z1__^_SI?CKI^O*X*_?-L7J< M_JBZZ2]/__S'PWO3?NU>JZJ?`,.Q>YR^]OUI,YMUV]?J4'9WS:DZPLASTQ[* M'OYL7V;=J:W*G9YTV,^B^7PY.Y3U<3HP;-I+.)KGYWI;%'[>;7EV/3EE_VL.[O M*BFWEEO_X=$?ZFW;=,US?P=TLT&HO^;U;#T#IJ>'70TKP+1/VNKY<9JJ39'< M3V=/#SI!?];5>T?^/^E>F_=_M?7N/_6Q@FQ#G;`"7YKF*X;^ND,()L^\V9]U M!7YO)[OJN7S;]_]MWO]=U2^O/91[`2O"A6UV/XJJVT)&@>8N6B#3MMF#`/AW M]:^/TWAYMUC-8P7ADR]5UW^ND7(ZV;YU?7/X:PA2AFH@ MB0P)?!J2Q'%\,"\V\^#3S%/)W4K-U_$*+O[!Q,1,A,^`:G_B;%BU3F)1]N73 M0]N\3V!GPKJZ4XG[7&V`S&9O8!CS^;-T0AZ1)$66QRD<*!L.V(]E3T9I?.1MBU+#M,#FYAQ0486J@L)>KP6#8#;"RL9@J MCH2<(2B"`I$@64_#E(P9+D:$3G/<3#0<@,M%8[`6;2N3&80DS$,*BK!K+_FU M\50L8*U7G@IDX:(,LF)IBWEN\S'(KJ6@"-,)1)?G"(.]PB[XQ;,A2!0VX4&Y M82*%'1%:6,?-1*/SDI;S\=G`8)Y#@Y#">DA!$7;M-;\V%G8%[?[JTB(/EV40 M2`0Y$4N1N#%H+"U%F%(%3GAYFG2T5]Q[?OG,1(GJKGA4;KE(>1U$5^?HN7)L MVZ3`F.1(+>^K4\T2+=IF[*#NQ8!`7C%V<"/YX1V)G M],Y1(GI?9J)XJI.Y3+7AHJD>(9)J0L^58\LGRC'5\3W>Z%S;JY0Q#YII`]%, M1]()<;ERXRPTFP9:C@)RO$W%G>2@@D%<`)H`$:!/5;2^H7?!]63SLA`MM4I< M_]:W8[F+3H M>:;1/4BFSR@W7N.NEBD#N;KF/E0PB`M`4R`"L-0*'PQ@OUQY"Z*,OU!UH^70 M7+A>;FH]1KE:4X@)CJ[R*AVM:VVI,POQ_2>;NHNR$PL&<4TA%UK<<%QPMPFO MMQ"3NY#-W44YN:-Y`<3E8MLG-?]XTT7&)$A9+<0U"5O*79339+AT`^>:`NYR MO[[%72+?72S$];IG@6$;NBBG=[0E+X?8T"_/H6G_-(<&XIJDE41CE--$(9Y# M[/%$T^T.C:8N]Z&!N%YAD+F=2!R:05QOP&9NK+EO,]'H%J3U+*3-N"B7WW&B M5W-8.\WOF7.#T=)F%LX']*;+HB&*V\Q"VHR)HG<4#J+K<_0\T\)FM*''ZI8N M'_D>9"#B90RU=Z^>9OLI[XM%[;%(R"]%2FR@'%2R*"4B$A>AGLFAUP_.$ M9N+V8B%6ZI7PRMQ%V545#.)ZA>-\7.ID-!52Q)5HS9F)X@U\)7W&K5S;Y\JO\IUD]!V;E,Q"M,XF MRD$%B^("A'WH([VZO^5(^]:2&(B76OAD[J+LJ@H&<;W8UXG;G"DU1LM'G97H MRUDR1(E22Y,Q4:S4AIYU;T+/E0O?N?V6"-XDD`_!%@)!SH!6SD<&GW11+M.& MB_CD\);!\`/YH6I?JKS:[[O)MGG#-PB2-?RT/<+F]88DV:10,V`5([`_X)\F."=5L!.'WQ(DFX+UP"\+`38%ZPG.216N)[12 M^'H;Y@17JF"_P3?.@>M$L![XKC8T`NN!]A,:@?T&WU>&1F#OP#>#_D@*HH/7 M!\E!Q2`X%)^J.>0RJ$J!WN!(JF"OPT]?OJI,@=[@"+P MI@">PI8(UA`V1'`_P';0\;-Q"\&[4J?RI?JM;%_J8S?95\_0">?Z<;8=WK8: M_NB;$[@-O#'5]/"6E/[O*[P55\&K*G.TU.>FZ>T?D*+9^)[=T_\!``#__P,` M4$L#!!0`!@`(````(0`<)/;@O`,``"D,```9````>&PO=V]R:W-H965T4F7_C.5_MWJXX?%F8L'>:14>`5+>'+GHN"*'@5AT!6@I),)Q5Y$`V'DZ`@K/0-0RRNX>#[/4MIPM-304ME M2`3-B0+]\L@JV;`5Z35T!1$/I^HFY44%%#N6,_6L27VO2.,OAY(+LLMAWD_A MF*0-MW[IT1._!=>!G=DU.N M?O#S9\H.1P5VW\*,<&)Q]IQ0F4)%@680W2)3RG,0`+]>P7!I0$7(DWZ>6::. M2S^:#FZGPU$(X=Z.2G7/D-+WTI-4O/AC@L*:RI!$-0D\:Y+1U;GC.A>>3>[D M6@&!F8RN34(462T$/WNPX$"NK`@NWS`&XJ8H9@IMF?Y5)2@/DJR19>G#3H$" M2+#V<15%DT7P"':D=^O!K56_JCKPQ,:%935B<;0]);,11`\9> MKP:#837`S"PY73/KH)'V.ARZ8K?UUW%;VJ1&8*-<)'740M#U:C%8JVTLV=2( M5:D>DMB(,_;D/6-CL#NV02+=Q?02WO:0Q$:ZU.LRQJD9>T*)JUSCI2\4RTNL;K"C'855@CED4])+$19^SY>\;& M8'=L@]@6]9#$1IRQ0SAU[(EKC_`8>,LEG>@*J:&.3^.VX&;]-(F642^0[=2\ M37058P^]VBKH+]UZ-9!E5A]*',@5@"WR>@&FH4+W:?OK0XD# MN0*P+5H"T+/9',_X-W867$9ZQ3!0Q[-.K]XVB;9G-1?TP7931J.7OFD4F[N+ M.9\+*@YT2_-<>BD_X;T$:KQ:M+"Y-&W""&Y-NEJ=+W"=6E_"-WC-PNIVXC=` M=#%^%,/!TH]?C^.UN:YUB6YCZ*_]A,TDAMYW`9_%L-DOX/,8-N(%/,09Z"D$ M[=!P4:O(@7XCXL!*Z>5T#P4;#J9@LC!7/?.B>`6%A"L75W!%TW^/<"6G<*`. M<1?O.5?-"PP=M)?\U5\```#__P,`4$L#!!0`!@`(````(0#&1-NY%@,``-`( M```9````>&PO=V]R:W-H965TN/:F5JJH?SPZ88!U@9#N7NW_?-08*(8W2JB]Q&':'V=DU9GW_ M6A;6"Q62\2I"CCU#%JT2GK+J$*'OWQ[O`F1)1:J4%+RB$7JC$MUOWK];G[AX MECFER@*&2D8H5ZH.,99)3DLB;5[3"NYD7)1$P:4X8%D+2M(FJ2RP.YLM<$E8 MA0Q#*&[AX%G&$AKSY%C22AD200NB0+_,62T[MC*YA:XDXOE8WR6\K(%BSPJF MWAI29)5)^'2HN"#[`NI^=3R2=-S-Q82^9(G@DF?*!CILA$YK7N$5!J;-.F50 M@;;=$C2+T-8)XR7"FW7CSP]&3W+PWY(Y/WT0+/W$*@IF0YMT`_:+E3Q/EM%R&Q6U9 M8&U9/-L-?,=?:)(KB?,V$=8VT5G9@>][BV!Y/=-K,V%M,^<+VU_.YHWNZ2.Q M*;SQ,2:*;-:"GRR83:A,UD1/NA,"66>@8>@M_9.C8*4FV6J6",&F`J\D3,'+ MQ@F6:_P"K4O:F-V%F''$0Q>A^Z1IXP&`06\O&HS^#Z(UBQ;=/6[7`;^K<,\4 M=A%=2CP`1@JAHT.%E^>Q-J]'IA<8O` MD;+%6)G>#3X,X5_N!LTREMPBRY&&X$QZ']15&@^1D4X@&CKXCSHURUAGBXQU MKLYT]D&]SB%B=)HWMGG3E%0*U^`VG"I##N MOT4VOP```/__`P!02P,$%``&``@````A`-/+"=Q1`P``P`D``!D```!X;"]W M;W)K&ULK%;;CILP$'VOU']`O"^W7$A0DE42M.U* MK515O3P[8(*U@)'M;';_OF,,CH'=;![Z$L+)S/&9,P.3U?U+65C/F'%"J[7M M.YYMX2JA*:F.:_OWKX>[A6UQ@:H4%;3":_L5<_M^\_G3ZDS9$\\Q%A8P5'QM MYT+4D>OR),9PY*T4TY8"KAW%W)F%WL3_F,15134>Q4B@S8K1LP5S!ZIYC>04^Q$0=^:H M2K1=[[D%-DF2K619V_#`@`\<.OR\"6PDE?X=NCUIDG@V&H#//\Y>#D MG8KQU4Q)<_8C)#:1GAKHJ^G7=34R&(8!*GN_EVW,1'5Z8%+[XU0;&[<(3+JF M])<3G=;3"D&F5CF/(4SY1P,HTQK576MV"@E@AHQ#I_K09L+V;9JA52-FVF66 M>UKG?:W7?97!?84M$FJC]B,D-I'>V6'_;.G3#&J]KD$F]34H9.#2?.!2FV:X MI!'3I5"G]93*-6J\8:XKE,%]A0H)+H?O1TAL(KVSE_VS;YTFF=97H9"!3PM= ML)JF-NTB%=9:0P0/@#&$2YVFM*K-I=[*)69'O,=%P:V$GN16"N$ATZA>F-M` M3LT`W\$B;=X00SR(X$WU1OPD@I?&&-].HVVSD(<\\P@&`,2O$H/][;?X!``#__P,`4$L#!!0`!@`(````(0"T->&;DPD``*@K```9```` M>&PO=V]R:W-H965TO])>[\:AI5\?-:E\?J\?QCZH9 M__KT[W\]O-?GK\VVJMH1:#@VC^-MVY["Z;19;ZO#JIG4I^H(+2_U^;!JX>OY M==J=FMJ[A>OQVJ8ZN5G*O]JH7Q M-]O=J4%MA_5GU!U6YZ]OIU_6]>$$*K[L]KOV1Z=T/#JLP^+U6)]77_;@]W=O MOEJC[NZ+4'_8K<]U4[^T$U`WU0.5/M]/[Z>@Z>EALP,/5-A'Y^KEB=]K- MP!_GT:9Z6;WMVS_K][S:O6Y;F.X;\$@Y%FY^Q%6SAHB"FHE_HS2MZST,`/Z. M#CN5&A"1U??N\WVW:;?P7S#QYK-;D!Y]J9HVW2F-X]'ZK6GKP_^,C-&D=?A& M!WP:'<'MY&8Q"SREY$K'P'2$3]/1OYDLO-E]L+C><6XZPB=:]"=S_V9Q]T\F M06_G+WRB28CYE3'>F@[P:3HL+O&YTFUANL$Z0SN?<^W>=(1/T]%;?"J8'OBA MIU(ED9ZG:T.=ZDSH$BM>M:NGAW/]/H+5"I/=G%9J[7NA4HHII;V])-E'.0;) MI;0\*S6/8_`?\J>!A?'MR;N=/4R_03*OCIC5V0N"!U0>:" MW`6%"TH+3"$LE]A`BO\_8J/4J-B@5TL$%"S?"01*8)?8!8D+4A=D+LA=4+B@ MM``+!"Q9%HC^_09S04D_CN'OE5S0,IYW"4HD2"Q((D@J2"9(+D@A2&D3YCIL M.@-<5]*PDB".5WPW0D&W3.Z=F3>-\TM@8D-@#^O5R48+0@-&JZ2[T6*:+0VQ MID606)!$D%203)!AB01)!4D$R07)!"D%*F["PP*!96*XO5"7-?3=D<2I1)]3E)75%?D!2J+QGBD5'UR>>3'0Y5 M-PD,8I'14A:*C11$1M5O_LR;NT'1?4``1YU2'T29-):3E-$<<,T%":":DB$> M#U6F#(B'KFK@4$;=2W5`PSJQG(\DB@UR,N6.#STA*52?2I1)]3E)V9GBJ"]( M"M67#/'(J#)F0&1,U6-'1B-[O_`$BA'12DLD2B7*$-%VE",B785$)4/<9U4? M#?#9E%.VSQKY<*I:.X);F'E&BL[&&!&5]@DBMKMXSDTH12G8]UVM_ZZK&'8L!GTG+JJJC57 M0E.\V9'6*("MWO+;V0PB]8L&K,Z`JM`8$>E*$.DR.G#VJA2;8=8L4XY4AE)D M*D=$I@I$_:9*;/[(%(^MJMWLV/;$$,J22Q!-J4>C67H:0;KBCA`AHDR)$5&F M)(CL[=OH(JD,I4A7CHBD"D2DJT3427&?51DWP&=3]=D^:^0DS@U?,)%GI&@V M8T1TGTH0J2!_>[J?WWG.GINB!'7*$)'J'!%)%8BT:L_W`Z>N*%&BZ\2#I$I` M.T@_M^AT(0E'!";'TM.(;V^>>Z%!*9KVV*"`$BU!!(&V5I7C9(JZ/MILNOTA M0RFRF*-ZLE@@XA:=&2M1UT<6>:15#6I'^A^6H!)W*DV-(!TQRI%G$"5(C(@2 M)$%$*RE%1%(9(M*5(R*I`A'I*A')[((#G?O\4]G5:>&A,,C)+O?P1"F:Z]@@ M.[L0L;GVW<,3=9'?&2)2GZ,N*Y40755?HBZYC?FJ_/U\WG3B3K!T`0V;P"5O M4(I0+%$B42I1)E$N42%1R1!;*_ZP6KL3=WPVY3>/NE/K1-C1#L.E(P8KD5*I M1)E$N42%1"5#/`S#"FNX6+A;!B)R,)(HEBB1*)4HDRB7J)"H9(C[K`K>`>FN MZV/[Y/$U`A,X@Y%$L42)1*E$F42Y1(5$)4/<9U5Z#O!9EKCJ(9BZ6EI'@T0Q M(HI,(E$J48:(U.>(2%NCDC!%1"9@8-)]UMSHO M@,?/SO4PE;TR1*0[1T2Z"ZX[N%W<.=M*R3KQ*+E%XT\5WO!;B+NU&*0L4_#$ MM0ZEZ"H1(Z(K8H((RA;2Y3N_RZ0HQ7_G<"JY#*7(8HZ(+!:(N$7GYYD2I3ZR MR",]K%0-3'E)@UH:!/F(2SY"1`D2(Z($21#1KR$I(I+*$)&N'!%)%8A(5XFH MD^(^NW7ISV67+%?A+2:5<#R[?&=%12A%( M2'V!Z*IZ]5I6YY!U-=:O6>FW80[5^;6*JOV^&:WK-_4*57<:7[!^OVOI^Z&Z M)4!ZB)8`6KI]4[3,H:4SZ[3`VV+/O;K@+;+.94=^J8SWV0;3?9:?Y^$SN-TS MV)L0GJSW\-L0'BWW\$4(3V)[^%T(#RY[N`\>P)U2MD#A%JHC6;9`_09]^JQ# M$0,M??;A)(>6/FUP4(;J&.RSEL\B*\N5IS`P_..4#W-Z-$&+>K9A&R! M$A]&T!=E*-AA!'TM2XC!LM>?"%I4I=1GYQ;L],4-RDIHZ8L;%%C0TJL-PM8; M&PA:'U]ZLU`]39/C@D>OH7JH)EO@"2Q$LRM$1)P]:.G+&W@6!RU]VN`9;*B> MKDD[\"@6YJ;/#CR/A);.SO0R!'A/\K1ZK7Y?G5]WQV:TKUY@$YAUSSS.^DU+ M_:6M3U#%P.N2=0NO2';_;N&-V`K>(9BI]T]>ZKK%+S"HZ>4=VZ>_`0``__\# M`%!+`P04``8`"````"$`^/UL]U(#``!="@``&0```'AL+W=OQ'5(E;"45L>- M^^OGX]W2=83$58H+5I&-^TJ$>[_]^&%]9OQ)Y(1(!Q0JL7%S*>L((9'DI,3" M8S6IX$G&>(DEW/(C$C4G.&T&E06:3B8A*C&MW%8AXK=HL"RC"8E9\1DAL(I8;*.SM;A09N@%F9A1S4*J])LV:6B\'*>F'\S[96"/0TQ2!%(9R$G=1)YT]@4?9P?PKOIFHY#O`]G,Y-38?X-(*M[0)_%L$N,\9W\VC7 MG/)#G2""U3/F[\,H#B_ABPC:Z`)_&<7-1CW47^FO"]0_@-.]QD?R#?,CK813 MD`PRF305Y.WW07LC60U9P1'/)!SKS=\&PO8V%L8T-H M86EN+GAM;#R.00H",1`$[X)_&.;N9O4@*DD6%'R!/B!D1Q-()DLFB/[>>/'2 M4#14MY[>.<&+JL3"!K?#B$#LRQSY:?!^NVX."-(J6]2_X2 M7&3H!A:#H;7EI)3X0-G)4!;BWCQ*S:YUK$\E2R4W2R!J.:G=..Y5[@*TVD,U M>#XBQ/X!(?U26:W^(_8+``#__P,`4$L#!!0`!@`(````(0`4=`L;`P,``/8( M```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!```````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````)Q676_:,!1]G[3_D.6]#=!J8U5(U4&W3NH*:FCW M:+G.#5@D=F:;"/KK=YT42*AA7=\<^WZ<>^[Q=<++59YY)2C-I1CXW=..[X%@ M,N%B-O`?IM]/^KZG#14)S:2`@;\&[5]&'S^$$R4+4(:#]C"$T`-_;DQQ$02: MS2&G^A2/!9ZD4N74X*>:!3)-.8.19,L),22U3XUVO&&1AT#P,$5T,;*FX64>= M,&A^AC&C&0PQ<)323$,8[#;"&Z"6M`GE2D=A:2Y*8$8J3_-GI.W<]YZH!@MG MX)=4<2H,PK)F]4>US@IM5/1;JH6>`Q@=!FA0;U;+IFUSS<^CWM?*`E='+>M@ M=S2'Q+NG8@;_DZ/K3F%!UL5B[C8-4VXRT.-T0I5QL'*&:MO14F&K2:EA;H1" M4'[D6AAL"?DI:D%Q68%Y(6=+TU`*+3.>4`,)^48S*AB0^!69;[$G$_KO%+'! M3%;,FHQ3,BY0$]O8MKLUOK;5<%X1CZ60V$BV<+JT"MGSIZVF;;.,U8P*_ER) MG%PA97?4+!4<`_9#HF0)YF*@A!-'O,QSJM8V2,QG@N,%1NF2*\;D4ABGRSUD M%?VVZ6LR551HRNS-<\/&BYISK24FN9,&R#TPX"5]RMQJ`0;Q\TO!GB:H@UZ75 MAC/,<6;KN[8O[V9J!(`4N&.W[&(H`GM.GY8N7B1H%5AG=+HP5P)L@7.Z',_RB9*;;-'MG_5[_W M7"ST0S&5(QP(FS>SO1G&EKT$1_WF?+<1WN!SJ3(;I)Z9R<;F]8%]X1_KWYBH M>W[:.>O@X]W8"X/=#TOT%P``__\#`%!+`P04``8`"````"$`1G$B&S$!``!` M`@``$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````G)%!3\,@&(;O)OZ'AGM+::-1TK)$S4XN,7%& MXPWAVTHLE`#:[M_+NJ[.Z,DC>5\>GN^C6@RZ33[!>=69&I$L1PD8T4EEMC5Z M6B_3*Y3XP(WD;6>@1COP:,'.SRIAJ>@%,3EI:A5V-LXTZ9ZRI3B$$%M>TS%\K?&Q-]]D,U)/`OXE'`!N]?_XY M^P(``/__`P!02P$"+0`4``8`"````"$`)05>7MD!```$%```$P`````````` M````````````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U M53`C]0```$P"```+`````````````````!($``!?I6;@0,` M`"D*```/`````````````````$4*``!X;"]W;W)K8F]O:RYX;6Q02P$"+0`4 M``8`"````"$`2-STDP`%```U$P``&`````````````````#S#0``>&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`*I?<%P4!@``NA@` M`!D`````````````````*1,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+NS#HU[`@``N@4``!D````````````` M````T"$``'AL+W=O&PO=V]R:W-H965T M&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`(>&S"VY`P``G`P``!D`````````````````\3`` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'IZ8G78`@``+PD``!@````````````` M````[#@``'AL+W=O!@``&0````````````````!D>@``>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&BY2+D\"0``OBD``!D````````````````` MW8```'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*L9,['.`@``>P<``!@````````` M````````,I,``'AL+W=OP$``#U$P``&``` M``````````````#QF@``>&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`"D<'&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`!PD]N"\`P``*0P``!D`````````````````&;D``'AL+W=O&PO=V]R:W-H965T&UL M4$L!`BT`%``&``@````A`!1T"QL#`P``]@@``!``````````````````]]$` M`&1O8U!R;W!S+V%P<"YX;6Q02P$"+0`4``8`"````"$`1G$B&S$!``!``@`` M$0`````````````````PU@``9&]C4')O<',O8V]R92YX;6Q02P4&`````"<` ,)P!Z"@``F-@````` ` end XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Loan Payable - Related Party (Narrative) (Details) (USD $)
12 Months Ended 0 Months Ended
Nov. 30, 2014
Mar. 20, 2014
Nov. 30, 2013
Short-term Debt [Line Items]      
Loan payable to related party 10,000us-gaap_LoansPayableCurrent     
Shareholder      
Short-term Debt [Line Items]      
Loan descriptions

The amounts owing are unsecured, non-interest bearing, and due on demand.

   
CVI USA, Issued Promissory Notes To Globe Farmacy Inc. | Shareholder      
Short-term Debt [Line Items]      
Loan payable to related party   $ 10,000us-gaap_LoansPayableCurrent
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= GLAG_ShareholderMember
/ us-gaap_ShortTermDebtTypeAxis
= us-gaap_NotesPayableOtherPayablesMember
 
Loan descriptions  

 Under the terms of the note, the amount is unsecured, non-interest bearing, and due on demand. 

 

XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary Of Significant Accounting Policies
12 Months Ended
Nov. 30, 2014
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

 

3.Summary of Significant Accounting Policies

 

a)Basis of Presentation

The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is November

b)Principles of Consolidation

These consolidated financial statements include the accounts of the Company and its two wholly owned subsidiaries, Nevada incorporated Cannabis Ventures Inc. (USA) and Vancouver, British Columbia incorporated Cannabis Ventures Inc. (Canada), from the date of their acquisition by the Company effective June 26, 2014. All inter-company transactions and balances have been eliminated on consolidation.

c)Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and investments, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

d)Cash and Cash Equivalents

 The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As of November 30, 2014 and 2013, there were no cash equivalents.

e)Development Stage Company


The Company is a development stage company as defined by section 915-10-20 of the FASB Accounting Standards Codification and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders’ deficit and cash flows disclosed activity since the date of its inception (March 15, 2010) as a development stage company. The Company has generated no revenue since inception (March 15, 2010) and is still devoting substantially all of its efforts on establishing the business.  All losses accumulated since Inception (March 15, 2010) have been considered as part of the Company’s development stage activities.  Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required for annual reporting periods beginning after December 15, 2014 with the option for entities to early adopt these new provisions. The Company has elected to early adopt these provisions and consequently these additional disclosures are not included in these financial statements.

f)Financial Instruments


Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, and amounts due to related party. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

g)Long-Lived Assets

In accordance with ASC 360, “Property Plant and Equipment”, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.

h)Income Taxes

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

i)Revenue Recognition

Revenue will be recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is assured.  The Company is not exposed to any credit risks as amounts are prepaid prior to performance of services.

j)Advertising Costs

The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $nil during the years ended November 30, 2014 and 2013.

k)Stock-based Compensation

The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.  As at November 30, 2014 and 2013, the Company did not grant any stock options.

l)Comprehensive Loss

ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at November 30, 2014 and 2013, the Company has no items representing comprehensive income or loss.

m)Basic and Diluted Net Loss per Share

The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at November 30, 2014 and 2013, the Company has no potentially dilutive common shares.

 

n)Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V M,CDU86-C86$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=OF%T:6]N7T%N9%].871U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-U;6UA#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A M8W1I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M5].;W1E7U)E8V5I=F%B;&4\+W@Z3F%M93X-"B`@("`\>#I7 M;W)K6%B;&5?4F5L871E9%]087)T M>3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;6UI=&UE;G1S7T%N9%]#;VYT:6YG96YC:65S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O&5S/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O&5S7U1A8FQE#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=O:6YG7T-O;F-E#I.86UE/@T*("`@(#QX.E=O#I7;W)K6%B;&5?4F5L871E9%]087)T>5].87(\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R M:W-H965T&-E;"!8 M4"!O3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V,CDU86-C M86$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T,65?83@Q M.%\T9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!);F9O2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^ M3F]V(#,P+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L2!A(%=E;&PM:VYO=VX@4V5A'0^3F\\2!A M(%9O;'5N=&%R>2!&:6QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!& M:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M4VUA;&QE3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,C`Q-#QS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6%B;&4@=&\@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)FYB'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F5D.B`U,#`L,#`P+#`P,"!C;VUM;VX@3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V M,CDU86-C86$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T M,65?83@Q.%\T9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)FYB'0^)FYB'0^)FYB'0^)FYB MF5D/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P+#`P,#QS<&%N M/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D M8C!?8C`P.5\Q,#0V,CDU86-C86$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-C)B.&,T,65?83@Q.%\T9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O M'0O:'1M M;#L@8VAA'0^)FYB'0^ M)FYB2!A8W%U:7-I=&EO M;B#B@),@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB M'!E;G-E*3PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-S@L.#&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S M<#L\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)FYB7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA65A2!N;W1E(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)FYB6UE;G0@;V8@ M9'5E('1O(')E;&%T960@<&%R='D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V,F(X8S0Q M95]A.#$X7S1D8C!?8C`P.5\Q,#0V,CDU86-C86$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T,65?83@Q.%\T9&(P7V(P,#E?,3`T-C(Y M-6%C8V%A+U=O'0O:'1M;#L@8VAAF%T:6]N($%N9"!.871U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`Q-7!T.R!T97AT+6%L:6=N.B!L969T)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M2<^ M/&9O;G0@F%T:6]N#0H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(&%N9"!.871U28C.#(R,3LL("8C.#(R,#MW928C.#(R,3LL M("8C.#(R,#MU'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P M<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!H860@82!C:&%N9V4@:6X@;6%N86=E M;65N="!W:&5N($UR+B!2;V)E2!A M8W%U:7)E9"!T=V\@,3`P)2!O=VYE9"!S=6)S:61I87)Y#0IC;VUP86YI97,L M($-A;FYA8FES(%9E;G1U2!C;VUP86YI97,@ M:&%D('1R861E9"!P61A>2!C=7-T;VT@=&%I;&]R960@=V]M96XG'!L;W)I;F<@9&EF9F5R96YT(&AE;7`@86QT97)N871I=F5S(&]F(&9A8G)I M8R!A;F0@;6%T97)I86QS(&YE961E9"!T;R!P2!A M;'-O('!L86YS('1O(&5N=&5R(&EN=&\@=&AE(&UE9&EC86P@;6%R:6IU86YA M(&-U;'1I=F%T:6]N(&EN9'5S=')Y(&%S(&%P<')O=F5D(&EN('1H92!5;FET M960@4W1A=&5S(&%N9"!#86YA9&$@=&\@8G5I;&0-"FQE9V%L:7IE9"!C=6QT M:79A=&EO;B!O<&5R871I;VYS/"]F;VYT/CPO<#X-"@T*/'`@6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2!U;F-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2!#5DD@*$-A;F%D82D@:6X@1F5B2`R-BP@,C`Q-2!A;F0@ M2&5A;'1H($-A;F%D82!A8VMN;W=L961G960@2`R-RP@,C`Q-2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!L M:6-E;G-E#0IF2!P86ED('1H92!O=VYE6UE;G0@;V8@)#0L,#`P M#0IA(&UO;G1H(&%N9"!T:&ES(&5X<&5N'1E;F0@=&AE('1E3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V M,CDU86-C86$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T M,65?83@Q.%\T9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3H@07)I86PL($AE;'9E=&EC82P@4V%N2<^/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`U<'0G/CPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE0T*2!T;R!C;VYT:6YU92!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S M/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!!6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W9E'0M86QI9VXZ M(&IU6QE/3-$)W=I9'1H.B`Q-7!T.R!T97AT+6%L M:6=N.B!L969T.R!V97)T:6-A;"UA;&EG;CH@=&]P)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2<^/&9O;G0@ M2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG#0I0 M;VQI8VEE2<^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^#0H\=&0@ M'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2!T:&4@0V]M<&%N>2!E9F9E8W1I M=F4@2G5N92`R-BP@,C`Q-"X@06QL(&EN=&5R+6-O;7!A;GD@=')A;G-A8W1I M;VYS(&%N9"!B86QA;F-E6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I M9'1H.B`U<'0G/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'!E M;G-E2!E=F%L=6%T97,@97-T:6UA=&5S#0IA;F0@87-S=6UP=&EO M;G,@"!A6EN9R!V86QU97,@;V8-"F%S'!E;G-E2!A<'!A28C.#(Q-SMS(&5S=&EM871E2<^#0H\=&0@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE2<^)B,Q M-C`[/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`U<'0G/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ M(&IU2P@86YD('1H870@=&AE('-T871E;65N=',@;V8@;W!E2!A;&P@;V8-"FET2!A9&]P="!T:&5S92!N M97<@<')O=FES:6]N2!T M:&5S92!A9&1I=&EO;F%L(&1I6QE/3-$)V9O;G0Z(#$P<'0@07)I86PL($AE M;'9E=&EC82P@4V%N2<^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2<^/&9O;G0@2!I2!B92!U'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE28C M.#(Q-SMS(&9I;F%N8VEA;"!I;G-T6%B;&4@86YD(&%C8W)U960@;&EA M8FEL:71I97,L(&%N9"!A;6]U;G1S(&1U92!T;PT*2X@ M4'5R6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`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`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2!A8V-O=6YT&5S('5S:6YG('1H92!A&5S/"]I/BX-"E1H92!A"!AF5D(&9O"!C;VYS97%U96YC97,-"F]F('1E;7!O2!D:69F97)E M;F-E2<^#0H\=&0@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE'0M:6YD96YT.B`T.'!X.R!M87)G:6XM8F]T=&]M.B`P M)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE&ES=',L('1H92!S97)V:6-E(&AA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&IU M6QE/3-$)W=I9'1H.B`S,'!T.R!T97AT+6%L:6=N M.B!R:6=H="<^/&9O;G0@2<^/&9O;G0@'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE28C.#(Q-SMS('!O;&EC>2!R M96=A2!I;F-U'!E;G-E#0IO9B`D;FEL(&1U65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE2!I;G-T'0M:6YD96YT.B`P<'0[('1E>'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E M'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`S,'!T.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@2<^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^/&9O;G0@'0M:6YD96YT.B`T.'!X.R!M87)G:6XM8F]T M=&]M.B`P)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M0T*9&EV:61I;F<@ M;F5T(&EN8V]M92`H;&]S&-L M=61E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^#0H\=&0@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!42!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2!46QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2X\+V9O;G0^/"]T9#X-"CPO='(^/"]T86)L93X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2!O=V5D M("1N:6P@*$YO=F5M8F5R(#,P+"`R,#$S("T@)#(X+#(Y."D@=&\@=&AE#0H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("!F;W)M97(@4')E2X@5&AE(&%M;W5N=',@;W=I;F<@=V5R92!U;G-E8W5R960L(&YO M;BUI;G1E6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M2<^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!L:6-E;G-E(&9R;VT@2&5A;'1H($-A;F%D82X@5&AE('!R;W!E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`R-'!X.R!M87)G:6XM8F]T=&]M.B`P)SXF(S$V,#L\+W`^ M#0H-"CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`S-7!T.R!T97AT+6%L:6=N.B!R M:6=H="<^/"]T9#X\=&0@2<^/&9O;G0@7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@3H@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD M96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!N;W1E(&%G2!);F,N("@F(S@R,C`[1T9))B,X,C(Q.RDL M(&%N($%R:7IO;F$@;F]N+7!R;V9I="!C;W)P;W)A=&EO;BP-"F9O'0M M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@ M+2!296QA=&5D(%!A3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL2<^/'1D('-T>6QE/3-$)W=I9'1H.B`Q-7!T.R!T97AT M+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E2<^/&9O;G0@3PO8CX\+V9O;G0^/"]T9#X-"CPO='(^/"]T M86)L93X-"@T*/'`@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU2<^#0H\ M=&0@'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E2<^ M/&9O;G0@0T* M87!PF5D('-H87)E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H.B`U<'0G/CPO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE28C.#(Q-SMS#0IO=71S=&%N9&EN9R!C;VUM;VX@7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'1A8FQE M(&-E;&QP861D:6YG/3-$,"!C96QL2<^/'1D('-T M>6QE/3-$)W=I9'1H.B`Q-7!T.R!T97AT+6%L:6=N.B!L969T)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M2<^ M/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE2!L:6-E;G-E M(&9R;VT@2&5A;'1H($-A;F%D82X@5&AE('!R;W!E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2`V+"`R,#$U(&%N9"!W92!W:6QL#0IB92!R97-P;VYD:6YG(&)E M9F]R92!&96)R=6%R>2`R-RP@,C`Q-2!A;F0@=V%I=&EN9R!T;R!H96%R(&)A M8VL@9G)O;2!(96%L=&@@0V%N861A+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&IU"<^ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!L:6-E;G-E#0IF2!P86ED('1H92!O=VYE6UE;G0@;V8-"B0T+#`P,"!A(&UO;G1H(&%N M9"!T:&ES(&5X<&5N'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2!P M87EM96YT('=A2!O=VYE0T*=VEL;"!B92!S=6-C97-S9G5L(&EN(&]B=&%I;FEN9R!A M(&QI8V5N'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&IU6QE M/3-$)W=I9'1H.B`Q-7!T.R!T97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL M93TS1"=F;VYT.B`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`U-B4[(&9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&QE9G0[('!A9&1I;F"<^/&9O;G0@&5S/"]F;VYT M/CPO<#X\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@."4[(&9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`X)3L@9F]N=#H@,3!P="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@9F]N=#H@ M,3!P="!4:6UE6QE/3-$)W=I9'1H.B`Q,B4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q)3L@ M9F]N=#H@,3!P="!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE0T* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("!R871E M/"]F;VYT/CPO<#X\+W1D/CQT9"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&QE9G0[('!A9&1I;F"<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`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`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`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@<&%D9&EN9RUL969T.B`R-'!X)SX\9F]N="!S='EL M93TS1"=F;VYT.B`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`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`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&QE9G0[('!A9&1I;F"<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0M86QI M9VXZ(&QE9G0[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@9F]N=#H@,3!P="!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W9E'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`S-7!T.R!T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@2<^ M/&9O;G0@2!H87,@86=R965D('1O(&ES M2<^#0H\ M=&0@'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E2X@5&AE($-O;7!A;GD@:&%S(&%G6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`U<'0G/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD M96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL2<^/'1D('-T>6QE/3-$)W=I9'1H.B`S,'!T.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UE2!O=VYE9"!S=6)S:61I87)I97,L M($YE=F%D82!I;F-O'0^/'1A8FQE(&-E;&QP M861D:6YG/3-$,"!C96QL2<^/'1D('-T>6QE/3-$ M)W=I9'1H.B`S,'!T.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@2<^/&9O;G0@'0M:6YD96YT.B`P<'0[('1E>'0M M86QI9VXZ(&IU2!R96=U;&%R;'D@979A;'5A=&5S(&5S=&EM871E2!B87-E2!D:69F97(@;6%T97)I86QL>2!A;F0@861V97)S M96QY(&9R;VT@=&AE($-O;7!A;GDF(S@R,3<['1E;G0@=&AE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2<^/&9O;G0@0T*8V]N2!O9B!T:')E92!M;VYT:',@;W(@;&5S3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2<^#0H\=&0@'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2!A2!A M2!H87,@9V5N97)A=&5D(&YO(')E=F5N=64@6QE M/3-$)V9O;G0Z(#$P<'0@07)I86PL($AE;'9E=&EC82P@4V%N2<^ M/'1D('-T>6QE/3-$)W=I9'1H.B`S,'!T.R!T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@2<^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE'0M M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UEF4@=&AE('5S M92!O9B!U;F]B'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE28C M.#(Q-SMS(&9I;F%N8VEA;"!I;G-T6%B;&4@86YD(&%C8W)U960@;&EA M8FEL:71I97,L(&%N9"!A;6]U;G1S(&1U92!T;PT*2X@ M4'5R'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M:6YD96YT.B`P<'0[('1E>'0M M86QI9VXZ(&IU2!0;&%N="!A;F0@ M17%U:7!M96YT)B,X,C(Q.RP@=&AE($-O;7!A;GD@=&5S=',@;&]N9RUL:79E M9"!A2!N;W0@8F4@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`U<'0G/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT M.B`T.'!X.R!M87)G:6XM8F]T=&]M.B`P)SX\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE'!E8W1E9"!F M=71U"!B M87-E69O2!E;F%C=&5D('1A>"!R871E"!A2!T:&%N(&YO="!T;R!B92!R96%L:7IE9"X\+V9O;G0^/"]P/CQS M<&%N/CPO'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL2<^/'1D('-T>6QE/3-$)W=I9'1H.B`S,'!T.R!T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@2<^/&9O;G0@'0M:6YD96YT M.B`T.'!X.R!M87)G:6XM8F]T=&]M.B`P)SX\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE&ES=',L M('1H92!S97)V:6-E(&AA'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD M96YT.B`T.'!X.R!M87)G:6XM8F]T=&]M.B`P)SX\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE'!E;G-E(&%D=F5R=&ES M:6YG('=H96X@:6YC=7)R960N(%1H92!#;VUP86YY(&EN8W5R'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2!R96-O2!I;G-T2!I;G-T2!I;G-TF5D(&)A'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL2<^/'1D('-T>6QE/3-$)W=I9'1H.B`S,'!T.R!T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`U<'0G/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!C;VUP=71E&5R8VES92!O9B!S=&]C:R!O M<'1I;VYS(&]R('=A0T*:&%S(&YO('!O=&5N=&EA;&QY(&1I;'5T:79E M(&-O;6UO;B!S:&%R97,N/"]F;VYT/CPO<#X\'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0O:F%V87-C3X-"B`@("`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`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$ M)W=I9'1H.B`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`@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!R96-O=F5R>3PO9F]N=#X\+W`^/"]T9#X\=&0@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`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`R-'!X)SX\9F]N="!S='EL93TS1"=F;VYT.B`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`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`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&QE9G0[('!A9&1I;F"<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA"!0&5S(%-C:&5D=6QE($]F($EN M8V]M92!487@@4')O=FES:6]N($1E=&%I;',\+W-T&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(W."PX-S4I/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E8W1E9"!T87@@ M'0^)FYB'0^)FYB3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V,CDU M86-C86$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T,65? M83@Q.%\T9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M&5S("A38VAE9'5L92!O9B!$969E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)FYB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!);F,N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!N;W1E(&EN=&5R97-T(')A M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V,CDU86-C86$- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T,65?83@Q.%\T M9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!/9B!3:6=N M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A!8V-O=6YT:6YG($-O'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!4'0^)FYB M'!E M;G-E(&]N('!R;W!O2!4'0^)FYB M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB6QE/3-$)VUA2!4'0^ M)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V,CDU86-C86$- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-C)B.&,T,65?83@Q.%\T M9&(P7V(P,#E?,3`T-C(Y-6%C8V%A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2`H3F%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$ M)VUA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6%B;&4@=&\@3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,C`Z,3QS M<&%N/CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!C;VUP;&5T960@82!F;W)W87)D('-P;&ET(&]F('-T;V-K M(#(P.C$@;VX@4V5P=&5M8F5R(#$W+"`R,#$T('1H870@:&%S(&)E96X@2!R969L96-T960@:6X@=&AE'1087)T7S8R8CAC-#%E7V$X M,3A?-&1B,%]B,#`Y7S$P-#8R.35A8V-A80T*0V]N=&5N="U,;V-A=&EO;CH@ M9FEL93HO+R]#.B\V,F(X8S0Q95]A.#$X7S1D8C!?8C`P.5\Q,#0V,CDU86-C M86$O5V]R:W-H965T'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA&5S("A.87)R871I=F4I("A$ M971A:6QS*2`H55-$("0I/&)R/CPO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE;G1S('1O(&%C<75I6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S M('1O('!R;W!E2!P87EM96YT2!O=VYE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7S8R8CAC-#%E7V$X,3A?-&1B,%]B,#`Y7S$P-#8R.35A8V-A80T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V,F(X8S0Q95]A.#$X7S1D M8C!?8C`P.5\Q,#0V,CDU86-C86$O5V]R:W-H965T&UL/@T*+2TM+2TM/5].97AT4&%R=%\V,F(X8S0Q95]A >.#$X7S1D8C!?8C`P.5\Q,#0V,CDU86-C86$M+0T* ` end XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Subsequent Events (Narrative) (Details) (USD $)
0 Months Ended
Dec. 02, 2014
Dec. 16, 2014
Nov. 30, 2014
Nov. 30, 2013
Jan. 09, 2015
Preferred stock, shares authorized     10,000,000us-gaap_PreferredStockSharesAuthorized 10,000,000us-gaap_PreferredStockSharesAuthorized  
Preferred stock, par value per share     $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare  
Subsequent Event | Series A Preferred Stock          
Preferred stock, shares authorized         500,000us-gaap_PreferredStockSharesAuthorized
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesAPreferredStockMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Preferred stock, par value per share         $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesAPreferredStockMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Subsequent Event | Common Stock | Consultant for marketing agreement for advertising services          
Shares issued during the period for services 1,500,000us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
/ us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis
= GLAG_ConsultantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
       
Subsequent Event | Common Stock | Consultant - Consulting agreement with a consultant who is to become a director of the Company          
Shares issued during the period for services   500,000us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
/ us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis
= GLAG_ConsultantOneMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Commitments And Contingencies (Narrative) (Details) (Cannabis Ventures Inc. Canada, Property Acquisition Contract, USD $)
1 Months Ended
May 31, 2014
Feb. 28, 2015
Other Commitments [Line Items]    
Payments to acquire property $ 600,000us-gaap_OtherCommitment  
Contract expiry date

The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada.

 
General and Administrative Expense
   
Other Commitments [Line Items]    
Monthly payments to property owner 4,000GLAG_MonthlyPaymentsToPropertyOwner
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_GeneralAndAdministrativeExpenseMember
/ dei_LegalEntityAxis
= GLAG_SubsidiariesOneMember
/ us-gaap_OtherCommitmentsAxis
= GLAG_PropertyAcquisitionContractMember
 
General and Administrative Expense | Subsequent Event
   
Other Commitments [Line Items]    
Monthly payments to property owner   $ 2,500GLAG_MonthlyPaymentsToPropertyOwner
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_GeneralAndAdministrativeExpenseMember
/ dei_LegalEntityAxis
= GLAG_SubsidiariesOneMember
/ us-gaap_OtherCommitmentsAxis
= GLAG_PropertyAcquisitionContractMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
XML 20 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
Going Concern
12 Months Ended
Nov. 30, 2014
Going Concern  
Going Concern

2.Going Concern

These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at November 30, 2014, the Company has not earned any revenue, has a working capital deficit of $192,673, and an accumulated deficit of $387,071. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to successfully implement its business plan and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

XML 21 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (USD $)
Nov. 30, 2014
Nov. 30, 2013
Current Assets    
Cash    $ 104us-gaap_CashAndCashEquivalentsAtCarryingValue
Total Current Assets    104us-gaap_AssetsCurrent
Total Assets 0us-gaap_Assets 104us-gaap_Assets
Current liabilities    
Accounts payable and accrued liabilities 8,038us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent 8,902us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Due to related parties 174,635us-gaap_DueToRelatedPartiesCurrent 28,298us-gaap_DueToRelatedPartiesCurrent
Loan payable to related party 10,000us-gaap_LoansPayableCurrent   
Total Current Liabilities 192,673us-gaap_LiabilitiesCurrent 37,200us-gaap_LiabilitiesCurrent
Total Liabilities 192,673us-gaap_Liabilities 37,200us-gaap_Liabilities
STOCKHOLDERS' DEFICIT    
Preferred Stock Authorized: 10,000,000 preferred shares with a par value of $0.001 per share Issued and outstanding: none      
Common Stock Authorized: 500,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 119,140,000 and 118,140,000 common shares, respectively 119,140us-gaap_CommonStockValue 118,140us-gaap_CommonStockValue
Additional Paid-In Capital 75,258us-gaap_AdditionalPaidInCapital (47,040)us-gaap_AdditionalPaidInCapital
Accumulated Deficit (387,071)us-gaap_RetainedEarningsAccumulatedDeficit (108,196)us-gaap_RetainedEarningsAccumulatedDeficit
Total Stockholders' Deficit (192,673)us-gaap_StockholdersEquity (37,096)us-gaap_StockholdersEquity
Total Liabilities and Stockholders' Deficit $ 0us-gaap_LiabilitiesAndStockholdersEquity $ 104us-gaap_LiabilitiesAndStockholdersEquity
XML 22 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements Of Cash Flows (USD $)
12 Months Ended
Nov. 30, 2014
Nov. 30, 2013
Operating Activities    
Net loss for the year $ (278,875)us-gaap_NetIncomeLoss $ (35,990)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation    475us-gaap_Depreciation
Impairment of promissory note receivable 189,972us-gaap_FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown   
Changes in operating assets and liabilities:    
Accounts payable and accrued liabilities (864)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 3,991us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Due to related party    6,724us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent
Net Cash Used In Operating Activities (89,767)us-gaap_NetCashProvidedByUsedInOperatingActivities (24,800)us-gaap_NetCashProvidedByUsedInOperatingActivities
Investing Activities    
Loan receivable 189,972us-gaap_PaymentsToAcquireNotesReceivable   
Net Cash Used In Investing Activities (189,972)us-gaap_NetCashProvidedByUsedInInvestingActivities   
Financing Activities    
Proceeds from related party 174,635us-gaap_ProceedsFromRelatedPartyDebt   
Proceeds from loan payable - related party 10,000us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt   
Repayment of due to related party 5,000us-gaap_RepaymentsOfRelatedPartyDebt   
Proceeds from issuance of common stock 100,000us-gaap_ProceedsFromIssuanceOfCommonStock   
Net Cash Provided By Financing Activities 279,635us-gaap_NetCashProvidedByUsedInFinancingActivities   
Decrease in Cash (104)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (24,800)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash - Beginning of Period 104us-gaap_CashAndCashEquivalentsAtCarryingValue 24,904us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash - End of Period    104us-gaap_CashAndCashEquivalentsAtCarryingValue
Non-cash Investing and Financing Activities    
Forgiveness of related party debt 23,298us-gaap_DebtInstrumentDecreaseForgiveness   
Supplemental Disclosures    
Interest paid      
Income tax paid      
ZIP 23 0001517126-15-000047-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001517126-15-000047-xbrl.zip M4$L#!!0````(`'6+;4;I76LU3U0``*(X`P`1`!P`9VQA9RTR,#$T,3$S,"YX M;6Q55`D``TU6`U5-5@-5=7@+``$$)0X```0Y`0``[%UM<]LVMOY^9^Y_P'JW MO>V,)9-ZL2R[R8YBQZEO$]L3.^GMIPY$0A(:BM02I&WUU]]S`+Y*E$12E"7' MRNQT99+`.3AXSBL!\)=_/XTM\L!UPX(LPW'Y/;PS<&7NUKO[OSJ MZH#\^^U__Q>!?[_\HU8CEYQ9YBFY<(S:E3UPSL@U';-3\H'9S*6>XYZ1K]3R M\8ISR2WFDG-G/+&8Q^"&HG1*6O6F06JU'-U^9;;IN%\^7T7=CCQO=!_KHN-]$W7#R=7?G^*[!HKZ&%AW^V=#TEJXWM?K3`)B_H![<@&OM'QH7 M6A/^HS?O]>:IWCUM:3F)>-3S141$>]*"?ZKY+T]]U^*G^%\"\K?%Z9/@;PX2 MXWILUAUW>-30-/WH_SY]O#-&;$QKW!8>M0UV$+:RN/TMJYW>[7:/Y-WPT;DG MD7A(HWF$M_M4Q#TC@TN>G^,$[II>U"#YMINFUIAX^[K+!0I:/C^!N^"`73JNA=Y:-3ST1-O!%;4CI)&HP MH*(O'PYN9#`#=US'8B*SC;R3TNZ1-YVP(WBH!D\QEQM1N]6- MT@V`![R@8H'WCHU"+#D(%05"="@G=SVQ` M)!Y/1W*64.UJL=H)\R"XC;3?'`B.!N.`'(5=*84Q'-MC3Q[AYIN#2]<90P>- M&OQ/TST'?C=K.K`;T8^:,=OCWC2Z&EWG)MX9<+!0DDN6DF&(M?.KWP[>@NKJ M;;W9TIJ_',TVCLD=9=(+J$U`_HXYSP4HDNNAS7D;#R?L*;XWUPRL8M@H&'=, MWDPU":^G&`@O!B)=+.>>N!F@+:QI2.:%R5:9*>]M/("(1'"G4B&]3``FA#2# MI(T(J?'2A=38I)`6F[4_`U_S)T138\>^\QSCVR")%:MY2; M5_8YG7"/6J\*#TMEL'
5S('D8[!J,MNY8]'G87#]MV.9^91[G-S/?4M;D] M%*\*%-F#WSN9/$YF#YRM`V?+;F6/@%U"P'/4`F<1<.LR(6?B^YCZS\R"N3=O MP>1.[UUJ"VI@R"#>39-WTCB8$<'W"H`@DF@F(HG6BRP,IYQMLXRS;3V#LWV9 MLDV`L;4=,.XMT\Y8IA>E:'O<[`QNGMF(+,N-]V#8-AA>1FK3>B+ALYELG<[P-@=R/']>Z9.[Y@?>]^ M.F%I+*T0RVIL;0KLN%#J=&XVMFKX)*`V:O@D#;T;1$\*P(N`F1?9>P"_9@"G MC'4`KZ(17PKWU1KK&/?MFGX2XAY^=_?OX+?]#GX6.CA#A:'33N!M(]#)2CB_ M5U_^PLW/[B6<2_*-/89V$D.[EV_D*'Q=<)<9GN/.I!I^'](X3EW.Q(W-7A^\ MPC9I\503L9F,GWYD0VJ]E_)+XCE+['N[6+0.L\?T'M-+,+VS=AIBTFYLI^%W M`M-),;Z.)#L34E&B,B>.:K/I36?VFTV'NB5,MH3;YN&M'\?PUCMYX+U/LGYN[ALOTM-=M>"+)?^[YC:]]?IBG9PVC' M8+1#)F:_#GKKZZ!?IE'9`V?KP'EF,]*N:9$9D;\;)TO+F:E\FOW'1ZD^1*NQ MPJ:WK@-<>=.>`1(7TD:?`VV7&MY,-^K,+ZMGFSUSS&TNX"&//[#W3Q.8QA=> M0ZV\9ED$];)JA($W]\8QV"7UE=-3+2=7MN&,6:2%'QV#(LFT]N4"0L4EN#2$ MYXMPF1C?JB<)U+68)PGT>M-%$KW6Z.Y7K>[^JM5@JG;R[<1)K1&5;^%W9U\Y MV7;E9+9&BS-4N$:+4_F\+[:TQAXZNP:=DB^-M,:&>PNV[6FOCSKSYO7OU0=^(XS]D<%,S\XCBE`WZZ!B_'$Z-#96KDGJI=Z.]5(_KDXOOYM=&WO5 MW)!J[L8&DT`)2FAGO,!Z4U]YT6M:O'\=!`S!6._690/FNLQ,:M]2K=TK8(4* M>&Y1`?,CA3_#Q>+YV6(6%J"HNBS,M[F"Z9>[BSEDC1D5OLO>!I_L.H5GPL[" M6VD2V-N"_J6U$0M)!/*2#Y6F`?S=+J!C\@>`]+QLL>VU/U9?UYM'4P$9S/*8 MU6N"Z`6S'4@\5I%=+9=9NED=A_=34L@AT%OF&H!5.F0K)FX"/_-/&R:J*D=- MN#@U<3>^AY#&CR22`+"?\:MF,]_*(MB=O!',-S&9P MPL\"_G*4CUK(6VPBX"FUOUTH-YW%3_A9JI@?U*,$,]K!VUJSHW7!N2SNN1SM M1A[:NJYMCO22-X/+F-+U$YB;ZKE:_9F6;7!5[(L/2R>SU=&>0VZ[QV'.`\V7 MLM9I-#:A"CE/VEZNI-J)O@D+TO.9#>5K M>MN[IF.6%R=O/U"+D@^6TZ<6@>[KR8)0NLN,\A3#90K6E6VRI]_8-#?-9#U] M86]).X8^#:GAN*KI6^TWUGVR>U>VMK`>_5^\U?7'*YL+0#\SBSK-]MYM.\8 M%0[@^TH(G[FYR5X[20`LZ&V>[%?'\FV/NM-+;D'.5I+<3"\9\%9R^,PF#B0. M]A!?B_CYJ?V!)>E5O[`;D`[$G5/\+4IM:=)%E)=9RF" MFG(%X$NXEG^PEW^DE6"NI\7D$&'%B.'O+')13W-9(.N#[013)A^^8,)P^00] M0Q;)S1PG_Z/EG4V(\*86>W,P`*JG1-PFV[QF&4$(AZI`\B`G0<_OA/O7D&(2DQ?49`#B8#XF8]IH7\'DTD?7Q4 M_0?'("]%-Q,Y^2(9KS49Q0ZJ3@EY3-TAMT^))J5X'XD'Y/:("@*M5XJ)9(CH M.<>>?VOL_/@>6;$!RBDF._8O$'H)4??,!P:64,`H@U6+5:17B:!]GD`Y%HJ& M[X58`']`IW+%ZPCIWUN<2P"EJW; M-CN-)/5$CP6)Y2I[SKQ[R$=MS!?0[AF&-'F!M\7URH8! ML#2KD\=)%Q4G4-0$+NE^S9G/ M&,92<16?O)4O$*@8P;3A_^&+J0=JR660WCEUW2D8_:_4\EDEP\M%J3+V\JS- M:+2ZVV.PY'PM*#B57AHSLUY@0?=K<)%'V6;>Y.9D(F%C8`:J6RZ40NTJ(E4P M5=`>%64IM>M'>&7?`:Q$9@XR10.QQDDJ$ILE41$+I;Z=\,QL5_7)A\+FYB_H M30:_]\X"O93%B$IFNYE:#I";]J:9KNY=P\8X*[^*9N>%GN_%QBK)W[J.P9@I MD.`S9:E%2195E]DE*\OH;8"WQ46R76&ZT.?#"D]NI?$M#+B*W/6OYU M.L_.6G4[K%:OB%EK:'/+9RI"0UN;D_D24FMRE1L(ZW$UGU_@BRC5=`)9R(+W M6Q5][*:AG2Y=1IOF9;Y.G`X=>H;ACWWI."[8`#>.E,KR95#7.Y5M_, M+C\NSEQ:G\#+WKARRYXI#>PM!'5ZGC-%.:.\KH) MX_J\HU64Y(J+@F:V6+BTBLYBPUF&3ND%UQL@5GYD"=/[7,J>@V1%7*ZCYNMQ M61[R)1:#*S)K<%/I$O!L;GYG?#@"`?8>F$N'[-I'BW0SD$T2X'Y'!3=ZMGG! M+=^;8397@IY?C.4XVMRXEE7+<3J[EK&9<8<008GWMB4EJ7KQ,7\_8 MP%%#38S'LX*3"AA?67_)9'Q^X\9ZC*L%N/?T*5AN\8[9$*)MJD95@%J.\M0J M:C<3W)`/PMCLAH0,,B4Y*;SN_>2DJS7+<1+,0"426220D$8I)HH*8Y$L%C&Q MXD2X:N32UA,V<@7%"A@LO/*HE9)9008OV,2%WNBBY7Y%Q=5*.I1DYT4)5V`[ M/C-(8?S2ZK%.]Q5P'^L_]GD.-+CM@RX$2H%'6;.!X[+('C-Q`3^$QXU-6,@U MV-GPR-;>:53AT&0TJ^+8"Q_7LJK%YLGX]M)Q<>E'E2\2LS8Q-A=5=V=J8[F8 MK7:8Q3YOD;=JO<%QR=RMS.RM6#22B^UYXIOFNNSQ#SL^FO(OO,$0[O;0JGGA MG;!O**%-YP^+J53B/=6>@HT.9#F)"D8QNZ_`^D;'*(V4M%E=4`/9+-PVXJ"?H:K9-4B:X`_:IY+QS6Y5@ZG(_S M:^9ANUO7P9/WS'?3+X)!HTMN4]L`\]HS(*&:WT-1G?JMQT!A/>QT4^MK\E// MR?>5_8#!\O8$EY.!XH@[Z78[C962RR"?D_&H`+*VY):J>7[JU?)=O%;6[1QW MJN![U@1-.HY5*.'-3KYKS:BH3,RSDV=1323&NV]67B3$/'YL; M37$X'R\%19G1)!<\8DH!)IO=#!*)W#.L7,U-=]V,>2712K@L6Z[8`/\W[I#: M_&\:?(Y%.!8WY1_XADC<##""Q;-_Y25?<(PI$[N1%8(04YA[.G@.-A/W,-QW M5H$96K:A'6_A.0+ESA3`3>S8(KV;/[W5WT-5(`:SK`DU\74D2E;^+2;4"/\N M2/Z,J&'4/&<"0XG^[#N>YXQ/R?'$BSCTW+!WNU\,#V(1X'MS;#](S>]$;#7GGCI=A8;>-6(LX\_='4\0#];QIX9C6R6LW9B MV)G/+1QL)7PGT5[L'``\/^":>K[+\#B*N(Z;0P[A-!UY;GP+,9=QZD1R>+4! M'7-K>KHVT*)KB()3TM`B='`;DU-H-HN7:D7ODJ-HK!]Z'WO)@YC(3^HPCI-& M0SO#PSV"`UVBJ_K9(4D\\L@6W?%%X@YQW.0]QW<3-W\FCU00;AN..W%9;=#AQW M#!UZ#IFH*)(,J8O9.?$HMQQ7GLD!:**6%X"(B.`S&_5<]NK[`\F-4L9/=$KT MKI1QZY!08HRH/60X->A'7,<*3X()Q>T8!H:E)GD<,9M<77P@7X%3T%%!/GIF M_9!DX$GOG`F\'G5JX82(>"N&.C,&'"%.D23)/4&:A^U6YQ!\K7I4S+"2ZMV0 M[A8D`2[PD+CX6A)]*-(YUNI:ZP=L#(@D7*V"0C0XJ45UV%ZQ(8D=H@PHX(D_ M(#3E13+Q`9-8Z?#BC[,@ZCZ!AW9%G?Q**33\R`;L`9Y6]LLP*'Z,X)7C[']] MFY'&<0BT)*)&U$P!#_JA0_F-$(6Q3VX=>H>HS".7+N,$ZWM#&^=0D*C8)X4= M[H>8"(U0@,'?GI MRUWOY\.TN02H7;*^ZT,GI-%1D@QL*,Q,VGZB-#)[!ML/U^&1GY7.S5+H`>`M MTHU[_PKAK.-#D'1(WKF0K(@1#-;RQWU.ZT"-RYU]2MZ@%_$X231&.<&@,)#; MHSK!](#&P./<52=%Q9M@27^:MC6R4\SBC4ZM.EOCO5 M0K>N_+MT[8=J?F'"`^!:4V+BRA'>]Z4A!--:LS&>@C"`P8Q.33#^:E]9)IK!3&.!CI$9$P]^$A$!DRQ#/:7SY%>)A]@ZF1Q" MC&0X>O[N(ADU!D;*A$&Z4X4ZV2E^50JA/L`S^1!RCII/$X!M.1-EF3$&P"A2 M'46&+IZY!H`MR$9PPB.@0!0"@S`5RI.<2@XB6WH+Z/?J)!%1!VH7ZQS,X#<\ M@(9*X,)XR,"B#U*Y[D&C:@-NC0FJY42-)_X;F+`X*B814^&Q,?%Q11Z5'(`F M0WST@$---`#;*,_DHWUP6OTHIB9CB&U&2/'E,^#134?L%)AAE>5 M,"!XEB<\(M<.?L&+>:'3$O@-.CGIP?A!:QWL3##V3=J7A"4W,*XR0;F%8HE+ M5:0RM`L/B@MXM7W\("WS918N9VH"P=8XOA1,/[B2^GV0+T3^%EF8P)P(-!P, M>XZQ!BF!;`\3PO_R`;(P29:'\9P$3P`JH@(!&'HLOB\V1W\HLQ(1PA7]*O3< M][FE0&'A%W_5+KU$OTXZ3]W;$:D?J6`]S+TPOK%\R-9F-!=18BB-LQT._AX_ ME0BN!/S(2,[&([,L^6XX5-^SK"Z"^9>\##'^D#&)X]MF\+P%3-C*>DCP0W0B MX0YRD6]Z#LF0V0Q`"..S*$0=81XYH<8W.I1/(':_R5\!+S#SRM[(W(*Z9K+V MH71-)JPQ1+D-((5(IQ]A\K6Z(&S,\4=H;^589^)7#(W3+N/K5]$KHT&5!YH4Y#RHP(Y?2 M&$_#>`!<1\_E?SM@3O'83^A"[1M0601:P.3QV&FB4@0SQHR-L9X9U"'DD MQY`O>7:M9`2/*A6Q0P)?VOZ!@/V&0=K^6*DQ)HK!,:T7S%`";>HJRJF3GI"T MY4-H'^2F2W0CT`M6I61M`5)7"I>9C"#EH2V='@"!@Q?FJM#&@K7PR8F)8\-YR;U2W5QNX0[3*?JLE8MN[,W= MO+G#2F9LZ"(1SE@\68"DAH=:%!1K(OW$"`!^3F?*'D'HAR[[7\>:)@N2\P5T MU6UR8NJ2K2L9GR\J6Z+IL<,JXH`:J.%8R9'5IF10.ML,JUL8X*C(AZELYU<56*EQJJ0A[E,$%2SX4^#B.;`M?8B9(3.(:VU) M@;]6Q;X*ZYQ6)@PA"\/B!IZDC5_R-M2T2B^;$G\4&7[Z=/N9?`RFZ:=/,.DC M.>EX_U,`A5L?G"ZFB)_9$$]U0,\2P`XG$0S*Q,'F``6+@G]S,?:5P36FPGB< M-\PAB]/>-"?HTZ+[,.>I\?!$,5*E_.TZ^3VD"3Y&2I@01M.T\ M@H"&S%0D0>09YLF:.>:P7$9.&#_@O+8@\;>]$;0%=\QE*:[G M#X&+R.\>(AAPH6JJT"IC$"":M(J9!D-RD64TU$IX%3<,,%J1C!#U.>QTC7R" M*ZWQ`AH6-Q'U*(LCPTJ789@G[5AP!K<,+%IH?%75.""`8))$P_CC_]O[TMZV MD6S1OT+DI8$$D-U:[-A.[@S@SM*30=(QXF3F8Z,DEJ3J4*2&BVWUKW]GJ2H6 M%\F2+=EBS`;N'<,?_\*>$VP"PR"!U&:& MR6FRP"XQ8QC%VGRA?.8B1YL./:9V=\;HB(5*>.58ZF08?A@VNHS1G%;A759& M52?V`G@^>%3O5#(*(KPY_9Y55`71<(YIC0Z<9'"%(20!K"?"Y$!+AE4+/M^UOF)IGRXV[/\!BM+90POJ! M]/X<](B(C=Z?1'K:%)(6JWT;20/]@9G]>E7GZLM84HH$\X>LZOER!KH:",3N M%)#"R<7`JM, M=6S\\K/#ET3WKL M.^OM6\>]4!^BL5!"KL+HX5P2)7C97#OV!H^^YYQ;-D=5SU8"XLVM1$$H\7=. MI#"W.<`OQ6.C1SFK"D\:C%(.C2.-9):4K'\?!^V"*2!YE/W8-!'Q)RSK\KR]O!8A5O0*<7"H[;PG>VX-U[- M\ELTD@8-->XNL]D,^178VN$4+V<50K3AESTPZ`H\TS^:WU2H:QL](T^=B085 MZR]&&7]_S(J7#>`.\NZ1)5S_OA$4_V04[4@$%7" M2WT_O#P$4RX(1)P42UA=DW%,-_YZ"_`;/`SV`6T:3Z,53]L53\,FB*>+G$(Q MV>G&)5LAM4]"2DAF*`*4Y6[L2`:*3JPGV6S. MXI8"?H)DM:WCXG0O1A!G5G4Y@74W7F@"[1RUX]H?LKNI9W+).^4,LQ,3Y4Z0 M?+]")\/K0(K-:%U\2)H!T[ZI%#$OD1-`=2+%QNZ8BIIBT+L2ZU().Q9/K-U* MN(IY?,Z2:"Q&4J-PQ*D;.\*;(TH M2W0_I(F)FP0\]B4`IA-36CW$G0LLUD,=E5=%CU0\RF880!\A?3.&DBS@P^+$ M#A(N_86K/+#8#.@33^BOS)_H(Q]&&5/(2-]US'7#N$PYQU,F16UPQ9D(F!:3 MM$0>3.^QI'`[[,-7Z`Y2MU^HTQZ,AB3*8L0^T0R@!)?4^R$HU);_?!-N%1LURCQK\X,Q) MW%,CIGM_;5X(%V^A`,Z6J^$P`1"MV'4\!1(*L/`1L@,_$QW!0@X'5<:* M)9W&4NKB2TR4!IA3U7J4"BNQ[U'/AO)81H_PM&1^6JQ&SHG'*XEM.E_,D76T MB+F6)")K5FFTC?98\JJ!LDDV03:]JTZO:]LVGM2+DQ@NJ^4+-6>_XH-<]Z'?=&L\/YY>_.7E'/!YJ5TW@ M6WY>?T!6$0@VMMB%':+L>!5)7NDI;@$O=LIMT3ZN]:%(MM%4%P"#%TVG$7OH M*U;O:"-*B]UBBB*WFO2L(>=&4<>TLU4]5+J!LG4,9GYB-HO`\#32A9Z+X#I* MBB.+/*6*>C:<`58O*[@QKE2^@Z+_@^5)NK2&*J.-/V4F,JSX$BZ MBNB`G>H9M'9ISI(M!))CL/53#%("`BA^01.412# M]G$Y:'G`T&A;.F#VK_40CF56=_7DA1T-Z\+VOAC9[!D=2A3/0RPXM!OG;3.L MU+%[Q3K:D5>57N\!?:XSDRQE"79AR.,$/9Z70D?<7$HV?M'[1=<`1`Z7A(]3 M71MO.RPKTY9K__XH>6"Q721Q>@N48CT_/*M=]H',8Y/4:OS!Z%BCVY<\3Y+@;(F M#T?F18J,;'J!YA:0E"0;RLIC"L#>J!G6**-,S=C,B(8XHX1X5X7S+,WCC7@; M6_GI+*P\SZ/K9@0;S>Q!@"E,=FBVDRM:%)3.$^!Z@M('O;G0DT^B?%!F@"J) MI^C8BN$.@/N7UG@2&_Q1!\-WJ=W3*'$-5I;H33/6BG`Y0CGW=XMC%D%43_"^ M>&%'FJ`ZTE4:M5L`;/,N;%TS6%0X;<'9RIP"BCS**''*XG0@UUEWEI\V(9)` M0&329#E007_+Q-VO'@:$WCE]SU30"JZ/78J-U_NCBHX>D@\_(9)H?[T6`]RK MS5:5#FIC;,>)::/MQ9'S//+[ORQ*>=0ACSAB*U7:N6#X#GLW-.^J;MT],H0> M"??]%@-WHSXM]YS1F45ZM/D51V69F0.A;Y,C@PH_]L[(H3F,KBT.O5J_JGJL%/NDMD0>JB#]W!=Q*J^)8+V> M>PD`4YWI%-5[,X'GN]A&'*^R77.VUH!#F%P248M7FNIY0PEVIR0RK[HP^\7` MVTAH7XX>]$*^=H(GGE%,D*'4&3\>;(KS4;,G/D2DK3C8;A1LTH0HV"B>!K7NSQL?[X6G4-=@%WM?4.H.7G5M+*MPH4H>L;HP,UAHY#2)(JSM MF+LQ&;J.I3#(26)!5;7,+=(VNC>)HVRNFZZCN%PB1T$KS#+Q*YPKX:)&MW@, M@T^8'Y0VVZ;BO!B,=1"%6##T/W0*\0)YZ+UU5^((DM84U,`,?(0)$QP)=*4` MMSIST/&&65X7AK7FG+!X73!1.UM`[\?H-4XFYM:%JX]7!@UK9]" MJD%(0#LF:5X[FCD+P<E28DNB&&QI(G<\K&%I$\E`@L5];QH#NW!M-'P'#X4J#&0(=?BZ2O M:"_4*48@N)'7"FV[N[.-(HX!9>?-YAUM=884I:DS.T0*H[4)67L:!BH8CX-O6#Q+P99^$`12(HP-I!-QZ'9^/_HEF#N",[2:B$K"<[#!,- M*:>\];PP[!4/G\/H=L8:B8XZ7*E$EW):&:`+/NG2/#<`W=H2V[4EIDVP)?@B M>8]NDG\T,Z)@$!R=MMUTE=I(ZX:2AV;+XB5FE$R**1>'-GYHKYRHM@"C&71R MY";UG&(D_$J%,NBAO-I^Q>?TH&L=[;3E_+:.OZ8X/9:N-#/J-]?'7(>-*]CJ M!V._H(25,VS7BQ?>LE+OW$7-ZSY(:,.*W"^PM(F#7?MQ18^;]UE7P`9Q#CM* M7WCT&BNY#KUW:VY=AWE\YS3S6>(R%*QZ8(W85JL'XEKCUZKM(5T.PXV%N4)P M,:([LAU51D97N?$#*05SHC7M%OP6W0]4QL$Q>4;=)^%ZM<6'[)NA" MCU85;5D5J2:HHJ^ZONXKRX']Z>]^*(WT=#ZZU[I7TZ&NKN`6'TAXL#=1B MG:9Y\-T1YBZM`&L&B\X3*A"W#K-4MTRC^&[8;\.D!G9KSE>\25&C'T^8P_L*%;0D'1F*)L2&\QI9"0IRS>U\!7J]"ZF\V M#Z*%=(888`+,?-_BS((JDM(F3%>@#4*5+IJ[!2-5S&K@"OUJ]0/#BWW5!6+U ME4\NRR3F].N"R59W737=Y6@+/O9$:P=-T-K($[&'G4+S46);OXWF*N8H,)<3I_GLOL;BN*X=)$#?$3.Z*XCGA+,(^Q=<'1>"BLT`+`VB+]E435K@JC" M6=(CW0<89&A4_2%3%EF(,;S<]W**%D3?2HI") M2KHK,T3N1.KW%Y>%:=36>,W+T/3&K%0\])ATX56ZRIF1@'TB!(JOKA3%GZI( M$5="!?E%'[,9?(U`TO,MO!P&^^`!*(:+PK+,'@Y+$I,[O/\!MN`&^83$PF&(/].(@"_XYBVKGQ MVP&V^,7*^DYF.HW)4=#-2624Z[R_'DY`@I0N$(Q-BI@?R]=0XP/](&:$M0OX M,=1H)PCR[;`V,ICBI2CO8NLH'3B5;K(%`C6)&//1"HXQ:3)C+VJ8W\3GYZ5= M\D;&(\7U=`7W`Y7<-25PS.0H%_WRAHHFDV5XUY]7IMQ='Q3=ZYBJ`_/&AGJ: MP-"ZVGX+2]\,`(7C?K(.U/*[+BHC@UJ#Y5ZH#IM@L'R5(UFX`<:[B*,0?A[) M?1X8\?@V0\$]L%>;H4H#H8=2)WQ2":^EM_W17\3=K"H`1##I@48YU%> M+UX[-_3V"[_6N\2K?/775^XTN\!&LV].)'4W]ZON`?4^#?&\\XM:CQ[D+J^' MN)5,[8LE"J6*!L%9_5ZLMBGC^ MJM/M=KT7J!"\`RJ$>(F^E#,T?RRE[6K':C!0KWAQ&/4-Z\A/++$WJS1,L$;O M[1OK%;FG99CM9JIVP2Z:XN\%Z2IV67O&W`/]5V3?3=@/'YZ0#8O]9^::""?F MDT8I(!A^>-X?=/IGISK]?JW+4!][Y^7_[$0"#$7FXR^Q:/4`&^GX/NDU[ZJ. MKE'V8=77B_*3)`;[IXB1EUKL[24^-A+%?&N#(8)K*IF3-,`DD2,L`NB`7Q4> MT#U4."QN".QA+YS&Z18Z0OO8FR[_YTM@\;K^D7W3-*V1MX\ZJQ'W(=[9R,M+ M@/PK'B2`I:Z]DZ/.J\%QR>2C$+AP\QAE=0*B<)R%.-AF8<83V?XX`H)J:D$N M\R3BT'Z6XNV_?_BH[\81&(V9J22)8II8(`V<0Q'(.D$EUI13.E&"LJHYK'0^;X1I53M-(&Y&68"/SL77_)* M5'7R_%6WRYZ?DT9E=N=EW7PJ9[P^4L9JV;1X9,F0ITQ$F'C%3B4]"'YCLV$"-=OM[*C@;*CD?S^V$9T M^;];0D;Z'@1[A1P:%>`O5<-(^5UXF)?GZT1"2X-BN MQ%C-9,LE0)Y5VB`_5$XM74ZC./T&A_9.#M-[9I'6VDCK'NUSQNCX03)&V[W< M`'^XL([&9F+E#_1*OI)70ERZFV32NHSQ-.ITOK#HOY3SM!RX6W6W.WA^^KKX M@])U\8NR`UNRG\M>J)C$4MJ+HKC",4RG$;SY>?0.#4:_8"R;7Q8*#]'M_3V( MAM+[(.*9&"TTJ,Y[X`F[K]!-&>>Q^AL6(]\6X!KC9!E](SU([(ZM>WO>.SWK MG)WTGVHQERE=71D@&%+SK@T1B-0[_H7J1O$BJ%G'7->E(P7VPJ=!C^FMU,94 M=SUDWKVDA][$5E9@^-SSD9!,F6$6ZND-RHX3]L99$+@#WL`,BB?2LQ=VB-!= M$@MNJ$AE)GQ9NEQWC>*26EU>UOCXQ_L6CC16LSZ*4GW54*7Z":GS0D_'/O`* M-1@[TI0_C?SZ$GJ?Z8:^?KV+Q45H`N0\!V?*.HH4EQ.C-57SA51/+KZ^%QPP M.PL5E^JX,[NPAGK]1-#RX&I)\BR1*15GP[D;DCM?T?YJA=%#"J.3A@JCMUSB M3KTF^U#TU99![GV6X$4C*KM`4YQG$UC-ZY_4J`HV/O'"!P;&L5MYFA3 M<8?3`2,R<&5BZN\W[3]CVR!"G2X40#\Y1KU#N@=TS3'_2/\T+30A%6#83A^G M*8@6P)(*>+-7?M$D]F3HD\6+9O)8!7KZ`!>$\]0!L^U3;8[_U+S*NDODQ#:H.R5N;C,^^`C/^\>]KKD)KMM8Y0KG,38=PZRAD>(4Q$! MK_<3,V>;7-LB2S4B,U]@J=Y).=1CPXA&5PEXX'7/T].?-27L;&3HQI M71>N[/NA_:Y2ZLHZ#WVL/8#-R!#[GEH'\"$=P-,&.X":@,B2+)#0$W$(MV!$ M?N3LRV>Q:"N/]K#RZ$DD=S0-_CL+:HF0O46*6N)5G2,^5,K3%9!OARI]_GSQ MU?ND#^G%9SCR*1TY_OVS)H2++,8)V8GW54[TE5+)R_S."[R,$*^?0$((\%(F MNN/=:$X2.OD4P@H9D)-K_PXG7M@/`/]!#N,,2>D5&1O'),&N9>&&!P:!=+R^ M;\F^I2,#^C6A4N[J\*989S04QB4ODN9FQ%5ST!6R.9[?/+%<=3Y!1PO"J=!! M&$7S/DRYTY$'UE4ZA7?ES5Q1'9B.;IAD8P?/"Z>W%$NM,8"C9J[\\6IE#R>& M:^1/+MEM_1G.K(^RF$'2TU.*Z0>:_XZ_0&EEK4\KQB@]'4LL`B?AF!>"$QC/ MCTBJ"_T!;NY7B1W7;+*83U2ZU=`,SC*XYLPN?)$+`W$^I\8@'#[_@..0\FF? M^=@FNAR.>S/A+(J'Q4>XY,A,VJAT9-=3A=<8IYY`8<(*UUYN0-)V-:EQMCP7 M3R":F,!H^6!A*8;E(EXJP_%#V,#S?N>XVR7%&4N^OL";P#("E'L^YZ&\/[JN MP2""9X,C'@LUAZYIP7-;]5INH,3<^Y!D(V0QO+8.#)AHB#8-E1BLU/:?02SC M;6MTIP(O[M/=A6-F`1[O5V0V.\L"YTQ8ZP)/*M%SI>:!U%:,+90LLV2(MT,E M9@(&K%I"F>+;@G!GQI[!J^>D'CI(DL6GC\(F;T_H;>:ME7T]'HKX3=P\YH"* M+4^9SIV+)6[&DP@<[=P[/6NH=UJY4^UQG=$'&2>(>NWYX/2DTSWIH<#"`7K5 M"U%%'"N>P$W!,Q!,T7B,%\REXH;X0\_<`RFL[X+C.QFX1YG,*:F-\)%I0,-G M0;2``=;O#KKEJW'R6_1`'(82:^SXJK0DG_^FZR&<88#D;"Q,7.[[I3>6.$@[ M<)>+M:P?'/UBU!ENFJ:U:IO=O<)OS19EM"E!">+4(G:M\5-FV%#B[JY"3Y7! M9KM(,]F/6#'GW4/.#;&W.S[`4CDQ3^1KS_STQC-"IMO]Y8VW&?06E*42C^7C M7=9%W5:4)1O+B)UD_^JDW%Y!5D(>'#300_B/9X.-E5Z+R(8ATBBVEB_W$++M MD5/1TAA1^-ANH3:VQ,^L?]S&OD6/_>;^V+E;.]Y`SSZNL?B]?=TIVAE-@_GY M,K>J9:N6K?9CIQBN:!K,:[)5J[/W&++FF8`M(A_-EL:4X(0RF.AG1_%K+YX, M7_2[1YW^X+33/SY^N1W>-;&W5QOXZ]7PX1M/APUTMN;,D7GSS57G=A6;3#?3 M:6XL*+71P`U,&HW3TXU#(`_+-Z6X\+T(X.$ED@&[?V>XMU4PV3\Y[9R>'&\& M]B-C>[,:SY:2GP8E#XX[9V?=GX>0MZ%V_SM5J7Q8.WF5?C4YPMY\KY7N92K2 M+-UXF`=F9W850*C%X2-**YU%,<#\%F`1&(#D)5&@_&:)L-WL94MB;5`31*O; M1"V+/>8I_+)=WZQE@)8!?B(&V%^?>G.&K"KP-K*S#;MI?]&YFVL='@38_49L M2ZQJH!YC*_^0(B[\7NW(R6^FS_]+G[*AS MVCO]621/2Z,_(XWV^N"3G/PL-/HSN&J-#\G^1P29P'KTS=2G"(+H&J^&:>.R M;5AJN^FF313QWL6FULR@MES0+"QKK%+=AV=:8;\-=+9WN+SI; M.FT=SZ8XGMQ8OYG72?W3<72E$G186\^SM;EW(.B.>^ZV-MS@WIGBNY/>+9>T M7/*TN*1L-Y0FNY2&9ZPS@8]TZ::F0P'66V=XK`;C3LJ_;%;@#;?W/P,SA28! M"-48K#`]QB4*:4IC-/9\?6.!.[E%)(G4@V,#)88X.53)^N$L]!!=;XICT?'V M@@BCV,GK999$,_%XZ[T"#T6G]]I$F;1OW48[J^8Q?>S]A:QY;:$M(A_-SV_Y MLH'DU`[5V-L!%>VLFI:M6K9J9]6LSU:MSMYCR)IG`K:(?#1;NIU5\VBS:HK# MFLNCFC>U;]IQ'P\@GO9FW$=OT.N\ZC9K;LT=D=U2]).@Z,&KSLGIFJ64C<)U M8RLI&U^\TG9-K">ZVJS\@]6+;Z*V]R[_WK9-M&RPG5EU&^CZ9G'!_CK@FW-E MVT'15J8W!MC]1FQ+IRV=MI[GT_$\-XX%+RV:;'W0UOAN*\,?3W:W7-)RR=/B MDMI+ MWH\_]+KWN!?Z#A#7KK@=--\?&3E1;V;B,0NL@<>[WDZ]$=EO\W[VVUI9?O9K MV0<53MV2%A*;7?7R.)>P?PF]=W+$35S]F@NV"6]4U4CN31IY`D_GAZ32%S&) MI9S!G['NQ1,^'4F"?TED?*5&>(WWM\)MW0F_0W>9JR3)I-?K''>[G6ZWZR53 M$4OJ0L,KRZ,0-@3:QEP6CD"!XDFR(,6V-5@).]=DF`A,$C(`7J)N#N#-=`H' M&L_XXSF0,['PAI+^I$*AKRZ7"E:.P52,TP7VM.%W9.@C&`@RK48P^%EL;CC' M%?"!U%W^<.LR8:,;ZU7H2SQX['!K!463!,6P:8*B]VI-2:'YM2@JKH'A\K\A M+U]/41B@2!A*"J`(SU>Q'*7`TYK+]$=N%2<$Q6J!XMTJ3,IR`]^6(4@S+YO# M*OBR#^*C(@$ZV/Y*$*"%K,(,WX`?`KT%^SV`"DX'((MYQ5F69B(HX\C9-\%L MQ):79*-IH^1.472TTN(^C#AJB+3XMP@S$2^\,Y(5QU59@:WB*DV\821B4K>& MYX&ILW0:Q>IO8&SAA?"=42`28F2PW17H:14F:9S-J&N=J>NTW^N](0@`M'/O M(C8QV4OD^0[PS/`O6!T9*5^=>57,50K65&`:>% M-PCEUGR=&)!CQ,%8!$&_'"Z.EH($4NV*Q-90R9"GFNZLNY^_;_?VE M/GS9V?]-)"KY,CX?C2*46.'D(@K4:,'__\EX_LO]^4'W*7L)1!U(ST"["=`1 M:%03PF((UYP'`,)&AC$40+/#O(ZPFZLGA$VPT# MVT3XK5#!T"Z$KZ@@H!X'N'MJBPB^^7YRP2_P-@11GP9L?[+5:I2J;PZ2";#55Q-6_92O![ M^/++CC<&453V515W;HL1F-&)HL#9<%'8GQR/P4Q6H"/^G872ZVM7_]`[#P)T MZVFDC_9)8P$.\PA7X>E00Q$(/)H@?0B8^&0%.NV-KE8/]Y%G7"G!D_'$4 MSS!(0(:L-CV]&",'*"7A*V+"4;8T@G_]`!/4B@TR2L$#G\U9JJ53D7J"1"+G M(4!2`AQ1C`)-S*R&6#8B#_[MVTP[!R+)Z)04=%PV5J\<8+1[Y>%]^7[QW64@ MQ1(\_DP#@5>QA0G\PTEB\$MDX0.R([\86XWE)`,K'-2;O*).+'C9XLG&;UQ< MQ3(@.:_#J_K"-][8`B$*(BSW`]7BNWM7X16L2_OI,,*65=-Y5Z8E+._R2@X) M%A?RH<"-HHY>?JZHBS+X"&:N0(/!EZ#L$.B.QA#&@^FP MKJ=J-,4<%FOL(?G;F-("^L03^BOS)_K(AU'&%((MYPO\(\6FZSP=:8UD#O$SP"9)/#- MPIRXHX]Q`'\HTVNT2^BM`GFDE8V`"96A9>4>E&[[1QJZ5F`1P7&S>)#^[?9, MT4:I^)@BF9Z'/O[/>Y!5<*IXX*VSN6O#QF^"88-4061*/SCTL:<63O=QC08W MSX!.AP(QG*#6`#D_F8*`"12@T"_D$72T'W@3="1KK'0:2\DE`)2L`U_?*FC@ M8E+0&+"GN!D+_Q&>C\S/A_439P:6C\OM:-EU+4GVUJQRJZ^TCO0HBYQWH+F" M:([[OTS!*GJ/_MT\5HG\G2-]>9G@'[P MG4>,9^V<^TKSO2=E.W':0'H?Q]#:E&`M"W`<A4J9&,TD12S M\LYZQP>][D&_2[!H7^O#^>5O7IX=P.,)?1'["7S+IYGI[("$Y&QI5PH9$'\- MMF/N[B7&YT378S5XL=3>)?D42;US2[I!(9H!#%XTG48<\%BQ>D=;MUIM%1-# MN3G;T;XE"/AI%*"Z=&QNPMX(O!UZF\TB,!@S1*V9*-*%C@>K.+(J MR?7R7GP6,;@Z6!``NJ+[LH(;X^/F.Z@6_7`>"IU-T)7:T=5?7O4E3A4!/8(= M`%^,Z(`Q;HM%.=H-"0+C2)$'.08G+"5_$;P%X#>53(W_/,S@BV`0%"H`X'6< M!X8^Q0C\O8Q=8@;MXW+0\H"IL5;H@#GP(>*T%(4NN$/5D]>'H60!MO?%R&[/ MV"!$\:.I"">20]OL^ALG!XPBH.6YC8!$7E5Z@=U0\#*3I2S!OB6%`L`.L@Q" MU9MAR,Y7,2R!/AN(G)"*R,:IGCV:UZ(=ZVW8DJEH;@M"I8$+H)84S!`^_%F# MB(4E]JJCFDI5&>CKZVM>UB$I\S(S!OS`Q1;!8ATLI";A8+*HB:SE_-N-OSO9 M<65C\(-0,0[=`1_U@X'B8VX?LRGY(/[G.;KN'>]?,KB2:&R`U!=AOSR[?>:5]/5E9T2,#`'G&P M]UD*9/8\2NP(`(*/7D#3P)3M4E6=8[)0;/Q&S=3?K,TS-C2B(5;V$U^K<)[I MU6@X68$&XKS,0),T4OM)?.6,2@H83`+Y02+"MD\1&6D*V-JP0=,\PYL03'84[!MWHJQ1PD\'6D&N\6Y MM$?'V)VU9_F)'QK:P-*=")/(?U-HU^Z7JK,YMD'?TW%?W1Z!V#"JOHJ-#6_R MV:7[W$_$[[!_@UF8VG67F4)/!_?]%@-WHSXM^SA]!?(N+-&C37TY:@O7(?^> MTH_.1SBRS'T826DA?"D!=1B(>`EX%=)_4[/$+9P`B["^TLQ#[@\HIVR,GCJZ M9E=8-B3Q-16.8W9,BC4[+SB>70#EY1M\8Q;Y,C@`-Y2RM3;O2J`S8AUMQ-ZR MM@:*"(2EX`G4*F8M74U*SC9F^3KT3`1Z>:@+FX:+CKL$PX71!-%R_[(K*9X0 M!N[&_776J#:B\JJ"F4RGD1\%T621BX.BV66K0!Q[RY9IY-:8Z0S;K6]5/5:*?BJ,NG$_'@HLXXLX%>]$L%[/J7C75-?1I*GW9DS]N]A& M'+'".IO8UU*::Y$IB,G5*K5X!0Z*HQNJ0G"*0O."&+-?#+V-A/;GZ$$O%%01 M@2C544&&4N=,?2JG`%C]3,>5;P]>K15W*@>K+F(,7:>+BP".[#ST,>=)\:^V M7F+7`:M)$P)6G[#6[!-9'.?$+'L:K+J_3/YX+SR%NAZ\V/V#\F_PJFLC2QU7 MM.7Q(\.$'G$A"07+AX[D*[1^PCZPZJQ:"QAI:]G#$89S3GV@U"O5$5((25YQ M`BO6>0NN_'0K[#`4A+DZ:3-?*LXKYE@;4,`#P_!#IUHQD(?>6W",P\*<"MCN)WO&&6%\]AW3LG#UX73`A?CK`^D$$F0X+M6Y+\!;OA M3<7&UO5Q[J;=1)0W"EBF4Z7*!(2^+E9\DR>C=/4LE_XYZP?84^O)FY%,;,N# MQE($^P6Y#,K75O916L0Z1TXS`=GR)+M'YE/.?HR&X<1.GDC$UXKWZ5`%_VQ( MZE77Y7"!YL(H3/T43?T`2$!/)6E>8)LY"\''(]`IJ5G*B5$ZL%$"1\/'6V1D MV<0I$R<6_;'?!=^$0_XA*=<#/HXFI"0"$D$%J)(Y94:+2!Y*!-8=,N(6JOH( MV#@+8.$QT.'7(NDKV@OURG&_L!L#+=.VNSO;M.*8,DS1RNWIJS-I*&6QHGX-D66Q+P99\0`15R+:F'MH$-]#2H7_Q<- M#,0=62Q")63'@$*.4P'_BR:-4P-\#K\!$:-BLLGI5B8*:(\B.`!L)2?148(SK7:T,T%6Q(RG]I!"FOLV86=L8FE M8(0H^EU]T&*`E;D1HZEW37LV(\KMH-YG_43;%"E+/'UW7S@-[]; M<^LZR.,[IZEM!.R+"06K.U@CMFT$@;C6^+6FPE"2;47E-[D28]69K*+N7_&]6H/&-K0$>/ZWJ[]E:JRL M[KYRS=97)JVVJ?XA])YJ@M[3A.$YE-&JO[U1?_ITV"76[4^.>HC"8)$+./9H ML8]-W:";3ZU]>H@9'%('W<`D$TFA0H.F+H(\C-'#G;$S!HZ?[IC34R6Q.B^? MF*2UFM_117@!ENT5?2:4X6XI9*ET&"4=B-^(RT!H[*/6&[%*?B14HJKCQRBI MJ1-5^5Q=840K;`;;]X3>A)U_>:O(O%44EF7G>3YF\RVZ\:WDW+7D_*L)DM,A M"X_HHI6;>R,W5Z6^YEQ7&\L)V*9D_CH'R5,Q=7MNX2\D9L'C0'.TU+IM?EMX M7J]A+//GH0K<9G"6]ZF=KLTNT4X56;,XPB]WS#8]-:9O_F%*KC/ M0Q\KYD/,,&$XY2$KD)^6?/O1!/E&PQ(/.##I$DLKYO95S%F/-7&.KC"T>UG\ MHW?JQ#_)Y1H1K*EC9-(NPZP2HN;<21 MU6=&!F-S#L,"VY.4P3)A$=L*7#NHE%,XL1TMI5\LA-JK)21+/JF_6'V^\ET] M4537'6!@@>NU$O;X8XE!CV"A8QV<`'M?G;+*JY`VFLV#:"&=L0F833+?MSBS MH(JDM`G3[F:C*UQ-8-V(6S!2,P*V.C3UG/JT;VFX+A"KKWQR!"8QYS(73+:Z MG6@-0_X.NJPZ9G`&S@5H=G2*.);2SF%]&!T8-$$'%NC#^Q0EK9&_/]H/-!?7 M)Q>:6F"PT1881?$3.4+[/>1@P0E<$1R="L`P!`%MGSM]Z8J\L+M^+&-M" MDPL9D_!MI>2NI>2L"5(21_R.=-=;D*&=]8=,65I2URX0.I%+*SOW1G:6/0>4 M)QFFU$*9&G'R`H7)RWSR_C+OH?_*E;]&1GC%8^>DJ7D^GPXX=P>F!7(AQZ3+KR*D1^-!.R(T'/, MKA1%B*I($5="!23!P$`WEYT@2'J6@_ZXM3LI14$G[S!9!`1*-<80D&)X\>F0&"AM]P`Q.0Y8G)>F)4'8]>>5*>S6 M!X7Y$GC@P+RQH8E`8&@SP7X+2\L,`(7COMTRN$7#EPT"$#'.8/$+]0A(&5PGDKAW@@7 MI;:ARC@E6N#8X418C(WUFZ,5(Y!(_48RT<6V5+EB*W1UIQ="Q\TO*^')!R[E MLW=,C(O`07;@OPD[3M0`B*'+`HSS*"^`KIT6>KNHVU1V55(IHZGTLT!^&;^U M#N"7L2W(><_YG]]D*,:X"O.1 M$);*J([\R.J?LP?I%;E_(V6A+]/&T@4Q3^1KS_STQC/7"7>[OVQZ7ZX%9:G: M8+EREW6KEYMOML9]CGU7U\4_"&0EY,%!`SV$_W@VV-AR:!'9,$0:FZ'ERSV$ M;'OD5%1V:&?*V&YA7F?6\C/K'[>Q`='6N[D_=NS5608':_TWT$&6&IO&V]>= MHG70-)B?+P&X9:N6K?9DI^@M-`WF-=FJU=E[#%GS3,`6D8]F2P_%Z,>$AC^B MGQW%K[UX,GS1[QYU^H/33O_X^.5V>-?$-5]MX*\7=1M&]MYX.FR@XWQGCLR; M;ZXZMZO89+J93J/J!-/X7M_0NMJDT3@]W3@$\K!\4X2V=R\">'B)9,#NWQGN M+6407O1/3CNG)\>;@?W(V-XLZ]%2\M.@Y,%QY^RL^_,0\C;4[G^G*I4/:R>O MTJ]V:OA\KY4N7JJ>V?DW:ZM>[$O?50"A%H>/**UT%L4`\UL`I(<@>72'<+-$ MV&[VLB6Q-J@)HM5MHI;%'O,4?MFN;]8R0,L`/Q$#[*]/O3E#5A5X&]G9AMVT MO^C<":,_#+#[C=B63ELZ?7C$_H2>YOXYE6]U@\%F/F4^J`P'G_',S)J+2YN; MI6X,D^R)]#D[ZISV3G\6R=/2Z,](H[T^^"0G/PN-_@RN6N-#LO\Q4S@W4Y_" MC.QLX[)M6&J[Z:9-%/'>Q:;6S*"V7-!RP6HNV$35-XL+&NL4MV'9UIAOPUTM MG>XO.ELZ;1W/ICB>>HC81EXG=3WCH/2D=F1JZWGN)[\UQ.;6FSGNN=O:<(-[ M9XKO3GJW7-)RR=/BDK+=4!J:4QJ>4=LPJ,>&%'3IIJ9#$=;R_-Z[#U!9/HO% MW#0%"YS354SGH?\IOV5J&W-8MHTDBYJ-3N5.ME#9RNH?;<,^,L,$W6M7\Z&H M.)?'7I&57]FV]!JP5;//>.`0CFO%H'[R>IEAU4P\KF+MS0GD?A1Y]TT$I6D] MMVZC'=WSF"&'_86L>5VR+2(?+>S1\F4#R:F=,;*W\SK:T3TM6[5LU8[N69^M M6IV]QY`USP1L$?EHMG0[NN?11O?H`=;AA(?XC$0<*[ZW[EK$_J;V33O]Y`'$ MT]Y,/^D->IU7W6:-\;DCLEN*?A(4/7C5.3E=L[*T4;AN;&%IXVMYVB:2]417 M6Z3P8.7SFZCMO2M':+M(6C;8SNB^#71]L[A@?QWPS;FR;2AI"_4;`^Q^([:E MTY9.6\_SZ7B>&\>"EQ9-MCYH:WRWA?*/)[M;+FFYY&EQ2>WURW6='!NU7Y2[ M.-[3#<7J2MH>D*\BE5_E*`I'L`"%;<_3#Q)(1`1V0'OAX;J.CK[3T3'0'1U> M%BI^Z$+&6%\C)O(9:-R1FHD@^<>SCW]\>/;/[N'@R+D:_?[0/="&ZUI8]F/# M%?+X8O+=GZ(D>2OB>*%3W4EA8^?)EW'MZ7V_?.?NHOOLGX-7)Z)>AVJX!_/ MTC@#GOKUKLLOV>UMR[_-8/'0\&&E<6YSB5B#XWY_X!#`+5_<`H"K)5@5P+.C MT][IG0',159!MKV=BG`"PF]3XKTCD@]*6+X_5`^SSTW/ZJ!T6-O?YZ=(A,F% M6*"QH4EAB^R\YNIKR:XN_)=CHF;E.W^\.SCH=__4K_WY1Y1*\]J7="IC_7/R MF>JN_QQE"9BC?UY.12RG40!LPW_8$O2^5*_?AZE*%Q?9,%"C#T$D[HRTX_[9 M61\_7+MJQ<3Z7P8/?$R2#"D%;!_:X_DLRL):R0.8.\NI&7_N6RR^C6:S*+Q, MP72M0\\%+9W46%4]!TVK`*JT->.G^#P2?@\/DCDC^1B^%7.5HND59Z,TB^5E M-DSD_S)`O'[D6_1'AG!2AS6"3@`NW7;O5;[MWHG=-BZK?"5B9>EE'8PLP4:O M=]H[*E+.;K991N;VK;?!Z4GWI)?O8WUC;?F3G]0,-HOB+?D2?D_6EKC_!!6G M8GQ\-I,A=LU2N$"%WE@E(Q%X_>Z@NPZH90#N29-?91I'@MV(V1Q^6$)]IP=] M2WWP\\D*$J-N_(V:AC>-^!ZDT?RUU[7_--[Z*R?0LSQP#B\7/77=DOVL&@[0 M16N#8PP#[")DL590PM1A.[NK?6[5GNX,XI?0.\\FL)K7/^%N_XX'&LK#F1`B MY.O7Q!Q'*4G?$R$&PV,I@#&`M/&Y-`)R\T(2`#AJ0&3I-(K5W_!TPN(.?CDB M(@+X<.C#&(C..SGN@`S"_X,5O&/^D?ZIW\*1`_")>:SM#YYPD"\`)@*^V2N_ M>.A]`Z@$,*$_0^U\C>,*5$#`^YXDGQK^$>7;/N5M']XG`'-/IBPS^0<5"A(B M8)-)=46F`CZIT!"+(U"WTG\GA\#$B5X3GOUOK%+Y+KH.[V@-WV9X;1^H34W7 MWNG9V4D_1_O](-K]_BK&S*"[CE:_Q5I\1!1]%J&8R!GY=E([=3NBMG4_M2D- MO2J8/G5?V2(D]D@O0#(I'Y98XPAW!V'-L:P+X6W'=1%'(RG]!+_T5<[%8L;C MA+[*0("\O1!QND`ZVQ&UW.?S&TNAHO6\[J<-R+]_.O_]]7^C^`&\EMT/@)U%4L2.;F(V-4IW>&S]]41MWUS&S#N M@9Q?=YM$(R:V\^4Z!(-EJN9+-G5\T#LUFX*?S^[C=PZ.CTZ(;^HA*,"7ITB^ MC'FY;[$($S`$I;]-4%>F8D`,'VEH5\%3C38/TX\A*E,\CX_8.0ZJ%9,Q[TBW MPEHJ6K:+W5+1RNT68_CK[*'B5./'$=TJG2V/BQT?#'HVWN7LZDLHB\$PD*O@ M)*<+HN=$44P25HS!7%Y3B;I2N@1<@=P^P[+38)&SD/DT46?=41T?=*U0HI_[ MIZOWY)XCQT[>7UE=N_:.[3*_RQ`CZ^>A?^[/5*C@J`1Z$UKWKX&?_K'EQ=7; MOR>FZ,1SHM[>Z6\1%T?=#7%1^ M&^ZLIY6ET(*[WC'"N]5]O#BB6UVQ&S M';RPPM/$2V'"Q;LEE0,[XY;2"$V,"(/^Q-A0X8`3PB\$")S#`6=.3-D,F2#D5T).(#^^UU M-&;0LT&HR)L`&[O!*`XX*:S%C#S!=@[]+@0[)TE$O/`"P#QZ/Q0C^I<403KU MWH)[Y(O#O%+3&"&5,S%'%JCPQ^MQ%*4A*-=/\`_OAGZ5+N:``C@T&?K2?Z9_ M&T>(TVF:SE__^NOU]?7AS3`.#J-X\FN_VQW\BG_^%1]\IIL8B.;`K&A>1XHK`:$_%/&O\6&0[\\\*K+[Q[/> M_1#06T(1O?OCMK>$(I8L_;"X[2W';6\5;LV:!1!!;D<96,6;L'(9.`=%%HR; M60"_QRR(#`^^7S[[YSN)?TL\P8-%0`Z"A9Z`\`()^?P%F-^]EQZ(<`YB'_[? MKP60'VTG_9J=?'/D,4X9#B3&TX69D>(E\T"EN$$.UO>[KWL8;;^4\Y2G"O=T MG@$WCUHB\892AEZ_ M_-^OB`/U&O\__//_`U!+`P04````"`!UBVU&`;'#@7,*``!X=0``%0`<`&=L M86`L``00E#@``!#D! M``#M76U3XS@2_GY5]Q]TF;HMYD-(0IC=A1ENBR&PE2H6*&#V[MN4L)7@&L?* M2C:!^_77\DMB^55*[,A4W7R`X*C;3^MIM5IM6?/EM]>%BUX(XP[USGJCPV$/ M$<^BMN/-SWK?'OKG#Q?3:0]Q'WLV=JE'SGH>[?WVK[__#<&_+__H]]&50US[ M%$VHU9]Z,_H9W>`%.46_$X\P[%/V&?V)W4!
.2QBZH(NE2WP"7T0W/D7' MAV,+]?L*:O\DGDW9M_OI6NVS[R]/!X/5:G7HT1>\HNP'/[2HFKH'&C"+K'7- M73S_?C0<'8]&X^'AZPS`3[`/7\"U3_\\F@S'\&,T?AR-3TCU/QXPES@H`1CY^^LES)M-3ZD;#XX&@Y'@__\8,8BO41*:"F2&YV)'#6FN%;IZ)]"@EW M3GD([YI:V`\=J_8VJ+2%^*N?-.N+2_W147\\.GSE=B_I_+`'&77)/9DA\1L< M9'W7.0967?J$H94%GK$8B!8#8"E8$,\_]^Q+SW?\-T$96X2(P8I0Y3,CL[.> M\(K^QBNX_4%%UG];PFCACG#V'AKL`O4K7(:^?7@FQ.=UV`H;MP7F#C/HAF?B M.Q9VM9`52C8(4PPZ(CCBM[/;I0A%P$UMYU5+M03OXAE[<\*GWH-/K1_/U+4A M+D[(S+$<7P>PBIZV3,#\^6$NMU<@U"O&-TX7!.V=L-]4'0(LX+?A)J MJR'6R34(\9IB[PZ_">W]=,_40:R3:Q`B)),+&@6\.E0%31L&XOAA9(-P`0-3 M>#CDT@JC1$&T0:!3R.\7Y!&_U@,K:-IHB'GBY*\`S+Y\$;;7!Y/B]GN/>LU& MOQ:C8(J_1S$8=0B7!=H!)58Q=N#"M+J^"-'MQ1&+P@GQL>/J(-;0UK8YD'01 MQHB]_O*<<\AY=[%)367C&10O3X!N,!.?7HBB65LK;"G#TL6O(KOW6+2Y?>#:Q$ST"=!/U0+@L%,7EVQ'J MHT0J_1%[-HI4($E'N_B+ZWX2X"-`N2[`P&=P&PXAWA9Q!<7R*%808TW0NM22 M$+JBMDN93'0,,"S@SC!_"JNX`>_/,5X.A`,,B.OSY$KH$OWA*"[F?H@O?X\2 MFXN`B0)A<@,7/Q$WO.WWN%VFV<`<8%''$H,0?EW^%-3#E/^?,0I39A)WU1LE],+,DK\E7UN,6`RYR`*&F[X!G)/(S1A=5 M_1WW+=W&E#0O@**'5L29/_LA>H,\1A;6>5Q7F"BAH)BFKG7UM8.?'-?Q8;JJ M'>A%;4UZ290,\S@O`W>'*RP@MHY-6DI,^UNY85G?T^^:SGGF)""/-)5KJ[!9 M):-&WI%Y\NH-[QQ78GF4.%M]&"EJK,;.V#P[%:9VCY:-44I1O5,1KJS_WT\$ M2S_]%5G8YKE+GH6BM@:AW[&XRAGBJLF;"QN;]J3RSL\X5(6IG?.HU).SNK5, MKJ7I^4^9D#(C.\?&N6T[PF[LWF''GGH7>.GXFSTT!<2^Q,R#9:\HH`>+($RM,OMQ\FRIR*H1=VR>./6.Z!R'J1D?%C(ZDVJ] MI.E92M6V\B2HL[0I;*8HGK9*A4S/8%N2I;RKI(X\@VLB'7LK&E::^660M?(: M_MY?J;YX(ZQ4MQ^KU^W1@:3O8]M/'6HVS$IF'%>9L5&$;F//+ MUR7Q>%4`*6AJLH9%EHQ8CO3HJJ!J);4R/265=G:V3%5@6^CE%U<40.V% MXSG$'5 M;+YIT9E9,=_1N96V;-4NN?T>IH]:>\K'3-ZPOMG1L+'E"NR-5EH!(-\DL5_) MC#*2VFPV@0\<,O1R']Q)J6FW;:!'RMRAP'&Z%AVO'`]69(!U\W(.GRZ6V&'$ M?F0T@+_M"7GR[\%@%EA^P*#MOQGTZ(2N*A+V7?6:'OS->T4S/=V]B')#?)69 M-=/,]*@O1)UAK`D?Z-IX7V.-IZJOL/:9597X2P5,CU!U!DNMK1E,!JIMVJ]( M2T6K3YFBE5RGBO6AJ8?2&G_Z\.O1Z)?/*/?`9@\6YEZJELSY6;T&)S2A2)71 M2"APA"]R0:]\??O&Q3M0ZW3@W/*=EYJM)CHZ_A_T]4.&)D&9>%(<<[H6X]LK MJ;8:S7>CYEW46M]WMMU>%7!G]EM+KHUG:XQ@3B8D^CWU5+8M5R9S6^DS793< MV3]VZ\AWX!?;;`77TZ+F`Y_>DP^\PVWD);TP]5[$NG.G'+-0A\D-MO@MS.\? M:?BL@1%QA@S/'R)3L-NV5K*CF6@%C=DMN8J=T\EZ49'IZQE\!P\NU&%TBSBU M"+'#\E'ZE7B1B51X;Z541SVW@K[<9O+Z3NE+7J$5LBVM%UT79# MM;)[.KV9@2\I,L\EB9Z.&4.K31AS8*VS6K]@3-M"&C8=:06!R%\DA6 MT"[PVG,U)>"C+/"-.!+RJ&AEU`[PVM,V)>!'6>!"',7R60+:AEX4%"6TXRS: M2`)EYHKVT-6]02&A/2Y"&VL(XV#)FR7MP"\ZO5."^RD+-Y)`L4C;X:_D-$\) MXL_Y0)>(H42N"V&Z,ER/KA&!\FGUE_E*#_\4S(F-VNFO08=1*+[!*MS M[J=D26X6E2U)]"(Z2WV#UKH_HH-8_4>##\C;VWRRSY?VH@KQ%;'%2P,:QM0* MFB[MU.V6H7KF='1QO[82LA[(GATW>F8<[8Z9>LG9M>M3:\4+]A$'KDM7\?\; M4N>O.^@V7?[1\X+F>K-S*\Q=CC9.Q^ZCW,*A/'8GZM-!/+I#-R)XCL\;4G76 M5&%KHSMC,H#63P_%AI[PY+\992O,[(J'#UI*3,?T*L)R.VBT.Z=SP7VGZ/TN MPO,NA&H%7\,[8;<_@5V*O;G:1UIO:;T/':RUI^/N'JN`:M;E"B125=",% MTRZ9FZNPZ*Q-4Q?#6WXTTSV:Y[Q+]N=J-D45R-"QC9BF?0*\9%RNPE-5[#-C MH-)9\9)1N9I04A,,=9BQ0N4<> MERPK>-Z2*4-661//].*'^$\LX`L` M`00E#@``!#D!``#M75ESXS82?M^J_0]9`E^9C,./&F/#ZF5.6Q7+:3 MW3<53$(2=RA"`2@?^?4+\)!XX:!$"I"7>9C($KKY-3Z@`30:X*^_O?WA^[YP\5PV+%(`'P'>,B'9QT?=7[[U]__9M'_ M?OU'MVM=N]!S3JU+9'>'_@3]8MV".3RUOD(?8A`@_(OU!_"6[!MT[7H06Q=H MOO!@`.D/T8-/K>.#(]OJ=A74_@%]!^'?[XB\O+P<^>@8O"'\G M!S924_>`EMB&*UU3#TS'A_W!\6!PU#]XG5#PER"@/]#O3OYY>-D_HO\,CAX' M1Z>#SZ?'?<6'!"!8DM5#^J_]^+](_%?/];^?LG^>`($69<0GIZ_$/>ND3'LY M.D!XVCOL]P>]_WR[>;!G<`ZZKL^8L6$GD6):RN0&GS]_[H6_)D4+)5^?L)<\ MXZB7P%EIIK\ZP4H@7?BD%_V8+NH*5*=`$_>4A);<(!L$81N4(K*X)=A?W:18 MEWW5'1QVCP8'K\3I)#R%E8V1!^_AQ&+_IVUI]=0IH`W`0T^`EK)I(YKW6(D> M)70YAWYP[CM7?N`&;XQ=/`\14RM"E3,,)V<=UH"ZZP9$G!]49(.W!>U8Q&7] MHF/UMH'ZA7Y-Z_9A!F%`9-A*"S<%Y@Y@6@TS&+@V\"HA*Y6L$2;KGY!Q1$:3 MT8)Y+^C1=N90)Q.\ M/6+@$V`KL2Z3JQ'B'49SEQ"$WVY10`5MZ#Z#)Z96#%$F5R/$&P3\._#&M'?3 M-2.#*).K$2*==\Y1Y/!DJ$J*U@S$#4+/1MT%[9BLA=-IMT(O41"M$>B0+@7F M\!&\RH&5%*W5Q3P1^.>2FGWUS&R7.Y/R\COW>O5ZOP:]8(J_1]89JQ">%6@& M%%OP.$N/#JNK+ZEW>W;9^O$2!L#UJB"NH*UI<^BD"V(,G=6/YX30.>\V-JFI MK'T&1?@3H%N`V:=GJ&C6Q@H;FF%5Q:\BNW-?M/[F`I&@,B>U/J31^1MK(56M MJZ9E!Q.GJ@94U5/_Q&I&E^F56Y6*;#,NN"I2!='=S!$WJ>**JAJ`>+P2=TYG#]!7!%N5K1YK,#SJB$,!9K' MY:/@O"JT1&:G;1).P-(+-FZ4B7@6,_W:]5TVH-_0/S.XX6L`?0PV85 M5BQO)0IV![9\(R"#_$@=N?4AH^^GABV1[!=DK#@66;%69(TF5EK5SO`K;1]D M+#K)690U(M9'.X&5UOCC#Y\.!S__8B6:8_,2`SUD9ZSRV"8BPJ5.*'0>$T"> M0@^R)-TI`(L>FVGTH!>0Y)MP[M'M#^)=PQ_BK\ MQX7+RO8,@/Z8#OT*8,?E\I#7S>D<)^!C#ZPXS$5N_]2F,U#:`*^\\&ETZ(!3 M]B%!-L%H+JW/N.Z0T()T!5,@'0MAVJK..H/^&HN'"'3..@%>EIBL@Z6K/Y=T M.&`Y$L@/I^ROKDI;*Q>KE!K,(XA3O%9B MBI-R&2O""DSO/3OC08D-=1&43%"W]87;,A@:R2/Q2"^)J=VW;_'* MC4=@H>BX=NZR2T@.+^)>@N28S71VYXX3UAOP[H#K#/T+L'`#X,E8$8HUT+UJ MITAN`)W#"*!,BY8Y->;E+]/HIWCY9! MF%A+X2MYN(+4^$0/3\HSH0D"5T+I>8;1U#["(G\@_1]]<( MLX1/2:=3TF$\I15-X7%Z8B*GX8&'[2@MJMA71CF6\`C]J)706QA$^]TWB`C" M3YEBQA-31,NK_)]3L?1>S@[ZE.\[B[,7TMXS0?6/ZML$3),5JVITFT`]&3YC MRL]L6\PE+!Y+R],_TGHLJLB*-.UTRZ,T<3X#^U,>=BABK62:W9&IEC*?`?XY M#SQ6QNHWI2NMH%'IO&'E9EGX&[%$>;"1AQ2*-@Y-EZF?`'I>! MC36$#C"GHU'T9>G\&;0G>;21A!6+-.SW.-G]&80?BQXN$;,2.0/[*WK'3YJZTN2OO*G>%0/M@BIY[#G0C M$NB'?-W3K\8WD,X%HU1ZSJA#2Q4*&3K&E$%M9!_.`D6NXP+L0FD"5;'LSO/;>(T:J0#E^FZ],]6' M&<+!(\3S2_@4/-*G2982Y<4-=>]BT-Q.818ALNDI5T#3\D%8V1)B#%\XU,6- MD2-+??R9/.2P+3\2[Z*%"5SQ9^GX(Q'4E6PMZT*HLA'<@6K3"7#)K2TWYU_' MT5'$H3]Z\2$F,W=14O>L8*'!W7SU6O2,3LFI8B;W(EM[D'HETNR2NU_URZ&(:=LIC&4'1!,DESZ:IB M@)G3,N9>ASX)<'B?P)".J;2]!??4\'3J(9\[-7GC&:Q@!H]'O4G1UZX/?)LB M7;>`JIT?5QFJ[J0EI7)0^1L29N0_J)Z7US&VD)>5Y6LF-27X2-_TE([%>^; MRYA?R!0KRWD,\^N4M\XLDFV$S=<8D M/:BRG%^V;U.+^Y$IH6:8.-9918>^`.A67.9/^E:M--/R+M(X9;&YLK)Z0J8; MU#N?.,-#J-LQ9'+@M`$630ZDWM&%G^O0"I$%3G,%->5>"+H(DL'=4?`NC&%% MI\6Y='[<'%5'(#N+UNE[F<^Y8P M6\>(526OMHY]O3:OMLVK?1=YM;RE82JG=.1#\?*PK.S.5RB27%DQ4.[:1.]< M]AOPP31L2-<07KTN:)L3;"Z4E1X/-*6);;A3P+?!S/AO-CWA$MH8`@*OJ2[W M&?I0=,.25'3?N%,TR,QEX^42/J*4X=1%7"PQ3KGN$@:Y,GM'G<22)J=2VT2$ MD0VA0ZYI+60B4[0ABL+#?*E]XTUN"X\YO4E1>5=!;.PNTB_9D;O+E8WFL@P_1)$M9GF%HC6.7G2NX;/>7XN;L'&G/)*K\7,I-J5+CF273=EW'I M1IE3"`5*)>=B;@Q++J5#-("J3,B912,P/-SV(7Q/[D06T[X<;58C8ZJBC M86=/VZ..QNP,M4<=VZ..O%."[^&DH[$AK/_#S%7ET:V.!%6]<:TV0;5-4-4U MW.U-@FKM^9'Z(QY5TB.-#$V<[90:^1V'^@1 MHU?H-SN/"\8W^847%*C%`@L7JB>WZ8M]<>MSGA[;7';;*WT2N; M-ME;D4&3@WKMM<>F.+OBRUU9S#&Z_HNLLM$?XNM0X#T,,&(K[F?(+DZQ!4NG M;34;_W[`6@PTN%6T+UW=T!0SXQ[IM"Z&&?@V'$U*7HHFSFXK%36>034+N*.E M`3.>!#5M>F&[.Y^S:XED$Y]R*>/IDH+G,67`NZH+(T+T/ON%YU8>+->2QC.F M9`"/-0/>1JT^CJ_?"Q@7>42W2U:)*W\2#@NU38P4G[>G+:06LWGM2N]+L5.C M2X1UM`Q(`'R'3B"4UCL%*>,YEH+G,:7S#=JIUQZJ1;8+;]G,OMY0P_6`@K?' MJIE4>-FF\&VRQ@7OP]R8%.1".RWV,X&(1I^11R6)Z'.*&Q/8E_*2\Q]"\W<9 MYG^GQ^+%];O!L?==OK.K/?9N0+4:&3I_[\?>]^74N['QS+S?$V^YEI"$/8E5JG#@$0KMQ?BC8+9IVRL< MR#*O)Q'3,RBI5+\2888/44UP9O*`53.O)J<&?84^Q,`[]YUS9T[KG@11H#&^ MMTF6+J0DKNM>2+7.AC8TB-M7-;\*=K61<_7,TD7E!]AY`GLQ`DK,-6[+N@A7 M>D::+Z(IZ552Y5*"#!_MZN3(Y%&N)AY-'MURH%5>%U\HKNV$D[3C"`E*@>>2 MH]<7YMR\2?G)DO[\`7#G`"&6,CX6E[X!>]%U7'@A,X;7?QV2:>@G%HO%MR+FN;`5H@Y[#SA).<8%5,T/A??8IFH ML2(]QJ5EM&5FH^/M(O*=E'9+BKW:E&YSVM*8_-.VC/_ M[0O>VC/_1K!C]!C5GOGG'2-YGV?^]3J[\&C.%T"7<%\1:!Z:D12YH1.2[0@Q>N*P-6DF!P:H)WRV^%$%O@=P",<&NW\`;SEZM(T5=YX\GO&G]`, MA<46+QDL_I[]\T17)/2;_P%02P,$%`````@`=8MM1FV(WZI<)0``C0H"`!4` M'`!G;&%G+3(P,30Q,3,P7VQA8BYX;6Q55`D``TU6`U5-5@-5=7@+``$$)0X` M``0Y`0``W5W[;^0VDO[]@/L?>+-WEP08C^U,]K"937;1?LTVUF,;MB>Y0W`( M:(G=UD4M=2BU[=Z__DCJ+?$E=9NLV0-NX^FN8G\4/Q6+CZKZX:\OJQ@]$9I% M:?+CF^-W1V\028(TC)+ECV\^WQW,[D[G\SQ^@@P.+9G\B29C2S[?SNMG'/%]_.#Q\?GY^EZ1/ M^#FEOV7O@M2NN;MT0P-2M[6,\?+7;X^.OSL^?G_T[F7!P)_AG'W!/OOC?WQ[ M=O2>_<_Q^_OC]Q^.O__PW9'EC^0XWV3UCQR]')7_5ZC_$$?);Q_X_SS@C"`V M(DGVX26+?GS3ZMKS^WW1T?/C?GR[O@D>RP@=1PD_\?ZP@E.WS+Z--/(M)%GT(1/P+M,`YX)8QI]!2@G^ MKX-*[(!_='#\[<'[XWOCB"=(T)K=D@40W/^3;-2-K%G&NO2D_>Z1D M(0<34WK(]0\3LF0#'O(?^I[_T/%_\1_Z0_GQ)7X@\1O$)1D%E?WZOM-6J73H M&NP-H5$:GB?34/>U/<%G[P[-=^A`6]]Y%^[3',>3P+>*/G_DFS MF81,>](MS2[LF']XR?[J`"'_)YZI#$>59]*)`>?[][\ MI9!#0O"'PZ8E?_S@_@E9D20__WT3Y5ONGS%/+\FSV4N4*7IKT'')&ROX;0YI M%<#PR09EGUN%*&IDT2]<^G]A\&P6AA'W!W%\@Z-PGISB=<2F.:U-,NBXY)D5 M_#;/M`I@>&:#LL^S1@=Q);;:0:4:#*;=DAQ'"0G/,4W84C;34DPE[));>L!M M4LDEP;!)"V]`HR#8K#8Q=\/0&5E$093#X,\->RQ1R`RHEC@#*9>,44!L4Z4G M`H8C8; MMNC?[V9OT3S+ M-IQU['%%69;2+1(-HOL4?8R9.447F*YPL$7S)'@'@X]WCRG-[PE=G9&'_)[] MFF[=*9=UNM[4P>VL,V6"8'BF0]=GEY`]R)DPXM)O$9??DTWC9RX'S9D+X\7' MR]E'!@]3\IC&(:%2LZ02BT'PTY4OIYVFNH+N;0, MZ[W?/##W/L(T(MEU0C3OOES0W?NO`]K8 M`)F4]W$W0ANX%SA)\$.4\?/W?,-@"/NHQ)HQV\<2'DGB1&:I<%@2Q0XE"&_;_CQRI-IGT\AZYHX2KA][@P$0=%' MA6[@?M:R2`B#Y(UIM:J2]L@=[8I5+@J5/Z95:X]!#E:M-S1=$[XO&/R^B3)Q M1G::)CG%@=S$V"HY\VJM.U![N$8-[^P9!;-/HDH/M111I0G#)HE=0GZM),I7 MAFL;F60!KL\?(8I:LJ`\Y^*6=CQ+PEFXBI(H8[3.HR=R M_K(F229??8_4=4FN4=UIL\U*$0S]QJ#M\['413@)45<;E>HPF,F6"^F*U)>@ MJKOD&MNFU7#)0@OH;>YIQ,$PSHRQS[-"`]4JJ-)Y70>,SI0E9K>-T2\A=";5U&^!D>[=9K^.(4.V1 MY6Z-NCW;W,<#Z!Z"[M*B=_KOM1O#!6HAXLHD:L]3I&(>#*/Z+$4BXYT?!F`: M"WF`RG]T#>1SE#\BC()&\/DQ15&&\A0]$#&G8A2VCN+8^D)<^,;)%H@1)7QW M>';#FB24DM`<>*+5<&K^S-`[MDTM[IV8]A@'5DEHH!FJ=4`&JYS&.,NN%P*: M3:#*4-Y+D(H*MC1`I2\,AU4&A`.[Q\6XM1*"KSO?G:7!AD-CFJ M6+`\9&+C3F;%[?25BKBXFZ$!6MQ-D,MX)8P`VB((K*-'(BCP,_FAQ2OAI03Q/ M0O+R=[)5=FX@YY88"IA=9O2$`%%#CDS!C5(8"6G$Q'VPH[)C_%A2TJWNUZZX M(`-54:#]'8B1EP!23A9$8935]ZI][XH-4E@5"SI?@AA]&:)!L&DE@[B0C[$^ MW;#%-,,890&._X=@JC8&:E%7##"!K%/.(*7HU#X:S\ M3.+X[TGZG-P1G*4)"46(5W\OS4+>K3MI@-UU*Q7"($AD@W!P^IE5"U.,N.;! M;UP55;I%E![]JS]2_93&FR3'="MR\LGNSRODW))(`;-+GIX0(-+(D>G(4FL@ MH>*1(:4QO"7KE/(SBB*+H7KYI1!WO(;5@NXM9:6R@-BC!:@DT5<9JC7*U).H M;,DCFP2;3]D\NDRI>@>D)^66.U*(78)F>>N&"176]RD6N8V2ZU M6=0J.9YO+#K0FW4T&H"(9`%3M;7:RF_X%A7*J*7M<6B,])[+!H][]R; M`'9P8ZJ^Y)XN4*V,*FWT2Z4/).IGEF4DSPPT[`LY3;4J!=C)K=J1`$,B*:S! M2<3=W?G]'20JE/L#5HP8R+HGA@+ND!\]06`TD:-3'4H4.C!8IR%68%440#+Z,O;I+QHSM5)M3MKI@IJ.1@`?9R.:SD_GE M_'Y^?H=F5V?H[O[Z].]_N[X\.[^]^PJ=G5_,3^?WX+AJYVGK%#SQT<+G5DM# MY-PX[SMN%&%P:A8$Z8:Y;V5V:)X+(@CHAH3#+JH,_I@6G,Z;X[O6F5SMU<'P M>\\VY#YM)=(WDE6GX#3%KQ%X)]VO4AH,\XP0 M!SOO&\)CD6E9WF!=Z,"@U66*D^H=TO-)*NET:E5#[Z^PV7T":R%B!S3[T1Q<`0L-30<@(< M%]H)`9.0YXB,DB5)`C4WM!JN:Z\:H/>KL"K$PGNLEA=(=W4DG' M90]54'NE#_MB8)BCQC;,/=Q)P(-FF_PQI=$_2/@!'1^]/3H2_X_6M5A6W+8L M;YM91_/WIW='2,UH064E6A,+Y-D#:W,S^@)$V`I`!MW4'5'B@/ MQ#Q5+5-2P,"J%]4/#X^/NWQ]\5S?(OCX__5/^[ M\S-OV4HR6Y.`IZ^-@2PD%?6451M_*FD`E:VEFZMR4:>,?B+T(C;KX7H5#)&@Q=M7+,]'O*Z5@F][V`5N MLH6%-%#"22#:VL!(*,&EESK6WUK+-]$4T?Z6*J`I9X[W5_$N?9U8_[WL(ULZ M?%H-3[O+-JZ>1AP,V;9W:C5.(0J27A0,GM6^0O+<1:9KL5+S2RN"T@4[0-`*D%2+)1GG[LOG:[1EH%U3W MI+/X#@PA>H#Z#*B^AC'B'-$*J4-HT84.(,`*J7 M65P(!F&NTB3M=J`DM&'A;J'GDDS6W6A3RZ@$9N:S13I@7/Y(*"HW";\N=;Z! MP;PR27.RO"4!B9YX7HILOEKCB)+PGJ8;]N_PC#SDMX1U<1/D&\ID?Z913L[2 M9]5VP*Z-NN3L?AY`F]"[M0B&[7OIQF"G7#1090B/>3846C)DQLT?T!SDY='Q[R3&H.EG.Q M>T>&>8"R##T()91S>4C<9QTH)ZD3DI"%,JA.*>V>LTK(0SX.1,%87#V^X:W# M](DMGMG2F;$(185W`8A+5R0W+G]Z,DY]51F\CE_:%H!ECV30^O1@,H`6.%7\ M9W6G[`1G43!+PK,HWN3*VUA&+9>$L>Q"FT(&%3"&QPZGBF'BQI_00P=(J(KS MA%(9!O]^)M'RD:&9/;$9>TFN-JL'0J\7`G7KQI`=+:)I+8'A M]D[P^Y2O&D-E:Y*J?G#?@?IZTCU?;"D>5U_(2W6M#D!I'2TA`89C4ECJVEB_ M"#$@5\-J6)=10N;L3Y6O)A/TPHX!4"E#:BEX+.E#TS"%BR(AJZ7+*S[VO=X: M_M;I8*Q%V4SV-&FN\Z:M$/?'Z`2S?P:DNC_L:7`FY_@`.1`:G,K'CU<\V3L, M4SH+_V^3%8DV[U-%XB5Q%J`Z6;?7=YL4:V2WNFFR+)7!F.FQB/O4O&`_%3V1 MA+"54;KHWF=`(7D`0E;QLA71.&=BZ[XH,MR.TF$]X=7.=&^K90/.\QZ-ZMC` M5EII@R'L:,B2G<2`D#!#_$&B#,X?/WU@TR':$DS_&=8H[SVX MQN=).'F%\OZ?-G^T8"7;@1)Y,&8 M6@N0ZLTA-MMQ)22TP(6GO.T7 M[?EA*;>6]O0[8%ZJ5^S<,.E[_5-%2;KRQU!2N?CL4_YWP&>;#8_@B1)4WX1& MN/ZA#YZ<3'!W>-TNYBSRL.^I/_KKO&LV*%&6I72+DC0G$&_V4H(S MEG)?UYQEQ;H!QW<@1W:L=RW24AN,=1P->9`#Z)']BR>7ZABR+"-YD;B[52=8 M:]1\DM>F5++U\[-KS"^IQW183W";EJ"9\)UZ\647R1YV?739['%-^.7YN-+: M8_0!&_!]E-\&$B]NOR#>>44-=:MCMRT.<+?MQ^&6'96(G3JNB.8)@KO1H>CK M/'GBT4R[[]II&P)`98N.6E!:TPH8"SP9^C#Y8:D!CLS,+ZJN\?!$(Y1M&ZQ6KQ2BKT?)E#;3=4=E"J!(9_MDCUEB\J-?N7[V$PT=[?W=EA MAKJ2V6T%\T4LRM6XE8ORJ@ETLD5PUS(86WXROH1MJ3&7M!*=VRETD$<<`5`\A^PV[HW$X4 M/`[DB@TZ^[/9I4Y"R>1X%F5!G&8;:LHOO7NSKB>4?3R$/M-W:1/4Q+.'C@P< MJC0Y$/?"F],-?I4,KDO%5]?SA-]RYNOH:BYM)6U0/#\+/;=UKRR[T2V&95"" M=N?1%O"7FH-CLU['(I@/Q]7[.4\6*5V)K,*FV$Q;;:=AFN.ZU(G8M%,%8U'' MX1W$<;:T46-N@5C)>9(3!B;G66^45SC;(FYOS`[!=6_$-M^#88L$U/`F52'" M[%0$Q*]L93374J$GY24!>!>B-/%W(0*($S)SCKXT)NJ9+G$3_*(Q8$E[AG'^X:)+=*^:EZ1\FMJ&=\+M M"'P0J-W21ZP!5+2`KA>H:0.&`6M#/66HTC@*Q3]XDM[L>G'#'C&?@\5'FRSB M+N,9R0(:K_O MH:E]:W+RTZ3Y?6N/D\C'E,9J<>%2UOK'2\#!EZ*!+9@>9N'<"VF,VK:-!=8O@%Y#$VM*W:)1 M<%M>V`2\6VA8)>W=6EE#5(0W[6NT@"6-AT+1],_&>XB3CZ7[4FP#V:F[OC]IU MHGN'5*\#AHZ60(=W28M#$:&'VHK@3*6JA_9^WZ@6(##3TBLK_;.HIJZ MK[Y^O:ES7/%0U292U6XM:];VL*ZU[9)DC6M2]TQI?D_HBI^7&UU'A;!35U$+N.,:2B6A+7BU*-VQR6B]>.!\F2VJ;87MC)=1 MV8/MLNR0Q'09-*%9+CNXTD0)-W586F?>A&&Z^`MC[\8II5U?O;)TSQ2BT,R7 M'J9+4ADM6"L\RX.F M5_%R[=G26.GDH;ER%ECAL^MN\Y"1WS?,0IX_"5MKBN91B;L-W]&#[L;KR&6] MFRA+@,.3^4H<%?+@SD'['3*N3]7R/DFE7W^JA,'2RGSCH\+7&"9"+'Q:BG"H-TL9"]7'F4BS4!FNZ(V:CF-IK;K0B>D6J\"AFYV.`?!U8T6$FHP MJ';WB"DYP1D)^3J'))G8<[RN$J8PD\R\`3;#W&UHQN M!@QUIV,?',_Q"Y\'HBG4;@L&JSDB2AX9*-:9PJT8ERX0[Z(='XU:+FEHV84V^PPJ8$AGAU-V M-AR(3?&S*-[PH!Y>+X5SCB>[1Z(E&.R[(L^MXV^:)NS/@+3VH.SH.+X9MS5^ MIG6R6^EG7!M@&#P1^'!EQ!V!3GJ53ELNKRK?\XBY\1>6^VI^KRW+.Z&_O-S5 M\4ZQD4!UFSNHT(!A%.^"1Q)NXJ*(VSI-BM*"=??.7[AO2TY(0A91+H`;+Q#N MTJ+3%='N7>^LC*8WYYW=^^O#8*54MLCO;S0O05%*+0.S8FKZ?486A%(2,I#% MICY;&%Y&^"&*13V2D6_`R-;\L']2E^7,']440-9/P:]C?-5>F_K[.2L:XT.< MD1Q'\7@G8J#GUXM0=$/O1O24O'-N+%*M(U%3[5IN7%'9IJ=2<04DOA3DY6*+ M:+\-;U-$G9)%V'P+[(\NC0'WN-ZDYQY4!=<9F'[V052B-^8K[0:CRL@]0 M_,OSQ8+P:EY-?VZQR*+%Z,.L:E%.(+\@(;^I=)?C?,.`;#O"JNV*?;3L=.MH M?X^BL[VT>[-@7H[]]66X8U\*(_:6`=F0.MTPWR"INC/PKU5[PR8MI[OR=EWH M;,;K5;%.'UE'V)LW<(+Y MY;WBU8OC])D7;C?=>-FA82^WCG9^$-+[29-;!?,.[*TK_=>D%D2XDO3JI%I9 M+H6H8^?26/#>!%-7*VQ?VS)CEJ?#Y7?]9<&JJ>O7\0W[7>!.?1#Z%?#85KT; MG[UWQ7H-K=ZNL5E)NPSTZ=G=H9W;5N M*(^UNG>>3\G7DY'GD M(7N!;'LO1+TRK0562RTF!\LQU2"46;2PFHVCQD'%7.^5G--J57/]G!":/49K MF5\B$7+F-"H!U@[@0,+[)*>%-7#,SCZBGTC"2TQFZ#(/WZ(LC4.4\3MD&XDI;)BJ(,(*2 M?H%K"WEGC+&!79-')PR#1Q8(!ZE%:A5^'ELQJ=;RM.EP@[?B)ME].@M^WT24 M\+3#65/406;?33J.MR$L/`=KQ))J%P$A88;X4^.;IZ`JI_#,]TTT\IR'VY,L MYVVRJZ+$]AWJ%^KP*SIW7A,@JLIP9+P$BQ1J6X\4'K% MD2O#XY-E\U)E\]4:1]S+HNF&_3ODG;XEO--!+GKY,XU8A]/G1#:BN[7XZWNW M'B?S)K06:$^]&?@IH@F1)8,4>ZQ.:V!?L;4]YJ>DHS9&[5KP7"/;U#5#S6R5 MNG<+-!VSMN@QJI7WM4&I(.+/*?V-0\;KB"WRV$(N"@8'U#I!9[32`JW9(Y6" M01(=M#X72ED4%,)\Q3!PK_.X M)*9POS\$XWUXY=ZI2BU?&TLMMS\3/[5_8[SW?`KEB;#"6Y()>LJ:T`.J2)10 M2D%;]RH1?BE9$>IC5E79W9-MYYOVED7O64QLRT\DQ(3NRN,@1C3DW/DM>MCVOOY%M`HD=;[B.5Q&"9GG9*4Z6S>K`2@6/NB$187P6@<,9RV! M6M<"1[]P521TM21\Q0'[A!.\%('&%X1HYD&9'+P]8"W*_K@TPHA)^PI;J7:? M>7Q&FV!\HTBZ,:^1AS<@5F@EC@H_O2^WXOFU$KXQCXOSE*)^(@R3W=WA/2-9 M0".1W\=J1[@C[V\'7@);O>G>$@9CEDT(AVF''W(4U0HH)W0%SA?NUFNW9Z=')C]3)>PVJYP.<#=QG$P2 M#JMT\`9\ZG/(O]>XIQD$G+MBABHM-1\V@E`F$FFIZ>)F5#9/ROW^N_(8DMR2 MG*:XB(5E8,H8J&*B0AD7A4PYY<3=U'8M1>[3J\WJ@5"1=8U-Q85!WX^7 M8/UC_NF]KP>V@W-H^4O`7Z4]=4^2VJ+V$U$@&O#D+I9@A<40B*\W>9;C)&2> MCXP%.OE?OX/F$EJAU0Y.VBA4*:'V:#3'Q/9/NZIJU8#?6/T)%U4MM+T;ELF0 MM3'V0"]&C8Z:AQ(D/RXF_@L(@=]7Q/L65+B[NE>7T2HJJJAGU\EGY86\,0W` MX)^J8W9\[&M_`?Q40.[S]5K-510W32`VA6]VCR;9$WWS1T*Y7Q'E11B?YLQ3 M(>N4E#JX'?[)!.%038-NP"HNBUK"L$XS^UVY-!QH:N1]$FD`6T>F2W`GFR:$ M%J2ZM#O>],8LNYY[99$%=Z`R1A4/6T9W\[P,N(COYOGC1$7=5UIB?DJ3_#'> M-G'E505?D5A"MI0Q:3A;1-I!KU>->G'O3+''.+CB62BA=8L]%6M0RA5?*[L+ M^V&^7CU_64=T>S;,*ZV4'K'ZZ MX!ZKX7EZ>HRMJD8:P@ZE`#U>#;C!G=!&U#=_6U`,3QSFH[9YQKY,0QA&?%;! M\0V.POKX6VHKY**`'KD)X3!$JY)'7('?]BQ5/(W&+3_J2TA8E16>!6SBWXB` M,XEW8J\%:(Q&@!V&H!:JJ-)%7[>T4:G^C<_[N)U[)7:7:QQ?IAAW-49Y=Z(M M^A4J[S;.\IQ&#YN<[Z?S38H;#&/2F"6AW>B8=`"]1]90-7..2`-;B'L:I/J, MKPQSUA_&5T*`AD&-37V<68FB7YC)PILX1^)JDZ\PJ!I84V9/.PJ-&,1QD*!3 MCT1YX^9K+NYKWJAB3%I+@`9QQPXH MHWB^KAK\AKMX59NH;%18P;)9Y-\COR(Y#UT1!4E#$IYL/V>\9DM-VAD/7U)R MP%X;T+A/`"V[W,3;0%4C/$_.U[P=-N3?H.:5;]J"-;[SY(D7+)TXOA)M^..K M`SUR?.NFP(YOG59WTOA*M.&/KP[TR/&MF_(_OOWHZF)FN6!-14\D(7+GR:@$ M:#3ML4ISDC2J;U&E_!:UU+VM!]E")V1+G>:J=EV67KX65,L#&BTKF,,U8*F$ M&BWTB\C2N45<'0E]7RN2;I(2W2#))0$-CP&@,4N&_\'@."Q?&84HH.$P(91: MM/8[XF\\>F$FK8@GBS@:B32`41D!H@%8Z,W0#U9"$.C@JB>F#>HM*7@^/3 MO6+Q3SA#-@;MT-4H2S=2FH"'J$V/*LA$6&4"T`C,[D$ M`)Q1T8#3Y?\_5Q:2:G]TR?YB'U;!T``-K4`0`5`!P`9VQA9RTR,#$T,3$S,%]P&UL550)``--5@-5 M358#575X"P`!!"4.```$.0$``.U=6W/;N))^WZK]#]Q,[=;,@^,XSER2F=E3 M\BWE.H[ELCTSNT\I6H1D[E"$!B1M:W[]`B0E420N#8H46CK.0^+(Z%9W?T"C M`30:O_SC91IY3X0E(8U_?7/T]MT;C\0C&H3QY-$GJQX$? MT9C\^B:F;_[QW__^;Q[_\\M_'!QX%R&)@D_>&1T=7,9C^K-W[4_))^\SB0GS M4\I^]G[WHTQ\0B_"B##OE$YG$4D)_T7QQ9^\#V^/1][!`8#M[R0.*/OM]G+) M]C%-9Y\.#Y^?G]_&],E_INS/Y.V(PMC=T8R-R)+7)/(G7]^_._IP='3\[NW+ MF`M_YJ?\%_RS[__S_=F[8_[7T?']T?&GHX^?/KP#?DGJIUFR_))W+^_*/P7Y M+U$8__E)_/7@)\3CB,3)IY430[?OWMW=/@_7Z[N1H]DZA^$ ML4!F1-XLJ`07&=W1QX\?#_/?+IHV6KX\L&CQ'<>'"W&6G/EO0TW[BB1)^"G) MQ;NB(S_-.Y;Q:SQE"_&_@T6S`_'1P='[@^.CMR])\&9A_-R"C$;DEHP]\2_O M(,MOG?@,Z:%H<B5QRL>D42?`.A3>\(^Y;>\>"4D3DVS2QGT)<^,S M;H9'DH8C/[*23$K9H9ABT!&!43(<#V?"%7%LC,;34_4DWNFC'T](/%Q%]MC)P@ZA#X89LXL?AWSE^?)1>]4Q(RV%9<.Q;\E$>]G`7^7'BCT"HF^@Z%/&&T6F8))3-KVG* M"4?NM>KUOOUZ,7K.!W+P:C#>#K!/T()58Q01;Q:77Y(?=N3Z%8%)Z1U`\C M&XDMN/6M#@^Z"&,D6/YRD"0\YMU$)QC+SB.H1!T`7?M,_/1$@&JU9MA3A&4K M/X1VZ[YH]\<[%:?,A?<4_6",A+RF)`Q(L&`FI MN]@0Y!\+1N7^[9%WX"VHJC_Z<>`5++PJCU+\A0(1':W)'(GM4LJ,T]#5X/-7 MG:R#AR1E?-VZ8!3Y#R3*V7\5M##2PS;"EO;--W`3,GH[H4^'`0D/A?SBAUR1 M@W='Y?;M-_RCKX4,MV02BJ^.4[%E+I&<-Y6WK`M:[18#-O(H"PCCB"UX^FRT MUAF:.\YEB\-9OD-Y,'H,HV4_&O/%MZTI2[-1@R)5ZW(1M@[!*5>$^=$E'S8O M_R1S'0:-ID`0CO"AH-#:!0P+/>XY6[GUUUL`C?X>D]%E.KJT]0UA(>4:!.*8 M3V_T6E.@]8\Q6E^JM0L8!ER:0$ATP:)HG_&]#F^(WY"8Q)<)DE&F&X"5I(` MD?D!$S(@*[B#YW<:9=R";)YGKR0Z6!I-@7#\B`\.A=8.P]-B_-Z2&65BK5LD MU6BC5`4%$)2?\(&BMX$[;/(^J]DL&G'&OO)0PY2EAQ, M?']6]"X2I>-RT5Z](!S`K M4F_G:O_A2?=>;%,TRG@="DJCN;-M=;V%93`H5,6!AD@T%J>D_)_S MO[+PR8_$H>,@/?49F_.H)+^8H48'2.YL/QX$!&VC$B80U]0##B6'V_2MAY#$ MZESH(OGKJE!7*5HN5TI3/\I;(L#+!)3#'?VN9J!]`>PJ]!_"B.M-1$I)]0Z) M3C_ZFL#V,`P%0>KRK*1S+/<%1,"5 M1LD^BX[(W9E+-R"#+WFZ]JQM%GX=+/5Z.)SI!KA=6>'=+/Q$+K!A2U/:&(I4 MCULQEMAH=,8!2N4LW+3)W&@)A:/'39(6/DZF+0XL!D&0[^_XT8T?!I?QJ3\+ MTU7M&(,H85"WMN^B#7D<(OL/OI-X]C$*G!TM[%WTDV,LB\+"9-AVA]& MP%'O;5NFQU.(7O!WGX`DKQJWEHUT#,]&\KY=X_?=:W;2=A8G15KH($L?*0O_ M7G4'TSJE2;>[V4LPB^"(G-=EY6-FR'+-@SS*OR$L%Q^*HIK>=;Y39W":3(01 MUJ(+YK>N+`?D@L9U`E3'HW'=%'@AT]\WT"C8YL)!;[MT'8/7\YV#3G:$X-.@ MEFB'$Z@`QD"'FOWT!R+>X8PH"^.@0Q,VZRD)7*=!=3GV,,YWEI?K5*JUF>EZ MW,GK#C/8-.=DW6XHI;ZV9O^@6[.O&'G#L5=AY:Y;%F7CEH*9%^A*`J=;YD\D MSG0'\JL6CM?9!GLW=K[7%M79$LBFOKL. MY36-Z;IV967<.Q@!ML"ARLMMTOBR>K5H^1R.O-#W@7O&$BY]-DHSQMO^P<*4G-%G342_*5_7UWO@,-).]<;4-U:.ZH*;I\BOS[BX MJ_VB$S*FC%0J_I_Q'Y(T')FV;5HR=7[%R,X7=&#`79\:EJJ5P^>$K\/&NLQ1 M)8'S*TEML%.\_[OG:>MWZ$5_+S+F.ORO&_OOGI_=&//WL+SBB2 M<=O=A@21.[TO44IX7WTY5J-)V:.HCDR5'0]KAY$RA6JG)'A2-CZ0D3D`\K26C1UG=70!@ZEQCBB M>,7-7Q,X!C+760]M@`)9`@=H];N[)K14[5TG/K2!2:\[#GPAF M2:AV.U:S_%T"+@M+W>];;>E:>?_#SP1I#_>'40$Y"/XO2XKB2_=4,0\,TT?] MA`AFX3J;"0R[M5EP>-^\MQ:W%<[R(\GB,9/J+88+RD1M<\-P!?)PG0]E-XRM M#(,:T/P&T69XREBX3JG:%$ZU67"@V>LY7?^W?4I3)X&I M4*23B.8\#MS',YL%IA:@]E_ZQCXT[1%*]T=MW)M?1/19<4_N!_@].<')*U@A MV%"O:&9U?B:A>*K= M*-%L3I8M+89C1NTWYZBW?-#V5M^96&=M[7I+1C0>A1%9$_B>=C9:^_DVUUM^ MG?63/L'`T=UZO!K:W]MC?:*R*[=*=_S.0&^;A%OL')U?,]C1*K7KO[`V'P_UC8V%C+X#D$HU"X\OX2=S!ZV3S M25'B@I%KFI)D%46K`393.K^=N@$XU%)73)C" MU>YB^"*XB=KKN-USY[Y<.7?@W+6\G-^2[:Z7`&R&PQ-PP4>$!/EU^TI0.A=; M(1K/KJ5R?A]V`U#J1;W-UL&(XZR MPZ9]":Z%NN+-9?Z/R"![\B/AHHIDVOHFH29-THJ+\Q<%6_2,-G;",>[ED@]X M1V=LSONTZ>U=&#FF]P(WPU1AF?VX[+.-SF"10ON^MQVTOKK#?N5*+TQS3>,1 M_W&UB10'DCGO+$Q&$4TR!B@'NCEG:!?"M#G7E3UQS!QB:7(9B[P3887%[';! M>85/)":ZI$\`*13?WK;5.@.KGNX%M-KN'[W?9;-9E`\1/UI8\S(>4S;U@6^S M0AE`.\LVGN"#.@-+Z^`8\Y=Q2KAM4W'/59_2[V6EJ[G0C15Q@+& MLIRL"8]:0R@D_=W+W1`2J>)8"@`.V<2/P[\+3>+@VD_YM&!^R>M'[\!;32/\ M/U4^'F?D%9PZ>,IKPN7.>]71T?&[O$]]OAI\_KKZ=J,*&N$MSSOG,2:3=$ M>_Y:5Y>>6O<`Z6C?"C98?,=G*I+T>,A)6"QW$S_5W41.XBUH>G$'5:G`(U]. MY'"07X5\W1Z$Z7PE(V",ZJEP##$=/K71!#%"QTL/-U>#L^G49_/A^"ZHP`XQ9*+WC M6\%FQ.IK1BN[8)G3JN?9]\R/$ZZ@,@P^>EU4?CBMP3 M]%Z%02^AITI<5NEG8%5D`@\F*0VJ$FK"W5L-*0L6.`:9!C=C MU36#=?9EJ(5%20R1(Y._@#@AL7*+Y>B#;.B5'/*SCG4>O8W%FM#E]UD-31,+ MQU4M%;!8#5=;/GC&+`Q?235,>[-A6>!53D?E8^_[^M@K*+R"I)>A5I$)/+:D M-!B.VZV&CIX*QT#1H*,Z>=_S^>PN>TC(7QGG>?XDW(!\(/W0/"=8D'DEG
    <5:6Z0W,AL.Y"_\ MD.5W\H;C\KZ.'ZTNWI2]5HTTD-QUH5AK9*W,@@/)&T9GA*7SFT@L*^)`^)Z\ M:X(=,IR#ZWJOUGC:&@<'I,M])#"$:@K7U5:M(3,IO_LW_V[Y]!%G(@.$\H6[ MU<(#0.JZYJHUX&!SX!B<@X!WI#1,\ISRQ"+N-1*Z+H1JC1S0%#APRU]N._$3 M$HC7HDF+]]AO"\OX)AM)(Z+Q8J36"0%O@`.Z:/%<4 M9#3F/XY(96$%1M*>D_/ZI=;0MK46EE.ORK'Y??XRC_Q@JW%ALYINX7U;D+8[ MN++)NRB^ITWV19W298@S>B1!%A6%%&$O>WWG?ENS[=^;E M%[7QY@U2Y]N`XL$\426W2+3,>#"PJ@UQ0L9T77S^0Y*&(]-.84NFZ-RY`FGI MEN)&AL3AS\_'8R**JJTDO?7SJV3Y(XO%*YF#](($XA!*5-W*N"#SM<::Y5$7 MS/'Y>5@7Z="R.+I*^?Y8*7$C:M%L>)@(G>52;`@QT"(XX%OUK+4N>/KHQQ/Q MX%P]&A&'E@4"442?135UP&'1!KR=96=T,A5T85=D_00ZO)4$SK(PND+4.)PW MKS&/)WA?=-3E+XONJHO@WS=JAZ@C^`7[:BA??,,VXWBHNFT"?7O>3O.T:FYI M^1RE"&KS&ML\?GWV6:`M*VS!!%VDW[8O-%*WK"V)P]%O-.-W.:5O,73O"W/0 MI+ZCR24-9:^))AJ0M\87X??5$RK&V?U`H2@%FJA+B5YS]^:+1:XV3&@4-:KR M55;:];Y=.]+ML9G?IAK$9'T1P9*KH>5]^7EBNT6GXYKI]25OWY0J8/A*EQ MD31U?4M2V[,D)4^DFG:Y-DS(Z.V$/AT&)"PPX#_43<\_^GI%>/QW'O.@;:YP M5;Q5HQ&R(2!U3#*Y*VN-K5FX^'ZEK^%-UELXMJW,;`W#KDN,PG^(`@YA$/HL M)(G)@O]A845@O=JT!O"Q.T=?T*&X_SN0)*7:A\3MMIU MK-E63^*\-X/,#%$;Q_S,AU>>[7]/!R.^5F$D'X#-DO22"]U&2M?%-FAR.9WY MH3AT8C3C_P^$7K=$Z#5*?Y(4)8".H\>"!38W-RH?Y5WZWS1&WF5&L M#\F[_CH]-3\4]UY53]&=S-=^8\B::<<.57)-R^Z@O`]K90DDB3<*F1MK M$O"CC5?HDG(VZ?BP5QROT&7RP%35GV[9\/B7@5JJ/8Z\H*I3G+I7E-Z M]S&E=Q`$>05>/[KQP^`R+O>"34[/0.;ZM-DFU1=D@=>T7P<^3I,=W$GNWFMV M<$>N2!7!5O)AAS'11['RMLZ"*4/&KT9D3&'4%S_V)_ET=4&(\;A#WAK3\DRW MAU=SZSK5]RUWZ(R,&/$30^,Z8&N+N-$,./SP#:,C0H*\&N':^ISW6-U.F8[*=5I?2\@@IMB# M\5ES1YRV=L6P+W6N760 MXO=:YQ9?[NQKG=O7I-C7.K>[5>=V$U>VFBD+M<3.5%$X+5FFZMZ5A6'(+4D9 M]8M7_:8S>=RS[+*;?7U!VZB>/!O"! M/)ROV:Q@MC+,[J?95).)A(KB99_\#>^%4X,E5RE(72?%P6OF01\=3$6M$E,$I*)RG0T'Q@JB/`Z8Y/-&_NG=+-(].6FF=)W1MN'DV30" M9LB44[VXP4#^RK@9RB;W]#H34>#2>>231V=1%/C[7*?5]15;61H<1Z>JS".% M>,,L35(_#GB,`5H82:A1MGHE% MN>W=YO77G7KLU7+_>U?><%7+>15.P\+>R3#^37]Q6/%V.9)$% M5Q':6_0ET+ MD-TU=2LZ.71\K5NQ+W4KN@_$]J-N17V8Z3,7Y*UWR&%H]<"1B5V7S92OH&J/ M$Q5-GH)*D7YK>]!:R]V08V`PUD5J]W5 MCJ+X)F%3K<_2$N$<)#K7I54'QWN;"A%-CLQ`A@,J0!>$`88J#>LSB0GS([XX M'033,`[%&E0L2LMJ3J;4+""YZU-^4+^LH6=E&1Q>8Z,J9_I4<'HU6I> M`+P>PA>.-W9%]>N@KF!0K(.^\'C_,9JO'H-=K`GRQY(5BR`3D>M43K#)((@0R@C#!:R=OJ1H"=GK#46LM^"N\-U0W+.U(`P/PR+0=5&JUT7@ZR)P M&]?6]F\1^'KA^O45HM<+UZ\7KO?APK6XXW#B)R3X3&D@\@*ON4[3643GA-P1 M]A2.2%*I878RO\MFLR@DS%1?=#.^R(:=OO3H9JKB."VUU6*A@[F4Z69\D72$ M3H;)AAVG;II^,E).:9QD4>IK`LYR'ZW6S+57[J8'U_8*I:;H;Q.V_#I3$J*T MI>O=[C[MCS1M<3D_G$9^D@S'^30/7`0T29"X.JL%0%,+'$?<5;E,4Y2L+3(L M5/VK'FQ*-$$1[_/A'Y)D<+.X+0N*_+5$K@^=U!VL/E3,JF-Q9I!Z,@M'KO-P M=GR.S M(M0]M"9[)(%8'^>5OQ%\//';EG_P_4$L#!!0````( M`'6+;49B..R*!PD``!=5```1`!P`9VQA9RTR,#$T,3$S,"YXKO6(^!,<)S`Q9 MV"T.9JCL,21%V)VM^S*EV$JBPY:")$.RO_Y:?DD>B1"4L[.&O9AJX$(<[A+V>2L\=NP>3Z\Z/4:Z)>?__X#@I_3 M?S2;Z",EGMM%E]QI]MB8_X1NL$^ZZ(HP(K#BXB?T._8"7<(_4H\(=,']F4<4 M@8JHI2XZ.NPXJ-FL`?L[82X7O]WVEK!3I69=RWIZ>CID_!$_<7$O#QU>#V[( M`^&0)=;$PY,O[99]9-N=UN%\#,9?8@454';\8_NRU8%?=N?.[G3MD^Y1JV8C M"JM`+AMIS5OQ3SWU3U0Z2V7K/Y/9T[OY+?UC0MC[X!*S6^ MOOKO_?3QLWH:.][#_Q;R_G/'NGU8B#']=>+?.Y->U.2I=*;$QPC"S>19(T7A M4^>0BXG5;K5LZX]/U\-0KA$)=N<>9?=%XO;)R8D5UB:B.T06ZH0U!4J,,Q;XQ>RX2EAJ,2,6 M"#5!B@CJ+/6JE=85P`9=7&Q=6%-@W=7U^=5288)A!'E\A"'`#HQ"WTI&$\PD M'O$)4Q^Y\"_)&`<>Q.\A`,DQ)6X#*2PF1.DN+V?8(74@D\&#&>,PQF`JB4MT MV6Q&81!!P=].=6_K:G;OP`>D'V`",32@)2P8AH&V]YRY'YBB:J''I/##9AJ( MNF<-HX1N&,P(FW;)F#(:VA>/?!LU4:*>?L3,11$62H&=6EF8%'@@B=MG/X?/ M,T$DP(1*UU`0*\8B)4H.]IS`VTQG94JA2ER04/[\(/P;BF'8#Z>$*!FQOEYD MIKD-W.K9E\0\7W`FN4==*'%1#(0BI#W'(0T#+,"Y*5$43"X@?+W>S'ZG/OOH M8`WXS>Y&8TF8[(_[,YU"09-QUR^I,T?AR!2%%2+JC]$*<\^_YOABBMF$R!X; M*N[<3[GG0L(*[R[J4)6/B%':'*/C3(S6PQ(#PQL!I:'_]<_W;?L=9*A1$_N0 MA4'`^+"6;TS]`XR(1N8*TC2'[NJA8S M1^6=3I-@)>1Q"8KP1QH0`2**(/?S6!26*PZ+=NBZ#A%QNKI68B;[?9;L4!?% MRKM+ZC#P?2P6_?&03ABL6QP,V;_C\`!2=C89P"SA4)),/?5DS8$XR08B1M6] M/(6+5L`H0=[=*-T23\_5D%&JQ9W`3&(G-1&5UAHC8;>RD8AQ4`B$TDB[R_Q` M<)]*R<7BABMR2QQ"'_'((Q'SI;5FYNTL\RL?YN,TI5F&9# M9@=IAWZS$;9ZN9H$S(P?%3$>0X5IY!K8[H:@Q^"1W.%Y0GFZP$SQ<9;B2!6% MNKO+Z#`82?(0@$\?'G5O2]+$3*F9V[?YA##11Q'`+A-<)^-^3I9>+UNW=GCO,S7%W.D4(S_SQ,7F,.16K^GY!QU$&'N:-1OZ^ZX;>*0_7A9" M=OU(]6?Y2Z(P]?(QJ*-C#E!N5;L>H*0!Q,>I&K1LY`TZB-O9!W$]()=D3(0@ M[K+R7$JB9'4D*Q2-X6SGEL;EX4S:2<JBS?)+W!0C\]DK60;JYF M#FANQ9UNH'2O%1TLF]D',[,#6QPWHX0Y1+FE^=H.[3X4S\D,5R477*J2L?8R M4.;@YG8%-LDC4X5AVV_VG<&KV![6;19'NZ:L.9RY+8>BK>-P:MU'JM:F9G&L M:DN;HY7;O3!M>NXCYA5MA4XQ.%8<):.$.3*YO8]DLS0$VX>B=(%0'`F3@#D0 MN7V.]81_'X>:>]GE(Z2N@CE.N8T0XU[W/G#9I'%]9[8L'ZR0,H>HX`-_9C_W MKQX6_4M?!;@E8Q1>(>CJD^9G#4GU-9%&7#859'S6T/!4/&2HQ/`!156GV0:@;I=J"S6"_A MLH='F[H,*L3[AKY>:_P7=1)ZWZ9.9CKL-W+U8M7*BSH,0V=3A]='VS?R]W+9 M2-K=^(*%M;IA$?^=O85Q"HYSH1#+W>DP7?")KB9=$,JCHOYJ)7E,7->UV MLV,?SJ6[LG03(U8T;&9$HO<,(XS7C$JL*-31#\V563.T7*EK$4S(I M^4IK\O>-GF].B/4,>VI[V=A6=486]Y"%Z;>=8HJZ2>IU?-9PTE`CVYZ%M^79AT*'?OPKDQ M&KXJJ1I%ET+.&HX@KD:(9M"H$I9ZD/R(14\17VN#RY`KP505:(>O!`]FB2@% M$9,ST8GZ'NL_,2+DE,X21XHJ*IUP`Q'?"DN;*\-5Z0L8.R#"TA$N/.SZ(7CV+D.;$ATJI M#;S(=">7C+YE;P+#!7;4A_F,BH6^,+SL3D4US^U/2L`0>P%SP_X1W2'Y1/S1 M*@!%%9OWG/"R:M?E/J;L):P%1>I2+"!/Z3.2L;BD\M6M3KKNN?,04!FF4$E? M6/>@CN"K>Z-OP`2>GJC7C2\HWR);<[VEN.K5+39=(SX'3-T7$A?JR>+X*?'I MU:>_ M[DA:=6]Y:?PMIK+BO%`Q0` M```(`'6+;4;I76LU3U0``*(X`P`1`!@```````$```"D@0````!G;&%G+3(P M,30Q,3,P+GAM;%54!0`#358#575X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`'6+;48!L<.!`L``00E#@``!#D!``!02P$"'@,4```` M"`!UBVU&+\/#`-@/```-^0``%0`8```````!````I(%<7P``9VQA9RTR,#$T M,3$S,%]D968N>&UL550%``--5@-5=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`=8MM1FV(WZI<)0``C0H"`!4`&````````0```*2!@V\``&=L86`Q0` M```(`'6+;48XAY1>;!T``-K4`0`5`!@```````$```"D@2Z5``!G;&%G+3(P M,30Q,3,P7W!R92YX;6Q55`4``TU6`U5U>`L``00E#@``!#D!``!02P$"'@,4 M````"`!UBVU&8CCLB@<)```750``$0`8```````!````I('IL@``9VQA9RTR M,#$T,3$S,"YX`L``00E#@``!#D!``!02P4&``````8` ,!@`:`@``.[P````` ` end XML 24 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Going Concern (Narrative) (Details) (USD $)
    Nov. 30, 2014
    Going Concern Narrative Details  
    Working capital deficit $ 192,673GLAG_WorkingCapitalDeficit
    XML 25 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Related Party Transation (Narrative) (Details) (USD $)
    0 Months Ended 12 Months Ended
    Nov. 30, 2013
    Nov. 30, 2014
    Nov. 30, 2013
    Related Party Transaction [Line Items]      
    Management Fees   $ 6,000us-gaap_ManagementFeeExpense   
    Forgiveness of related party debt   23,298us-gaap_DebtInstrumentDecreaseForgiveness   
    Due to related parties 28,298us-gaap_DueToRelatedPartiesCurrent 174,635us-gaap_DueToRelatedPartiesCurrent 28,298us-gaap_DueToRelatedPartiesCurrent
    Advance received from a shareholder   174,635us-gaap_ProceedsFromRelatedPartyDebt   
    Option expense on proposed property acquisition – related party   28,000us-gaap_AcquisitionCosts   
    Mr. Robert Frei (Former President And Director)      
    Related Party Transaction [Line Items]      
    Management Fees   6,000us-gaap_ManagementFeeExpense
    / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
    = us-gaap_PresidentMember
      
    Due to related parties 28,298us-gaap_DueToRelatedPartiesCurrent
    / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
    = us-gaap_PresidentMember
       28,298us-gaap_DueToRelatedPartiesCurrent
    / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
    = us-gaap_PresidentMember
    Debt instrument terms The amounts owing were unsecured, non-interest bearing, and due on demand.    
    Mr. Robert Frei (Former President And Director) | Additional Paid-In Capital      
    Related Party Transaction [Line Items]      
    Forgiveness of related party debt   23,298us-gaap_DebtInstrumentDecreaseForgiveness
    / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
    = us-gaap_PresidentMember
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_AdditionalPaidInCapitalMember
     
    Shareholder      
    Related Party Transaction [Line Items]      
    Advance received from a shareholder   174,635us-gaap_ProceedsFromRelatedPartyDebt
    / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
    = GLAG_ShareholderMember
      
    Debt instrument terms  

    The amounts owing are unsecured, non-interest bearing, and due on demand.

     
    Director of CVI | Cannabis Ventures Inc. Canada      
    Related Party Transaction [Line Items]      
    Option expense on proposed property acquisition – related party   $ 28,000us-gaap_AcquisitionCosts
    / dei_LegalEntityAxis
    = GLAG_SubsidiariesOneMember
    / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
    = us-gaap_DirectorMember
      
    XML 26 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 27 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Organization And Nature Of Operations
    12 Months Ended
    Nov. 30, 2014
    Organization And Nature Of Operations  
    Organization and Nature of Operations

    1.Organization and Nature of Operations


    GALA Global Inc. (“the Company”, “we”, “us” or “our”) was incorporated in the State of Nevada on March 15, 2010 (Inception). The Company was formed to provide garment tailoring and alteration services.

    On May 19, 2014, a change in control of the Company occurred when IDG Ventures Ltd., the Company’s then controlling shareholder, sold all of its 3,547,000 shares of the Company’s common stock, representing 60.04% of our issued and outstanding common shares, in a private share purchase transaction to Messrs. Haas, Lefevre and Naccarato.

    On June 26, 2014, the Company had a change in management when Mr. Robert Frei resigned as President and Director of the Company and Mr. Lefevre was appointed as his successor. Concurrent with the change of management, the Company acquired two 100% owned subsidiary companies, Cannabis Ventures Inc (USA), incorporated on February 27, 2014 in the state of Nevada and Cannabis Ventures Inc. (Canada), incorporated on April 9, 2014 in Vancouver, British Columbia. Neither of these subsidiary companies had traded prior to their acquisition by the Company other than as described below. 

    GALA Global, Inc. is currently distributing all-natural everyday custom tailored women's clothing products from England. The Company is exploring different hemp alternatives of fabric and materials needed to produce our all new custom designed apparel.  Our new products are scheduled for launch in the latter part of 2015.

    GALA Global, Inc., since its change in management effective June 26, 2014, has expanded into the Hemp and Cannabidiol (“CBD”) industry. The expansion is focusing on the development, research, and commercialization of products derived from the Hemp and Cannabis Plant. GALA Global, Inc. currently markets a new CBD flavored Thin-film strip. The film strip delivery system uses a dissolving film strip that is absorbed in the mouth. The film-strip method is an advanced method of providing CBD for dietary supplement. GALA also is seeking acquisition candidates in this area of interest in the nutraceutical and pharmaceutical industries.The Company also plans to enter into the medical marijuana cultivation industry as approved in the United States and Canada to build legalized cultivation operations

    GALA Global, Inc.’s services include the development of cannabinoid based health and wellness products; the development of medical grade compounds; the licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry.

    Cannabis Ventures Inc. (USA) (“CVI”)

    In September 2014, CVI entered into a promissory note agreement with Globe Farmacy, Inc., an Arizona non-profit corporation (“GFI”), to finance a potential cultivation project. CVI has advanced funds of $189,972 to GFI under the promissory note, which is unsecured, bears interest at 5% per annum, and was due on December 31, 2014. As GFI was delinquent in performing certain obligations under the terms of the promissory note and our ability to recover this advance is currently uncertain, we have a provided in full against the value of this promissory note and recognized an impairment expense of $189,972 effective December 31, 2014.

    Cannabis Ventures, Inc. (Canada) (“CVI (Canada)”)

    In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI (Canada).

    In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) in February 6, 2015. We responded on February 26, 2015 and Health Canada acknowledged receipt on February 27, 2015.

    The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada. During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been recognized in our statement of operations.

    The Contract had been extended on a month to month basis and as of February 2015, the Company continues to pay the property owner a reduced nonrefundable payment of $2,500 a month while it awaits the determination from Health Canada. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.

    XML 28 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Consolidated Balance Sheets (Parenthetical) (USD $)
    Nov. 30, 2014
    Nov. 30, 2013
    Statement of Financial Position [Abstract]    
    Preferred stock, shares authorized 10,000,000us-gaap_PreferredStockSharesAuthorized 10,000,000us-gaap_PreferredStockSharesAuthorized
    Preferred stock, par value per share $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare
    Preferred stock, shares issued      
    Preferred stock, shares outstanding      
    Common stock, shares authorized 500,000,000us-gaap_CommonStockSharesAuthorized 500,000,000us-gaap_CommonStockSharesAuthorized
    Common stock, par value per share $ 0.001us-gaap_CommonStockParOrStatedValuePerShare $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
    Common stock, shares issued 119,140,000us-gaap_CommonStockSharesIssued 118,140,000us-gaap_CommonStockSharesIssued
    Common stock, shares outstanding 119,140,000us-gaap_CommonStockSharesOutstanding 118,140,000us-gaap_CommonStockSharesOutstanding
    XML 29 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Summary Of Significant Accounting Policies (Policies)
    12 Months Ended
    Nov. 30, 2014
    Accounting Policies [Abstract]  
    Basis of Presentation
    a)Basis of Presentation

    The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is November

    Principles of Consolidation
    b)Principles of Consolidation

    These consolidated financial statements include the accounts of the Company and its two wholly owned subsidiaries, Nevada incorporated Cannabis Ventures Inc. (USA) and Vancouver, British Columbia incorporated Cannabis Ventures Inc. (Canada), from the date of their acquisition by the Company effective June 26, 2014. All inter-company transactions and balances have been eliminated on consolidation.

    Use of Estimates
    c)Use of Estimates

    The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and investments, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

    Cash and Cash Equivalents
    d)Cash and Cash Equivalents

    Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. As of November 30, 2014 and 2013, there were no cash equivalents.

    Development Stage Company

    e)Development Stage Company


    The Company is a development stage company as defined by section 915-10-20 of the FASB Accounting Standards Codification and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders’ deficit and cash flows disclosed activity since the date of its inception (March 15, 2010) as a development stage company. The Company has generated no revenue since inception (March 15, 2010) and is still devoting substantially all of its efforts on establishing the business.  All losses accumulated since Inception (March 15, 2010) have been considered as part of the Company’s development stage activities.  Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required for annual reporting periods beginning after December 15, 2014 with the option for entities to early adopt these new provisions. The Company has elected to early adopt these provisions and consequently these additional disclosures are not included in these financial statements.

    Financial Instruments
    f)Financial Instruments


    Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

    Level 1

    Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

    Level 2

    Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

    Level 3

    Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

    The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, and amounts due to related party. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

    Long-Lived Assets
    g)Long-Lived Assets

    In accordance with ASC 360, “Property Plant and Equipment”, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.

    Income Taxes
    h)Income Taxes

    The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

    Revenue Recognition
    i)Revenue Recognition

    Revenue will be recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is assured.  The Company is not exposed to any credit risks as amounts are prepaid prior to performance of services.

    Advertising Costs
    j)Advertising Costs

    The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $nil during the years ended November 30, 2014 and 2013.

    Stock-Based Compensation
    k)Stock-based Compensation

    The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.  As at November 30, 2014 and 2013, the Company did not grant any stock options.

    Comprehensive Loss
    l)Comprehensive Loss

    ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at November 30, 2014 and 2013, the Company has no items representing comprehensive income or loss.

    Basic and Diluted Net Loss Per Share
    m)Basic and Diluted Net Loss per Share

    The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at November 30, 2014 and 2013, the Company has no potentially dilutive common shares.

    Recent Accounting Pronouncements
    n)Recent Accounting Pronouncements

    The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

    XML 30 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Document and Entity Information (USD $)
    12 Months Ended
    Nov. 30, 2014
    Mar. 11, 2015
    Document And Entity Information    
    Entity Registrant Name Gala Global Inc.  
    Entity Central Index Key 0001513403  
    Document Type 10-K  
    Document Period End Date Nov. 30, 2014  
    Amendment Flag false  
    Current Fiscal Year End Date --11-30  
    Is Entity a Well-known Seasoned Issuer? No  
    Is Entity a Voluntary Filer? No  
    Is Entity's Reporting Status Current? Yes  
    Entity Filer Category Smaller Reporting Company  
    Entity Public Float $ 5,299,200dei_EntityPublicFloat  
    Entity Common Stock, Shares Outstanding   123,140,000dei_EntityCommonStockSharesOutstanding
    Document Fiscal Period Focus FY  
    Document Fiscal Year Focus 2014  
    XML 31 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Income Taxes (Tables)
    12 Months Ended
    Nov. 30, 2014
    Income Taxes Tables  
    Schedule of Income Tax Provision

    As at November 30, 2014, the Company had no uncertain tax positions.  
     

           
      

    November 30,

    2014

    $

     

    November 30,

    2013

    $

           

    Net loss before taxes

       (278,875)   (35,990)

    Statutory rate

       34%   34%
               

    Computed expected tax recovery

       94,818    12,237 

    Valuation allowance

       (94,818)   (12,237)
               

    Income tax provision

       —      —   

     

    Schedule of Deferred Income Tax Assets

    The significant components of deferred income tax assets and liabilities at November 30, 2014 and 2013 are as follows:

     


           
      

    November 30,

    2014

    $

     

    November 30,

    2013

    $

           

    Net operating loss carried forward

       131,605    36,787 

    Valuation allowance

       (131,605)   (36,787)
               

    Net deferred income tax asset

       —      —   
    XML 32 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Consolidated Statements Of Operations (USD $)
    12 Months Ended
    Nov. 30, 2014
    Nov. 30, 2013
    Income Statement [Abstract]    
    Revenues      
    Operating Expenses    
    Depreciation    475us-gaap_Depreciation
    General and administrative 54,903us-gaap_GeneralAndAdministrativeExpense 35,515us-gaap_GeneralAndAdministrativeExpense
    Management fees 6,000us-gaap_ManagementFeeExpense   
    Option expense on proposed property acquisition – related party 28,000us-gaap_AcquisitionCosts   
    Total Operating Expenses 88,903us-gaap_OperatingExpenses 35,990us-gaap_OperatingExpenses
    Operating Loss (88,903)us-gaap_OperatingIncomeLoss (35,990)us-gaap_OperatingIncomeLoss
    Other Income (Expense)    
    Impairment of loan receivable 189,972us-gaap_FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown   
    Loss before taxes (278,875)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic (35,990)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
    Provision for income taxes      
    Net Loss $ (278,875)us-gaap_NetIncomeLoss $ (35,990)us-gaap_NetIncomeLoss
    Net Loss per Share - Basic and Diluted $ 0.00us-gaap_EarningsPerShareBasicAndDiluted [1] $ 0.00us-gaap_EarningsPerShareBasicAndDiluted [1]
    Weighted Average Shares Outstanding - Basic and Diluted 118,386,575us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 118,140,000us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
    [1] Denotes a loss of less than $(0.01) per share.
    XML 33 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Loan Payable - Related Party
    12 Months Ended
    Nov. 30, 2014
    Loan Payable - Related Party  
    Loan Payable - Related Party
    6.Loan Payable - Related Party

    On March 20, 2014, the Company issued a $10,000 promissory note to a shareholder of the Company.  Under the terms of the note, the amount is unsecured, non-interest bearing, and due on demand.

    XML 34 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Promissory Note Receivable
    12 Months Ended
    Nov. 30, 2014
    Promissory Note Receivable  
    Promissory Note Receivable

     

    5.Promissory Note Receivable

    On September 30, 2014, Cannabis Ventures Inc. (USA), a wholly-owned subsidiary of the Company entered into a promissory note agreement with Anthony McDonald (“McDonald”) and Globe Farmacy Inc. (“GFI”), an Arizona non-profit corporation, for $189,972.

    The amounts owing are unsecured, bears interest at 5% per annum, and is due on December 31, 2014.  As of November 30, 2014, the amount receivable was deemed to be uncollectible and a full impairment charge on the loan receivable has been made by the Company.

    XML 35 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Summary Of Significant Accounting Policies (Accounting Costs) (Narrative) (Details) (USD $)
    12 Months Ended
    Nov. 30, 2014
    Nov. 30, 2013
    Summary Of Significant Accounting Policies Accounting Costs Narrative Details    
    Advertising Costs $ 0us-gaap_AdvertisingExpense $ 0us-gaap_AdvertisingExpense
    XML 36 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Income Taxes (Schedule of Income Tax Provision) (Details) (USD $)
    12 Months Ended
    Nov. 30, 2014
    Nov. 30, 2013
    Income Taxes Schedule Of Income Tax Provision Details    
    Net loss before taxes $ (278,875)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic $ (35,990)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
    Statutory rate 34.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate 34.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
    Computed expected tax recovery 94,818us-gaap_CurrentFederalTaxExpenseBenefit 12,237us-gaap_CurrentFederalTaxExpenseBenefit
    Valuation allowance (94,818)us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance (12,237)us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
    Income tax provision      
    XML 37 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Income Taxes
    12 Months Ended
    Nov. 30, 2014
    Income Taxes  
    Income Taxes

    9.Income Taxes

    The Company has $387,071 of net operating losses carried forward to offset taxable income in future years which expire commencing in fiscal 2030.  The income tax benefit differs from the amount computed by applying the US federal income tax rate of 34% to net loss before income taxes. As at November 30, 2014, the Company had no uncertain tax positions.  
     

           
      

    November 30,

    2014

    $

     

    November 30,

    2013

    $

           

    Net loss before taxes

       (278,875)   (35,990)

    Statutory rate

       34%   34%
               

    Computed expected tax recovery

       94,818    12,237 

    Valuation allowance

       (94,818)   (12,237)
               

    Income tax provision

       —      —   

     

    The significant components of deferred income tax assets and liabilities at November 30, 2014 and 2013 are as follows:

     


           
      

    November 30,

    2014

    $

     

    November 30,

    2013

    $

           

    Net operating loss carried forward

       131,605    36,787 

    Valuation allowance

       (131,605)   (36,787)
               

    Net deferred income tax asset

       —      —   
    XML 38 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Common Stock
    12 Months Ended
    Nov. 30, 2014
    DisclosureCommonStockAbstract  
    Common Stock
    7.Common Shares

    (a)On August 27, 2014, the Company approved an increase in the total number of authorized shares of common stock from 75,000,000 to 500,000,000 shares and in preferred stock from nil to 10,000,000 shares. The amendment was filed and effected on August 28, 2014.

     

    (b)On September 2, 2014, the Company issued 1,000,000 shares of common stock at $0.10 per common share for gross proceeds of $100,000.

     

    (c)On September 17, 2014, the Company effected a 20:1 forward stock split of the Company’s common stock, thereby increasing the number of the Company’s outstanding common shares from 5,907,000 to 118,140,000 shares of common stock.
    XML 39 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Commitments And Contingencies
    12 Months Ended
    Nov. 30, 2014
    Commitments And Contingencies  
    Commitments and Contingencies
    8.Commitments and Contingencies

     In May 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.

    In July 2014, CVI (Canada) filed the application with Health Canada for the MMPR License (Marihuana for Medical Purposes Regulations). The response to last round of comments received from Health Canada was received by CVI (Canada) on February 6, 2015 and we will be responding before February 27, 2015 and waiting to hear back from Health Canada.

    The Contract had an initial term of 4 months, expiring August 31, 2014, to give the Company the time to acquire the necessary license from Health Canada.  During this four month period, the Company paid the owner of the property a nonrefundable payment of $4,000 a month and this expense has been

    The Contract has now been extended on a month to month basis and the Company continues to pay the property owner a nonrefundable payment of $4,000 a month while it awaits the determination from Health Canada.  As of February 2015, the monthly payment was reduced to $2,500. There is no guarantee that the property owner will continue to extend the term of the Contract or that the Company will be successful in obtaining a license from Health Canada. Moreover as at the date of this report, the Company does not have the funds to complete the purchase of the property nor is there any guarantee that it will be able to raise the required funding.

    XML 40 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Subsequent Events
    12 Months Ended
    Nov. 30, 2014
    Subsequent Events [Abstract]  
    Subsequent Events
    10.Subsequent Events

     

    a)On December 2, 2014, the Company entered into a marketing agreement for advertising services. The Company has agreed to issue 1,500,000 shares of common stock to the consultant as compensation for a six-month term. The agreement may be terminated by either party at the end of any month during the term of the agreement.

     

    b)On December 16, 2014, the Company entered into a consulting agreement with a consultant who is to become a director of the Company. The Company has agreed to issue 500,000 shares of common stock to the consultant as compensation. The agreement commences upon the date of the agreement, and continues until the Consultant resigns or upon mutual agreement with the Company to terminate such agreement.

     

    c)On January 9, 2015, the Company and its board of directors authorized a new class of equity instruments – Series A Preferred Stock, subject to authorized capital of 500,000 shares with a par value of $0.001 per share.  As of the date of filing, no Series A Preferred Stock have been issued.  .
    XML 41 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Organisation And Nature Of Operations (Narrative) (Details) (USD $)
    12 Months Ended 1 Months Ended 0 Months Ended
    Nov. 30, 2014
    Nov. 30, 2013
    Sep. 30, 2014
    May 19, 2014
    Proceeds from receivable $ 189,972us-gaap_PaymentsToAcquireNotesReceivable       
    Impairment expense 189,972us-gaap_FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown       
    Cannabis Ventures Inc. USA | CVI USA, Issued Promissory Notes To Globe Farmacy Inc.        
    Proceeds from receivable     189,972us-gaap_PaymentsToAcquireNotesReceivable
    / dei_LegalEntityAxis
    = us-gaap_SubsidiariesMember
    / us-gaap_ShortTermDebtTypeAxis
    = us-gaap_NotesPayableOtherPayablesMember
     
    Promissory note interest rate     5.00%us-gaap_DebtInstrumentInterestRateDuringPeriod
    / dei_LegalEntityAxis
    = us-gaap_SubsidiariesMember
    / us-gaap_ShortTermDebtTypeAxis
    = us-gaap_NotesPayableOtherPayablesMember
     
    Impairment expense     $ 189,972us-gaap_FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
    / dei_LegalEntityAxis
    = us-gaap_SubsidiariesMember
    / us-gaap_ShortTermDebtTypeAxis
    = us-gaap_NotesPayableOtherPayablesMember
     
    Common Stock        
    IDG Ventures Ltd, sold shares to Messrs Hass, Lefevre and Naccarato       3,547,000GLAG_ChangeInOwnership
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    Percentage of shares transfered       60.04%GLAG_PercentageOfSharesTransfered
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    XML 42 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Common Shares (Narrative) (Details) (USD $)
    12 Months Ended 0 Months Ended
    Nov. 30, 2014
    Nov. 30, 2013
    Sep. 17, 2014
    Sep. 02, 2014
    Aug. 27, 2014
    Nov. 30, 2012
    Proceeds from issuance of common stock $ 100,000us-gaap_ProceedsFromIssuanceOfCommonStock           
    Common stock outstanding before stock split 119,140,000us-gaap_CommonStockSharesOutstanding 118,140,000us-gaap_CommonStockSharesOutstanding        
    Common Stock            
    Increase in authorised shares of common stock        
    On August 27, 2014, the Company approved an increase in the total number of authorized shares of common stock from 75,000,000 to 500,000,000 shares and in preferred stock from nil to 10,000,000 shares. The amendment was filed and effected on August 28, 2014.
     
    Shares issued during the period for cash 1,000,000us-gaap_StockIssuedDuringPeriodSharesIssuedForCash
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    [1]     1,000,000us-gaap_StockIssuedDuringPeriodSharesIssuedForCash
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
       
    Proceeds from issuance of common stock       $ 100,000us-gaap_ProceedsFromIssuanceOfCommonStock
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
       
    Equity issuance price       $ 0.10us-gaap_EquityIssuancePerShareAmount
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
       
    Forwards stock split     20:1      
    Common stock change     118,140,000us-gaap_StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
         
    Common stock outstanding before stock split 119,140,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    [1] 118,140,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    [1] 5,807,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
        118,140,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    [1]
    [1] The Company completed a forward split of stock 20:1 on September 17, 2014 that has been retroactively reflected in these financial statements.
    XML 43 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Statements Of Changes In Stockholders’ Deficit (USD $)
    Common Stock
    Additional Paid-In Capital
    Accumulated Deficit
    Total
    Balance, amount at Nov. 30, 2012 $ 118,140us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    $ (47,040)us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_AdditionalPaidInCapitalMember
    $ (72,206)us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_RetainedEarningsMember
    $ (1,106)us-gaap_StockholdersEquity
    Balance, shares at Nov. 30, 2012 [1] 118,140,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
         
    Net loss for the year       (35,990)us-gaap_NetIncomeLoss
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_RetainedEarningsMember
    (35,990)us-gaap_NetIncomeLoss
    Balance, amount at Nov. 30, 2013 118,140us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    (47,040)us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_AdditionalPaidInCapitalMember
    (108,196)us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_RetainedEarningsMember
    (37,096)us-gaap_StockholdersEquity
    Balance, shares at Nov. 30, 2013 118,140,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    [1]     118,140,000us-gaap_CommonStockSharesOutstanding
    Forgiveness of related party debt    23,298us-gaap_AdjustmentsToAdditionalPaidInCapitalOther
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_AdditionalPaidInCapitalMember
       23,298us-gaap_AdjustmentsToAdditionalPaidInCapitalOther
    Proceeds from sale of common stock, shares [1] 1,000,000us-gaap_StockIssuedDuringPeriodSharesIssuedForCash
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
         
    Proceeds from sale of common stock, value 1,000us-gaap_StockIssuedDuringPeriodValueIssuedForCash
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    99,000us-gaap_StockIssuedDuringPeriodValueIssuedForCash
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_AdditionalPaidInCapitalMember
       100,000us-gaap_StockIssuedDuringPeriodValueIssuedForCash
    Net loss for the year       (278,875)us-gaap_NetIncomeLoss
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_RetainedEarningsMember
    (278,875)us-gaap_NetIncomeLoss
    Balance, amount at Nov. 30, 2014 $ 119,140us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    $ 75,258us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_AdditionalPaidInCapitalMember
    $ (387,071)us-gaap_StockholdersEquity
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_RetainedEarningsMember
    $ (192,673)us-gaap_StockholdersEquity
    Balance, shares at Nov. 30, 2014 119,140,000us-gaap_CommonStockSharesOutstanding
    / us-gaap_StatementEquityComponentsAxis
    = us-gaap_CommonStockMember
    [1]     119,140,000us-gaap_CommonStockSharesOutstanding
    [1] The Company completed a forward split of stock 20:1 on September 17, 2014 that has been retroactively reflected in these financial statements.
    XML 44 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Related Party Transactions
    12 Months Ended
    Nov. 30, 2014
    Related Party Transactions [Abstract]  
    Related Party Transactions

    4.Related Party Transactions

     

    a)During the year ended November 30, 2014, the Company incurred $6,000 (2013 - $nil) in management fees to the former President and Director of the Company.

     

    During the year ended November 30, 2014, the former President and Director of the Company forgave all amounts outstanding totaling $23,298 which was recorded in additional paid-in capital. As at November 30, 2014, the Company owed $nil (November 30, 2013 - $28,298) to the former President and Director of the Company. The amounts owing were unsecured, non-interest bearing, and due on demand.

     

    b)During the year ended November 30, 2014, the Company received advances of $174,635 (2013 - $nil) from a shareholder of the Company to fund payment of operating expenditures and advanced to GFI under a promissory note receivebale. The amounts owing are unsecured, non-interest bearing, and due on demand.

     

    c)During the year ended November 30, 2014, CVI (Canada) entered into a contract to acquire certain property in Vancouver, Canada for $600,000 (“the Contract”). It is the Company’s intention to facilitate the cultivation of medical marijuana on the property if it is able to acquire the necessary license from Health Canada. The property is owned personally by a director of CVI Canada.

     

    During the year ended November 30, 2014, the Company incurred option expenses of $28,000 (2013 - $nil) under the term of a contract to purchase property in Vancouver, Canada to a director of CVI.

     

    XML 45 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Income Taxes (Narrative) (Details) (USD $)
    12 Months Ended
    Nov. 30, 2014
    Income Taxes Narrative Details  
    Net operating loss carryforward $ 387,071us-gaap_OperatingLossCarryforwards
    Operating loss carryforward limitations on use Expire commencing in fiscal 2030
    XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 46 114 1 true 15 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://galaglobalinc.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://galaglobalinc.com/role/BalanceSheets Consolidated Balance Sheets false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://galaglobalinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 00000004 - Statement - Consolidated Statements Of Operations Sheet http://galaglobalinc.com/role/StatementsOfOperations Consolidated Statements Of Operations false false R5.htm 00000005 - Statement - Statements Of Changes In Stockholders’ Deficit Sheet http://galaglobalinc.com/role/StatementsOfChangesInStockholdersDeficit Statements Of Changes In Stockholders’ Deficit false false R6.htm 00000006 - Statement - Consolidated Statements Of Cash Flows Sheet http://galaglobalinc.com/role/StatementsOfCashFlows Consolidated Statements Of Cash Flows false false R7.htm 00000007 - Disclosure - Organization And Nature Of Operations Sheet http://galaglobalinc.com/role/OrganizationAndNatureOfOperations Organization And Nature Of Operations false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://galaglobalinc.com/role/GoingConcern Going Concern false false R9.htm 00000009 - Disclosure - Summary Of Significant Accounting Policies Sheet http://galaglobalinc.com/role/SummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies false false R10.htm 00000010 - Disclosure - Related Party Transactions Sheet http://galaglobalinc.com/role/RelatedPartyTransactions Related Party Transactions false false R11.htm 00000011 - Disclosure - Promissory Note Receivable Sheet http://galaglobalinc.com/role/PromissoryNoteReceivable Promissory Note Receivable false false R12.htm 00000012 - Disclosure - Loan Payable - Related Party Sheet http://galaglobalinc.com/role/LoanPayable-RelatedParty Loan Payable - Related Party false false R13.htm 00000013 - Disclosure - Common Stock Sheet http://galaglobalinc.com/role/CommonStock Common Stock false false R14.htm 00000014 - Disclosure - Commitments And Contingencies Sheet http://galaglobalinc.com/role/CommitmentsAndContingencies Commitments And Contingencies false false R15.htm 00000015 - Disclosure - Income Taxes Sheet http://galaglobalinc.com/role/IncomeTaxes Income Taxes false false R16.htm 00000016 - Disclosure - Subsequent Events Sheet http://galaglobalinc.com/role/SubsequentEvents Subsequent Events false false R17.htm 00000017 - Disclosure - Summary Of Significant Accounting Policies (Policies) Sheet http://galaglobalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary Of Significant Accounting Policies (Policies) false false R18.htm 00000018 - Disclosure - Income Taxes (Tables) Sheet http://galaglobalinc.com/role/IncomeTaxesTables Income Taxes (Tables) false false R19.htm 00000019 - Disclosure - Income Taxes (Schedule of Income Tax Provision) (Details) Sheet http://galaglobalinc.com/role/IncomeTaxesScheduleOfIncomeTaxProvisionDetails Income Taxes (Schedule of Income Tax Provision) (Details) false false R20.htm 00000020 - Disclosure - Income Taxes (Schedule of Deferred Income Tax Assets) (Details) Sheet http://galaglobalinc.com/role/IncomeTaxesScheduleOfDeferredIncomeTaxAssetsDetails Income Taxes (Schedule of Deferred Income Tax Assets) (Details) false false R21.htm 00000021 - Disclosure - Organisation And Nature Of Operations (Narrative) (Details) Sheet http://galaglobalinc.com/role/OrganisationAndNatureOfOperationsNarrativeDetails Organisation And Nature Of Operations (Narrative) (Details) false false R22.htm 00000022 - Disclosure - Going Concern (Narrative) (Details) Sheet http://galaglobalinc.com/role/GoingConcernNarrativeDetails Going Concern (Narrative) (Details) false false R23.htm 00000023 - Disclosure - Summary Of Significant Accounting Policies (Accounting Costs) (Narrative) (Details) Sheet http://galaglobalinc.com/role/SummaryOfSignificantAccountingPoliciesAccountingCostsNarrativeDetails Summary Of Significant Accounting Policies (Accounting Costs) (Narrative) (Details) false false R24.htm 00000024 - Disclosure - Related Party Transation (Narrative) (Details) Sheet http://galaglobalinc.com/role/RelatedPartyTransationNarrativeDetails Related Party Transation (Narrative) (Details) false false R25.htm 00000025 - Disclosure - Loan Payable - Related Party (Narrative) (Details) Sheet http://galaglobalinc.com/role/LoanPayable-RelatedPartyNarrativeDetails Loan Payable - Related Party (Narrative) (Details) false false R26.htm 00000026 - Disclosure - Common Shares (Narrative) (Details) Sheet http://galaglobalinc.com/role/CommonSharesNarrativeDetails Common Shares (Narrative) (Details) false false R27.htm 00000027 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://galaglobalinc.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) false false R28.htm 00000028 - Disclosure - Commitments And Contingencies (Narrative) (Details) Sheet http://galaglobalinc.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments And Contingencies (Narrative) (Details) false false R29.htm 00000029 - Disclosure - Subsequent Events (Narrative) (Details) Sheet http://galaglobalinc.com/role/SubsequentEventsNarrativeDetails Subsequent Events (Narrative) (Details) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Nov. 30, 2012' Process Flow-Through: 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00000004 - Statement - Consolidated Statements Of Operations Process Flow-Through: 00000006 - Statement - Consolidated Statements Of Cash Flows glag-20141130.xml glag-20141130.xsd glag-20141130_cal.xml glag-20141130_def.xml glag-20141130_lab.xml glag-20141130_pre.xml true true XML 47 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
    Income Taxes (Schedule of Deferred Income Tax Assets) (Details) (USD $)
    Nov. 30, 2014
    Nov. 30, 2013
    Income Taxes Schedule Of Deferred Income Tax Assets Details    
    Net operating loss carried forward $ 131,605us-gaap_DeferredTaxAssetsOperatingLossCarryforwards $ 36,787us-gaap_DeferredTaxAssetsOperatingLossCarryforwards
    Valuation allowance 131,605us-gaap_DeferredTaxAssetsValuationAllowance 36,787us-gaap_DeferredTaxAssetsValuationAllowance
    Net deferred income tax asset